Trait_category,Trait,Protein,Protein_definition,sample_size,Estimated_effect,se,lowerCI,upperCI,Pvalue
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,FGFBP1,Fibroblast growth factor-binding protein 1,42181,-0.153865645254532,0.00328910745121558,-0.160312295858914,-0.147418994650149,0
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,GCG,Pro-glucagon,41843,0.535485169905636,0.0124281858456285,0.511125925648204,0.559844414163068,0
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,MFGE8,Lactadherin,42137,0.224494866922583,0.00443399182014109,0.215804242955106,0.233185490890059,0
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,NPY,Pro-neuropeptide Y,42262,0.262028245295853,0.00639519009391385,0.249493672711782,0.274562817879924,0
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PLA2G7,Platelet-activating factor acetylhydrolase,42137,-0.127066668628763,0.00325294312523358,-0.133442437154221,-0.120690900103305,1.11253694122338e-308
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PRAP1,Proline-rich acidic protein 1,39966,0.14932431727692,0.00394473438486039,0.141592637882594,0.157055996671246,1.99200031957969e-295
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,AGRP,Agouti-related protein,42296,0.19499660296971,0.00524634652578153,0.184713763779178,0.205279442160242,3.57880166353506e-288
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PRSS8,Prostasin,42080,0.156916732793928,0.00424344887398673,0.148599573000914,0.165233892586942,3.44877604720807e-285
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,LDLR,Low-density lipoprotein receptor,42170,0.186157068787404,0.00520251625623255,0.175960136925188,0.19635400064962,4.85631588956135e-268
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PON3,Serum paraoxonase/lactonase 3,42185,-0.105292156705951,0.0029971794786715,-0.111166628484147,-0.0994176849277546,7.3446876770476e-259
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,IGSF9,Protein turtle homolog A,39958,0.306588061623416,0.00876221443624036,0.289414121328385,0.323762001918447,8.03045141601349e-255
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,C9,Complement component C9,39990,-0.198644764907148,0.00589599320005526,-0.210200911579257,-0.18708861823504,2.6923615195569e-237
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,IGFBP1,Insulin-like growth factor-binding protein 1,42287,-0.421485717268644,0.0130464059393066,-0.447056672909685,-0.395914761627603,9.84162867054352e-221
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,LPL,Lipoprotein lipase,42145,-0.15428858095914,0.00496024168994806,-0.164010654671438,-0.144566507246842,3.11010430318684e-205
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PYY,Peptide YY,39575,0.318349493579988,0.010295328809603,0.298170649113166,0.33852833804681,2.26066633760688e-201
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,APOF,Apolipoprotein F,39990,-0.0819130539360316,0.0026716683723354,-0.087149523945809,-0.0766765839262543,1.96897143247921e-198
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ADIPOQ,Adiponectin,39979,-0.213360499151279,0.00709499454452364,-0.227266688458545,-0.199454309844012,3.02946256059588e-191
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TMPRSS15,Enteropeptidase,42070,0.261986556891323,0.0091081747337226,0.244134534413227,0.27983857936942,1.25253066919738e-176
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,MXRA8,Matrix remodeling-associated protein 8,39736,-0.0912204334193605,0.00318951680751521,-0.0974718863620903,-0.0849689804766307,1.15378569851567e-173
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CES1,Liver carboxylesterase 1,42163,0.249727782661502,0.0088031127030086,0.232473681763605,0.266981883559398,5.00845503444754e-172
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ASGR1,Asialoglycoprotein receptor 1,42016,0.0872503477144354,0.00314441038014361,0.081087303369354,0.0934133920595169,7.97585951802081e-165
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ADH4,All-trans-retinol dehydrogenase [NAD(+)] ADH4,41900,0.230613676545679,0.00848278507872438,0.21398741779138,0.247239935299979,1.94774206639224e-158
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,INHBC,Inhibin beta C chain,42137,0.112162054143275,0.00412863091644922,0.104069937547035,0.120254170739516,2.70239216161851e-158
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,UPB1,Beta-ureidopropionase,39958,0.251930024488618,0.00941792223409051,0.2334708969098,0.270389152067435,6.34483708063048e-153
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,LGALS4,Galectin-4,42123,0.156121345161274,0.00586611853595028,0.144623752830812,0.167618937491737,3.73783300560213e-152
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,MVK,Mevalonate kinase,41913,0.227044867723294,0.00858747253668136,0.210213421551399,0.24387631389519,3.54546781385855e-150
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,RTN4R,Reticulon-4 receptor,42262,0.0918769953917474,0.00351204315515444,0.0849933908076447,0.0987605999758501,3.06606383053308e-147
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,GPR37,Prosaposin receptor GPR37,41900,0.176848562827887,0.00678236622705409,0.163555125022861,0.190142000632913,3.22641335318242e-146
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ACY1,Aminoacylase-1,42145,0.169915058911491,0.0065506879896108,0.157075710451854,0.182754407371129,8.17557585680452e-145
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,RARRES2,Retinoic acid receptor responder protein 2,42230,0.129893094949724,0.00503427576132144,0.120025914457534,0.139760275441914,2.28064894188742e-143
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SHBG,Sex hormone-binding globulin,39990,-0.123946854255465,0.00489199125394945,-0.133535157113206,-0.114358551397724,7.92247595372181e-138
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PLTP,Phospholipid transfer protein,42267,-0.0991311881604606,0.003940659119532,-0.106854880034743,-0.0914074962861779,1.51684482654139e-136
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CCN1,CCN family member 1,42047,0.187965701584755,0.00748284638845137,0.17329932266339,0.20263208050612,4.08036706151399e-136
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,MAMDC4,Apical endosomal glycoprotein,39919,0.148226811485458,0.00591104151788579,0.136641170110402,0.159812452860514,4.22132842086446e-135
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,APOM,Apolipoprotein M,42199,-0.0731429078573742,0.0029609022323221,-0.0789462762327256,-0.0673395394820229,7.84253191200071e-132
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,OXT,Oxytocin-neurophysin 1,42249,0.373281502385554,0.0151253343712205,0.343635847017962,0.402927157753146,1.34186405572845e-131
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PPY,Pancreatic prohormone,42089,0.264823217584338,0.0107362844918226,0.243780099980365,0.28586633518831,1.9709830385111e-131
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SMOC1,SPARC-related modular calcium-binding protein 1,42262,0.0829898085371907,0.00337506073180964,0.0763746895028438,0.0896049275715376,1.12054729800793e-130
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SLC39A5,Zinc transporter ZIP5,42119,0.135571663724943,0.00553712173678658,0.124718905120841,0.146424422329045,1.41705644949876e-129
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CPM,Carboxypeptidase M,42195,0.0866373069202096,0.00355163566186121,0.0796761010229617,0.0935985128174576,1.1423509501805e-128
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,NFASC,Neurofascin,42296,0.0740525628611419,0.0030441251942153,0.0680860774804799,0.0800190482418039,5.26142743456312e-128
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CD4,T-cell surface glycoprotein CD4,42100,0.0732889101061426,0.00303226209872391,0.0673456763926437,0.0792321438196414,2.2029133665248e-126
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,DCBLD2,"Discoidin, CUB and LCCL domain-containing protein 2",42181,0.0883331193916665,0.0036692080020983,0.0811414717075538,0.0955247670757792,1.94523562310299e-125
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CCL27,C-C motif chemokine 27,42145,0.157076398552498,0.00653150012009814,0.144274658317106,0.16987813878789,3.53044539417054e-125
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,APOD,Apolipoprotein D,39468,-0.105369980625056,0.00441225246948046,-0.114017995465237,-0.0967219657848739,6.79795648725882e-123
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PTH,Parathyroid hormone,39649,0.206559209471785,0.00871348322475615,0.189480782351263,0.223637636592307,3.24218098404165e-121
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CCL16,C-C motif chemokine 16,42310,0.126387509096013,0.00536219221571242,0.115877612353217,0.136897405838809,1.91098180099443e-120
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,BAIAP2,Brain-specific angiogenesis inhibitor 1-associated protein 2,41843,0.158342786054135,0.00683062212230907,0.144954766694409,0.171730805413861,1.44827470032595e-116
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,FURIN,Furin,42181,0.0800337187718136,0.0034572415110492,0.0732575254101572,0.08680991213347,2.58422825722873e-116
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,FGF21,Fibroblast growth factor 21,42247,0.289147849528104,0.0125702858707681,0.264510089221399,0.31378560983481,6.65653886661748e-115
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,GSTA1,Glutathione S-transferase A1,42119,0.203345034037059,0.00887796051546258,0.185944231426752,0.220745836647365,6.1028438420597e-114
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,DEFB4A_DEFB4B,Beta-defensin 4A,41921,0.349697572534924,0.0153007467795427,0.319708108847021,0.379687036222828,1.95623470956446e-113
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CTSD,Cathepsin D,41225,0.0988206356344191,0.00433861238062505,0.090316955368394,0.107324315900444,1.41618135236016e-112
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,FTCD,Formimidoyltransferase-cyclodeaminase,39910,0.206549605204203,0.00907400596488485,0.188764553513028,0.224334656895377,3.47698269984268e-112
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SIT1,Signaling threshold-regulating transmembrane adapter 1,41913,0.129786651951694,0.00571723128643125,0.118580878630289,0.140992425273099,5.77463968862432e-112
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,NOS3,"Nitric oxide synthase, endothelial",41839,0.120297100590181,0.00530286136037699,0.109903492323842,0.13069070885652,8.35150547685649e-112
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CD300LG,CMRF35-like molecule 9,42137,-0.0878402828661079,0.00390806454954797,-0.0955000893832219,-0.0801804763489939,7.10984871410444e-110
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ACE2,Angiotensin-converting enzyme 2,41900,0.128177777470104,0.00571372575661729,0.116978874987134,0.139376679953074,1.97219259549365e-109
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,EPHA1,Ephrin type-A receptor 1,42162,0.0754519640532195,0.0033778844544098,0.0688313105225763,0.0820726175838627,1.44895963541963e-108
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CLUL1,Clusterin-like protein 1,42123,-0.102763398285046,0.00468742750681891,-0.111950756198411,-0.0935760403716809,1.03001055314065e-104
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PRCP,Lysosomal Pro-X carboxypeptidase,42238,0.0725292965443302,0.00332871753906839,0.0660050101677561,0.0790535829209042,1.70397916047186e-103
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,MME,Neprilysin,42070,0.176801857649277,0.00817059116925672,0.160787498957534,0.19281621634102,4.20631583673003e-102
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,COL18A1,Collagen alpha-1(XVIII) chain,42194,0.0534830002145331,0.00248104441792189,0.0486201531554062,0.05834584727366,2.26519403147272e-101
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,GIP,Gastric inhibitory polypeptide,39638,0.114025387501636,0.00531901215923382,0.103600123669538,0.124450651333735,6.42986422900593e-100
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,NHLRC3,NHL repeat-containing protein 3,39481,0.0725202213751861,0.00339954399121887,0.0658571151523971,0.0791833275979751,5.94908263125481e-99
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PSRC1,Proline/serine-rich coiled-coil protein 1,41843,0.133976501701116,0.00629526454934494,0.1216377831844,0.146315220217832,7.45876548951657e-99
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,MUC13,Mucin-13,41839,0.117383875115141,0.00553456294977036,0.106536131733591,0.128231618496691,3.3478493701289e-98
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,RBP5,Retinol-binding protein 5,42070,0.125124658490267,0.00591089152830731,0.113539311094785,0.13671000588575,7.26276270772878e-98
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SCG2,Secretogranin-2,42193,0.0721510947470522,0.00346911406845163,0.065351631172887,0.0789505583212174,1.32912061539018e-94
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,IGSF8,Immunoglobulin superfamily member 8,42145,0.0666959903755718,0.00326277407920179,0.0603009531803363,0.0730910275708073,1.70764520121374e-91
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CA14,Carbonic anhydrase 14,42262,-0.0788662640281279,0.003860153120174,-0.086432164143669,-0.0713003639125869,2.05413810757204e-91
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,NCS1,Neuronal calcium sensor 1,42262,0.0603115145805425,0.00297345794497449,0.0544835370083926,0.0661394921526925,3.81894818252502e-90
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CNTN3,Contactin-3,42137,0.0603258239260012,0.00297774110581586,0.0544894513586021,0.0661621964934003,6.34842232937989e-90
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,GSTA3,Glutathione S-transferase A3,41843,0.163387797579668,0.00811684602045604,0.147478779379574,0.179296815779762,8.62419737590451e-89
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,KRT18,"Keratin, type I cytoskeletal 18",42070,0.179256892947986,0.00893242150632577,0.161749346795587,0.196764439100384,2.72279341980459e-88
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SCLY,Selenocysteine lyase,42224,0.102455532962784,0.00512124116491831,0.0924179002795437,0.112493165646023,8.85408688092356e-88
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TNFRSF10A,Tumor necrosis factor receptor superfamily member 10A,42016,0.0712125143334679,0.0035598173427998,0.0642352723415803,0.0781897563253555,9.51876677235575e-88
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,IL1RN,Interleukin-1 receptor antagonist protein,42092,0.110767408628415,0.0055388978385588,0.0999111688648399,0.12162364839199,1.06179571877174e-87
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,VMO1,Vitelline membrane outer layer protein 1 homolog,42070,0.144437189201264,0.00722376241036308,0.130278614876953,0.158595763525576,1.13898254090506e-87
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CD38,ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 1,42070,0.0689710463431428,0.00344991965258179,0.0622092038240825,0.0757328888622031,1.1994680999221e-87
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ADGRG1,Adhesion G-protein coupled receptor G1,42070,0.169001328000277,0.00845450606126547,0.152430496120197,0.185572159880358,1.26113169410666e-87
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,NTRK3,NT-3 growth factor receptor,42249,-0.0443582064869521,0.0022320730271957,-0.0487330696202557,-0.0399833433536486,1.16401091510097e-86
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,IL17RB,Interleukin-17 receptor B,41934,-0.112360924749105,0.00567809748067227,-0.123489995811223,-0.101231853686987,6.36758035201633e-86
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,VPS37A,Vacuolar protein sorting-associated protein 37A,42070,0.166507856064687,0.00841684750226032,0.150010834960257,0.183004877169117,6.92291699010252e-86
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CLEC4M,C-type lectin domain family 4 member M,39945,-0.1030825171106,0.00521765739249577,-0.113309125599892,-0.0928559086213083,1.91125292945817e-85
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,DSG2,Desmoglein-2,42137,-0.0560971260591411,0.00284501411992267,-0.0616733537341895,-0.0505208983840927,2.38555104409264e-85
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PGF,Placenta growth factor,42296,0.0537353822986572,0.0027553590989679,0.0483348784646801,0.0591358861326342,1.42652642182995e-83
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,DNAJB1,DnaJ homolog subfamily B member 1,42070,0.174899200329638,0.00898818469820266,0.15728235832116,0.192516042338115,3.39240639246043e-83
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SMAD1,Mothers against decapentaplegic homolog 1,41843,0.171976052365781,0.00884797066748952,0.154634029857501,0.18931807487406,5.38161058261475e-83
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,NOTCH3,Neurogenic locus notch homolog protein 3,42310,-0.0684453292553935,0.00352291072902046,-0.0753502342842736,-0.0615404242265134,5.74647724110762e-83
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,MEP1A,Meprin A subunit alpha,39930,0.156000452352461,0.00802277960293683,0.140275804330704,0.171725100374217,7.19161187825402e-83
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,AFM,Afamin,39979,0.0410464099467316,0.00212955054208229,0.0368724908842503,0.0452203290092128,1.73230065594732e-81
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CRIP2,Cysteine-rich protein 2,42016,0.0736081805121703,0.00382624067876857,0.0661087487817839,0.0811076122425567,2.22296398093218e-81
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,GHR,Growth hormone receptor,39736,0.0571467315700704,0.00298579393580002,0.0512945754559023,0.0629988876842384,2.29273688305262e-80
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,MAD1L1,Mitotic spindle assembly checkpoint protein MAD1,41966,0.0980997819277707,0.00515812086566628,0.0879898650310648,0.108209698824477,1.34380025333942e-79
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PCBD1,Pterin-4-alpha-carbinolamine dehydratase,39728,0.0972741993033253,0.00512550772108597,0.0872282041699968,0.107320194436654,4.52934281517809e-79
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,FAM20A,Pseudokinase FAM20A,39958,0.0563483104068212,0.00297080396106051,0.0505255346431426,0.0621710861704998,5.24983144489695e-79
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ELN,Elastin,39958,0.0693226375725584,0.00366430670706201,0.0621405964267168,0.0765046787183999,1.29443122693197e-78
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,KHK,Ketohexokinase,39638,0.12554703154395,0.00665333707666737,0.112506490873682,0.138587572214219,3.41520287634307e-78
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,F9,Coagulation factor IX,42199,0.0363615583074624,0.00193125626434003,0.0325762960293559,0.0401468205855688,4.37480328381373e-78
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,LECT2,Leukocyte cell-derived chemotaxin-2,39958,0.130762208455941,0.00696550596424709,0.117109816766017,0.144414600145865,1.86325397268202e-77
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,RIDA,2-iminobutanoate/2-iminopropanoate deaminase,39736,0.0989336323068605,0.00527656069566249,0.088591573343362,0.109275691270359,2.99713861040111e-77
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,AMBP,Protein AMBP,42239,0.0396720732809836,0.00212497070130523,0.0355071307064254,0.0438370158555419,7.93428048918092e-77
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,HHEX,Hematopoietically-expressed homeobox protein HHEX,39929,0.151554089577583,0.00812664290426522,0.135625869485223,0.167482309669943,1.78520593099399e-76
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TNFRSF6B,Tumor necrosis factor receptor superfamily member 6B,42016,0.112741253256481,0.00607564802545006,0.100832983126599,0.124649523386363,6.4541870819274e-76
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SELE,E-selectin,42310,0.0986037397260613,0.00531745724010444,0.0881815235354566,0.109025955916666,7.7823642314113e-76
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CPA2,Carboxypeptidase A2,42205,0.129790295073175,0.00700846382419819,0.116053705977746,0.143526884168603,1.22918572609278e-75
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,GH1,Somatotropin,42129,-0.346365286048132,0.0187339150907083,-0.38308375962592,-0.309646812470344,2.15640913381993e-75
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,HGF,Hepatocyte growth factor,42296,0.0666031149946263,0.0036375588078602,0.0594734997312203,0.0737327302580323,5.26335190764752e-74
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,HSD11B1,Corticosteroid 11-beta-dehydrogenase isozyme 1,42119,-0.0759199298412804,0.00416581401397266,-0.0840849253086668,-0.067754934373894,2.48430554143549e-73
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,KIT,Mast/stem cell growth factor receptor Kit,42199,-0.0558365617806213,0.00306830836699608,-0.0618504461799336,-0.049822677381309,3.95125290225769e-73
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,GLA,Alpha-galactosidase A,39713,0.0751495815617303,0.00414379161891485,0.0670277499886572,0.0832714131348034,1.84591452942689e-72
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,HAO1,Hydroxyacid oxidase 1,42262,0.23566249200166,0.0130378081400829,0.210108388047097,0.261216595956222,3.45128601489966e-72
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CA5A,"Carbonic anhydrase 5A, mitochondrial",41900,0.174196107176041,0.00966324645389908,0.155256144126399,0.193136070225683,8.58790249261675e-72
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TTR,Transthyretin,39862,0.047147073652786,0.00262121383218668,0.0420094945417001,0.0522846527638719,2.45418651252634e-71
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SERPINF1,Pigment epithelium-derived factor,39815,0.0495410804105911,0.00276731699071439,0.0441171391087909,0.0549650217123913,1.08724143116861e-70
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,IL18R1,Interleukin-18 receptor 1,42296,0.0621769896372951,0.00348270524537997,0.0553508873563504,0.0690030919182398,1.71834360084338e-70
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,MCAM,Cell surface glycoprotein MUC18,42217,-0.0602686200697421,0.00337798269662026,-0.0668894661551178,-0.0536477739843664,2.12237915733159e-70
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,HEG1,Protein HEG homolog 1,39736,0.0520739354532263,0.00291735575480775,0.0463559181738031,0.0577919527326494,2.75820779379157e-70
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,F7,Coagulation factor VII,42194,0.0581765645361885,0.003272291965469,0.0517628722838693,0.0645902567885077,6.40199793241722e-70
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ADAMTSL2,ADAMTS-like protein 2,39966,0.0650545902771199,0.00366394506268062,0.0578732579542659,0.0722359225999739,1.35899809710577e-69
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,INPP5D,"Phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 1",39638,0.107399852473548,0.00608166302600773,0.095479792942573,0.119319912004523,7.56189450989318e-69
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CDKN1A,Cyclin-dependent kinase inhibitor 1,42070,0.198165652919027,0.0112688915716631,0.176078625438568,0.220252680399487,1.85830791034222e-68
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TNFRSF12A,Tumor necrosis factor receptor superfamily member 12A,42181,0.0690928741780766,0.00392990693017355,0.0613902565949365,0.0767954917612168,1.95945532965308e-68
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,NPPC,C-type natriuretic peptide,42119,0.0971298194711615,0.00555060322418549,0.0862506371517579,0.108009001790565,8.14267241054408e-68
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,FGFR2,Fibroblast growth factor receptor 2,42181,0.0415115749921907,0.00237336919944779,0.036859771361273,0.0461633786231084,9.33288303074062e-68
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PTS,6-pyruvoyl tetrahydrobiopterin synthase,41783,0.101045680185518,0.00578566805318286,0.0897057708012801,0.112385589569757,1.52641442967004e-67
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CHI3L1,Chitinase-3-like protein 1,41907,0.154133632387819,0.00883047534316816,0.13682590071521,0.171441364060429,1.78533083670586e-67
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,IGFBP2,Insulin-like growth factor-binding protein 2,42286,-0.111093792212664,0.0063775867140553,-0.123593862172212,-0.0985937222531152,3.11749654518759e-67
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,KLRB1,Killer cell lectin-like receptor subfamily B member 1,42296,0.0711244020831472,0.00409601317495,0.0630962162602452,0.0791525879060492,7.97767570519869e-67
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CCL23,C-C motif chemokine 23,42185,0.0772407735986148,0.00445788708696339,0.0685033149081665,0.085978232289063,1.53163792414279e-66
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PLAT,Tissue-type plasminogen activator,42272,0.0934687289587323,0.00539876386131486,0.0828871517905552,0.104050306126909,1.91619828580441e-66
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CKB,Creatine kinase B-type,39966,-0.105032493763918,0.00607009221784481,-0.116929874510893,-0.0931351130169417,3.12566075318573e-66
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CTSO,Cathepsin O,42296,0.0557936712246296,0.00322890116640614,0.0494650249384736,0.0621223175107856,3.37668303828407e-66
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ANG,Angiogenin,42152,0.0597018435921761,0.00345947341192405,0.0529212757048049,0.0664824114795472,4.98382874687129e-66
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CXCL13,C-X-C motif chemokine 13,42249,0.103606740271169,0.0060662628534144,0.0917168650784765,0.115496615463861,9.96560100407071e-65
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,LEP,Leptin,42145,0.125297706816085,0.00735042993231108,0.110890864148756,0.139704549483415,1.74899180767668e-64
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CCL15,C-C motif chemokine 15,42310,0.0779943267682678,0.00459540336485345,0.068987336173155,0.0870013173633806,5.92164694475852e-64
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ITGA11,Integrin alpha-11,42119,-0.0606532166147408,0.00357427558974654,-0.0676587967706441,-0.0536476364588376,6.34384986764891e-64
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,FCAMR,High affinity immunoglobulin alpha and immunoglobulin mu Fc receptor,39958,0.130277629503078,0.00768256496542093,0.115219802170853,0.145335456835303,1.02607962635947e-63
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,GPRC5C,G-protein coupled receptor family C group 5 member C,39919,0.101041340697064,0.00596502965277126,0.0893498825776322,0.112732798816496,1.40589002669638e-63
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SKAP1,Src kinase-associated phosphoprotein 1,41997,0.128871568897756,0.00761806001958706,0.113940171259366,0.143802966536147,1.54837742329526e-63
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SORD,Sorbitol dehydrogenase,42204,0.122533711781941,0.00726510737487231,0.108294101327192,0.136773322236691,3.50197108749434e-63
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,MET,Hepatocyte growth factor receptor,42158,-0.0340967197036915,0.00202856869053271,-0.0380727143371356,-0.0301207250702474,9.15890262808815e-63
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,GPD1,Glycerol-3-phosphate dehydrogenase,39919,0.0946940701333383,0.00564232539708539,0.0836351123550509,0.105753027911626,1.85007949164248e-62
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,KYNU,Kynureninase,42296,0.0804394589726983,0.00479883762500711,0.0710337372276844,0.0898451807177123,1.9282009917159e-62
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CD2AP,CD2-associated protein,42145,0.11168490003663,0.00666841355224481,0.0986148094742298,0.124754990599029,2.46418039462669e-62
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,GRP,Gastrin-releasing peptide,39638,0.0948414511970556,0.00565818600741833,0.0837514066225157,0.105931495771596,2.72730461435673e-62
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,REN,Renin,42145,0.143398009279418,0.00858239230527089,0.126576520361087,0.160219498197749,4.75387263077063e-62
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,41900,0.0981868441457174,0.00588293477419724,0.0866562919882908,0.109717396303144,6.58660374901653e-62
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SERPIND1,Heparin cofactor 2,39959,0.0514229079455849,0.00308352198537865,0.0453792048542427,0.057466611036927,1.04665572551948e-61
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,AMOT,Angiomotin,39736,0.0675660365317725,0.00406152204707116,0.059605453319513,0.075526619744032,2.11296987085151e-61
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,MENT,Protein MENT,39736,-0.0418972801140522,0.00251936776210375,-0.0468352409277756,-0.0369593193003289,2.31352965733456e-61
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CD74,HLA class II histocompatibility antigen gamma chain,42249,0.0607835456425293,0.00366190040561328,0.0536062208475273,0.0679608704375314,2.8266708255916e-61
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,LRCH4,Leucine-rich repeat and calponin homology domain-containing protein 4,39575,0.120571431257517,0.00725907927859165,0.106343635871478,0.134799226643557,3.30086507332639e-61
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,FUOM,Fucose mutarotase,39736,0.113412991509712,0.0068326025435123,0.100021090524427,0.126804892494996,3.84859179558522e-61
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CST3,Cystatin-C,42184,0.050126511042736,0.00302782693048385,0.0441919702589876,0.0560610518264844,5.79573661324855e-61
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CLEC4A,C-type lectin domain family 4 member A,42119,-0.0623727231769326,0.0037683937592053,-0.069758774944975,-0.0549866714088902,6.19948125557517e-61
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,GDF15,Growth/differentiation factor 15,42310,0.079524180708546,0.00483473455851752,0.0700481009738517,0.0890002604432404,3.24105494382924e-60
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TNFRSF11A,Tumor necrosis factor receptor superfamily member 11A,42296,0.0686774855908851,0.00419692422195488,0.0604515141158535,0.0769034570659167,1.27533683289394e-59
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,MTSS1,Protein MTSS 1,39930,0.193458263829022,0.0118203264613066,0.170290423964861,0.216626103693183,1.59322028363727e-59
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CD209,CD209 antigen,42171,-0.067362027712966,0.00411983993242519,-0.0754369139805194,-0.0592871414454126,1.5941593885893e-59
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ITGAV,Integrin alpha-V,42262,-0.02871309882034,0.0017574055768359,-0.0321576137509384,-0.0252685838897416,1.92629931590635e-59
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SERPINA4,Kallistatin,39802,0.0402638917954714,0.00247883210444384,0.0354053808707615,0.0451224027201814,1.16756266089521e-58
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,POSTN,Periostin,39966,-0.064970162328558,0.00400583289997988,-0.0728215948125186,-0.0571187298445975,1.67925724064794e-58
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,IGFBP4,Insulin-like growth factor-binding protein 4,41930,0.0775011577210467,0.00482130987372765,0.0680513903685405,0.0869509250735529,1.33400324484635e-57
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,AGRN,Agrin,42185,0.0604897098427137,0.00378814366243748,0.0530649482643362,0.0679144714210911,7.00682840767197e-57
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,DPY30,Protein dpy-30 homolog,42216,0.101381197627027,0.00635138419670187,0.0889324846014909,0.113829910652562,7.69237107137867e-57
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,AGR2,Anterior gradient protein 2 homolog,41740,0.169295373885269,0.0106183902751332,0.148483328946008,0.19010741882453,1.07266322031605e-56
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,F11R,Junctional adhesion molecule A,42137,0.093652689942678,0.00588895436102511,0.0821103393950688,0.105195040490287,1.95438515194109e-56
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PLXNB2,Plexin-B2,42255,0.0410917111040456,0.00258545280684708,0.0360242236026253,0.0461591986054659,2.25183040736543e-56
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ACAA1,"3-ketoacyl-CoA thiolase, peroxisomal",41843,0.137884287101764,0.0087262568395986,0.12078082369615,0.154987750507377,9.86888761671939e-56
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,APOA1,Apolipoprotein A-I,39979,-0.0458267521045925,0.00290372380312072,-0.0515180507587091,-0.0401354534504759,1.60160107933216e-55
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,GGT1,Glutathione hydrolase 1 proenzyme,42113,0.0863783916951005,0.00547883227326044,0.07563988043951,0.097116902950691,1.66863340572272e-55
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PON1,Serum paraoxonase/arylesterase 1,39990,-0.0454028663003317,0.00287777970461548,-0.051043314521378,-0.0397624180792853,1.72888605505453e-55
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CRELD1,Protein disulfide isomerase CRELD1,39736,0.0625079833984106,0.00397376867365394,0.0547193967980489,0.0702965699987724,3.68181688946654e-55
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ADH1B,All-trans-retinol dehydrogenase,39736,0.127347700067883,0.00809660042309435,0.111478363238618,0.143217036897148,3.77465876735236e-55
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,DMP1,Dentin matrix acidic phosphoprotein 1,39638,-0.0942649209664332,0.0059961152308312,-0.106017306818862,-0.0825125351140041,4.29174253693388e-55
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ADAMTS15,A disintegrin and metalloproteinase with thrombospondin motifs 15,42070,0.0677487918251257,0.00438050480039631,0.059163002416349,0.0763345812339025,1.69633460538793e-53
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ADGRG2,Adhesion G-protein coupled receptor G2,42145,-0.0441706162904085,0.00286047612430335,-0.0497771494940431,-0.0385640830867739,2.44217374562955e-53
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CD248,Endosialin,39966,-0.066094385664605,0.00429055675134472,-0.0745038768972407,-0.0576848944319694,5.22372303115352e-53
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CXCL6,C-X-C motif chemokine 6,42296,0.122754521440529,0.00798325606430185,0.107107339554497,0.138401703326561,6.50913056087054e-53
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PSME1,Proteasome activator complex subunit 1,42002,0.0588847356866384,0.00383605829256589,0.0513660614332093,0.0664034099400676,9.89566558734695e-53
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,IGSF3,Immunoglobulin superfamily member 3,42070,0.0594408479874425,0.00391881635329502,0.0517599679349843,0.0671217280399007,1.53314946751822e-51
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ACY3,N-acyl-aromatic-L-amino acid amidohydrolase,39575,0.0900131279641338,0.00593910535287829,0.0783724814724924,0.101653774455775,2.28598461573209e-51
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ERMAP,Erythroid membrane-associated protein,39657,0.0715857481262616,0.00473346031665142,0.0623081659056248,0.0808633303468984,3.68630666265332e-51
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CDH1,Cadherin-1,41697,0.0640152525775244,0.00426333699669596,0.0556591120640003,0.0723713930910484,1.53467178809467e-50
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,HS6ST1,Heparan-sulfate 6-O-sulfotransferase 1,42262,0.052992977088578,0.00353813479262209,0.0460582328950387,0.0599277212821173,2.57642172273101e-50
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,HJV,Hemojuvelin,39934,0.0670036419496677,0.00447695500357759,0.0582288101426556,0.0757784737566797,3.6678629055637e-50
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,BCHE,Cholinesterase,39806,0.0426287858323572,0.00285743398940624,0.037028215213121,0.0482293564515934,7.50263806767898e-50
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SSC5D,Soluble scavenger receptor cysteine-rich domain-containing protein SSC5D,42217,0.0675288370578482,0.00453141545073718,0.0586472627744033,0.076410411341293,7.85363943682536e-50
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,FAM3B,Protein FAM3B,42070,0.055473486071472,0.00372592406454387,0.048170674904966,0.062776297237978,9.72459642781336e-50
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ENO3,Beta-enolase,39638,0.0993952742051414,0.00667912688993255,0.0863041855008736,0.112486362909409,1.3141392387447e-49
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,LCAT,Phosphatidylcholine-sterol acyltransferase,39990,0.0342528987875753,0.00230461081126516,0.0297358615974955,0.038769935977655,1.67126903603477e-49
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CPB1,Carboxypeptidase B,42310,0.0974633826642767,0.00656474916506354,0.0845964743007522,0.110330291027801,1.77574616878997e-49
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,OMD,Osteomodulin,42185,-0.0641864121832333,0.00434357532590101,-0.0726998198219993,-0.0556730045444673,4.92747510672442e-49
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CDH2,Cadherin-2,42145,0.0552339890865283,0.00373773562419589,0.0479080272631044,0.0625599509099523,4.93498467576193e-49
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CRHBP,Corticotropin-releasing factor-binding protein,42123,0.0427730231433505,0.00289694957716418,0.0370950019721087,0.0484510443145923,5.93544469388483e-49
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,FGF23,Fibroblast growth factor 23,42250,0.0789672878306438,0.00535254396888033,0.0684763016516383,0.0894582740096492,6.976114958646e-49
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CXADR,Coxsackievirus and adenovirus receptor,42119,0.0761129021703462,0.00518209501026483,0.0659559959502272,0.0862698083904653,1.8263814941546e-48
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,IL32,Interleukin-32,42119,-0.0688698052766228,0.00470456420331855,-0.0780907511151271,-0.0596488594381184,3.70254988983557e-48
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SEMA3F,Semaphorin-3F,42145,0.0413383073813366,0.00282476460520985,0.0358017687551253,0.046874846007548,3.95600589269734e-48
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,LILRB4,Leukocyte immunoglobulin-like receptor subfamily B member 4,41913,0.0679894487821465,0.00464813256682791,0.0588791089511638,0.0770997886131293,4.44106268156062e-48
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ALDH1A1,Retinal dehydrogenase 1,42137,0.0823895422923806,0.00563501935848684,0.0713449043497464,0.0934341802350148,4.79506251105303e-48
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PRSS2,Trypsin-2,42217,0.0883937250266576,0.00605149628347945,0.0765327923110378,0.100254657742277,5.8474795388001e-48
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,RNASET2,Ribonuclease T2,42258,0.0413955718638548,0.00283626015929484,0.0358365019516369,0.0469546417760727,6.91640229980264e-48
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CD5,T-cell surface glycoprotein CD5,42239,0.0549499287421537,0.00377052268242615,0.0475597042845985,0.062340153199709,9.45177903731873e-48
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PRKRA,Interferon-inducible double-stranded RNA-dependent protein kinase activator A,41843,0.105190396823903,0.00723521993123863,0.091009365758675,0.11937142788913,1.60060129536323e-47
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,RNASE4,Ribonuclease 4,39645,0.0429144337073539,0.00295416309846923,0.0371242740343542,0.0487045933803536,2.2396878017615e-47
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,REG4,Regenerating islet-derived protein 4,42144,0.0781212158575442,0.00539926054572665,0.0675386651879199,0.0887037665271684,4.27687420476026e-47
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CC2D1A,Coiled-coil and C2 domain-containing protein 1A,42016,0.111027398300834,0.00773182063704588,0.0958730298522242,0.126181766749444,2.0419185954816e-46
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PTGR1,Prostaglandin reductase 1,39958,0.127502439666758,0.00888236406501553,0.110093006099327,0.144911873234188,2.53425896010593e-46
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,GUSB,Beta-glucuronidase,42211,0.092362366003825,0.00646046249116267,0.0796998595211462,0.105024872486504,4.95137697797462e-46
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,YOD1,Ubiquitin thioesterase OTU1,39575,0.0923761021858022,0.00646070935680404,0.0797131118464663,0.105039092525138,5.80891267659972e-46
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,AREG,Amphiregulin,42070,0.0591616346945379,0.00415022343345094,0.0510271967649741,0.0672960726241018,8.97267706415895e-46
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,LSP1,Lymphocyte-specific protein 1,42119,0.061072374734248,0.00428658904992506,0.0526706601963949,0.0694740892721011,9.97987394732776e-46
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,FLI1,Friend leukemia integration 1 transcription factor,41843,0.168466214409931,0.0118339410741947,0.145271689904509,0.191660738915352,1.19156545240347e-45
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,IGFBPL1,Insulin-like growth factor-binding protein-like 1,42145,0.0509287341997488,0.00359540630608648,0.0438817378398193,0.0579757305596783,3.17445500208861e-45
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,UMOD,Uromodulin,42274,-0.0806627596083371,0.00569979915778054,-0.091834365957587,-0.0694911532590873,3.78742844541671e-45
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CHMP6,Charged multivesicular body protein 6,39958,0.0861686222786716,0.00608638598469398,0.0742393057486714,0.0980979388086718,4.05228716541423e-45
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,MLN,Promotilin,42119,0.133430189495715,0.00945961519391613,0.114889343715639,0.151971035275791,7.33204159161659e-45
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,LAT2,Linker for activation of T-cells family member 2,42070,0.188324955821126,0.013371953469441,0.162115927021022,0.21453398462123,9.9475853314237e-45
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,XCL1,Lymphotactin,42262,0.0812193893512246,0.00578126981517455,0.0698881005134825,0.0925506781889667,1.60070693217794e-44
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CDHR2,Cadherin-related family member 2,42070,0.0979372062060532,0.00697763932081762,0.0842610331372507,0.111613379274856,1.93321812725754e-44
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SELPLG,P-selectin glycoprotein ligand 1,42119,0.0413245175427706,0.0029469341088059,0.035548526689511,0.0471005083960301,2.3094237227845e-44
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PSIP1,PC4 and SFRS1-interacting protein,42119,0.0975296993520517,0.00696442208374826,0.0838794320679051,0.111179966636198,3.00206226311061e-44
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,NUMB,Protein numb homolog,39657,0.124926850129514,0.00892022190235738,0.107443215200894,0.142410485058135,3.46693320735555e-44
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,APOC1,Apolipoprotein C-I,39959,-0.0572372851044216,0.00409105923889939,-0.0652557612126644,-0.0492188089961787,4.11724188457336e-44
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,GAST,Gastrin,39929,0.19423492498474,0.0138996324944008,0.166991645295714,0.221478204673766,5.19835450314329e-44
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SBSN,Suprabasin,39954,-0.0525750781591234,0.00377130744386113,-0.0599668407490912,-0.0451833155691556,8.21299774066808e-44
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PXN,Paxillin,41839,0.0757603856200053,0.00543819888480409,0.0651015158057892,0.0864192554342213,8.34667558815583e-44
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,YES1,Tyrosine-protein kinase Yes,42070,0.168358034067787,0.0120978428573631,0.144646262067355,0.192069806068218,1.01124173028787e-43
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CPE,Carboxypeptidase E,42134,-0.057422956497428,0.00414476023837461,-0.0655466865646422,-0.0492992264302137,2.36630661243474e-43
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,AGR3,Anterior gradient protein 3,41827,0.0864264975924205,0.00627855302311543,0.0741205336671143,0.0987324615177268,8.12412351240048e-43
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PIGR,Polymeric immunoglobulin receptor,41987,0.0539549880991624,0.00392977066507575,0.0462526375956139,0.0616573386027109,1.30815091548165e-42
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,BPIFB1,BPI fold-containing family B member 1,42098,-0.0938531051016947,0.00685916436728015,-0.107297067261564,-0.0804091429418256,2.46189089920745e-42
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ADM,Pro-adrenomedullin,42262,0.0379544016482456,0.00277437890652368,0.0325166189914592,0.043392184305032,2.52905002505521e-42
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,FGFBP3,Fibroblast growth factor-binding protein 3,39929,-0.0535324682456372,0.00391717615983616,-0.0612101335189161,-0.0458548029723584,3.4942725023857e-42
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,HEPH,Hephaestin,39958,0.0405116314368477,0.00296598479582132,0.0346983012370379,0.0463249616366575,3.85117790206315e-42
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SUMF2,Inactive C-alpha-formylglycine-generating enzyme 2,42249,0.0752880028277289,0.00551937158736392,0.0644700345164956,0.0861059711389621,4.32961901105209e-42
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,C1QTNF1,Complement C1q tumor necrosis factor-related protein 1,42217,0.0616701549304471,0.0045396723062533,0.0527723972101907,0.0705679126507036,9.231565919445e-42
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,FABP1,"Fatty acid-binding protein, liver",42123,0.136661467653578,0.0100755141418017,0.116913459935647,0.156409475371509,1.22999388336205e-41
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,DCXR,L-xylulose reductase,42181,0.0778595456534099,0.00574920643696648,0.0665911010369556,0.0891279902698642,1.62827208573274e-41
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,EFCAB14,EF-hand calcium-binding domain-containing protein 14,39930,0.0406403593568223,0.00300537401891818,0.0347498262797427,0.046530892433902,2.40738428041341e-41
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,DTYMK,Thymidylate kinase,39958,0.096533994010335,0.00715053877017373,0.0825189380207944,0.110549049999875,3.23873869678163e-41
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,OCLN,Occludin,39934,0.0636115516322713,0.00471302975224974,0.0543740133178618,0.0728490899466808,3.38921928239664e-41
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,AP3S2,AP-3 complex subunit sigma-2,39929,0.0691700008742114,0.00512628093893865,0.0591224902338917,0.0792175115145312,3.56402848477439e-41
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CFI,Complement factor I,39979,0.0277833677544132,0.00206179601899175,0.0237422475571894,0.031824487951637,4.51064042183314e-41
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,AIFM1,"Apoptosis-inducing factor 1, mitochondrial",42056,0.150593528723955,0.0111876088098894,0.128665815456571,0.172521241991338,4.90560971400246e-41
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,AGXT,Serine--pyruvate aminotransferase,42145,0.109578889819589,0.00814405405091275,0.0936165438798002,0.125541235759378,5.27001226975125e-41
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,NPC2,NPC intracellular cholesterol transporter 2,39820,0.0472560359887779,0.00351221566287914,0.0403720932895348,0.054139978688021,5.99246427434115e-41
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,MYH9,Myosin-9,39966,0.162300224797661,0.0120707289997065,0.138641595958236,0.185958853637086,6.69245359735118e-41
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,RRM2,Ribonucleoside-diphosphate reductase subunit M2,41843,0.0694469507285078,0.00517490162393841,0.0593041435455885,0.0795897579114271,8.53267419364222e-41
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SMAD2,Mothers against decapentaplegic homolog 2,39919,0.101548399418947,0.00756411716885888,0.0867227297679835,0.11637406906991,8.8451393655385e-41
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,EPO,Erythropoietin,42119,0.103336896528022,0.00772809685956173,0.0881898266832806,0.118483966372763,1.60305977391757e-40
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,IL10RB,Interleukin-10 receptor subunit beta,42185,0.0421800874019569,0.00315783046494851,0.0359907396906578,0.0483694351132559,1.93195105189689e-40
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TNFRSF10B,Tumor necrosis factor receptor superfamily member 10B,42016,0.057461630509506,0.0043049871121684,0.049023855769656,0.0658994052493561,2.21046495905494e-40
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TGFB1,Transforming growth factor beta-1 proprotein,42284,0.0549112318456668,0.00411585435334615,0.0468441573131084,0.0629783063782253,2.37521796923677e-40
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PAXX,Protein PAXX,39736,0.0656322385405758,0.00492646408690592,0.0559763689302402,0.0752881081509115,3.48102247938187e-40
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,VAT1,Synaptic vesicle membrane protein VAT-1 homolog,42070,-0.0276070705248369,0.00207428719160529,-0.0316726734203833,-0.0235414676292906,3.67002283821352e-40
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CTSB,Cathepsin B,42153,-0.0714492880457066,0.00538067866257211,-0.0819954182243479,-0.0609031578670653,5.45645709993174e-40
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SUOX,"Sulfite oxidase, mitochondrial",39934,0.0898121406322803,0.00676483572182985,0.0765530626174938,0.103071218647067,6.30673064868177e-40
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,NOMO1,Nodal modulator 1,42137,0.0324033279693917,0.00246638617876546,0.0275692110590113,0.037237444879772,3.46416183587719e-39
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,RBKS,Ribokinase,41830,0.0687603113405545,0.00524608366070726,0.0584779873655683,0.0790426353155408,5.25418969941856e-39
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,BECN1,Beclin-1,39638,0.0829938284984526,0.00632980188579524,0.0705874168022939,0.0954002401946112,5.5233637931774e-39
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,EEF1D,Elongation factor 1-delta,39958,0.127046758155044,0.00969882387629367,0.108037063357509,0.14605645295258,6.36870932023601e-39
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,FAM3C,Protein FAM3C,42129,0.0421982564532883,0.00322605350013528,0.0358751915930232,0.0485213213135535,7.32774805365161e-39
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,EFNA4,Ephrin-A4,41992,0.0447291488832098,0.00342252890676047,0.0380209922259592,0.0514373055404603,8.546293038058e-39
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ABL1,Tyrosine-protein kinase ABL1,42070,0.0933492263418052,0.00715722939103603,0.0793210567353746,0.107377395948236,1.19954000550823e-38
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TNFRSF14,Tumor necrosis factor receptor superfamily member 14,42144,0.0436023461747163,0.00334580694256486,0.0370445645672891,0.0501601277821434,1.37401017112102e-38
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SERPINA5,Plasma serine protease inhibitor,39835,0.0416648501877164,0.00319921886620502,0.0353943812099545,0.0479353191654782,1.70925281217884e-38
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SPINK1,Serine protease inhibitor Kazal-type 1,42137,0.0582174474590593,0.00447654256973662,0.0494434240223755,0.066991470895743,1.94709870335361e-38
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SARG,Specifically androgen-regulated gene protein,39915,0.152206032168101,0.0116996201940999,0.129274776587666,0.175137287748537,2.03732779398477e-38
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SULT2A1,Bile salt sulfotransferase,42119,0.0809254332748868,0.00623375269865026,0.0687072779855323,0.0931435885642413,2.62828837154722e-38
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,INPPL1,"Phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 2",42070,0.134450264311121,0.0103667289964526,0.114131475478074,0.154769053144168,3.09033301374948e-38
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,LATS1,Serine/threonine-protein kinase LATS1,39657,0.119830660145212,0.00923567008833851,0.101728746772069,0.137932573518356,3.23223378441546e-38
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,BTN3A2,Butyrophilin subfamily 3 member A2,42119,0.0522234717241405,0.00403049908581986,0.0443236935159336,0.0601232499323474,3.61523702311119e-38
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TXLNA,Alpha-taxilin,42016,0.120418123747422,0.00932310179117539,0.102144844236718,0.138691403258126,6.14563916430855e-38
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,NECTIN2,Nectin-2,42129,0.042323065531348,0.00328315552969712,0.0358880806931417,0.0487580503695544,8.44558165334411e-38
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,DDAH1,"N(G),N(G)-dimethylarginine dimethylaminohydrolase 1",42070,0.0603885216357488,0.00469934604413441,0.0511778033892454,0.0695992398822522,1.42202456113773e-37
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,GFRA1,GDNF family receptor alpha-1,42247,0.0388576329747863,0.00302875857714071,0.0329212661635905,0.0447939997859821,1.84351137099328e-37
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,DCTN1,Dynactin subunit 1,42262,0.0869212659309854,0.00677859067959098,0.0736352281989871,0.100207303662984,2.00545598201115e-37
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,GZMA,Granzyme A,42296,0.0461275677538962,0.00359765945891822,0.0390761552144165,0.0531789802933759,2.03807891955944e-37
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SNAP29,Synaptosomal-associated protein 29,42181,0.124432451514444,0.00970652441961741,0.105407663651993,0.143457239376894,2.10165758405173e-37
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,IDUA,Alpha-L-iduronidase,42262,0.0639056036702483,0.00500157315511603,0.0541025202862209,0.0737086870542757,3.59229486491655e-37
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,IL16,Pro-interleukin-16,42296,0.0572367189283286,0.00448526957795807,0.0484455905555308,0.0660278473011265,4.39927210680353e-37
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TOP2B,DNA topoisomerase 2-beta,39657,0.108907608602094,0.00856518914027155,0.0921198378871617,0.125695379317026,8.81163300020905e-37
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,GSN,Gelsolin,39943,-0.0256266832234129,0.00201789110331235,-0.0295817497859051,-0.0216716166609207,1.0543411595142e-36
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PBLD,Phenazine biosynthesis-like domain-containing protein,41839,0.0710744929557219,0.00560150804675178,0.0600955371840884,0.0820534487273553,1.12024798202044e-36
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,IL1R2,Interleukin-1 receptor type 2,42100,0.0269167890687517,0.00212279078582048,0.0227561191285435,0.0310774590089598,1.23609032358993e-36
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CPA1,Carboxypeptidase A1,42310,0.0869212762260984,0.00686046725181003,0.0734747604125508,0.100367792039646,1.39245786313993e-36
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ITIH3,Inter-alpha-trypsin inhibitor heavy chain H3,42217,-0.0519199687462532,0.00409795848428411,-0.0599519673754501,-0.0438879701170563,1.39976201804091e-36
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,AKR7L,Aflatoxin B1 aldehyde reductase member 4,39657,0.0930786499221094,0.00737068665595511,0.0786321040764374,0.107525195767781,2.62707312309508e-36
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ECHDC3,"Enoyl-CoA hydratase domain-containing protein 3, mitochondrial",39958,0.102280783977966,0.0081070294328881,0.086391006289505,0.118170561666426,3.00390818002992e-36
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TIMP4,Metalloproteinase inhibitor 4,42137,-0.0531130743031773,0.00422373954269147,-0.0613916038068526,-0.044834544799502,4.6152927670092e-36
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,KRT19,"Keratin, type I cytoskeletal 19",42094,0.090351745826611,0.00719215968456913,0.0762551128448555,0.104448378808366,5.39436177239147e-36
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SORCS2,VPS10 domain-containing receptor SorCS2,41843,0.0476268445574633,0.0037920681025416,0.0401943910764817,0.0550592980384448,5.64493890641314e-36
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,IL12A_IL12B,Interleukin-12,42070,0.102597118146398,0.0081719281532205,0.0865801389660855,0.11861409732671,5.9445464245077e-36
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,MTSS2,Protein MTSS 2,39919,0.134072752886089,0.010710699687417,0.113079781498751,0.155065724273426,1.0301512803026e-35
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PDZK1,Na(+)/H(+) exchange regulatory cofactor NHE-RF3,39657,0.0616374899637005,0.00492471428963782,0.0519850499560104,0.0712899299713907,1.06558086860315e-35
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,THOP1,Thimet oligopeptidase,42081,0.0415565557871065,0.00332664615690997,0.035036329319563,0.0480767822546501,1.29925058944197e-35
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CDH15,Cadherin-15,42230,0.0915489993482104,0.0073366360760213,0.0771691926392087,0.105928806057212,1.53259438857743e-35
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TANK,TRAF family member-associated NF-kappa-B activator,41913,0.0936810692081559,0.00750770658697871,0.0789659642976777,0.108396174118634,1.55555273511856e-35
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,RAB6A,Ras-related protein Rab-6A,42119,-0.0586955074230398,0.00470734245333734,-0.067921898631581,-0.0494691162144986,1.72867779406299e-35
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PTP4A3,Protein tyrosine phosphatase type IVA 3,39657,0.0682994261784078,0.00549198157219927,0.0575351422968972,0.0790637100599184,2.86001953712187e-35
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,STC1,Stanniocalcin-1,42249,0.0602970020368243,0.00486112611330309,0.0507691948547502,0.0698248092188983,3.84836196991266e-35
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ANGPTL7,Angiopoietin-related protein 7,42262,0.0483545396871096,0.00390175486993199,0.0407071001420429,0.0560019792321763,4.40018592470221e-35
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,IL12B,Interleukin-12 subunit beta,42296,0.0720327651972775,0.00581423284291807,0.0606368688251581,0.0834286615693969,4.61678786202245e-35
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ERP44,Endoplasmic reticulum resident protein 44,42047,0.03415927874049,0.00276154993406567,0.0287466408697213,0.0395719166112587,5.9125511916978e-35
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,EGLN1,Egl nine homolog 1,42119,0.0732154168251677,0.00592880863646546,0.0615949518976954,0.08483588175264,7.59155855980582e-35
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,EPS8L2,Epidermal growth factor receptor kinase substrate 8-like protein 2,42231,0.0399641495333789,0.00323688063758601,0.0336198634837103,0.0463084355830474,7.80983499236574e-35
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,NFX1,Transcriptional repressor NF-X1,39575,0.0886938588868911,0.0072007698984679,0.074580349885894,0.102807367887888,1.23783749086231e-34
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,C19orf12,Protein C19orf12,41839,0.0872955409670337,0.00709207848171909,0.0733950671428643,0.101196014791203,1.25469022182315e-34
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SRP14,Signal recognition particle 14 kDa protein,42070,0.0780910980567925,0.00634688542318421,0.0656512026273515,0.0905309934862336,1.3246283749387e-34
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TFPI,Tissue factor pathway inhibitor,42152,-0.040664919992703,0.00330654670469346,-0.0471457515339022,-0.0341840884515039,1.41397416280941e-34
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PVR,Poliovirus receptor,42249,0.0487963549159407,0.00396857225258333,0.0410179533008773,0.056574756531004,1.45551291758882e-34
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PSME2,Proteasome activator complex subunit 2,41955,0.0459124880884568,0.00373616113968102,0.038589612254682,0.0532353639222316,1.60061134260642e-34
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TREH,Trehalase,39966,0.0982648161094695,0.008009143805714,0.0825668942502701,0.113962737968669,2.19008283053824e-34
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ARF6,ADP-ribosylation factor 6,39930,0.141762848436306,0.0115808169033813,0.119064447305679,0.164461249566933,3.0807713908445e-34
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,NCAM2,Neural cell adhesion molecule 2,42137,-0.0349746653398165,0.00285876684967048,-0.0405778483651706,-0.0293714823144623,3.09538759618185e-34
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SSC4D,Scavenger receptor cysteine-rich domain-containing group B protein,42129,0.161009282674255,0.0131617219938803,0.13521230756625,0.186806257782261,3.13529780646316e-34
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,EZR,Ezrin,42249,0.0315263868547957,0.00257934794057112,0.0264708648912763,0.0365819088183151,3.55116321767112e-34
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PTPRB,Receptor-type tyrosine-protein phosphatase beta,39958,0.03871097050162,0.00316785104588248,0.0325019824516904,0.0449199585515497,3.98269733471284e-34
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CCL11,Eotaxin,42296,0.0483284489711769,0.00396517181545372,0.0405567122128876,0.0561001857294662,5.38581803189591e-34
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,LEPR,Leptin receptor,42145,-0.0405477517324531,0.00333960352540066,-0.0470933746422384,-0.0340021288226678,9.531062813771e-34
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,FYB1,FYN-binding protein 1,42115,0.11913277561869,0.00981483238406437,0.0998957041459234,0.138369847091456,9.94607508320774e-34
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,FABP4,"Fatty acid-binding protein, adipocyte",42310,0.0646792846286846,0.0053381399853687,0.0542165302573619,0.0751420390000072,1.28358559489423e-33
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,IPCEF1,Interactor protein for cytohesin exchange factors 1,41992,0.115518882772054,0.00953573403192994,0.0968288440694711,0.134208921474636,1.32935615858683e-33
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PRKAR2A,cAMP-dependent protein kinase type II-alpha regulatory subunit,39909,0.100870811368841,0.00834823090865323,0.0845082787878807,0.117233343949801,2.08832934653205e-33
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PSMG3,Proteasome assembly chaperone 3,42119,0.0631507477763189,0.00524357179472854,0.052873347058651,0.0734281484939869,3.10605438331819e-33
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SCAMP3,Secretory carrier-associated membrane protein 3,42070,0.106821644078604,0.0088880711366499,0.0894010246507702,0.124242263506438,4.19296536971259e-33
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SCARB2,Lysosome membrane protein 2,41777,0.041990313705268,0.00349819276735681,0.0351338558812487,0.0488467715292874,5.06707212518648e-33
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TNFSF10,Tumor necrosis factor ligand superfamily member 10,42296,-0.0324884737356523,0.00270845558007775,-0.0377970466726047,-0.0271799007986999,5.50807094097469e-33
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ZBTB16,Zinc finger and BTB domain-containing protein 16,41843,0.0931378996976877,0.00777998940143636,0.0778891204708724,0.108386678924503,7.40703841871384e-33
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TNFRSF1A,Tumor necrosis factor receptor superfamily member 1A,42137,0.0393862350953817,0.00329081744741422,0.0329362328984498,0.0458362372923135,7.60727051433852e-33
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CFC1,Cryptic protein,41843,0.0607989419208574,0.00508388050711624,0.0508345361269096,0.0707633477148052,8.57742174797669e-33
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,DNAJC6,Putative tyrosine-protein phosphatase auxilin,39638,0.108103360306241,0.00903861576373746,0.0903876734093161,0.125819047203167,9.15365553035008e-33
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,LAT,Linker for activation of T-cells family member 1,42296,0.0960369702171778,0.00804307986528219,0.0802725336812247,0.111801406753131,1.05981846188024e-32
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,RET,Proto-oncogene tyrosine-protein kinase receptor Ret,42070,0.0465361104599155,0.00390817329120063,0.0388760908091622,0.0541961301106687,1.57728297139944e-32
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PLEKHO1,Pleckstrin homology domain-containing family O member 1,39929,0.088518467040105,0.00743697172909034,0.0739420024510879,0.103094931629122,1.79331107901328e-32
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,S100A4,Protein S100-A4,42181,0.070729705423891,0.0059472563575457,0.0590730829631015,0.0823863278846806,1.86867933930561e-32
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,BANK1,B-cell scaffold protein with ankyrin repeats,42119,0.134159723274071,0.0112869142293528,0.11203737138454,0.156282075163602,2.02224331827104e-32
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CFHR4,Complement factor H-related protein 4,39945,-0.0921327561373172,0.00777448351454806,-0.107370743825831,-0.076894768448803,3.30580057849121e-32
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CEP85,Centrosomal protein of 85 kDa,41843,0.0819312520112935,0.00691732627129939,0.0683732925195467,0.0954892115030403,3.34648947151538e-32
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,LDLRAP1,Low density lipoprotein receptor adapter protein 1,39934,0.125783541977165,0.0106473314960873,0.104914772244834,0.146652311709496,5.11430461606703e-32
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,AP1G2,AP-1 complex subunit gamma-like 2,39919,0.100124163492605,0.00847756774332193,0.0835081307156938,0.116740196269516,5.30948675845358e-32
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,S100P,Protein S100-P,41900,0.0667355158089685,0.00567910963358774,0.0556044609271365,0.0778665706908005,1.00077835747573e-31
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CES3,Carboxylesterase 3,42070,0.0885899239515395,0.00754617206972907,0.0737994266948705,0.103380421208208,1.13767297388611e-31
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TIMD4,T-cell immunoglobulin and mucin domain-containing protein 4,42217,-0.0534083696970833,0.00456652873804019,-0.0623587660236421,-0.0444579733705245,1.89731969786209e-31
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,YTHDF3,YTH domain-containing family protein 3,41913,0.106067522332786,0.00907536731506244,0.0882798023952639,0.123855242270309,2.10428095678048e-31
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ITGBL1,Integrin beta-like protein 1,39966,0.0487512297145751,0.00419145829143399,0.0405359714633645,0.0569664879657857,4.29541606161452e-31
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,NFKB1,Nuclear factor NF-kappa-B p105 subunit,39575,0.0927003930858224,0.00797422419729486,0.0770709136591244,0.10832987251252,4.67524878788997e-31
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,LBR,Delta(14)-sterol reductase LBR,42249,0.0838298942149716,0.00722548587139741,0.0696679419070327,0.0979918465229106,5.62699565535625e-31
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,GPKOW,G-patch domain and KOW motifs-containing protein,41839,0.0362042532386058,0.00312042108656841,0.0300882279089317,0.0423202785682799,5.65974033055912e-31
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PTGDS,Prostaglandin-H2 D-isomerase,42083,0.0389777677544042,0.00336177481321224,0.0323886891205082,0.0455668463883002,6.16725578646245e-31
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,LGALS9,Galectin-9,42129,0.0386453143812253,0.00333410743416373,0.0321104638102643,0.0451801649521862,6.414578647986e-31
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,NAGPA,N-acetylglucosamine-1-phosphodiester alpha-N-acetylglucosaminidase,39736,0.027220449854468,0.00235272347359142,0.0226091118462288,0.0318317878627072,8.79288682557867e-31
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,COL6A3,Collagen alpha-3(VI) chain,42310,0.0439159670204811,0.00380410819136962,0.0364599149653966,0.0513720190755655,1.09282963896366e-30
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,BACH1,Transcription regulator protein BACH1,42119,0.0917743152526263,0.00796084231832474,0.0761710643087098,0.107377566196543,1.3218809777502e-30
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,NUCB2,Nucleobindin-2,42231,0.0458501819741189,0.00398019386438387,0.0380490019999265,0.0536513619483113,1.45587546774461e-30
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PTPRS,Receptor-type tyrosine-protein phosphatase S,42310,-0.0306308030051325,0.00266946932655743,-0.0358629628851851,-0.02539864312508,2.43771883764286e-30
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PLSCR3,Phospholipid scramblase 3,39911,0.0704362584717644,0.00614449604155689,0.0583930462303129,0.0824794707132159,2.96209280545358e-30
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CDH17,Cadherin-17,42145,0.083065120163492,0.00725294633590424,0.0688493453451196,0.0972808949818643,3.14333820021328e-30
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ESM1,Endothelial cell-specific molecule 1,42123,-0.0420523579953548,0.00368462836941709,-0.0492742295994123,-0.0348304863912973,4.94597634240574e-30
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,RELT,Tumor necrosis factor receptor superfamily member 19L,42137,0.0365624245301473,0.00320393338334424,0.0302827150987925,0.042842133961502,5.01163540491295e-30
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ASAH2,Neutral ceramidase,42016,0.0643808965841066,0.0056417956210459,0.0533229771668567,0.0754388160013566,5.04368060992604e-30
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,VEGFA,Vascular endothelial growth factor A,42253,0.068595517352938,0.00601261331985941,0.0568107952460135,0.0803802394598624,5.17952260424306e-30
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,VSIG2,V-set and immunoglobulin domain-containing protein 2,39919,0.0752937859203048,0.0066165404460767,0.0623253666459944,0.0882622051946151,7.67221707223828e-30
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SIGLEC7,Sialic acid-binding Ig-like lectin 7,42145,0.0335166981091891,0.00295330175497363,0.0277282266694408,0.0393051695489374,1.02300662739172e-29
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,NFATC1,"Nuclear factor of activated T-cells, cytoplasmic 1",42119,0.120266807609597,0.0106200961410558,0.0994514191731272,0.141082196046066,1.34964308903376e-29
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,DNAJA2,DnaJ homolog subfamily A member 2,42259,0.0978696288379112,0.00865255663800168,0.0809106178274279,0.114828639848395,1.56520114583817e-29
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SNAP23,Synaptosomal-associated protein 23,42145,0.104401169752438,0.00923336486121507,0.0863037746244567,0.12249856488042,1.64382876606243e-29
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ACAN,Aggrecan core protein,41994,-0.032847737817722,0.00290891571298353,-0.0385492126151698,-0.0271462630202743,1.95036684383772e-29
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,MTDH,Protein LYRIC,39657,0.114786791826857,0.0101635643950011,0.094866205612655,0.13470737804106,2.03670187728876e-29
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CGREF1,Cell growth regulator with EF hand domain protein 1,42145,0.0519237907101185,0.00460628958037566,0.0428954631325823,0.0609521182876548,2.4272686647497e-29
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CTSS,Cathepsin S,39358,0.0292176718606474,0.00259039313609155,0.024140501313908,0.0342948424073869,2.42755797089515e-29
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SHMT1,"Serine hydroxymethyltransferase, cytosolic",42166,0.101188285952311,0.00899878767085026,0.0835506621174445,0.118825909787178,3.31280014089427e-29
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CEP20,Centrosomal protein 20,41843,0.0897865052996061,0.0079924758102772,0.0741212527114628,0.105451757887749,3.76571512018807e-29
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,LAIR1,Leukocyte-associated immunoglobulin-like receptor 1,42123,0.0472153655267193,0.00421200343810844,0.0389598387880267,0.0554708922654118,4.90587722524046e-29
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,KLK14,Kallikrein-14,42262,-0.0551543899559551,0.00492281146476847,-0.0648031004269013,-0.0455056794850089,5.22382245189747e-29
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,LAMP2,Lysosome-associated membrane glycoprotein 2,41734,0.0246000092222069,0.00219628626032959,0.0202952881519609,0.0289047302924529,5.47195515474356e-29
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PBXIP1,Pre-B-cell leukemia transcription factor-interacting protein 1,39930,0.0358974570379634,0.00320400852430468,0.0296176003303262,0.0421773137456006,5.53898172919755e-29
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SPINK4,Serine protease inhibitor Kazal-type 4,42119,0.0783404650577228,0.00700514294868602,0.0646103848782982,0.0920705452371473,6.5937304110778e-29
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,IKBKG,NF-kappa-B essential modulator,42119,0.108439368398934,0.00970332345777646,0.0894208544216917,0.127457882376175,7.19295809805825e-29
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,VSNL1,Visinin-like protein 1,39929,0.0461082123137713,0.00413118798463096,0.0380110838638946,0.054205340763648,8.93730342328001e-29
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SSNA1,Sjoegren syndrome nuclear autoantigen 1,39930,0.0611795649159244,0.00548795788749394,0.0504231674564363,0.0719359623754126,1.03317152949353e-28
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,HAVCR1,Hepatitis A virus cellular receptor 1,42239,0.0766742561686019,0.00688526489389604,0.0631791369765657,0.0901693753606382,1.11408936656774e-28
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ANGPTL2,Angiopoietin-related protein 2,42140,0.0467087381468902,0.00419716613598663,0.0384822925203563,0.054935183773424,1.21153628305996e-28
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CXCL10,C-X-C motif chemokine 10,42185,0.0778008235673519,0.00699765743580574,0.0640854149931726,0.0915162321415311,1.36036452503211e-28
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,FEN1,Flap endonuclease 1,41843,0.0759081300534477,0.00683714565526734,0.0625073245691238,0.0893089355377717,1.63308989341833e-28
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,RNF41,E3 ubiquitin-protein ligase NRDP1,41843,0.0782741533626332,0.0070621447447053,0.0644323496630108,0.0921159570622556,2.00878209034397e-28
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CFH,Complement factor H,39418,0.0277674779633154,0.00250489678991707,0.022857880255078,0.0326770756715529,2.10279240575575e-28
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TIMP1,Metalloproteinase inhibitor 1,42032,0.0338578571526513,0.00305721601375379,0.0278657137656938,0.0398500005396087,2.20752542494489e-28
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ABCA2,ATP-binding cassette sub-family A member 2,39575,0.0424871086293353,0.00383950222727893,0.0349616842638686,0.050012532994802,2.59473942801104e-28
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PNLIPRP1,Inactive pancreatic lipase-related protein 1,39929,0.0983919565655388,0.00890144140858329,0.0809451314047155,0.115838781726362,2.94013975098541e-28
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SH2D1A,SH2 domain-containing protein 1A,42119,0.0701658204199978,0.00635517758292996,0.0577096723574551,0.0826219684825405,3.20808483053083e-28
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TRIM5,Tripartite motif-containing protein 5,42119,0.101750816545144,0.00921617925191254,0.0836871052113951,0.119814527878892,3.21792962048826e-28
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,MTHFSD,Methenyltetrahydrofolate synthase domain-containing protein,39757,0.134575938724519,0.0121841079560941,0.110695087130574,0.158456790318463,3.23752807053912e-28
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SNCA,Alpha-synuclein,39736,0.138931065127712,0.0125835618357123,0.114267283929716,0.163594846325708,3.40502125668903e-28
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,FSTL3,Follistatin-related protein 3,42084,0.0383147638376419,0.0034752501796132,0.0315032734856,0.0451262541896838,3.81674150293298e-28
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SPINT2,Kunitz-type protease inhibitor 2,42185,0.0462108269191709,0.00419292192711109,0.0379926999420332,0.0544289538963087,3.97551595538342e-28
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CEP43,Centrosomal protein 43,41797,0.0824115681665797,0.00747917037355765,0.0677523942344067,0.0970707420987527,4.11207689113227e-28
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,APEX1,DNA-(apurinic or apyrimidinic site) endonuclease,42216,0.0674427046430139,0.00612294379931042,0.0554417347963655,0.0794436744896623,4.26306848153894e-28
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,EGFR,Epidermal growth factor receptor,42310,-0.0186580313911898,0.00169554663137474,-0.0219813027886843,-0.0153347599936953,4.78209384794917e-28
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,BCR,Breakpoint cluster region protein,42119,0.107885300850646,0.00980608169483641,0.0886653807287663,0.127105220972525,4.92118691816972e-28
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,HLA_E,,42119,0.0342513841671517,0.00311653426433527,0.0281429770090545,0.0403597913252488,5.59386201705651e-28
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CA6,Carbonic anhydrase 6,42103,-0.0730807900817897,0.00664982752646742,-0.0861144520336659,-0.0600471281299136,5.61648463784365e-28
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,GRPEL1,"GrpE protein homolog 1, mitochondrial",42070,0.0712507509137327,0.0064993559619064,0.0585120132283962,0.0839894885990692,7.56860386975431e-28
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,GFER,FAD-linked sulfhydryl oxidase ALR,41843,0.0742024801620796,0.0067760062395437,0.0609215079325739,0.0874834523915852,8.66832248246894e-28
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SORT1,Sortilin,42129,0.0443410446952688,0.00405328643137271,0.0363966032897783,0.0522854861007593,9.74599077917059e-28
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CBS,Cystathionine beta-synthase,39638,0.0602347113163535,0.0055156535901143,0.0494240302797295,0.0710453923529775,1.27080779291235e-27
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,NFKBIE,NF-kappa-B inhibitor epsilon,41843,0.0572449729216076,0.00524690068525573,0.0469610475785064,0.0675288982647089,1.34944315380339e-27
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,STAB2,Stabilin-2,39966,0.0326504708812944,0.00299371800297065,0.0267827835954719,0.0385181581671169,1.47206261041553e-27
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,WWP2,NEDD4-like E3 ubiquitin-protein ligase WWP2,42016,0.0607731658317168,0.0055758951203972,0.0498444113957383,0.0717019202676953,1.51570106144843e-27
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,FETUB,Fetuin-B,42199,0.03718037856583,0.00341715741199648,0.0304827500383169,0.0438780070933431,1.852630847665e-27
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,RNASE6,Ribonuclease K6,39937,0.0374426750609241,0.00344532840704846,0.0306898313831091,0.0441955187387391,2.24227213110516e-27
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SERPINE1,Plasminogen activator inhibitor 1,42310,0.0765964764608694,0.00705384976666673,0.0627709309182026,0.0904220220035362,2.33988134505767e-27
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,GRHPR,Glyoxylate reductase/hydroxypyruvate reductase,39958,0.0724870768236853,0.00667316895301587,0.0594076656757742,0.0855664879715965,2.37092975502427e-27
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TJAP1,Tight junction-associated protein 1,42181,0.095814141381805,0.00882901833278036,0.0785092654495555,0.113119017314055,2.5206318253775e-27
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CD40,Tumor necrosis factor receptor superfamily member 5,42129,0.0582432464552227,0.00536768501104493,0.0477225838335746,0.0687639090768707,2.56354376089917e-27
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,LRP11,Low-density lipoprotein receptor-related protein 11,42145,0.0427024844843171,0.00393717198149565,0.0349856274005856,0.0504193415680486,2.69797266274421e-27
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,WIF1,Wnt inhibitory factor 1,42262,-0.0387542760572349,0.00357760199347227,-0.0457663759644406,-0.0317421761500293,3.11635937652787e-27
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ARHGEF12,Rho guanine nucleotide exchange factor 12,42119,0.119574805899185,0.0110514705052025,0.0979139237089877,0.141235688089382,3.58371833622217e-27
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PARP1,Poly [ADP-ribose] polymerase 1,42119,0.0675944737108317,0.00625305285139395,0.0553384901220995,0.0798504572995638,3.99179304747477e-27
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,HYAL1,Hyaluronidase-1,42077,0.0264507095339634,0.00245035609833605,0.0216480115812247,0.0312534074867021,4.70747659742441e-27
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PAK4,Serine/threonine-protein kinase PAK 4,41839,0.0703728819371701,0.0065200538762376,0.0575935763397444,0.0831521875345958,4.79790032617472e-27
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,NAA80,N-alpha-acetyltransferase 80,39649,0.141813677151818,0.0131435611846639,0.116052297229877,0.167575057073759,5.25447396757368e-27
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SLC16A1,Monocarboxylate transporter 1,41839,0.0631672530031921,0.00586639312691071,0.0516691224744472,0.0746653835319371,6.32564660517938e-27
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ERBIN,Erbin,42070,0.116987810497094,0.0108917245081921,0.0956400304610379,0.138335590533151,8.38954047446107e-27
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,NFATC3,"Nuclear factor of activated T-cells, cytoplasmic 3",41913,0.0702678473684793,0.00654421384851041,0.0574411882253988,0.0830945065115597,8.74395615369501e-27
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PPP1R9B,Neurabin-2,42296,0.107878087946289,0.0100667491149603,0.0881472596809668,0.127608916211611,1.08911346378141e-26
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ENTPD5,Ectonucleoside triphosphate diphosphohydrolase 5,41900,-0.0251619114635643,0.00234791969355133,-0.0297638340629249,-0.0205599888642037,1.09224890842636e-26
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,39736,0.0330877595178533,0.00308833647363483,0.0270346200295291,0.0391408990061776,1.18257096138708e-26
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,FMNL1,Formin-like protein 1,41839,0.0719682442371036,0.00672350434951002,0.058790175712064,0.0851463127621433,1.2528852226158e-26
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CDC27,Cell division cycle protein 27 homolog,41843,0.0693288501823722,0.0064798087867994,0.0566284249602454,0.082029275404499,1.31833973471986e-26
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CCN4,CCN family member 4,42262,0.044470591316816,0.00415831608654836,0.0363202917871812,0.0526208908464508,1.37781192894474e-26
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,BCAN,Brevican core protein,42016,-0.0391695042581525,0.00366359011293727,-0.0463501408795095,-0.0319888676367954,1.42615682923806e-26
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,DDT,D-dopachrome decarboxylase,39966,0.0462332587125966,0.00433476962759812,0.0377371102425043,0.0547294071826889,1.96431682201271e-26
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,AXIN1,Axin-1,42119,0.109295727968648,0.0102528467790019,0.0892001482818044,0.129391307655492,1.99320601335233e-26
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SMNDC1,Survival of motor neuron-related-splicing factor 30,39930,0.0703246029839793,0.00659907179374281,0.0573904222682434,0.0832587836997152,2.16235715158556e-26
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CXCL9,C-X-C motif chemokine 9,42185,0.0735196868958893,0.00690293135284669,0.0599899414443098,0.0870494323474688,2.20384387007284e-26
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TCOF1,Treacle protein,39958,0.0368052263078863,0.00346014691535212,0.0300233383537961,0.0435871142619764,2.66846311843698e-26
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CBLIF,Cobalamin binding intrinsic factor,42129,0.0862403520251222,0.00811896322279571,0.0703271841084426,0.102153519941802,2.98469542612527e-26
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ITPR1,"Inositol 1,4,5-trisphosphate receptor type 1",39638,0.077727103393675,0.00732462163618405,0.0633708449867543,0.0920833618005958,3.51275668224399e-26
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CXCL17,C-X-C motif chemokine 17,42296,0.0479860574584635,0.00452431919195836,0.0391183918422251,0.0568537230747019,3.5212678755688e-26
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,AKT1S1,Proline-rich AKT1 substrate 1,41839,0.0748661039309153,0.00707026776951668,0.0610083791026626,0.088723828759168,4.26796732087961e-26
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ELOA,Elongin-A,42070,0.0605072143153938,0.00571846722561344,0.0492990185531914,0.0717154100775961,4.61867976175603e-26
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,IFI30,Gamma-interferon-inducible lysosomal thiol reductase,39662,0.0444531327682143,0.00420149831656873,0.0362181960677396,0.052688069468689,4.89679565653138e-26
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,FUS,RNA-binding protein FUS,41831,0.0446447877247131,0.00422278091948762,0.0363681371225174,0.0529214383269089,5.08294281104726e-26
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TDRKH,Tudor and KH domain-containing protein,41839,0.0955770640043262,0.0090468538347872,0.0778452304881433,0.113308897520509,5.5127954980678e-26
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,EIF4EBP1,Eukaryotic translation initiation factor 4E-binding protein 1,42145,0.0704224188335189,0.0066745624458871,0.0573402764395801,0.0835045612274576,6.34447079371008e-26
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PGLYRP2,N-acetylmuramoyl-L-alanine amidase,39862,0.0328302575094618,0.00311176267447781,0.0267312026674853,0.0389293123514383,6.68201718275271e-26
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,B3GNT7,"UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 7",39638,0.0424382895232225,0.00403123534385214,0.0345370682492723,0.0503395107971727,8.56090435734743e-26
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,DAAM1,Disheveled-associated activator of morphogenesis 1,39736,0.0932138178842232,0.00885508582892971,0.075857849659521,0.110569786108925,8.6102487680728e-26
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,IL7R,Interleukin-7 receptor subunit alpha,42137,-0.0582582798180881,0.00553825932871139,-0.0691132681023624,-0.0474032915338137,8.85625426038856e-26
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,UFD1,Ubiquitin recognition factor in ER-associated degradation protein 1,39930,0.157479934865505,0.0149726814480282,0.12813347922737,0.18682639050364,9.39694254174199e-26
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SERPINH1,Serpin H1,39757,0.144705562972997,0.0137666657508917,0.11772289810125,0.171688227844745,1.01051654348803e-25
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PTH1R,Parathyroid hormone/parathyroid hormone-related peptide receptor,42119,0.0421582991674446,0.00402081857830842,0.03427749475396,0.0500391035809291,1.26954761595252e-25
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,NPL,N-acetylneuraminate lyase,39958,0.0518920083625735,0.00495148735753572,0.0421870931418035,0.0615969235833436,1.39511110969121e-25
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CD72,B-cell differentiation antigen CD72,39736,0.0485233159058909,0.00463608739370984,0.0394365846142196,0.0576100471975622,1.61786647273909e-25
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ISM1,Isthmin-1,42119,0.0438269280136129,0.00419591025312968,0.0356029439174787,0.0520509121097471,1.92717681912467e-25
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,USP8,Ubiquitin carboxyl-terminal hydrolase 8,41900,0.105594064840414,0.0101110378218105,0.085776430709665,0.125411698971162,1.96909015674094e-25
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,HDGFL2,Hepatoma-derived growth factor-related protein 2,39929,0.0712918459734048,0.00682560267757239,0.0579136647253629,0.0846700272214467,2.0195857128241e-25
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,IMMT,MICOS complex subunit MIC60,39919,0.0496750721963501,0.0047612176855253,0.0403430855327205,0.0590070588599797,2.27752555363342e-25
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SRPK2,SRSF protein kinase 2,42119,0.0942920206068668,0.00904420676821212,0.076565375341171,0.112018665872563,2.36186330182309e-25
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ARHGEF1,Rho guanine nucleotide exchange factor 1,39929,0.0996703223204572,0.00957119182706055,0.0809107863394185,0.118429858301496,2.79558715347951e-25
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PIK3IP1,Phosphoinositide-3-kinase-interacting protein 1,42137,0.0322281036140717,0.0030966207982947,0.0261587268494141,0.0382974803787294,2.85384612177587e-25
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PDCD5,Programmed cell death protein 5,42249,0.0633337327259755,0.00608598259441716,0.0514052068409179,0.0752622586110332,2.87901479031859e-25
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SCPEP1,Retinoid-inducible serine carboxypeptidase,39601,0.056867032494074,0.0054633804717535,0.0461588067694371,0.0675752582187109,2.96204107319383e-25
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CTRB1,Chymotrypsinogen B,42137,0.0645045605091091,0.00620650570975924,0.052339809317981,0.0766693117002372,3.31722757956114e-25
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TOMM20,Mitochondrial import receptor subunit TOM20 homolog,39958,0.0854139297620879,0.00822054134874458,0.0693016687185485,0.101526190805627,3.5584399455598e-25
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,NIT2,Omega-amidase NIT2,39903,0.0808156540569166,0.00778932763369335,0.0655485718948776,0.0960827362189556,4.1685868080486e-25
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ADD1,Alpha-adducin,39736,0.0771732996170734,0.00744585510808273,0.0625794236052312,0.0917671756289155,4.66964662823746e-25
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CNST,Consortin,42145,0.119999919036208,0.0115846815194828,0.0972939432580222,0.142705894814395,4.74915518992009e-25
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,EIF2AK2,"Interferon-induced, double-stranded RNA-activated protein kinase",39906,0.121813889529081,0.0117570954211375,0.0987699825036511,0.14485779655451,4.83391482681135e-25
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,LYN,Tyrosine-protein kinase Lyn,42070,0.0934060606266916,0.00902328958729987,0.0757204130355838,0.111091708217799,5.1040190156463e-25
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TGFA,Protransforming growth factor alpha,42119,0.0497396712235958,0.00480820494219756,0.0403155895368886,0.059163752910303,5.47887109742441e-25
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SH3GLB2,Endophilin-B2,39929,0.0722333892569384,0.00701416424839798,0.0584856273300784,0.0859811511837984,9.22856487244807e-25
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,EIF4G1,Eukaryotic translation initiation factor 4 gamma 1,42296,0.106796941822973,0.0103878477168963,0.086436760297856,0.127157123348089,1.0559690263865e-24
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SMOC2,SPARC-related modular calcium-binding protein 2,42185,0.0426487783012401,0.0041495037657399,0.0345157509203899,0.0507818056820903,1.08987714456954e-24
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,STAT5B,Signal transducer and activator of transcription 5B,42070,0.149777061755182,0.0145766650261832,0.121206798303863,0.178347325206501,1.12508564323466e-24
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,BMPER,BMP-binding endothelial regulator protein,39736,0.0253387344334249,0.00246764692466438,0.0205021464610827,0.030175322405767,1.25963023196623e-24
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TXNRD1,"Thioredoxin reductase 1, cytoplasmic",42137,0.0503359178812796,0.00491820495857647,0.0406962361624697,0.0599755996000894,1.70392747113845e-24
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TNFRSF13B,Tumor necrosis factor receptor superfamily member 13B,42144,0.0378493108173956,0.00369840412212607,0.0306004387380285,0.0450981828967627,1.7152100025417e-24
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,B4GALT1,"Beta-1,4-galactosyltransferase 1",42185,0.0303202358448405,0.00296327130799475,0.0245122240811708,0.0361282476085102,1.7486295498148e-24
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PCSK9,Proprotein convertase subtilisin/kexin type 9,42310,0.0432182870588583,0.00422530894683888,0.0349366815230541,0.0514998925946626,1.81065571550424e-24
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CTSE,Cathepsin E,39736,0.0579146897285167,0.00566600880934014,0.0468093124622101,0.0690200669948234,2.03768623276163e-24
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CLEC4D,C-type lectin domain family 4 member D,42119,0.0671957107002844,0.0065768629001797,0.0543050594159322,0.0800863619846367,2.04163023990442e-24
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CD63,CD63 antigen,41992,0.0546560723868147,0.00535317926374741,0.0441638410298698,0.0651483037437596,2.19661954716511e-24
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,INSL5,Insulin-like peptide INSL5,39930,0.11164462734107,0.0109328304820383,0.0902162795962748,0.133072975085865,2.23726736384487e-24
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CPXM2,Inactive carboxypeptidase-like protein X2,39958,0.0276862070283036,0.00271532183709712,0.0223641762275932,0.033008237829014,2.62130367916879e-24
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,GALNT10,Polypeptide N-acetylgalactosaminyltransferase 10,42070,0.0305159450847719,0.00299471127554551,0.0246463109847027,0.0363855791848411,2.6935229778767e-24
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SDCCAG8,Serologically defined colon cancer antigen 8,39919,0.124216362272481,0.0121933621497468,0.100317372458977,0.148115352085984,2.87783484445348e-24
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ALPI,Intestinal-type alkaline phosphatase,39657,0.136083048912313,0.0133744301398987,0.109869165838111,0.162296931986514,3.28184679053985e-24
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,FCN1,Ficolin-1,39978,0.0605186035462004,0.00595730612620826,0.0488422835388322,0.0721949235535686,3.84108703133454e-24
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,GOLM2,Protein GOLM2,42249,0.0245343405435126,0.00241779033524377,0.0197954714864348,0.0292732096005904,4.14302617035389e-24
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,MMP7,Matrilysin,41881,0.0558602173301924,0.00551291860694985,0.0450548968605707,0.0666655377998141,4.84232057206675e-24
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ATG16L1,Autophagy-related protein 16-1,39930,0.0932100240766728,0.00920544266425211,0.0751673564547387,0.111252691698607,5.38426256925388e-24
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CCL3,C-C motif chemokine 3,42119,0.063776960033997,0.00630611124167329,0.0514169820003173,0.0761369380676766,5.85601073151908e-24
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,DLK1,Protein delta homolog 1,42310,0.0621459220537996,0.00614667311551289,0.0500984427473944,0.0741934013602049,6.0215380598945e-24
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,MFAP5,Microfibrillar-associated protein 5,42310,0.0434084067613504,0.00429489771564458,0.034990407238687,0.0518264062840138,6.2405300195114e-24
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,COL3A1,Collagen alpha-1(III) chain,39966,0.0253793856582516,0.00251355262844478,0.0204528225064999,0.0303059488100034,7.17963758885032e-24
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,FUT3_FUT5,3-galactosyl-N-acetylglucosaminide 4-alpha-L-fucosyltransferase FUT3_4-galactosyl-N-acetylglucosaminide 3-alpha-L-fucosyltransferase FUT5,42249,-0.0499660628261655,0.00495393282545443,-0.0596757711640562,-0.0402563544882748,7.71132103694135e-24
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SLA2,Src-like-adapter 2,39934,0.115059472718815,0.0114082244956822,0.0926993527072782,0.137419592730352,8.05738562694232e-24
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SEL1L,Protein sel-1 homolog 1,39638,0.0338055196114323,0.00335432483479213,0.0272310429352397,0.0403799962876248,8.74174043673155e-24
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,VPS53,Vacuolar protein sorting-associated protein 53 homolog,42070,0.0830136266245957,0.0082483875881372,0.0668467869518468,0.0991804662973446,9.6456271815873e-24
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CTBS,Di-N-acetylchitobiase,39860,0.029630914378108,0.00294499096131869,0.0238587320939234,0.0354030966622927,1.02987131350832e-23
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,MEGF9,Multiple epidermal growth factor-like domains protein 9,42272,0.020924143100627,0.002086084343405,0.0168354177875532,0.0250128684137008,1.35293976704278e-23
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,HNMT,Histamine N-methyltransferase,41961,0.0509495601421605,0.00507941113497234,0.0409939143176147,0.0609052059667063,1.35529239781951e-23
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,WFIKKN2,"WAP, Kazal, immunoglobulin, Kunitz and NTR domain-containing protein 2",42144,-0.0350006091997831,0.003500432561108,-0.0418614570195548,-0.0281397613800114,1.8576313732231e-23
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,APLP1,Amyloid-like protein 1,42145,-0.0540810086326588,0.00540954593036434,-0.0646837186561729,-0.0434782986091447,1.8878159442378e-23
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,GCC1,GRIP and coiled-coil domain-containing protein 1,39929,0.116154826990876,0.0116188371082211,0.0933819062587627,0.138927747722989,1.96201084291083e-23
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TARBP2,RISC-loading complex subunit TARBP2,41839,0.0840821882091437,0.0084173869638434,0.0675841097600106,0.100580266658277,2.05866985636487e-23
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,RPL14,60S ribosomal protein L14,39638,0.0416616149236124,0.00416963434805673,0.0334891316014212,0.0498340982458036,2.08393249421438e-23
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ULBP2,UL16-binding protein 2,42016,0.041680464982992,0.00418009008289756,0.0334874884205128,0.0498734415454712,2.45672199628575e-23
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ATP6V1G1,V-type proton ATPase subunit G 1,39638,0.0776417048713096,0.00778589248087981,0.0623813556087852,0.092902054133834,2.53390768872125e-23
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ST3GAL1,"CMP-N-acetylneuraminate-beta-galactosamide-alpha-2,3-sialyltransferase 1",42070,-0.0452884198775599,0.00454471822979663,-0.0541960676079613,-0.0363807721471585,2.60974888220198e-23
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ATP6AP2,Renin receptor,41843,0.0416745695808982,0.00418693028196235,0.0334681862282519,0.0498809529335444,2.93876542583922e-23
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PLXNA4,Plexin-A4,42119,0.0851006602114513,0.00855107008492827,0.0683405628449919,0.101860757577911,2.96999017260813e-23
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PDGFC,Platelet-derived growth factor C,41843,0.0295478139964523,0.00297246459708202,0.0237217833861715,0.0353738446067331,3.34483229239796e-23
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CNP,"2',3'-cyclic-nucleotide 3'-phosphodiesterase",39627,0.0839777036568768,0.00844557985517922,0.0674243671407255,0.100531040173028,3.37409175484006e-23
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CHCHD10,"Coiled-coil-helix-coiled-coil-helix domain-containing protein 10, mitochondrial",39929,0.0441963894190305,0.00444618574936507,0.035481865350275,0.0529109134877861,3.45909166703368e-23
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TRIM24,Transcription intermediary factor 1-alpha,39735,0.0701350151074601,0.00705657990342137,0.0563041184967542,0.083965911718166,3.51882127702163e-23
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ATXN3,Ataxin-3,39929,0.0646551891210752,0.00651384658544602,0.051888049813601,0.0774223284285494,3.99508343519517e-23
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CLEC1B,C-type lectin domain family 1 member B,42249,0.100685890723671,0.0101526519568731,0.0807866928881999,0.120585088559142,4.19517068932038e-23
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CTSZ,Cathepsin Z,42168,0.033998318551045,0.00343055896480522,0.0272744229800268,0.0407222141220633,4.49200966781535e-23
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,IDO1,"Indoleamine 2,3-dioxygenase 1",39638,0.0662992956708437,0.006691255119277,0.0531844356370608,0.0794141557046266,4.77824694499203e-23
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TNF,Tumor necrosis factor,41880,0.0382550199429699,0.00386604432949419,0.0306775730571613,0.0458324668287785,5.24927583924608e-23
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CEMIP2,Cell surface hyaluronidase,39657,0.0342360830608381,0.00345891847471515,0.0274566028503964,0.0410155632712798,5.29700418978559e-23
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,KAZN,Kazrin,39930,0.11083795344978,0.0112007542658873,0.0888844750886411,0.132791431810919,5.39255476344665e-23
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SNCG,Gamma-synuclein,42016,0.0700232922735699,0.00709354675094071,0.0561199406417261,0.0839266439054137,6.6283686672795e-23
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,DUT,"Deoxyuridine 5'-triphosphate nucleotidohydrolase, mitochondrial",39930,0.109589724359645,0.011107745363248,0.0878185434476795,0.131360905271611,7.22155082275749e-23
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CANT1,Soluble calcium-activated nucleotidase 1,42084,0.0209783655392326,0.00213134041238279,0.0168009383309624,0.0251557927475029,8.7864944857027e-23
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,DKK1,Dickkopf-related protein 1,42249,0.061528383645131,0.00626695718340585,0.0492451475656555,0.0738116197246065,1.12077786153925e-22
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,KRT5,"Keratin, type II cytoskeletal 5",41839,0.0557351223302869,0.00567808492732612,0.0446060758727277,0.0668641687878461,1.14999678375238e-22
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ACP5,Tartrate-resistant acid phosphatase type 5,42211,0.0345458540018525,0.00352253477422469,0.0276416858443721,0.0414500221593329,1.24711761159211e-22
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,USP25,Ubiquitin carboxyl-terminal hydrolase 25,39919,0.0756259519657072,0.0077141857200827,0.0605061479543451,0.0907457559770693,1.33782634088613e-22
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SERPINA9,Serpin A9,42025,0.0753029294148975,0.00769213011406979,0.0602263543913207,0.0903795044384743,1.48460501236063e-22
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,HEXIM1,Protein HEXIM1,42119,0.0839789774021161,0.00857942453279947,0.0671633053178292,0.100794649486403,1.50025975585396e-22
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,AMN,Protein amnionless,41913,0.0489665261372054,0.00501390835533336,0.0391392657607521,0.0587937865136588,1.87155136100814e-22
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,COLEC12,Collectin-12,42123,0.0284196160175828,0.00291024301439683,0.022715539709365,0.0341236923258006,1.88055073303626e-22
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ASS1,Argininosuccinate synthase,39575,0.0806575010967324,0.00826074656343523,0.0644664378323993,0.0968485643610654,1.98369021418261e-22
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,MAPK9,Mitogen-activated protein kinase 9,42119,0.0444185112912353,0.0045532330670342,0.0354941744798483,0.0533428481026224,2.07405454472589e-22
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,AP3B1,AP-3 complex subunit beta-1,39930,0.0803372505988286,0.0082327204705976,0.0642011184764573,0.0964733827211999,2.08292064944365e-22
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PALM2,Paralemmin-2,39929,0.0403230956187812,0.00413596145121311,0.0322166111744035,0.0484295800631589,2.27219739708687e-22
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,EHBP1,EH domain-binding protein 1,39958,0.0778263594757937,0.00799629245904122,0.0621536262560729,0.0934990926955144,2.67002261283861e-22
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SERPINA3,Alpha-1-antichymotrypsin,39951,-0.0153964756551271,0.00158460589534141,-0.0185023032099963,-0.0122906481002579,3.13688376212738e-22
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ASPN,Asporin,39958,-0.0288484308162118,0.0029690917655047,-0.034667850676601,-0.0230290109558226,3.13751026593458e-22
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CMIP,C-Maf-inducing protein,39919,0.0869870263962911,0.00896648996437301,0.06941270606612,0.104561346726462,3.62944643118868e-22
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,IL4R,Interleukin-4 receptor subunit alpha,42119,0.0385944177619867,0.00398142639017945,0.030790822037235,0.0463980134867384,3.78907695472822e-22
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,GMPR,GMP reductase 1,42296,0.0490553424295707,0.00506152485249309,0.0391347537186842,0.0589759311404571,3.84795638003156e-22
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,FGR,Tyrosine-protein kinase Fgr,41839,0.0605223932110413,0.00624974017077568,0.0482729024763209,0.0727718839457616,4.17549227894479e-22
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,VWA1,von Willebrand factor A domain-containing protein 1,42247,0.043489740150171,0.00449170435091021,0.0346859996223869,0.052293480677955,4.22581560007433e-22
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,KCTD5,BTB/POZ domain-containing protein KCTD5,39739,0.0474986640162813,0.00490754709932317,0.0378798717016079,0.0571174563309547,4.53660155007221e-22
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SNAPIN,SNARE-associated protein Snapin,39934,0.0603097837277107,0.00623919223130005,0.0480809669543626,0.0725386005010588,5.09938888427468e-22
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,FABP5,Fatty acid-binding protein 5,42218,0.0683495020516569,0.00707946766812786,0.0544737454221264,0.0822252586811875,5.52681179571883e-22
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,BRAP,BRCA1-associated protein,39813,0.113592952338994,0.0117649554578043,0.0905336396416974,0.13665226503629,5.68900933267751e-22
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CCL14,C-C motif chemokine 14,42152,0.0414770794534998,0.00429925255432641,0.03305054444702,0.0499036144599795,5.92497949174493e-22
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,VSIR,V-type immunoglobulin domain-containing suppressor of T-cell activation,42119,0.0628767991771586,0.00652556409097139,0.0500866935588547,0.0756669047954626,6.66045083807948e-22
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,RNASE1,Ribonuclease pancreatic,39990,0.0254571059801054,0.00264191946759526,0.0202789438236187,0.0306352681365921,6.8391098262565e-22
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,QDPR,Dihydropteridine reductase,42081,0.0431993960276384,0.00448509256555146,0.0344086145991575,0.0519901774561192,6.90514202507452e-22
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,NRP1,Neuropilin-1,42230,-0.0279581417739588,0.00290421953550074,-0.0336504120635402,-0.0222658714843773,7.23718698470847e-22
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,IL18BP,Interleukin-18-binding protein,42217,0.0321283006183342,0.00333826071296806,0.0255853096209168,0.0386712916157516,7.41296180781658e-22
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,LTBP2,Latent-transforming growth factor beta-binding protein 2,42310,-0.032797680864444,0.00340967253845648,-0.0394806390398187,-0.0261147226890693,7.79021650396756e-22
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,NUDT5,ADP-sugar pyrophosphatase,42137,0.0509294839827053,0.00530658520140162,0.0405285769879581,0.0613303909774524,9.61387101548236e-22
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TNFRSF1B,Tumor necrosis factor receptor superfamily member 1B,42137,0.0376470582483413,0.00392629315668193,0.0299515236612448,0.0453425928354379,1.0480580813945e-21
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,DAG1,Dystroglycan,42185,0.0482847183355077,0.00504545009397618,0.0383956361513143,0.058173800519701,1.25137366520209e-21
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ERBB3,Receptor tyrosine-protein kinase erbB-3,42084,0.019704958430936,0.00205954489170109,0.0156682504432019,0.0237416664186701,1.28113584344716e-21
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,AHSP,Alpha-hemoglobin-stabilizing protein,42115,0.0817509255195517,0.00856061267300937,0.0649721246804533,0.09852972635865,1.52169218037938e-21
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PENK,Proenkephalin-A,39736,0.03162123296347,0.00331312266467521,0.0251275125407066,0.0381149533862334,1.65690090199412e-21
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,EIF4B,Eukaryotic translation initiation factor 4B,42016,0.0568946703597697,0.00596442166269851,0.0452044039008806,0.0685849368186588,1.68710622440332e-21
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,HBEGF,Proheparin-binding EGF-like growth factor,42224,0.0739483226047435,0.0077611138284727,0.0587365395009371,0.08916010570855,1.86913968069635e-21
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CCL21,C-C motif chemokine 21,42185,0.0387569585215242,0.00406968122561085,0.0307803833193269,0.0467335337237215,1.95622727333041e-21
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,BLOC1S3,Biogenesis of lysosome-related organelles complex 1 subunit 3,39929,0.0419132115387898,0.00440469244753132,0.0332800143416284,0.0505464087359512,2.17186121113156e-21
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,F10,Coagulation factor X,39990,0.0294283049825121,0.00309894709460696,0.0233543686770825,0.0355022412879418,2.6093978740414e-21
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SH2B3,SH2B adapter protein 3,41843,0.0993647822167668,0.0104903711731542,0.0788036547173845,0.119925909716149,3.20450387645572e-21
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,COCH,Cochlin,39958,0.0464274970293328,0.00490101275091615,0.0368215120375372,0.0560334820211285,3.25495965568574e-21
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,IGF2R,Cation-independent mannose-6-phosphate receptor,42137,0.0241553847425502,0.00255241544744826,0.0191526504655516,0.0291581190195488,3.45486109740994e-21
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PPP1R12A,Protein phosphatase 1 regulatory subunit 12A,42181,0.095458299399401,0.0100959070703575,0.0756703215415003,0.115246277257302,3.74670355113535e-21
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CD207,C-type lectin domain family 4 member K,41832,0.0391592701834758,0.00415467226013767,0.0310161125536059,0.0473024278133456,4.98897521343807e-21
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,FKBP4,Peptidyl-prolyl cis-trans isomerase FKBP4,42016,0.0430167146773367,0.00456901379246692,0.0340614476441015,0.0519719817105718,5.4974878750523e-21
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,RABEP1,Rab GTPase-binding effector protein 1,39736,0.0775149979242731,0.00823257604010833,0.0613791488856608,0.0936508469628854,5.62621110727896e-21
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ICAM4,Intercellular adhesion molecule 4,42119,-0.0525389781047537,0.00558507171620831,-0.063485718668522,-0.0415922375409854,5.91382867015672e-21
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TIMM8A,Mitochondrial import inner membrane translocase subunit Tim8 A,39929,0.0871497763402825,0.00927157526926231,0.0689774888125284,0.105322063868037,6.52159487614983e-21
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,GLO1,Lactoylglutathione lyase,41900,0.0564310832017239,0.00600532512315128,0.0446606459603473,0.0682015204431004,6.52734398714275e-21
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CHL1,Neural cell adhesion molecule L1-like protein,42189,-0.0298322350504385,0.00318785638982956,-0.0360804335745044,-0.0235840365263726,9.37399075980725e-21
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,THBS2,Thrombospondin-2,42137,0.0383947211752739,0.00410797400708957,0.0303430921213783,0.0464463502291694,1.04688234201731e-20
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SIGLEC10,Sialic acid-binding Ig-like lectin 10,42119,0.034339029627765,0.00367502683463252,0.0271359770318853,0.0415420822236447,1.07198178826948e-20
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,NFE2,Transcription factor NF-E2 45 kDa subunit,39638,0.0740134762139646,0.00792965323702623,0.0584713558693932,0.089555596558536,1.21711585976395e-20
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TFF1,Trefoil factor 1,42084,0.0797154729546008,0.00855672278681863,0.0629442962924363,0.0964866496167653,1.39116804614462e-20
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SPOCK1,Testican-1,42016,-0.0258395777862397,0.00277474653901773,-0.0312780810027144,-0.0204010745697649,1.44137800068949e-20
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ERBB2,Receptor tyrosine-protein kinase erbB-2,42181,0.0241554150588986,0.00259687856490614,0.0190655330716826,0.0292452970461146,1.59031494353847e-20
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TNIP1,TNFAIP3-interacting protein 1,39929,0.0877273828901566,0.00943242184744544,0.0692398360691635,0.10621492971115,1.65181331655925e-20
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TGFBR2,TGF-beta receptor type-2,42181,0.0338726999937225,0.00364463626949921,0.0267292129055041,0.041016187081941,1.71153825517122e-20
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,DNER,Delta and Notch-like epidermal growth factor-related receptor,42089,-0.0256795038690493,0.00276359126867532,-0.031096142755653,-0.0202628649824457,1.74174796723251e-20
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PCDH17,Protocadherin-17,42145,0.0370594231368929,0.00398942401872289,0.029240152060196,0.0448786942135897,1.78451840923351e-20
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,FOXO1,Forkhead box protein O1,42119,0.0855547922777013,0.00921403594152571,0.0674952818323109,0.103614302723092,1.85547393591269e-20
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,REG1B,Lithostathine-1-beta,42310,0.0563187871783141,0.0060664960159188,0.0444284549871132,0.0682091193695149,1.88131075467769e-20
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ILKAP,Integrin-linked kinase-associated serine/threonine phosphatase 2C,41825,0.0583312030724256,0.00628698971482414,0.0460087032313703,0.070653702913481,1.99025397793154e-20
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TFF3,Trefoil factor 3,42143,0.0355874639402208,0.00383723578528334,0.0280664818010655,0.0431084460793762,2.05585738769242e-20
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ADGRD1,Adhesion G-protein coupled receptor D1,39736,0.0406861566412914,0.00438658880086472,0.0320884425915966,0.0492838706909863,2.10102796060306e-20
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SLMAP,Sarcolemmal membrane-associated protein,39930,0.082701746081836,0.00891839296312399,0.065221695874113,0.100181796289559,2.1335079877904e-20
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ECHS1,"Enoyl-CoA hydratase, mitochondrial",39638,0.0959919249981037,0.0103528674782686,0.0757003047406972,0.11628354525551,2.16598148405857e-20
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PCBP2,Poly(rC)-binding protein 2,39934,0.0721840803914254,0.00781036755242569,0.056875759988671,0.0874924007941797,2.84781658895512e-20
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,GAPDH,Glyceraldehyde-3-phosphate dehydrogenase,39485,0.0304102632471911,0.00329308203140976,0.023955822465628,0.0368647040287543,3.07333580189997e-20
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ANXA2,Annexin A2,39492,0.0694658725173675,0.00752869272985286,0.0547096347668559,0.0842221102678791,3.30244926821918e-20
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SYTL4,Synaptotagmin-like protein 4,39958,0.0715348880583307,0.00776577835967225,0.0563139624733731,0.0867558136432883,3.777358644153e-20
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CTSF,Cathepsin F,42181,0.0394753114403412,0.00428884340903468,0.0310691783586332,0.0478814445220491,3.9389723170868e-20
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PLA2G15,Phospholipase A2 group XV,42181,0.0268525311849437,0.00292439213742429,0.0211207225955921,0.0325843397742953,4.82374925807601e-20
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SLITRK2,SLIT and NTRK-like protein 2,42262,0.0396229063080084,0.00431643047303987,0.0311627025808503,0.0480831100351666,4.94189588425853e-20
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,LGALS8,Galectin-8,42249,0.0593292396936655,0.00647369526046572,0.0466407969831526,0.0720176824041783,5.67000626471911e-20
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TALDO1,Transaldolase,39948,0.0431730973618785,0.00471574376327077,0.0339302395858678,0.0524159551378893,6.35829253817205e-20
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SELP,P-selectin,42217,0.0542990996900274,0.00593422722766924,0.0426680143237957,0.0659301850562591,6.4823614481491e-20
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,NCAN,Neurocan core protein,42249,-0.0364580993645078,0.00398688992492636,-0.0442724036173634,-0.0286437951116521,6.8266149803661e-20
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PQBP1,Polyglutamine-binding protein 1,41843,0.0548603181503242,0.00602058989197412,0.0430599619620549,0.0666606743385935,9.22558713847197e-20
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,DKK4,Dickkopf-related protein 4,41992,0.0446259104146504,0.0049023190148048,0.0350173651456329,0.0542344556836678,1.00123095888294e-19
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TAX1BP1,Tax1-binding protein 1,39929,0.0603213214765399,0.00662745549083126,0.0473315087145107,0.0733111342385692,1.03738594398864e-19
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PDLIM7,PDZ and LIM domain protein 7,42185,0.121274038260399,0.0133298029531434,0.0951476244722378,0.14740045204856,1.04673702120392e-19
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,METAP2,Methionine aminopeptidase 2,42247,0.0539281847543488,0.00593177140347654,0.0423019128035348,0.0655544567051628,1.11070399664047e-19
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,OSM,Oncostatin-M,42051,0.06673741410554,0.00734968495965896,0.0523320315846085,0.0811427966264716,1.23158804599604e-19
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CCL25,C-C motif chemokine 25,42296,0.0473980916034823,0.00522416114878469,0.0371587357518643,0.0576374474551003,1.31521652675654e-19
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CCL4,C-C motif chemokine 4,42148,0.0600106247403636,0.00661743693154496,0.0470404483545355,0.0729808011261917,1.36973507132493e-19
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,IFNGR2,Interferon gamma receptor 2,42016,0.0508463369866448,0.00560950655371745,0.0398517041413586,0.061840969831931,1.42556627305145e-19
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,WARS,"Tryptophan--tRNA ligase, cytoplasmic",42137,0.0372476074961915,0.0041095382810211,0.0291929124653901,0.0453023025269928,1.43199705204099e-19
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CCL22,C-C motif chemokine 22,41991,0.0499773266487021,0.0055160798686913,0.0391658101060672,0.060788843191337,1.47908688008834e-19
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,FGD3,"FYVE, RhoGEF and PH domain-containing protein 3",39934,0.0785649185178008,0.00867381179524153,0.0615642473991274,0.0955655896364742,1.54977167068131e-19
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,NSFL1C,NSFL1 cofactor p47,42249,0.0605552448810647,0.00668771118727114,0.0474473309540133,0.0736631588081161,1.55266474828305e-19
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TP53I3,Quinone oxidoreductase PIG3,39513,0.0514725146120954,0.00568582581374771,0.0403282960171499,0.0626167332070409,1.63040473501368e-19
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,GORASP2,Golgi reassembly-stacking protein 2,39930,0.0461870125502348,0.00510680605405767,0.0361776726842818,0.0561963524161879,1.75240948823604e-19
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,EBAG9,Receptor-binding cancer antigen expressed on SiSo cells,42016,0.0909984599260137,0.01008094310772,0.0712398114348824,0.110757108417145,2.00584336785458e-19
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,GOLGA3,Golgin subfamily A member 3,39934,0.0749758416756799,0.00830995601365054,0.0586883278889248,0.091263355462435,2.1356273858684e-19
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TRAF2,TNF receptor-associated factor 2,42119,0.0665144678355958,0.00737821362278382,0.0520531691349395,0.080975766536252,2.23036633246214e-19
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SIAE,Sialate O-acetylesterase,42147,0.044560977268299,0.00494511562323763,0.0348685506467532,0.0542534038898447,2.30949599237674e-19
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ZBTB17,Zinc finger and BTB domain-containing protein 17,41900,0.0402253281750214,0.00447211524451916,0.0314599822957638,0.0489906740542789,2.68571033202803e-19
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TNFRSF9,Tumor necrosis factor receptor superfamily member 9,42016,0.0409954981198846,0.00455950456534284,0.0320588691718127,0.0499321270679566,2.76863562911838e-19
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,EVI5,Ecotropic viral integration site 5 protein homolog,39657,0.0870239123230777,0.00970396263585367,0.0680041455568045,0.106043679089351,3.50911134529682e-19
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,FAS,Tumor necrosis factor receptor superfamily member 6,42272,0.0316868492791922,0.0035364875805442,0.0247553336213255,0.0386183649370588,3.66259457848504e-19
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,NPDC1,Neural proliferation differentiation and control protein 1,42145,0.031714397096046,0.00354293171645541,0.0247702509317934,0.0386585432602986,3.95937762118405e-19
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TNFSF13,Tumor necrosis factor ligand superfamily member 13,42185,0.0262825964796448,0.00293762929521164,0.02052484306103,0.0320403498982596,4.12473290968091e-19
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CSPG4,Chondroitin sulfate proteoglycan 4,39966,-0.0314740995994593,0.00351965153312913,-0.0383726166043924,-0.0245755825945262,4.39598056560596e-19
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CSTB,Cystatin-B,41959,0.0412370492680778,0.00462014839402916,0.0321815584157807,0.050292540120375,5.00969662782491e-19
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CD80,T-lymphocyte activation antigen CD80,39958,0.032612697707085,0.00365661503804149,0.0254457322325237,0.0397796631816463,5.43232977079525e-19
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,IMPACT,Protein IMPACT,39929,0.0515574233693288,0.0057893650585562,0.0402102678545586,0.0629045788840989,6.12095388845051e-19
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,IL1RL2,Interleukin-1 receptor-like 2,41913,0.0356532273766612,0.00400752586644923,0.0277984766784207,0.0435079780749017,6.49518180957635e-19
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PLIN1,Perilipin-1,41839,0.0321005607178964,0.0036136823850138,0.0250177432432694,0.0391833781925235,7.33435038097404e-19
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,OPHN1,Oligophrenin-1,39929,0.102820181314402,0.0115838205654302,0.080115893006159,0.125524469622645,7.95711659860469e-19
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,IL12RB1,Interleukin-12 receptor subunit beta-1,41913,0.035420631134761,0.00400013187278386,0.0275803726641046,0.0432608896054174,9.42702359544656e-19
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,RAPGEF2,Rap guanine nucleotide exchange factor 2,39757,0.0511337162486766,0.0057737190771576,0.0398172268574477,0.0624502056399055,9.52199191053013e-19
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,KRT8,"Keratin, type II cytoskeletal 8",39586,0.0794284314816067,0.00896934606166806,0.0618485132007373,0.0970083497624761,9.6062127677174e-19
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,AP2B1,AP-2 complex subunit beta,39649,0.0460095193354974,0.00519797279585895,0.0358214926556138,0.0561975460153809,9.95587729263622e-19
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,GDNF,Glial cell line-derived neurotrophic factor,41839,0.0359849692715367,0.00407878245247588,0.027990555664684,0.0439793828783894,1.25833687841144e-18
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TFF2,Trefoil factor 2,42166,0.054751067522638,0.00621617194518567,0.0425673705100741,0.0669347645352019,1.42885077126588e-18
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,LRRFIP1,Leucine-rich repeat flightless-interacting protein 1,39919,0.0460765959572348,0.00523142810321503,0.0358229968749334,0.0563301950395363,1.46369221640323e-18
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PACS2,Phosphofurin acidic cluster sorting protein 2,39575,0.0589353882481792,0.0067027760238126,0.0457979472415065,0.0720728292548519,1.67806609473752e-18
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,IGFBP6,Insulin-like growth factor-binding protein 6,42129,0.0292073979181485,0.00332751271108948,0.0226854730044132,0.0357293228318839,1.86898608642129e-18
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,FARSA,Phenylalanine--tRNA ligase alpha subunit,39649,0.0657464505548484,0.00749096434127896,0.0510641604459416,0.0804287406637552,1.92961509440616e-18
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,IGDCC4,Immunoglobulin superfamily DCC subclass member 4,39966,-0.0254698352170858,0.00290362528474754,-0.0311609407751909,-0.0197787296589806,2.00955982012878e-18
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PROC,Vitamin K-dependent protein C,42199,0.0239085407488147,0.00273081477326378,0.0185561437932177,0.0292609377044117,2.27737583721106e-18
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,GCHFR,GTP cyclohydrolase 1 feedback regulatory protein,39410,0.0464210064607677,0.00531305771780902,0.036007413333862,0.0568345995876734,2.74330000327265e-18
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CEACAM8,Carcinoembryonic antigen-related cell adhesion molecule 8,41900,0.045155141046016,0.00517197230334353,0.0350180753314627,0.0552922067605694,2.8289782076797e-18
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,LRP1,Prolow-density lipoprotein receptor-related protein 1,42070,-0.0248482259080563,0.00284894151009063,-0.0304321512678339,-0.0192643005482786,3.05280625968248e-18
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,DNMBP,Dynamin-binding protein,42016,0.0562027985504063,0.00644411299655692,0.0435723370771548,0.0688332600236579,3.06335540942963e-18
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,MASP1,Mannan-binding lectin serine protease 1,41997,0.0213493814068691,0.0024488026207062,0.0165497282702849,0.0261490345434532,3.15332405398685e-18
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TRIM25,E3 ubiquitin/ISG15 ligase TRIM25,39930,0.100750865081591,0.0115733222133049,0.0780671535435132,0.123434576619668,3.60074369389481e-18
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,FLT4,Vascular endothelial growth factor receptor 3,42181,0.0315078122731093,0.00362116436935558,0.0244103301091724,0.0386052944370463,3.66392759542971e-18
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CRELD2,Protein disulfide isomerase CRELD2,42166,0.0482467553904706,0.00555307050046031,0.0373627372095684,0.0591307735713728,4.09598970059908e-18
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CALCA,Calcitonin,41997,0.0640682356206879,0.0073782745520228,0.0496068174987232,0.0785296537426526,4.28264989299846e-18
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,IQGAP2,Ras GTPase-activating-like protein IQGAP2,42070,0.0494718991339743,0.00571250984730861,0.0382753798332495,0.0606684184346992,5.23664380036048e-18
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,IDS,Iduronate 2-sulfatase,42296,-0.00847477031442386,0.00097872063544049,-0.0103930627598872,-0.0065564778689605,5.28454000845452e-18
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SOST,Sclerostin,42129,0.0357047774317186,0.00412419762913226,0.0276213500786193,0.0437882047848178,5.36766503117147e-18
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,RAB27B,Ras-related protein Rab-27B,39958,0.0762741934230569,0.00881348047098472,0.0589997716999269,0.093548615146187,5.62826594550198e-18
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,APOA2,Apolipoprotein A-II,39990,-0.0457151260173131,0.0052839380874841,-0.0560716446687819,-0.0353586073658443,5.75260798685949e-18
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,FAM13A,Protein FAM13A,39930,0.0627850792295066,0.00726356505528215,0.0485484917211536,0.0770216667378596,6.16488696019137e-18
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ANKRD54,Ankyrin repeat domain-containing protein 54,41843,0.0521100234569645,0.00603056488837299,0.0402901162757535,0.0639299306381756,6.20641756505917e-18
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CEACAM16,Carcinoembryonic antigen-related cell adhesion molecule 16,39930,0.0781193164142215,0.00904173029698514,0.0603975250321306,0.0958411077963123,6.38170916245243e-18
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ESYT2,Extended synaptotagmin-2,39929,0.076920868154787,0.00890538949901056,0.0594663047367263,0.0943754315728477,6.51067922044813e-18
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SPARCL1,SPARC-like protein 1,42169,-0.0251110608002216,0.00290864140974226,-0.0308119979633164,-0.0194101236371267,6.62085884182218e-18
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TSPAN8,Tetraspanin-8,39930,0.0879675141290317,0.0101962369296369,0.0679828897469434,0.10795213851112,7.10864060368863e-18
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CLIP2,CAP-Gly domain-containing linker protein 2,42119,0.103524036055696,0.0120245152848787,0.0799559860973338,0.127092086014058,8.14787951980918e-18
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CD6,T-cell differentiation antigen CD6,42284,0.0476205621895936,0.00554202542798031,0.0367581923507522,0.058482932028435,9.41219432548404e-18
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,KLF4,Krueppel-like factor 4,39586,0.0371985688379142,0.0043395400758027,0.028693070289341,0.0457040673864875,1.15310458730838e-17
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SEZ6L2,Seizure 6-like protein 2,42070,-0.0220653580930574,0.00257641840690839,-0.0271151381705979,-0.017015578015517,1.20377387707068e-17
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ANGPTL3,Angiopoietin-related protein 3,42189,-0.0313569218592671,0.00366294757070286,-0.0385362990978447,-0.0241775446206895,1.2426100334305e-17
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,BTN2A1,Butyrophilin subfamily 2 member A1,42185,0.0247668370752795,0.00289649235355207,0.0190897120623174,0.0304439620882415,1.35385357831236e-17
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,NRP2,Neuropilin-2,42137,-0.0255862161526976,0.00299237366255326,-0.031451268531302,-0.0197211637740932,1.35615650101736e-17
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,OGA,Protein O-GlcNAcase,39930,0.0652520316132476,0.00763414388514714,0.0502891095983592,0.080214953628136,1.42016887828522e-17
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,NELL1,Protein kinase C-binding protein NELL1,42181,-0.0383121673756812,0.00448484963379819,-0.0471024726579257,-0.0295218620934368,1.45117641994449e-17
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CD34,Hematopoietic progenitor cell antigen CD34,42211,-0.0217903393256309,0.00255238715905091,-0.0267930181573707,-0.0167876604938912,1.5190589594237e-17
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CD27,CD27 antigen,42181,0.0387772450440849,0.00454596157224959,0.0298671603624757,0.0476873297256941,1.61642014768497e-17
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,IGBP1,Immunoglobulin-binding protein 1,39934,0.0547319775206673,0.00642021456894665,0.0421483569655318,0.0673155980758027,1.72232783730283e-17
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ATG4A,Cysteine protease ATG4A,41843,0.0527109761758873,0.00619764719687434,0.0405635876700136,0.064858364681761,2.00923614656359e-17
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,IRAK1,Interleukin-1 receptor-associated kinase 1,41913,0.0631865327424535,0.0074298254715809,0.048624074818155,0.0777489906667521,2.01773403231374e-17
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,NCF2,Neutrophil cytosol factor 2,42097,0.0751834607230504,0.00884329063711184,0.0578506110743112,0.0925163103717896,2.06201744925706e-17
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CCN2,CCN family member 2,42146,0.0510442537451531,0.00600871082730615,0.0392671805236331,0.0628213269666732,2.18323395798795e-17
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SHISA5,Protein shisa-5,39966,0.0235135048797222,0.00277017220756292,0.0180839673528988,0.0289430424065455,2.36069813109672e-17
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,NIT1,Deaminated glutathione amidase,39638,0.0402856329893004,0.00474748458170069,0.0309805632091671,0.0495907027694338,2.41842831328553e-17
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CARHSP1,Calcium-regulated heat-stable protein 1,41839,0.0449657998524612,0.00530105634121079,0.0345757294236881,0.0553558702812344,2.43773288260078e-17
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ENTR1,Endosome-associated-trafficking regulator 1,39638,0.0559371558615897,0.00661408095607062,0.0429735571876913,0.0689007545354881,3.08134465627527e-17
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ENPP7,Ectonucleotide pyrophosphatase/phosphodiesterase family member 7,41768,0.0752917240805811,0.00891984855525127,0.0578088209122886,0.0927746272488736,3.4751642713112e-17
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SEPTIN8,Septin-8,39906,0.0293805584472327,0.00348002562643233,0.0225597082194254,0.0362014086750401,3.48097295228971e-17
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,NCK2,Cytoplasmic protein NCK2,42185,0.0957608076590696,0.0113669745457813,0.0734815375493382,0.118040077768801,3.98465036807233e-17
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PAMR1,Inactive serine protease PAMR1,42137,0.023690721802299,0.00281233474453251,0.0181785457030153,0.0292028979015827,4.00681886875143e-17
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CACNB3,Voltage-dependent L-type calcium channel subunit beta-3,39934,0.0760374995200304,0.00902750304368597,0.0583435935544059,0.0937314054856549,4.11586416822486e-17
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,IL18,Interleukin-18,42069,0.0396717329656184,0.00471278129523567,0.0304346816269565,0.0489087843042803,4.21685941290696e-17
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CD83,CD83 antigen,42119,0.0308997659974969,0.00367214695531883,0.023702357965072,0.0380971740299218,4.33401524233841e-17
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,RFC4,Replication factor C subunit 4,39919,0.0199489448357998,0.00237140628552439,0.015300988516172,0.0245969011554276,4.50315182609201e-17
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,AZI2,5-azacytidine-induced protein 2,39934,0.0500795467236968,0.00595352443350164,0.0384106388340336,0.06174845461336,4.5230093546713e-17
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,MOCS2,Molybdopterin synthase catalytic subunit,39736,0.0604736904299983,0.00718928946142664,0.0463826830856021,0.0745646977743945,4.53634965594389e-17
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,41843,0.0692241902802942,0.00823738232891921,0.0530789209156126,0.0853694596449759,4.76585212102278e-17
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PILRA,Paired immunoglobulin-like type 2 receptor alpha,42137,0.0380644370392143,0.00453785862764849,0.0291702341290233,0.0469586399494054,5.42156482149785e-17
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CCL5,C-C motif chemokine 5,42217,0.0899566428789332,0.0107336278969528,0.0689187322009058,0.110994553556961,5.7670657122705e-17
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,RABGAP1L,Rab GTPase-activating protein 1-like,41913,0.0528518956210136,0.00632097910406665,0.040462776577043,0.0652410146649843,6.8122374498854e-17
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,GIT1,ARF GTPase-activating protein GIT1,39657,0.086611997439584,0.010367608837864,0.0662914841173706,0.106932510761797,7.38085863145452e-17
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PNLIP,Pancreatic triacylglycerol lipase,39990,0.0593688507134061,0.00710803201315362,0.0454371079676251,0.0733005934591872,7.46486875379709e-17
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,INPP5J,"Phosphatidylinositol 4,5-bisphosphate 5-phosphatase A",39934,0.0362048696335391,0.00434189343364363,0.0276947585035976,0.0447149807634806,8.3925176192238e-17
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,LARP1,La-related protein 1,39919,0.0555405663715732,0.00666240111351903,0.0424822601890759,0.0685988725540705,8.54165311308802e-17
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,HNRNPUL1,Heterogeneous nuclear ribonucleoprotein U-like protein 1,39934,0.0436459546145315,0.00523833577175129,0.0333788165018989,0.053913092727164,8.86136431393974e-17
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,STIP1,Stress-induced-phosphoprotein 1,42105,0.0565911871892045,0.00679681685189422,0.0432694261594918,0.0699129482189171,9.15037310690082e-17
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TACSTD2,Tumor-associated calcium signal transducer 2,40518,-0.0276084188664621,0.00331593616903613,-0.0341076537577729,-0.0211091839751513,9.27347768498803e-17
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,MSTN,Growth/differentiation factor 8,41900,0.047712256881291,0.00574445945134455,0.0364531163566557,0.0589713974059263,1.08684841949333e-16
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SCGN,Secretagogin,41913,0.0392021395339734,0.00471998737349506,0.0299509642819231,0.0484533147860238,1.08881857986472e-16
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SCARA5,Scavenger receptor class A member 5,42249,0.026958117836373,0.00324822481974192,0.0205915971896788,0.0333246384830671,1.14449732847171e-16
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TNFRSF4,Tumor necrosis factor receptor superfamily member 4,42284,0.0338561316500191,0.00408070295277491,0.0258579538625803,0.0418543094374579,1.17036710882533e-16
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,DNAJB2,DnaJ homolog subfamily B member 2,39736,0.0464941159784863,0.00560467816762472,0.0355089467699418,0.0574792851870307,1.20482752303025e-16
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,DGKA,Diacylglycerol kinase alpha,39657,0.0490943277259784,0.00592026633551884,0.0374906057083614,0.0606980497435953,1.2364132773914e-16
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SKAP2,Src kinase-associated phosphoprotein 2,42185,0.0916822514690327,0.0110626515652412,0.0699994544011601,0.113365048536905,1.26371494397403e-16
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PLAUR,Urokinase plasminogen activator surface receptor,42040,0.0250995642658092,0.00303046321356117,0.0191598563672293,0.0310392721643891,1.32034302912831e-16
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,DOK2,Docking protein 2,42145,0.108345196098238,0.0130875873524765,0.0826935248873839,0.133996867309092,1.36368597772429e-16
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,RARRES1,Retinoic acid receptor responder protein 1,41843,0.0278798023495413,0.00336794943568387,0.0212786214556009,0.0344809832434816,1.37209873304125e-16
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,BIRC2,Baculoviral IAP repeat-containing protein 2,41843,0.0556069870498645,0.00673181392989132,0.0424126317472775,0.0688013423524515,1.58977138367607e-16
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,STK11,Serine/threonine-protein kinase STK11,41900,0.0640653456383696,0.00776262420113241,0.0488506022041501,0.0792800890725891,1.6884607708521e-16
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,KLRD1,Natural killer cells antigen CD94,42296,0.0413987829520839,0.00502028880645146,0.031559016891439,0.0512385490127287,1.78158522737681e-16
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,AMPD3,AMP deaminase 3,39929,0.0606476111502684,0.00735722710834491,0.0462274460179124,0.0750677762826245,1.86017138537503e-16
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PCYT2,Ethanolamine-phosphate cytidylyltransferase,39930,0.0667559961308709,0.00810363292933578,0.0508728755893728,0.082639116672369,1.94687215081729e-16
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,MMP3,Stromelysin-1,42137,-0.0435462101987545,0.00528818555561359,-0.0539110538877572,-0.0331813665097519,1.96520702416534e-16
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SEMA7A,Semaphorin-7A,42272,0.0250200501066214,0.00303901520262094,0.0190635803094843,0.0309765199037584,1.99105565603289e-16
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,EFEMP1,EGF-containing fibulin-like extracellular matrix protein 1,42203,-0.0280862902293687,0.00341472605543442,-0.0347791532980202,-0.0213934271607173,2.12696187334058e-16
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,NRCAM,Neuronal cell adhesion molecule,42145,0.025152824879797,0.00306123266391378,0.019152808858526,0.031152840901068,2.28288994692324e-16
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CD302,CD302 antigen,42070,0.0272502258620762,0.00331671185530849,0.0207494706256716,0.0337509810984808,2.29406296379785e-16
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,MAP4K5,Mitogen-activated protein kinase kinase kinase kinase 5,41997,0.0975679214087431,0.0118761553482483,0.0742906569261765,0.12084518589131,2.30639779270144e-16
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,VSIG4,V-set and immunoglobulin domain-containing protein 4,42113,0.0377547648687452,0.00460485690467436,0.0287292453355834,0.0467802844019069,2.64325907840586e-16
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CDC42BPB,Serine/threonine-protein kinase MRCK beta,39930,0.0900050675544627,0.0109780223892468,0.068488143671539,0.111521991437386,2.69250613356475e-16
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ANGPT2,Angiopoietin-2,42262,0.0325862498139473,0.00397645921258517,0.0247923897572804,0.0403801098706142,2.7321595552914e-16
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,LETM1,Mitochondrial proton/calcium exchanger protein,39934,0.0470244433108931,0.00574252442079812,0.0357690954461287,0.0582797911756574,2.92070281223439e-16
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,WDR46,WD repeat-containing protein 46,39919,0.0320365663787575,0.0039182313675402,0.0243568328983787,0.0397162998591362,3.2392606447927e-16
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,HCLS1,Hematopoietic lineage cell-specific protein,42296,0.0480591544584424,0.00588185917263128,0.0365307104800851,0.0595875984367997,3.33192338420566e-16
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,EPPK1,Epiplakin,39638,0.0646169050015398,0.00791798043131603,0.0490976633561603,0.0801361466469192,3.68993219683467e-16
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ZNRD2,Protein ZNRD2,39930,0.0608741911286661,0.00746236515090173,0.0462479554328987,0.0755004268244335,3.78113334386017e-16
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,WASF1,Wiskott-Aldrich syndrome protein family member 1,41900,0.0823889546860286,0.0101181828695604,0.0625573162616902,0.102220593110367,4.20909904141191e-16
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,NMNAT1,Nicotinamide/nicotinic acid mononucleotide adenylyltransferase 1,42016,0.0629157789579952,0.00773223642129043,0.047760595572266,0.0780709623437245,4.41310666895875e-16
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PLA2G10,Group 10 secretory phospholipase A2,42016,0.0503124451258301,0.00618739223383294,0.0381851563475175,0.0624397339041426,4.61207403703686e-16
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,MMP1,Interstitial collagenase,41693,0.0780246592525957,0.00959743158895042,0.0592136933382529,0.0968356251669385,4.6865967407561e-16
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CASP10,Caspase-10,41839,0.061731490119606,0.00759773244142196,0.0468399345344189,0.076623045704793,4.86849680652131e-16
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,UROD,Uroporphyrinogen decarboxylase,39736,0.0589075580577261,0.00725271596047063,0.0446922347752036,0.0731228813402485,5.06341679110835e-16
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TRIM58,E3 ubiquitin-protein ligase TRIM58,39919,0.0747983361076607,0.00922545848704857,0.0567164374730456,0.0928802347422759,5.68405974416495e-16
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ZHX2,Zinc fingers and homeoboxes protein 2,39929,0.0292559227439045,0.00360883991330928,0.0221825965138183,0.0363292489739907,5.73394980540487e-16
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SUSD2,Sushi domain-containing protein 2,42137,-0.0244466416323452,0.0030179471247045,-0.0303618179967661,-0.0185314652679244,5.94295736247599e-16
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CNTN5,Contactin-5,42170,-0.0319179970043144,0.00394158569529426,-0.0396435049670912,-0.0241924890415377,6.07274156147479e-16
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,OTUD7B,OTU domain-containing protein 7B,39934,0.054797019297878,0.00676768447366334,0.0415323577294978,0.0680616808662581,6.21573576949223e-16
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PFKFB2,"6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 2",42047,0.0651835640576761,0.00806131485917698,0.0493833869336892,0.080983741181663,6.6915787086928e-16
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,BTD,Biotinidase,39979,0.0176856875101005,0.00218926921559247,0.0133947198475393,0.0219766551726617,7.22661805218313e-16
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CRTAC1,Cartilage acidic protein 1,42310,-0.0265977311600326,0.00329504020813442,-0.0330560099679761,-0.0201394523520892,7.48492528135274e-16
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TSC22D1,TSC22 domain family protein 1,39934,0.0570483098231928,0.00706826783382528,0.0431945048688952,0.0709021147774903,7.6728456879756e-16
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,VSTM2L,V-set and transmembrane domain-containing protein 2-like protein,41900,0.0491216407180058,0.0060919567495704,0.0371814054888478,0.0610618759471637,8.05382264361202e-16
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,NAAA,N-acylethanolamine-hydrolyzing acid amidase,41954,-0.051432231728814,0.00638117704803843,-0.0639393387429694,-0.0389251247146587,8.27507265335789e-16
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SLIT2,Slit homolog 2 protein,41839,0.0443313349772978,0.00550598526560388,0.0335396038567142,0.0551230660978814,8.87461695754945e-16
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CEBPB,CCAAT/enhancer-binding protein beta,41900,0.032157995577512,0.00400451952582541,0.0243091373068942,0.0400068538481298,1.05259045234013e-15
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PIBF1,"Progesterone-induced-blocking factor 1, Isoform 4",39934,0.0672701437817388,0.00837567539209545,0.0508538200132317,0.0836864675502458,1.05711850698282e-15
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,STAMBP,STAM-binding protein,41997,0.0537473154021764,0.00669435524627682,0.0406263791194738,0.066868251684879,1.06636112215399e-15
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,RNF149,E3 ubiquitin-protein ligase RNF149,39638,0.0271164603490522,0.00338185943092674,0.0204880158644358,0.0337449048336686,1.18124581323562e-15
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,VTI1A,Vesicle transport through interaction with t-SNAREs homolog 1A,39736,0.0493606503631626,0.00615741489726002,0.037292117164533,0.0614291835617923,1.19711729534812e-15
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TNXB,Tenascin-X,42137,-0.0222707274942257,0.00278252112747091,-0.0277244689040687,-0.0168169860843827,1.30415620830852e-15
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CLEC6A,C-type lectin domain family 6 member A,41843,0.0403631771273547,0.00505016507017027,0.0304648535898209,0.0502615006648884,1.43185805514624e-15
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,S100A14,Protein S100-A14,39934,0.0443111277254143,0.00554314373617826,0.0334465660025049,0.0551756894483237,1.43453314654765e-15
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ITGB1,Integrin beta-1,42167,-0.0179255359067892,0.00224578439958282,-0.0223272733299716,-0.0135237984836069,1.55665048345188e-15
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,RILP,Rab-interacting lysosomal protein,42224,0.0498191406219128,0.00624407087917875,0.0375807616987225,0.0620575195451032,1.59719371934049e-15
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SFRP4,Secreted frizzled-related protein 4,39736,0.0340650639433196,0.00428080769576087,0.0256746808596283,0.0424554470270109,1.92367620097432e-15
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,MDK,Midkine,42129,0.0433273031554081,0.00544859551589744,0.0326480559442491,0.054006550366567,1.97989881192082e-15
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,NGRN,Neugrin,39929,0.0190514752508691,0.00239543547743383,0.0143564217150988,0.0237465287866394,1.98950751750267e-15
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,HSDL2,Hydroxysteroid dehydrogenase-like protein 2,39638,0.0415850903623707,0.00523564778786784,0.0313232206981497,0.0518469600265917,2.17056616523389e-15
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,LGALS3BP,Galectin-3-binding protein,39979,0.0264612987003493,0.00333225569663478,0.0199300775349452,0.0329925198657535,2.19474272012846e-15
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,RASSF2,Ras association domain-containing protein 2,41843,0.0482170191602837,0.00608183395372581,0.0362966246109811,0.0601374137095863,2.40379269796572e-15
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,NCR1,Natural cytotoxicity triggering receptor 1,42095,0.0323580549494115,0.00408264269787446,0.0243560752615776,0.0403600346372454,2.44456040951454e-15
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PRDX1,Peroxiredoxin-1,41742,-0.0772840113249945,0.00975202987386072,-0.0963979898777615,-0.0581700327722275,2.46615610042212e-15
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,EIF4G3,Eukaryotic translation initiation factor 4 gamma 3,39934,0.0561327048787733,0.00708533657881523,0.0422454451842955,0.0700199645732512,2.54782263920001e-15
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TSNAX,Translin-associated protein X,39575,0.0332985178644711,0.00420507724073941,0.0250565664726219,0.0415404692563203,2.63263417764001e-15
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,KITLG,Kit ligand,42145,-0.0321614909416858,0.00406779734696939,-0.0401343737417458,-0.0241886081416257,2.85421347818288e-15
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,NBL1,Neuroblastoma suppressor of tumorigenicity 1,42181,0.0230547946260256,0.00291866128900139,0.0173342184995829,0.0287753707524683,3.0242007985593e-15
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SCGB3A2,Secretoglobin family 3A member 2,42166,-0.0660190708801287,0.00836153429610685,-0.0824076781004981,-0.0496304636597593,3.11089449334517e-15
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SEC31A,Protein transport protein Sec31A,39638,0.0653326047926424,0.00828396772629626,0.0490960280491018,0.0815691815361831,3.39716357512503e-15
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CLEC10A,C-type lectin domain family 10 member A,42016,-0.0306395534073768,0.00388600139575975,-0.0382561161430659,-0.0230229906716877,3.39820535038082e-15
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,DYNLT1,Dynein light chain Tctex-type 1,39649,0.066802115321574,0.00848902960235677,0.0501636173009547,0.0834406133421932,3.9013331127224e-15
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,USO1,General vesicular transport factor p115,42070,0.0745715544426827,0.00948192477530482,0.0559869818830852,0.0931561270022802,3.98341436141035e-15
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TXNDC5,Thioredoxin domain-containing protein 5,42249,0.0575417797858284,0.00732378612600775,0.0431871589788532,0.0718964005928036,4.23298702141285e-15
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,DNM3,Dynamin-3,39934,0.0462324344193664,0.00590187958517411,0.0346647504324251,0.0578001184063076,5.16751676922102e-15
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,APOE,Apolipoprotein E,39979,0.0583609265565193,0.00745113974452386,0.0437566926572525,0.072965160455786,5.20793984196376e-15
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,NT5C1A,Cytosolic 5'-nucleotidase 1A,39929,0.0258213310883581,0.00329942009795617,0.019354467696364,0.0322881944803521,5.48312789897395e-15
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TNC,Tenascin,42217,-0.0402266429548257,0.0051425491869313,-0.0503060393612111,-0.0301472465484404,5.56628924985659e-15
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CALCOCO1,Calcium-binding and coiled-coil domain-containing protein 1,42212,0.0852690377475634,0.0109007871344487,0.063903494964044,0.106634580531083,5.56788787067014e-15
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ST13,Hsc70-interacting protein,39736,0.0454822907455425,0.00581676100837477,0.0340814391691279,0.056883142321957,5.79633666434218e-15
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,DDHD2,Phospholipase DDHD2,39934,0.0554939871358416,0.00710428978174595,0.0415695791636195,0.0694183951080636,6.15742876194123e-15
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PLIN3,Perilipin-3,42145,0.0356359997686112,0.00456589867736165,0.0266868383609824,0.0445851611762401,6.39416009380668e-15
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ATXN2L,Ataxin-2-like protein,39934,0.0401498968063313,0.00515151801480372,0.030052921497316,0.0502468721153466,7.07041732199483e-15
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,MTUS1,Microtubule-associated tumor suppressor 1,39757,0.0475878887733117,0.0061061989722529,0.035619738787696,0.0595560387589274,7.10356075698503e-15
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,MNDA,Myeloid cell nuclear differentiation antigen,42119,0.0814558929524356,0.0104555234060285,0.0609630670766198,0.101948718828251,7.14786410694414e-15
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,STAT2,Signal transducer and activator of transcription 2,39657,0.0654969013259951,0.00840798628342714,0.0490172482104779,0.0819765544415123,7.3093122638383e-15
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CHAD,Chondroadherin,39736,-0.039060334255199,0.00501783988624768,-0.0488953004322444,-0.0292253680781535,7.63104780819224e-15
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CIT,Citron Rho-interacting kinase,39649,0.0380748946066772,0.00489782495556684,0.0284751576937662,0.0476746315195882,8.29021419078887e-15
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,LAMB1,Laminin subunit beta-1,39638,0.0260837509256099,0.00335671757913629,0.0195045844705028,0.032662917380717,8.50360007128786e-15
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ITGA5,Integrin alpha-5,42137,0.0205415191019758,0.00264665515389268,0.0153540750003462,0.0257289632036055,9.00607767937029e-15
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,POF1B,Protein POF1B,39657,0.0375766693518992,0.0048578625552885,0.0280552587435337,0.0470980799602646,1.12188962579962e-14
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CALCOCO2,Calcium-binding and coiled-coil domain-containing protein 2,39638,0.0626071915050445,0.0080941300019602,0.0467426967012025,0.0784716863088865,1.12502453823999e-14
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,THY1,Thy-1 membrane glycoprotein,42249,0.024051005742151,0.0031128481573252,0.0179498233537937,0.0301521881305084,1.18357564527303e-14
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,NADK,NAD kinase,42145,0.0449916161959377,0.00582625886831831,0.0335721488140338,0.0564110835778416,1.22324862824424e-14
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ANGPTL4,Angiopoietin-related protein 4,42166,-0.0366605469512718,0.00474778331780257,-0.0459662022541649,-0.0273548916483788,1.22887198869874e-14
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,MYCBP2,E3 ubiquitin-protein ligase MYCBP2,39934,0.0543576309961071,0.00704081772351567,0.0405576282580163,0.0681576337341978,1.25752292378142e-14
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ATRN,"Attractin, Isoform 2",39979,0.0137206358379933,0.00177833204429359,0.0102351050311779,0.0172061666448088,1.30617269894078e-14
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SNRPB2,U2 small nuclear ribonucleoprotein B'',39929,0.036494178739867,0.00473655053164388,0.027210539697845,0.045777817781889,1.41974779530556e-14
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,AAMDC,Mth938 domain-containing protein,39638,0.0434723970708915,0.00566735989317753,0.0323643716802635,0.0545804224615194,1.8550676471656e-14
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PTPRH,Receptor-type tyrosine-protein phosphatase H,39930,0.0410896538382275,0.0053689207673775,0.0305665691341676,0.0516127385422873,2.11871003861543e-14
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CKMT1A_CKMT1B,"Creatine kinase U-type, mitochondrial",42085,0.0519658002274535,0.0067917065107043,0.038654055466473,0.0652775449884339,2.12325577412264e-14
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,DAB2,Disabled homolog 2,42262,0.0902585538438605,0.0118069160592114,0.0671169983678062,0.113400109319915,2.23633305357186e-14
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,HSPA1A,Heat shock 70 kDa protein 1A,42162,0.0570871177979684,0.00747709374675797,0.0424320140543227,0.071742221541614,2.41010175804673e-14
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,GET3,ATPase GET3,39958,0.0440242905346376,0.00577721922067287,0.0327009408621188,0.0553476402071564,2.73154060445055e-14
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ALDH3A1,"Aldehyde dehydrogenase, dimeric NADP-preferring",42094,0.0550571083582932,0.00722834349990007,0.040889555098489,0.0692246616180973,2.7723666041664e-14
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,JAM2,Junctional adhesion molecule B,42249,0.0221618737133581,0.0029096288708086,0.0164590011265732,0.0278647463001429,2.77249865449218e-14
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,KLRF1,Killer cell lectin-like receptor subfamily F member 1,39657,0.0361565166403462,0.00474664375116856,0.0268530948880558,0.0454599383926365,2.80219749899827e-14
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,OGFR,Opioid growth factor receptor,42070,0.0260433313124818,0.0034198340751853,0.0193404565251186,0.0327462060998449,2.80401810889939e-14
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SPRR3,Small proline-rich protein 3,39929,0.0512147768509077,0.00673132901240607,0.0380213719865918,0.0644081817152236,2.99444580920782e-14
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CHCHD6,MICOS complex subunit MIC25,39919,0.0236265741463511,0.00310633729052006,0.0175381530569318,0.0297149952357705,3.05264907465101e-14
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PECAM1,Platelet endothelial cell adhesion molecule,42137,0.0244538633893846,0.00321787306187504,0.0181468321881095,0.0307608945906596,3.1705235739029e-14
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CFHR5,Complement factor H-related protein 5,39864,-0.033884456634228,0.00446210550058048,-0.0426301834153658,-0.0251387298530903,3.35148252096032e-14
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CPPED1,Serine/threonine-protein phosphatase CPPED1,42249,0.0523475334552778,0.00689730163785118,0.0388288222450895,0.0658662446654661,3.41742741553462e-14
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TADA3,Transcriptional adapter 3,39919,0.0328738081522339,0.00433089301960688,0.0243852578338044,0.0413623584706634,3.43595327434228e-14
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,GOPC,Golgi-associated PDZ and coiled-coil motif-containing protein,42119,0.0821845506879184,0.0108335122228628,0.0609508667311074,0.103418234644729,3.51068470850953e-14
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,RBFOX3,RNA binding protein fox-1 homolog 3,39934,0.0322955911680164,0.00425814266810813,0.0239496315385244,0.0406415507975083,3.60048679464681e-14
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ING1,Inhibitor of growth protein 1,41820,0.0384423886611134,0.00507780322260259,0.0284898943448123,0.0483948829774145,3.95870367025666e-14
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,GMPR2,GMP reductase 2,39736,0.0538287213812598,0.00711104092833172,0.0398910811617296,0.06776636160079,4.03508322153544e-14
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,MMP12,Macrophage metalloelastase,42146,0.0440750627760699,0.00582454453322423,0.0326589554909504,0.0554911700611894,4.06155032136678e-14
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,GCNT1,"Beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase",42070,0.0278946878818173,0.00368720057954026,0.0206677747459184,0.0351216010177162,4.12099611196621e-14
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CETN2,Centrin-2,41839,0.0548820185111233,0.00725591974556143,0.0406604158098229,0.0691036212124237,4.17373489533959e-14
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,LRG1,Leucine-rich alpha-2-glycoprotein,39979,-0.0214612061144633,0.00284042592673558,-0.027028440930865,-0.0158939712980616,4.48785225576339e-14
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ARHGEF10,Rho guanine nucleotide exchange factor 10,39934,0.0763637209539136,0.0101088420063539,0.05655039062146,0.0961770512863673,4.54018517501165e-14
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,FST,Follistatin,42166,-0.0391782404435773,0.00518741736092108,-0.0493455784709826,-0.029010902416172,4.54053251866779e-14
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SH3BP1,SH3 domain-binding protein 1,39930,0.0399096472214918,0.0052868911172885,0.0295473406316064,0.0502719538113773,4.73004995896345e-14
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TNFSF14,Tumor necrosis factor ligand superfamily member 14,42016,0.0462589558469456,0.00613828749742067,0.0342279123520011,0.0582899993418902,5.15091100805008e-14
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,LZTFL1,Leucine zipper transcription factor-like protein 1,39736,0.0581901086436901,0.00772349672352214,0.0430520550655867,0.0733281622217935,5.29537069269713e-14
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,OPLAH,5-oxoprolinase,39638,0.0559262925227213,0.00742652062129917,0.041370312104975,0.0704822729404677,5.44410975155469e-14
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,NEDD4L,E3 ubiquitin-protein ligase NEDD4-like,39657,0.0394738033702067,0.00524962722862151,0.0291845340021085,0.0497630727383048,5.93093272242847e-14
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,WASHC3,WASH complex subunit 3,39929,0.0609959410914544,0.00811904105549974,0.0450826206226749,0.0769092615602339,6.22759086019618e-14
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,RBPMS2,RNA-binding protein with multiple splicing 2,39638,0.0826270470791197,0.0109987863406523,0.0610694258514411,0.104184668306798,6.25485956388576e-14
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,HIP1R,Huntingtin-interacting protein 1-related protein,39904,0.0365666874925019,0.00487611580817053,0.0270095005084876,0.0461238744765161,6.9044367235737e-14
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,HS6ST2,Heparan-sulfate 6-O-sulfotransferase 2,39657,0.0299196381163336,0.00399578976840304,0.0220878901702636,0.0377513860624036,7.53728681275514e-14
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,BAP18,Chromatin complexes subunit BAP18,39929,0.0545348894321537,0.00728455180039807,0.0402571679033734,0.0688126109609339,7.605216910644e-14
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ITGAM,Integrin alpha-M,42137,-0.0251417411318712,0.00336240107733889,-0.0317320472434554,-0.018551435020287,8.05145676156512e-14
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TNFRSF19,Tumor necrosis factor receptor superfamily member 19,42262,0.0266986806433645,0.00357187653900808,0.0196978026269087,0.0336995586598203,8.20865749597593e-14
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ICAM1,Intercellular adhesion molecule 1,42126,0.0231714713945909,0.00310055007236296,0.0170943932527595,0.0292485495364223,8.29796443970593e-14
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TRIM21,E3 ubiquitin-protein ligase TRIM21,42119,0.0578219972647795,0.00773723001204698,0.0426570264411674,0.0729869680883916,8.30609626845627e-14
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CD164,Sialomucin core protein 24,42137,0.0214556843586479,0.00287559448013431,0.0158195191775847,0.0270918495397112,9.08876029196473e-14
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,HNRNPK,Heterogeneous nuclear ribonucleoprotein K,41837,0.0629378346952621,0.00845759043514663,0.0463609574423747,0.0795147119481495,1.0562199415272e-13
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,GIMAP7,GTPase IMAP family member 7,39736,-0.0256063137519728,0.00344373575155336,-0.0323560358250174,-0.0188565916789282,1.11719848508895e-13
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,KDR,Vascular endothelial growth factor receptor 2,42181,0.0198543272176404,0.00267096638674448,0.0146192330996212,0.0250894213356596,1.12179666038837e-13
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PTPRM,Receptor-type tyrosine-protein phosphatase mu,42100,0.0193194618143952,0.00259972958454248,0.0142239918286919,0.0244149318000985,1.13966449321154e-13
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SIRPB1,Signal-regulatory protein beta-1,42100,0.0377587717391186,0.0050845392189171,0.0277930748700411,0.0477244686081961,1.18464269599955e-13
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,JAM3,Junctional adhesion molecule C,39736,0.0404082588886398,0.00544319209343487,0.0297396023855074,0.0510769153917721,1.22263084181254e-13
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,YJU2,Splicing factor YJU2,39919,0.0262849388220109,0.0035409962832065,0.0193445861069261,0.0332252915370956,1.22674506735508e-13
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,EGFL7,Epidermal growth factor-like protein 7,41843,0.0306626152963327,0.00413330376802967,0.0225613399109945,0.0387638906816708,1.2573106260445e-13
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,MBL2,Mannose-binding protein C,39826,-0.0872433275383197,0.0117657376301547,-0.110304173293423,-0.0641824817832164,1.30350031258671e-13
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,GASK1A,Golgi-associated kinase 1A,39575,0.0338634856203125,0.0045754244952914,0.0248956536095414,0.0428313176310837,1.44865585662262e-13
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CA2,Carbonic anhydrase 2,42103,0.0521560684891985,0.00706130656900629,0.0383159076139462,0.0659962293644508,1.59965774816082e-13
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PRSS22,Brain-specific serine protease 4,39657,0.0272895906920065,0.00370371815315769,0.0200303031118174,0.0345488782721956,1.8532913265903e-13
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,COMP,Cartilage oligomeric matrix protein,42042,-0.0261422524404461,0.00355043286047963,-0.0331011008469862,-0.019183404033906,1.90111263323467e-13
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,REG1A,Lithostathine-1-alpha,42105,0.0390489189261255,0.00531234253740404,0.0286367275528136,0.0494611102994374,2.08654955667846e-13
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,HPSE,Heparanase,39866,0.0749851306561357,0.0101998582449002,0.0549934084961312,0.0949768528161401,2.09438991625543e-13
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PILRB,Paired immunoglobulin-like type 2 receptor beta,42145,0.0452001351194124,0.00615468537285597,0.0331369517886147,0.0572633184502101,2.19104451510606e-13
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TAFA5,Chemokine-like protein TAFA-5,42070,0.0287512960011009,0.00391548031265278,0.0210769545883015,0.0364256374139004,2.20875365235838e-13
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,YARS1,"Tyrosine--tRNA ligase, cytoplasmic",39930,0.114582351268238,0.0156251691657635,0.0839570197033419,0.145207682833135,2.40058626255253e-13
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,BOC,Brother of CDO,41900,-0.0181370253161431,0.00247524836190125,-0.0229885121054695,-0.0132855385268166,2.48267776082542e-13
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ADAMTS13,A disintegrin and metalloproteinase with thrombospondin motifs 13,42310,0.0182005767044705,0.00248531628579868,0.0133293567843051,0.0230717966246359,2.55540605396564e-13
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,FOXO3,Forkhead box protein O3,41843,0.0748892634038776,0.0102415529014154,0.0548158197171034,0.0949627070906518,2.77693987183081e-13
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CD160,CD160 antigen,42296,0.0376311819085631,0.00515864250250757,0.0275202426036483,0.0477421212134779,3.15571907502254e-13
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,HAVCR2,Hepatitis A virus cellular receptor 2,42137,0.0279841737657033,0.00384070671216559,0.0204563886098587,0.0355119589215478,3.36449832382308e-13
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CD244,Natural killer cell receptor 2B4,42296,0.0213163561152054,0.00293054695624295,0.0155724840809693,0.0270602281494416,3.68358757996028e-13
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,LGALS3,Galectin-3,42196,0.0228791066251022,0.00315251166597901,0.0167001837597833,0.0290580294904211,4.15928007151432e-13
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,STX7,Syntaxin-7,39657,0.0380429919572284,0.00524860018198044,0.0277557356005468,0.0483302483139101,4.5045680220246e-13
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,LMNB2,Lamin-B2,39929,0.022207317103076,0.00306483290730274,0.0162002446047627,0.0282143896013894,4.57652161866494e-13
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CD46,Membrane cofactor protein,42107,0.022105085691716,0.00305158642919128,0.0161239762905011,0.0280861950929309,4.59913543409588e-13
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SIGLEC6,Sialic acid-binding Ig-like lectin 6,42262,0.0258502623892728,0.00357064126577195,0.0188518055083598,0.0328487192701858,4.73805741937876e-13
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SPAG1,Sperm-associated antigen 1,39934,0.0453166712024168,0.0062584174341876,0.0330501730314092,0.0575831693734245,4.74522364702519e-13
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CDHR5,Cadherin-related family member 5,42145,0.0298381139137735,0.00412647673019953,0.0217502195225824,0.0379260083049646,5.05558190312121e-13
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,MAP2K1,Dual specificity mitogen-activated protein kinase kinase 1,39930,0.0496244116692901,0.00686854422781647,0.0361620649827698,0.0630867583558104,5.33738112261367e-13
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,DECR1,"2,4-dienoyl-CoA reductase, mitochondrial",42119,0.0736222180158744,0.0101963067705122,0.0536374567456704,0.0936069792860784,5.45723198531738e-13
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,MITD1,MIT domain-containing protein 1,42016,0.0741868069293322,0.0102767013258684,0.0540444723306302,0.0943291415280343,5.52162373877199e-13
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SERPINA6,Corticosteroid-binding globulin,39979,-0.0118816746469481,0.00164566179258698,-0.0151071717604186,-0.00865617753347764,5.53018457687513e-13
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CDH3,Cadherin-3,42249,0.0282766982783856,0.00392366405187107,0.0205863167367183,0.0359670798200529,6.03301942839966e-13
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ABRAXAS2,BRISC complex subunit Abraxas 2,39575,0.0512201188728066,0.00710721346171654,0.0372899804878422,0.065150257257771,6.1052474735054e-13
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ATP5IF1,"ATPase inhibitor, mitochondrial",42185,0.0837481342062783,0.0116338942392713,0.0609457014973067,0.10655056691525,6.4012984943391e-13
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,MAP2,Microtubule-associated protein 2,39929,0.036035359068385,0.00500709023517608,0.0262214622074398,0.0458492559293301,6.55059108329736e-13
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SUGP1,SURP and G-patch domain-containing protein 1,39930,0.0312744315326563,0.00435188870223629,0.0227447296762732,0.0398041333890395,7.06988309718211e-13
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CMC1,COX assembly mitochondrial protein homolog,39958,0.0701543804271589,0.00976958485094144,0.0510059941193136,0.0893027667350041,7.35819824776984e-13
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CD79B,B-cell antigen receptor complex-associated protein beta chain,42296,0.034883908445179,0.00486160062123502,0.0253551712275584,0.0444126456627997,7.5804465840296e-13
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,IL1RAP,Interleukin-1 receptor accessory protein,42137,-0.0341850445147256,0.00476465717546854,-0.043523772578644,-0.0248463164508073,7.62274108728496e-13
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PRKAB1,5'-AMP-activated protein kinase subunit beta-1,41913,0.04178817932347,0.00582581393159948,0.030369584017535,0.053206774629405,7.72863705344072e-13
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,42295,0.0213353538044057,0.00297753285036107,0.015499389417698,0.0271713181911134,8.14968013092096e-13
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,RLN2,Prorelaxin H2,39709,0.039504385365176,0.00551341710320254,0.028698087842899,0.0503106828874529,8.26315670253632e-13
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,RGCC,Regulator of cell cycle RGCC,39934,0.0587618674854956,0.00820392598929218,0.042682172546483,0.0748415624245083,8.40343772991181e-13
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,BSG,Basigin,42284,0.0159211590919725,0.00222416857706643,0.0115617886809222,0.0202805295030227,8.58761435988938e-13
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,RRAS,Ras-related protein R-Ras,39649,0.10071550782095,0.0140729265918232,0.0731325717009762,0.128298443940923,8.78907139043213e-13
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,BOLA2_BOLA2B,BolA-like protein 2,39638,0.0403925399770218,0.00564541142955697,0.0293275335750901,0.0514575463789535,8.90210323074801e-13
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,A1BG,Alpha-1B-glycoprotein,39979,0.012602198938984,0.00176497169574779,0.0091428544153183,0.0160615434626496,9.88952596502102e-13
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ERBB4,Receptor tyrosine-protein kinase erbB-4,42181,-0.0178159080167305,0.00249578743916711,-0.0227076513974981,-0.012924164635963,9.92246974834708e-13
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,NME3,Nucleoside diphosphate kinase 3,42144,-0.0181505263622661,0.00254503535605992,-0.0231387956601436,-0.0131622570643887,1.04137330673971e-12
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,APBB1IP,Amyloid beta A4 precursor protein-binding family B member 1-interacting protein,42070,0.0344519977427393,0.00483191542145687,0.0249814435166839,0.0439225519687948,1.05415026124228e-12
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CAMKK1,Calcium/calmodulin-dependent protein kinase kinase 1,41843,0.0339976633175555,0.00476932462492901,0.0246497870526946,0.0433455395824164,1.06802292982662e-12
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SNX15,Sorting nexin-15,39736,0.0411315769909787,0.00577596481915234,0.0298106859454401,0.0524524680365173,1.13617647749142e-12
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CXCL11,C-X-C motif chemokine 11,42249,0.0591336599682306,0.00831558671006559,0.042835110016502,0.0754322099199592,1.20776777446938e-12
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CCL2,C-C motif chemokine 2,41992,0.0391696775183374,0.00551517557497438,0.0283599333913877,0.0499794216452872,1.29018051059184e-12
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,RAB11FIP3,Rab11 family-interacting protein 3,39958,0.081606977687318,0.0115141736774298,0.0590391972795557,0.10417475809508,1.44623255663481e-12
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,GIMAP8,GTPase IMAP family member 8,39560,0.0379794666356875,0.00536223418592482,0.0274694876312749,0.0484894456401002,1.4996359157425e-12
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,DFFA,DNA fragmentation factor subunit alpha,42296,0.0503469963696761,0.00711232259767505,0.036406844078233,0.0642871486611192,1.52442308653894e-12
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CLPP,"ATP-dependent Clp protease proteolytic subunit, mitochondrial",41997,0.0731487701121008,0.0103395692860154,0.0528832143115105,0.093414325912691,1.57275791480542e-12
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,IRAK4,Interleukin-1 receptor-associated kinase 4,42119,0.0785425081345612,0.0111028254249343,0.0567809703016901,0.100304045967432,1.5782145795812e-12
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CCL20,C-C motif chemokine 20,42296,0.065126422164058,0.00921414470644756,0.0470666985394208,0.0831861457886952,1.64678747693959e-12
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,DTNB,Dystrobrevin beta,39900,0.0344042826963857,0.00486770532672597,0.0248635802560028,0.0439449851367686,1.66603441934355e-12
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TTF2,Transcription termination factor 2,39649,0.0376137930013103,0.00532636685304444,0.0271741139693432,0.0480534720332774,1.74219262012608e-12
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,EREG,Proepiregulin,41997,0.0601688048089196,0.00852900319984896,0.0434519585372156,0.0768856510806235,1.81583825621797e-12
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,GLRX,Glutaredoxin-1,42057,0.0417995372932275,0.00592738341692698,0.0301818657960506,0.0534172087904044,1.85056228318681e-12
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,LPP,Lipoma-preferred partner,39575,0.0498467560933144,0.00707028196832428,0.0359890034353988,0.06370450875123,1.89423529839536e-12
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CRKL,Crk-like protein,42143,0.0791085886581962,0.0112277300238728,0.0571022378114054,0.101114939504987,1.9327985761742e-12
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ADGRE5,Adhesion G protein-coupled receptor E5,42248,0.0233563637857256,0.0033189100546035,0.0168513000787027,0.0298614274927485,2.05265364864242e-12
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PDGFB,Platelet-derived growth factor subunit B,42185,0.0641807738002211,0.00912280937210047,0.0463000674309041,0.082061480169538,2.08505660169333e-12
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,DLG4,Disks large homolog 4,39929,0.0542365221271164,0.00771255702630033,0.0391199103555678,0.0693531338986651,2.1494938792588e-12
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PEBP1,Phosphatidylethanolamine-binding protein 1,42137,0.0417426218447987,0.00593869439148398,0.0301027808374901,0.0533824628521073,2.18101533924331e-12
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ASPSCR1,Tether containing UBX domain for GLUT4,39934,0.0500693676514588,0.00713499855781002,0.0360847704781511,0.0640539648247664,2.38875769634821e-12
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,S100G,Protein S100-G,39934,-0.0367481874686356,0.00523905868300342,-0.0470167424873223,-0.0264796324499489,2.44311367299938e-12
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,GIGYF2,GRB10-interacting GYF protein 2,39934,0.0574062929698439,0.00818430219836077,0.0413650606610568,0.073447525278631,2.44446664859206e-12
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CD8A,T-cell surface glycoprotein CD8 alpha chain,42249,0.0379162359064533,0.00541160407123891,0.0273094919268251,0.0485229798860816,2.55865566609065e-12
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ACHE,Acetylcholinesterase,39736,0.0256674501147058,0.00366614124769663,0.0184818132692204,0.0328530869601912,2.68352840813004e-12
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,MYL4,Myosin light chain 4,39638,0.0385827477008187,0.00551442617106865,0.0277744724055241,0.0493910229961132,2.77255481539418e-12
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,RETN,Resistin,42105,0.0319429373754053,0.00456772600279774,0.0229901944099217,0.0408956803408889,2.81359532964264e-12
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,MYDGF,Myeloid-derived growth factor,39958,0.074384074399221,0.010640237637703,0.0535292086293232,0.0952389401691189,2.88588697361486e-12
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,MDH1,"Malate dehydrogenase, cytoplasmic",39950,0.0293449778394127,0.00420193727574021,0.0211091807789619,0.0375807748998635,3.03616990799152e-12
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SAMD9L,Sterile alpha motif domain-containing protein 9-like,42119,0.0540956758964532,0.00774805267324613,0.0389094926568907,0.0692818591360156,3.04934207162241e-12
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,COMT,Catechol O-methyltransferase,41740,0.0620185872967573,0.00888779336978628,0.0445985122919762,0.0794386623015384,3.13875928691313e-12
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,POLR2F,"DNA-directed RNA polymerases I, II, and III subunit RPABC2",42070,0.0255971101271643,0.00366960767501694,0.0184046790841311,0.0327895411701975,3.19158913826215e-12
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,UBAC1,Ubiquitin-associated domain-containing protein 1,42070,0.0245479827333826,0.00352149949379987,0.0176458437255348,0.0314501217412303,3.29606524673027e-12
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,KYAT1,Kynurenine--oxoglutarate transaminase 1,42130,0.0421148930502468,0.00604384479242828,0.0302689572570874,0.0539608288434062,3.35808158965363e-12
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PDLIM5,PDZ and LIM domain protein 5,39934,0.0885667566798002,0.0127159210092499,0.0636435515016704,0.11348996185793,3.46512026108838e-12
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PIK3AP1,Phosphoinositide 3-kinase adapter protein 1,42119,0.0452143653092283,0.00649488118291836,0.0324843981907083,0.0579443324277483,3.52104561332144e-12
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,RAB33A,Ras-related protein Rab-33A,39575,0.0495129008043954,0.00711667172938237,0.035564224214806,0.0634615773939848,3.66582577536964e-12
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SAA4,Serum amyloid A-4 protein,39979,0.024463991221841,0.00351822775713459,0.0175682648178572,0.0313597176258248,3.75852092095521e-12
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,IL1R1,Interleukin-1 receptor type 1,42113,0.0176531024880572,0.00254006489865129,0.0126745752867006,0.0226316296894137,3.82405138946065e-12
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ADA2,Adenosine deaminase 2,42096,0.0324621914299226,0.00467487801525403,0.0232994305200247,0.0416249523398205,3.98685573195466e-12
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SCRIB,Protein scribble homolog,39638,0.0649543501605363,0.00937260778270065,0.046584038906443,0.0833246614146296,4.43570287084534e-12
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,APOA4,Apolipoprotein A-IV,39979,0.0254399700656496,0.00367356078444057,0.0182397909281461,0.0326401492031532,4.58967365673528e-12
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,NBN,Nibrin,41913,0.0399978017920386,0.00577900665925731,0.0286709487398943,0.051324654844183,4.68257535916219e-12
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ARSA,Arylsulfatase A,42137,0.0332485367279263,0.00480445331822004,0.0238318082242151,0.0426652652316376,4.70772327532073e-12
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ENOX2,Ecto-NOX disulfide-thiol exchanger 2,39575,0.0208512967976062,0.00301467585121873,0.0149425321292175,0.0267600614659949,4.88357965255075e-12
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,FBP1,"Fructose-1,6-bisphosphatase 1",42145,0.0542576690878459,0.00784740289499203,0.0388767594136615,0.0696385787620303,4.9196333679721e-12
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,RTBDN,Retbindin,42070,0.0220731997594879,0.00319391089149204,0.0158131344121635,0.0283332651068123,5.02802815617596e-12
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,GALNT3,Polypeptide N-acetylgalactosaminyltransferase 3,41913,0.0318588558109468,0.00461088560112999,0.022821520032732,0.0408961915891615,5.08527962876741e-12
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,LAYN,Layilin,41997,0.0262588834408752,0.00380613491828181,0.0187988590010429,0.0337189078807076,5.46857058140284e-12
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,EPHA2,Ephrin type-A receptor 2,41614,0.0238262104716493,0.00345432098816001,0.0170557413348557,0.0305966796084429,5.53682980268362e-12
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TRIM40,E3 ubiquitin ligase TRIM40,39649,0.0538026445552137,0.00779975316233755,0.0385151283570321,0.0690901607533953,5.56247208923434e-12
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CDCP1,CUB domain-containing protein 1,42016,0.041080535899311,0.00595793706009287,0.029402979261529,0.052758092537093,5.62377776655413e-12
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,FIS1,Mitochondrial fission 1 protein,42125,0.0563069638068355,0.00816769357255525,0.0402982844046272,0.0723156432090438,5.67049906350166e-12
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,APOBR,Apolipoprotein B receptor,39638,-0.0316743523875362,0.00459391488182291,-0.0406784255559091,-0.0226702792191633,5.6866338900586e-12
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,WFDC1,WAP four-disulfide core domain protein 1,39699,0.0400840657229398,0.00581881233862056,0.0286791935392435,0.0514889379066361,5.9349999253318e-12
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SLITRK1,SLIT and NTRK-like protein 1,39657,-0.0239330065032636,0.00347602368206525,-0.0307460129201115,-0.0171200000864157,6.08480854587755e-12
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CHAC2,Glutathione-specific gamma-glutamylcyclotransferase 2,41843,0.0422712771237356,0.00614344128917446,0.0302301321969537,0.0543124220505176,6.22299965892109e-12
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,DSCAM,Down syndrome cell adhesion molecule,39934,0.0267603885975757,0.00389130222973556,0.019133436227294,0.0343873409678574,6.43523907552823e-12
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,HMBS,Porphobilinogen deaminase,42262,0.0294554976610456,0.00428492160219552,0.0210570513207424,0.0378539440013488,6.50342839745949e-12
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,LRRC59,Leucine-rich repeat-containing protein 59,39958,0.0355106166326269,0.00517118864344391,0.0253750868914768,0.0456461463737769,6.89812123291404e-12
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ADAM8,Disintegrin and metalloproteinase domain-containing protein 8,42224,0.0222167899776414,0.00323612890081742,0.0158739773320393,0.0285596026232435,6.92548890748836e-12
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,FOLR1,Folate receptor alpha,42110,0.0215576406622286,0.0031434456661739,0.0153964871565278,0.0277187941679294,7.28851797111645e-12
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,DBI,Acyl-CoA-binding protein,42085,0.0567509621483812,0.00828687855338072,0.040508680183755,0.0729932441130074,7.79742486537114e-12
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TBCC,Tubulin-specific chaperone C,42016,0.0585557034381068,0.00855373480196245,0.0417903832262604,0.0753210236499532,7.94501832946871e-12
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,F12,Coagulation factor XII,39979,0.0301424107636139,0.00440573346498276,0.0215071731722477,0.0387776483549801,8.23130398348065e-12
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,FNTA,Protein farnesyltransferase/geranylgeranyltransferase type-1 subunit alpha,39919,0.0259138018038967,0.00378885574576024,0.0184876445422066,0.0333399590655868,8.35766065163933e-12
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SCRG1,Scrapie-responsive protein 1,39958,0.0199758388805848,0.00292250795889093,0.0142477232811585,0.025703954480011,8.6102656271929e-12
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CCN3,CCN family member 3,42299,0.0247022644385313,0.00361744658464871,0.0176120691326198,0.0317924597444427,8.93315576735883e-12
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,B2M,Beta-2-microglobulin,39979,0.0221908166733455,0.00325013247477339,0.0158205570227897,0.0285610763239013,9.07001045305948e-12
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TPR,Nucleoprotein TPR,39575,0.0356161601427475,0.00522911543966434,0.0253670938810054,0.0458652264044896,1.01902711406376e-11
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SLC9A3R2,Na(+)/H(+) exchange regulatory cofactor NHE-RF2,39930,0.0367406806146691,0.0054001156077136,0.0261564540235504,0.0473249072057877,1.07116830803195e-11
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TCTN3,Tectonic-3,39958,0.0221058997935438,0.00325137723958929,0.0157332004039488,0.0284785991831388,1.10679877517365e-11
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,BNIP3L,BCL2/adenovirus E1B 19 kDa protein-interacting protein 3-like,39657,0.0323671020103678,0.00476590622205223,0.0230259258151455,0.0417082782055902,1.16759954982053e-11
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ENPP2,Ectonucleotide pyrophosphatase/phosphodiesterase family member 2,42310,-0.0177151008041933,0.00261005442655556,-0.0228308074802422,-0.0125993941281444,1.18984967188601e-11
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CCDC80,Coiled-coil domain-containing protein 80,42145,0.0254568516959318,0.00375098670642513,0.0181049177513385,0.032808785640525,1.19492346544222e-11
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,WFDC2,WAP four-disulfide core domain protein 2,41430,0.0303518256565249,0.00447411254884514,0.0215825650607884,0.0391210862522614,1.22127248079266e-11
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,BAMBI,BMP and activin membrane-bound inhibitor homolog,41843,0.0215372943216155,0.00317503546177478,0.0153142248165369,0.0277603638266941,1.22429827190628e-11
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,LRIG3,Leucine-rich repeats and immunoglobulin-like domains protein 3,39640,0.0194675160593153,0.00287127738006661,0.0138398123943848,0.0250952197242459,1.26231802856697e-11
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SERPINI2,Serpin I2,39930,0.0418986968789573,0.00618483375976737,0.0297764227098133,0.0540209710481013,1.31088773343454e-11
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CASC3,Protein CASC3,39649,0.0312889206303169,0.00461956080324515,0.0222345814559565,0.0403432598046774,1.32419215331211e-11
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,MPHOSPH8,M-phase phosphoprotein 8,41900,0.0554353138009679,0.00818687989701028,0.0393890292028278,0.0714815983991081,1.33045901828666e-11
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,IL15,Interleukin-15,42119,0.0237446389786083,0.00350774324053665,0.0168694622271565,0.0306198157300601,1.3483123617381e-11
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ITPA,Inosine triphosphate pyrophosphatase,39575,0.0486587512968331,0.00719753315938366,0.0345515863044411,0.0627659162892251,1.4451976569319e-11
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CENPF,Centromere protein F,39757,0.0390049395521814,0.00577637475777152,0.0276832450269492,0.0503266340774136,1.52543191122492e-11
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PIKFYVE,1-phosphatidylinositol 3-phosphate 5-kinase,39657,0.0400294439972049,0.00593044065450962,0.0284057803143661,0.0516531076800438,1.55431279546909e-11
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,FAM3D,Protein FAM3D,39930,0.0630940753314984,0.00936469243171719,0.0447392781653327,0.0814488724976641,1.69011136685713e-11
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ACYP1,Acylphosphatase-1,39701,0.0469457553948747,0.00696924370962413,0.0332860377240114,0.060605473065738,1.70699743401833e-11
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,STX8,Syntaxin-8,42119,0.0343109241795435,0.00509478177311015,0.0243251519042476,0.0442966964548394,1.71114551082835e-11
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,MINK1,Misshapen-like kinase 1,39929,0.0670911001465936,0.00996485283767836,0.047559988584744,0.0866222117084432,1.74504278130588e-11
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SIGLEC8,Sialic acid-binding Ig-like lectin 8,39638,0.0335764819033399,0.00499313227276611,0.0237899426487183,0.0433630211579615,1.84857498798643e-11
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CD86,T-lymphocyte activation antigen CD86,39930,-0.0218443550533166,0.00325090620079163,-0.0282161312068682,-0.015472578899765,1.91136470065932e-11
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,GBP1,Guanylate-binding protein 1,39911,0.0464202938093766,0.00691090490450517,0.0328749201965465,0.0599656674222068,1.94449556506993e-11
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,BLVRB,Flavin reductase,42137,0.0455440098789619,0.0067861357369338,0.0322431838345717,0.0588448359233522,2.00531667261255e-11
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CCL13,C-C motif chemokine 13,42275,0.0486684916905595,0.00725265690923022,0.0344532841484683,0.0628836992326507,2.01683265258308e-11
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,HSD17B14,17-beta-hydroxysteroid dehydrogenase 14,39929,0.0457919243434631,0.0068230595183034,0.0324187276875884,0.0591651209993378,2.02037295239248e-11
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PAGR1,PAXIP1-associated glutamate-rich protein 1,39638,0.0304185936797559,0.00453641066592464,0.0215272287745436,0.0393099585849682,2.10617436902014e-11
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CSNK2A1,Casein kinase II subunit alpha,39934,-0.0320198215269298,0.00477563757310888,-0.0413800711702232,-0.0226595718836363,2.11226732487395e-11
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,DDR1,Epithelial discoidin domain-containing receptor 1,42249,0.016921036563421,0.00252459257700091,0.0119728351124992,0.0218692380143428,2.12953786361932e-11
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PPP1R2,Protein phosphatase inhibitor 2,42145,0.0575478208309463,0.00858918397623937,0.0407130202375172,0.0743826214243755,2.16604657386291e-11
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,GALNT7,N-acetylgalactosaminyltransferase 7,42070,0.0148221398446496,0.00221556158936893,0.0104796391294865,0.0191646405598127,2.31961992591955e-11
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PROS1,Vitamin K-dependent protein S,39979,0.0181385750581738,0.00271213710146663,0.0128227863392992,0.0234543637770484,2.36957847850265e-11
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,DEFA1_DEFA1B,Neutrophil defensin 1,41879,0.0381132731664983,0.00570115667408946,0.0269390060852829,0.0492875402477136,2.3985345164738e-11
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PLAU,Urokinase-type plasminogen activator,42137,-0.0203231428358374,0.00304189369488515,-0.0262852544778123,-0.0143610311938625,2.46455268135877e-11
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ESAM,Endothelial cell-selective adhesion molecule,42310,0.0231308485318734,0.00346552511866129,0.0163384192992973,0.0299232777644496,2.57510407649155e-11
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CCL19,C-C motif chemokine 19,42249,0.0802717012876508,0.0120308098380338,0.0566913140051045,0.103852088570197,2.61753315634942e-11
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,MPO,Myeloperoxidase,42137,0.0319260382225863,0.00479105302060909,0.0225355743021925,0.0413165021429802,2.77388336828663e-11
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,LYPD8,Ly6/PLAUR domain-containing protein 8,41843,0.0370136348244878,0.00556210155565105,0.0261119157754117,0.0479153538735638,2.95221982783887e-11
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ANGPT1,Angiopoietin-1,42085,0.0591512699017133,0.00889714813434151,0.0417128595584039,0.0765896802450226,3.07823027449142e-11
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,AARSD1,Alanyl-tRNA editing protein Aarsd1,42070,0.0379507705172288,0.00571694662201411,0.0267455551380811,0.0491559858963764,3.29487567840623e-11
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TP53,Cellular tumor antigen p53,41843,0.0314721621328481,0.00474261491968978,0.0221766368902562,0.0407676873754401,3.34769748616954e-11
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,MZB1,Marginal zone B- and B1-cell-specific protein,42163,0.0362538934614713,0.00546831173321812,0.0255360024643638,0.0469717844585788,3.48825246375066e-11
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,FOXJ3,Forkhead box protein J3,39657,0.032129075226748,0.00484527365905306,0.022632338855004,0.041625811598492,3.4893158277354e-11
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,DNAJB6,DnaJ homolog subfamily B member 6,39639,0.0604780762796358,0.00912138429689672,0.0426001630577182,0.0783559895015534,3.50496049948647e-11
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CAT,Catalase,39827,0.0371478482817845,0.00560320680214897,0.0261655629495725,0.0481301336139965,3.51682663134845e-11
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PAFAH2,"Platelet-activating factor acetylhydrolase 2, cytoplasmic",39757,0.0353835205856735,0.00533991846346923,0.0249172803972738,0.0458497607740731,3.60232936366243e-11
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,MARS1,"Methionine--tRNA ligase, cytoplasmic",39713,0.0611099118083073,0.00922391095840425,0.043031046329835,0.0791887772867796,3.62896011984522e-11
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CD69,Early activation antigen CD69,42082,0.0618906688207553,0.00934345036791067,0.0435775060996504,0.0802038315418602,3.62959299589656e-11
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,NDUFB7,NADH dehydrogenase [ubiquinone] 1 beta subcomplex subunit 7,39930,0.0629101068902174,0.00950071969149645,0.0442886962948844,0.0815315174855505,3.71360564031244e-11
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,GLOD4,Glyoxalase domain-containing protein 4,42106,0.0241733614982437,0.00365387281077257,0.0170117707891294,0.0313349522073579,3.83422385622522e-11
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,FABP2,"Fatty acid-binding protein, intestinal",42145,-0.0564094171841314,0.00852940710419567,-0.0731270551083549,-0.0396917792599078,3.89362894781115e-11
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TXNDC9,Thioredoxin domain-containing protein 9,39929,0.0378689721182008,0.00572921583655921,0.0266397090785447,0.0490982351578568,4.02117474117114e-11
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,NUB1,NEDD8 ultimate buster 1,42119,0.0592017952830067,0.00896034434535591,0.0416395203661091,0.0767640701999043,4.06626056590958e-11
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,OGN,Mimecan,42137,0.0304001606265058,0.00460663447834257,0.0213711570489544,0.0394291642040573,4.28730503226749e-11
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,XIAP,E3 ubiquitin-protein ligase XIAP,39657,0.0412180794971333,0.00624482181385203,0.0289782287419833,0.0534579302522833,4.2892704935668e-11
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PLXNB3,Plexin-B3,42099,0.0338175310066342,0.0051260519930261,0.0237704691003031,0.0438645929129654,4.34648452653494e-11
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,MATN3,Matrilin-3,41992,-0.0231462580192104,0.00351049237675982,-0.0300268230776596,-0.0162656929607612,4.45832525659704e-11
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,DNPH1,2'-deoxynucleoside 5'-phosphate N-hydrolase 1,42162,0.0348491286619454,0.00529498039743522,0.0244709670829724,0.0452272902409184,4.82710240994687e-11
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,COL1A1,Collagen alpha-1(I) chain,42310,-0.0164536239915151,0.00250065423982463,-0.0213549063015713,-0.0115523416814588,4.88423844821949e-11
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ANXA10,Annexin A10,41839,0.0573533897694731,0.00872445975408817,0.0402534486514603,0.0744533308874859,5.08648435566094e-11
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,BMP10,Bone morphogenetic protein 10,39736,-0.019892156311515,0.00302739375759027,-0.0258258480763919,-0.013958464546638,5.2306910070044e-11
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CWC15,Spliceosome-associated protein CWC15 homolog,39872,0.0441071928787752,0.00671955619082703,0.0309368627447542,0.0572775230127962,5.46810587752027e-11
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,GIPC2,PDZ domain-containing protein GIPC2,39929,0.0214027847276019,0.00326319975087935,0.0150069132158784,0.0277986562393255,5.65909228460682e-11
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CTSL,Cathepsin L1,42145,0.0170946617245426,0.00260995228747187,0.0119791552410978,0.0222101682079875,5.96945542738349e-11
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,VASN,Vasorin,41975,-0.0190819847800931,0.00292276329071378,-0.0248106008298922,-0.0133533687302941,6.8715932508769e-11
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CSF1,Macrophage colony-stimulating factor 1,42185,0.0187470035879664,0.00287565879380325,0.0131107123521121,0.0243832948238208,7.31788706474244e-11
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,REEP4,Receptor expression-enhancing protein 4,39934,0.0435536963588901,0.00668605269328003,0.0304490330800612,0.0566583596377189,7.62168445690473e-11
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,COMMD1,COMM domain-containing protein 1,39638,0.0425190070534147,0.00653205234990601,0.0297161844475989,0.0553218296592304,7.87827265485777e-11
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,HRC,Sarcoplasmic reticulum histidine-rich calcium-binding protein,39638,-0.0235515452591524,0.0036196769975583,-0.0306461121743667,-0.0164569783439381,8.02350154791018e-11
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CD226,CD226 antigen,39657,0.0295755923948433,0.00455765050042641,0.0206425974140075,0.0385085873756791,8.99721052931372e-11
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ADAM22,Disintegrin and metalloproteinase domain-containing protein 22,42016,0.0252686048614189,0.00389554632469164,0.0176333340650233,0.0329038756578146,9.09121534731235e-11
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PTPN1,Tyrosine-protein phosphatase non-receptor type 1,42016,0.0544577013705849,0.0084016646303494,0.0379904386951001,0.0709249640460698,9.38195618990353e-11
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ATOX1,Copper transport protein ATOX1,42181,0.0490575360361743,0.00757115118361549,0.0342180797162879,0.0638969923560606,9.51792809585802e-11
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,DHPS,Deoxyhypusine synthase,39919,0.027939827164334,0.00431549912702976,0.0194814488753556,0.0363982054533123,9.91947519427303e-11
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,LTA4H,Leukotriene A-4 hydrolase,42262,-0.0410486865267957,0.00634956228226781,-0.0534938286000406,-0.0286035444535508,1.04875015115701e-10
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,BAG4,BAG family molecular chaperone regulator 4,39657,0.0350231839191095,0.0054170662628162,0.0244057340439898,0.0456406337942293,1.05329174650172e-10
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PPCDC,Phosphopantothenoylcysteine decarboxylase,42249,0.0318331204190217,0.00493562264058707,0.0221593000434711,0.0415069407945724,1.15873228696666e-10
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SERPINE2,Glia-derived nexin,39958,0.0447512320456967,0.00693797493850838,0.0311528011662202,0.0583496629251731,1.16250437541004e-10
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CA1,Carbonic anhydrase 1,41890,0.0387477070351939,0.00601395053628356,0.0269603639840781,0.0505350500863097,1.21196108886723e-10
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,THTPA,Thiamine-triphosphatase,39897,0.0605564700048903,0.00940079455312163,0.042130912680772,0.0789820273290087,1.22996734142171e-10
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CAMSAP1,Calmodulin-regulated spectrin-associated protein 1,39934,0.0735143855286916,0.011413268449435,0.051144379367799,0.0958843916895842,1.23384931129694e-10
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,AKR1C4,Aldo-keto reductase family 1 member C4,41900,0.0348923130394162,0.00542285620415102,0.0242635148792802,0.0455211111995522,1.28289207475834e-10
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,GTPBP2,GTP-binding protein 2,39649,0.0565482186620861,0.00879100128819677,0.0393178561372204,0.0737785811869517,1.30698877882231e-10
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,GPI,Glucose-6-phosphate isomerase,39990,0.0329435402067709,0.00512423556411162,0.0229000385011121,0.0429870419124296,1.33610122477228e-10
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,MGLL,Monoglyceride lipase,42166,0.0596922190514057,0.00929343559561086,0.0414770852840084,0.077907352818803,1.38023329753266e-10
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,STK24,Serine/threonine-protein kinase 24,41839,0.0425462687217482,0.00663144401516841,0.0295486384520182,0.0555438989914783,1.44816865033119e-10
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,C2,Complement C2,42199,0.0154401249947001,0.00240742490616509,0.0107215721786165,0.0201586778107837,1.4687728112187e-10
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,MMP8,Neutrophil collagenase,42224,0.0488993686848916,0.00763218914291806,0.0339402779647722,0.063858459405011,1.53298920442258e-10
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CCL7,C-C motif chemokine 7,42119,0.0382555709959989,0.00598459527271357,0.0265257642614803,0.0499853777305175,1.68729836816351e-10
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,MPIG6B,Megakaryocyte and platelet inhibitory receptor G6b,42166,0.0517319153027477,0.00810883988029163,0.0358385891373761,0.0676252414681193,1.83203037413775e-10
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",39736,0.0715038811767267,0.0112202855898524,0.049512121420616,0.0934956409328373,1.93023745842402e-10
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,RWDD1,RWD domain-containing protein 1,42249,0.0422642357887697,0.00663517667224574,0.029259289511168,0.0552691820663713,1.95442346786932e-10
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,DBNL,Drebrin-like protein,42185,0.0628751751216762,0.00987169602768209,0.0435266509074193,0.0822236993359331,1.96089057310224e-10
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ADAMTS4,A disintegrin and metalloproteinase with thrombospondin motifs 4,39657,0.0248284583815263,0.0039014972609383,0.0171815237500872,0.0324753930129654,2.04571983042532e-10
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,HSPG2,Basement membrane-specific heparan sulfate proteoglycan core protein,42072,0.0182337499286279,0.00286586322334852,0.0126166580108648,0.023850841846391,2.05058211277378e-10
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,FKBPL,FK506-binding protein-like,39930,0.0403489896988978,0.00635449107174437,0.0278941871982789,0.0528037921995168,2.24016258526179e-10
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SCARF1,Scavenger receptor class F member 1,42310,0.0287198456657934,0.00452451939433805,0.0198517876528908,0.0375879036786959,2.25583088757906e-10
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,C8B,Complement component C8 beta chain,39979,-0.020487761480784,0.00322927491077718,-0.0268171403059073,-0.0141583826556607,2.31794028112256e-10
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CD300C,CMRF35-like molecule 6,42249,0.0237745280123912,0.00375489044943427,0.0164149427315,0.0311341132932824,2.50201422655723e-10
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,GRAP2,GRB2-related adapter protein 2,42145,0.0870794032172376,0.0137671705128386,0.0600957490120739,0.114063057422401,2.60939271660172e-10
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PDGFA,Platelet-derived growth factor subunit A,42310,0.0483919313429061,0.00765155399972316,0.0333948855034487,0.0633889771823635,2.62008650984168e-10
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,DDC,Aromatic-L-amino-acid decarboxylase,42129,0.0320218411421803,0.00507101064418228,0.022082660279583,0.0419610220047776,2.79172310991427e-10
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CEACAM20,Carcinoembryonic antigen-related cell adhesion molecule 20,39757,0.0302487518918864,0.00478987688999132,0.0208605931875034,0.0396369105962694,2.80177249790835e-10
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ITIH4,Inter-alpha-trypsin inhibitor heavy chain H4,39979,-0.0165108154936656,0.00261672841126665,-0.0216396031797483,-0.011382027807583,2.89929799767872e-10
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SOD1,Superoxide dismutase [Cu-Zn],41874,0.0318346142057033,0.00505043141134025,0.0219357686394764,0.0417334597719302,3.00505396478955e-10
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CD163,Scavenger receptor cysteine-rich type 1 protein M130,42217,0.0289493740383811,0.00460450362209365,0.0199245469390775,0.0379742011376846,3.331373868097e-10
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PTN,Pleiotrophin,41900,0.0333402765622959,0.00530355091120547,0.0229453167763332,0.0437352363482586,3.35049846095089e-10
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,BID,BH3-interacting domain death agonist,42119,0.0442001988031199,0.00705457550381349,0.0303732308156455,0.0580271667905943,3.82986770492038e-10
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,FCN2,Ficolin-2,42116,0.0270585277664165,0.004319328552254,0.0185926438039987,0.0355244117288344,3.85308826039914e-10
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,HTRA2,"Serine protease HTRA2, mitochondrial",42181,0.0404854337336457,0.00648232634222233,0.02778007410289,0.0531907933644015,4.35011410162905e-10
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,DNAJC9,DnaJ homolog subfamily C member 9,39930,0.0505062809663365,0.00808581309610817,0.0346580872979645,0.0663544746347085,4.35398683173129e-10
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SMAD3,Mothers against decapentaplegic homolog 3,39919,0.0348615310351739,0.00558291120177479,0.0239190250796953,0.0458040369906525,4.40875340658757e-10
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,GLB1,Beta-galactosidase,42016,0.028639926872777,0.00458726724230799,0.0196488830778533,0.0376309706677006,4.411980839563e-10
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,BCL2L15,Bcl-2-like protein 15,39657,0.0377852002439175,0.00605810259883803,0.0259113191501949,0.04965908133764,4.6193700029687e-10
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,GAS2,Growth arrest-specific protein 2,39757,0.0348151131498838,0.00558812779872266,0.0238623826643874,0.0457678436353802,4.82648371036767e-10
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PF4,Platelet factor 4,39914,0.064813999569831,0.0104177803019597,0.0443951501779901,0.085232848961672,5.09889914132553e-10
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,IFT20,Intraflagellar transport protein 20 homolog,39649,0.0290232218290788,0.0046703028380365,0.0198694282665272,0.0381770153916303,5.33705977125241e-10
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,GNE,Bifunctional UDP-N-acetylglucosamine 2-epimerase/N-acetylmannosamine kinase,41843,0.0431399602149865,0.00695624276519161,0.0295057243952109,0.0567741960347621,5.75475141665994e-10
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,UBXN1,UBX domain-containing protein 1,39736,0.045688337612193,0.00737451829037588,0.0312342817630563,0.0601423934613297,6.01772199974006e-10
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TPP1,Tripeptidyl-peptidase 1,42057,0.0312257170656518,0.00504370897557743,0.02134004747352,0.0411113866577835,6.15122411693764e-10
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PRG3,Proteoglycan 3,39966,-0.032904268519345,0.00531810060095165,-0.0433277456972102,-0.0224807913414798,6.33403944685034e-10
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PTPRF,Receptor-type tyrosine-protein phosphatase F,42310,-0.0187019195177913,0.00302319525094443,-0.0246273822096423,-0.0127764568259402,6.34067291090105e-10
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PARK7,Parkinson disease protein 7,42137,0.0333549786573223,0.00539269175754859,0.0227853028125271,0.0439246545021176,6.38012608439248e-10
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,LAMP1,Lysosome-associated membrane glycoprotein 1,39661,0.0180905686081359,0.00292599726529242,0.0123556139681627,0.023825523248109,6.52357979127671e-10
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CD36,Platelet glycoprotein 4,39657,0.0307804199933699,0.00498308350981659,0.0210135763141294,0.0405472636726104,6.76347853463116e-10
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,MMP9,Matrix metalloproteinase-9,42125,0.0393676508932817,0.00637472699071616,0.026873185991478,0.0518621157950854,6.78073440536155e-10
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,VEGFD,Vascular endothelial growth factor D,42275,-0.0253701344384599,0.00411139357178823,-0.0334284658391648,-0.017311803037755,6.99116692520849e-10
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,STX4,Syntaxin-4,42070,0.0387776156761205,0.0062894906860685,0.0264502139314263,0.0511050174208148,7.22849407342407e-10
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CSDE1,Cold shock domain-containing protein E1,39575,0.07959470945981,0.0129111485002114,0.0542888583993956,0.104900560520224,7.30498918961504e-10
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,F3,Tissue factor,42174,-0.0171821002904959,0.00278900254403844,-0.0226485452768113,-0.0117156553041806,7.44884808774164e-10
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SIRT2,NAD-dependent protein deacetylase sirtuin-2,42070,0.0571619235179558,0.00928186044713336,0.0389694770415744,0.0753543699943372,7.55465769973842e-10
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,QPCT,Glutaminyl-peptide cyclotransferase,42170,0.0176791212061967,0.00287498093959894,0.0120441585645827,0.0233140838478106,8.0009013433566e-10
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ARHGAP25,Rho GTPase-activating protein 25,41843,0.039855060651113,0.00648118183144773,0.0271519442614755,0.0525581770407506,8.00381932656101e-10
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CD274,Programmed cell death 1 ligand 1,42016,0.0220418241618139,0.0035919695566998,0.0150015638306823,0.0290820844929455,8.67790713119292e-10
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,LCN2,Neutrophil gelatinase-associated lipocalin,41747,0.0256466912269368,0.00417984050541292,0.0174542038363275,0.0338391786175461,8.71618051229634e-10
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CDA,Cytidine deaminase,39946,0.0312188752196008,0.00509705774890544,0.0212286420317461,0.0412091084074555,9.37557849929518e-10
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CDK5RAP3,CDK5 regulatory subunit-associated protein 3,39934,0.0389713783229785,0.00636785272439715,0.0264903869831601,0.0514523696627969,9.66557772365837e-10
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,MAVS,Mitochondrial antiviral-signaling protein,41843,0.0591427942850649,0.00966951757453354,0.0401905398389791,0.0780950487311506,9.83976674383052e-10
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CR2,Complement receptor type 2,42217,0.0303893095439053,0.00497272324829034,0.0206427719772562,0.0401358471105543,1.01581955508667e-09
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,LYZL2,Lysozyme-like protein 2,39560,0.0237733312389134,0.00389148093874262,0.0161460285989778,0.0314006338788489,1.03614645523438e-09
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TDP1,Tyrosyl-DNA phosphodiesterase 1,39919,0.0468268766798506,0.00767132648384726,0.03179107677151,0.0618626765881912,1.0673798432911e-09
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,GAL,Galanin peptides,42185,-0.043231017330209,0.0070941839239358,-0.0571356178211232,-0.0293264168392948,1.1319511248319e-09
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SELL,L-selectin,39979,-0.0151621245808786,0.00248808877966141,-0.0200387785890149,-0.0102854705727422,1.13769183779318e-09
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TF,Serotransferrin,39979,0.0139170813498933,0.00228980333297964,0.00942906681725326,0.0184050958825334,1.25704744050803e-09
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CNTN1,Contactin-1,42310,-0.0172490913333373,0.00284501409108603,-0.0228253189518659,-0.0116728637148087,1.3718258948017e-09
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ADGRE2,Adhesion G protein-coupled receptor E2,42185,0.0185224267499336,0.00305817377893306,0.0125284061432248,0.0245164473566424,1.42613945991055e-09
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,DOK1,Docking protein 1,39929,0.0889112522927465,0.0146830629270274,0.0601324489557728,0.11769005562972,1.4454333605081e-09
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,VWC2,Brorin,41973,0.0263570646896004,0.00435339249703326,0.0178244153954152,0.0348897139837856,1.44739845858447e-09
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,RECK,Reversion-inducing cysteine-rich protein with Kazal motifs,39638,-0.0140075878344706,0.00231361765591053,-0.0185422784400553,-0.00947289722888598,1.45517467952819e-09
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PPP1R14A,Protein phosphatase 1 regulatory subunit 14A,39934,0.0507567822427622,0.00838909757998287,0.0343141509859957,0.0671994134995286,1.49116765282334e-09
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,DPEP1,Dipeptidase 1,41997,-0.0295252379025996,0.00488624724563524,-0.0391022825040446,-0.0199481933011545,1.55751560232303e-09
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,BGN,Biglycan,41820,-0.0759217588379389,0.0125962049651207,-0.100610320569576,-0.0512331971063023,1.71104209993436e-09
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,GRSF1,G-rich sequence factor 1,39486,0.053657733078342,0.00890403784489628,0.0362058189023452,0.0711096472543387,1.732680914062e-09
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,RALY,RNA-binding protein Raly,39919,0.0310264583509344,0.00515272186176932,0.0209271235018665,0.0411257932000022,1.78309711729512e-09
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,LACRT,Extracellular glycoprotein lacritin,39895,0.0293316820916633,0.0048713760096376,0.0197837851127736,0.038879579070553,1.7847646781694e-09
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,FLT3LG,Fms-related tyrosine kinase 3 ligand,42296,0.0225578777934338,0.00374720924339554,0.0152133476763785,0.029902407910489,1.78969662461325e-09
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CD48,CD48 antigen,42166,0.0197117995760819,0.00327571356205389,0.0132914009944563,0.0261321981577075,1.81628972058921e-09
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,NOTCH2,Neurogenic locus notch homolog protein 2,39966,-0.0141200985052108,0.00235133561671011,-0.0187287163139627,-0.00951148069645904,1.97010878616086e-09
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,IFNLR1,Interferon lambda receptor 1,42119,0.0232826417526058,0.00387762284637042,0.0156825009737198,0.0308827825314918,1.97012396766889e-09
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,OLFM4,Olfactomedin-4,39347,0.0795614020794279,0.0132665485767222,0.0535589668690524,0.105563837289803,2.07280733446896e-09
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,BCL2L11,"Bcl-2-like protein 11, Isoform BimL ",42119,0.0263123847889201,0.00438997015067597,0.0177080432935952,0.034916726284245,2.10275846904258e-09
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,OMG,Oligodendrocyte-myelin glycoprotein,42070,-0.0439475207328298,0.00734064831295718,-0.0583351914262258,-0.0295598500394337,2.19355697038062e-09
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PLPBP,Pyridoxal phosphate homeostasis protein,42145,0.0427210043621184,0.0071634225231233,0.0286806962167967,0.05676131250744,2.52623092403455e-09
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,GRN,Progranulin,42077,0.0159493938144893,0.002674793116869,0.0107067993054261,0.0211919883235526,2.5407568381426e-09
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,AZU1,Azurocidin,41751,0.0477575297425046,0.00801062549225437,0.032056703777686,0.0634583557073232,2.55910596114137e-09
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,HS1BP3,HCLS1-binding protein 3,39638,0.0582624960833433,0.00977684742889858,0.0390998751227021,0.0774251170439845,2.61168540182852e-09
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,IST1,IST1 homolog,39850,0.0628233051453334,0.0105461294758336,0.0421528913726995,0.0834937189179673,2.64595172827854e-09
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CX3CL1,Fractalkine,42016,-0.0211681884491683,0.00355699148487076,-0.028139891759515,-0.0141964851388217,2.72906555960237e-09
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,COL5A1,Collagen alpha-1(V) chain,39736,0.0261101238665493,0.00439477068353701,0.0174963733268168,0.0347238744062818,2.91442719163098e-09
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,NT5E,5'-nucleotidase,42181,0.0340058683158478,0.00573160464667105,0.0227719232083725,0.045239813423323,3.04605562085118e-09
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CHMP1A,Charged multivesicular body protein 1a,42016,0.050085606354202,0.00844466272102391,0.0335340674209951,0.0666371452874088,3.08436050930518e-09
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TMSB10,Thymosin beta-10,42137,0.0480072541820563,0.00809641643507525,0.0321382779693088,0.0638762303948038,3.11366037303224e-09
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,GGT5,Glutathione hydrolase 5 proenzyme,42016,0.0151096762305519,0.00254862715876936,0.010114366999364,0.0201049854617399,3.13121071495932e-09
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,VEGFC,Vascular endothelial growth factor C,42181,0.0349695751101879,0.00590271214929683,0.0234002592975661,0.0465388909228097,3.21174947941002e-09
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TWF2,Twinfilin-2,39966,0.0538880045551452,0.00910769993201142,0.0360369126884028,0.0717390964218876,3.37826909117299e-09
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ASAH1,Acid ceramidase,39876,0.0298916523370383,0.00505735842829124,0.0199792298175875,0.0398040748564892,3.50884910390214e-09
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,YWHAQ,14-3-3 protein theta,39736,0.046942330504022,0.00794345882354356,0.0313731512098767,0.0625115097981674,3.53074466201104e-09
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CRLF1,Cytokine receptor-like factor 1,42185,0.0156422524771895,0.00264999531869102,0.0104482616525551,0.0208362433018239,3.66023566024568e-09
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CXCL8,Interleukin-8,42035,0.0426561922729496,0.00723358272190184,0.028478370138022,0.0568340144078772,3.79140791227691e-09
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,LAMP3,Lysosome-associated membrane glycoprotein 3,42284,0.0326270159037884,0.00553298263330609,0.0217823699425084,0.0434716618650683,3.79306595058291e-09
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,EHD3,EH domain-containing protein 3,39638,0.0745090074985791,0.0126462268707797,0.0497224028318509,0.0992956121653074,3.93174100499841e-09
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SESTD1,SEC14 domain and spectrin repeat-containing protein 1,41839,0.0404100623082017,0.00686945983470193,0.0269459210321859,0.0538742035842175,4.137056141123e-09
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SART1,U4/U6.U5 tri-snRNP-associated protein 1,39575,0.0236317621151138,0.00402730594995709,0.0157382424531979,0.0315252817770297,4.54152749045897e-09
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,DNPEP,Aspartyl aminopeptidase,39929,0.0357014390807464,0.00608810562822538,0.0237687520494247,0.0476341261120682,4.64102400593682e-09
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ERI1,3'-5' exoribonuclease 1,39757,0.0215916268012508,0.00368273815143279,0.0143734600244426,0.0288097935780591,4.67663194606374e-09
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,HARS1,"Histidine--tRNA ligase, cytoplasmic",42137,0.0479301559763933,0.00818340354414831,0.0318906850298626,0.063969626922924,4.82256715860577e-09
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,GLYR1,Putative oxidoreductase GLYR1,39919,0.036339557826947,0.00620896196298489,0.0241699923794966,0.0485091232743974,4.96893944058569e-09
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CCT5,T-complex protein 1 subunit epsilon,41843,0.02824009510904,0.00482624403480248,0.0187806568008271,0.0376995334172528,4.99094750960574e-09
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,BST2,Bone marrow stromal antigen 2,42249,0.0317971390518794,0.00543507970163699,0.0211443828366709,0.0424498952670879,5.01770087284208e-09
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SERPINI1,Neuroserpin,39713,-0.0181454163350863,0.00310192059242389,-0.0242251806962371,-0.0120656519739355,5.06237276696903e-09
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ARL13B,ADP-ribosylation factor-like protein 13B,39575,0.0432750780059739,0.00740452677647946,0.0287622055240741,0.0577879504878736,5.22837130446522e-09
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,EGF,Pro-epidermal growth factor,42081,0.0646236651481899,0.0110853125976072,0.0428964524568797,0.0863508778395,5.68095451111939e-09
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ZFYVE19,Abscission/NoCut checkpoint regulator,39930,0.0564402876005617,0.00968749418669244,0.0374527989946445,0.0754277762064789,5.82824639344744e-09
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ICA1,Islet cell autoantigen 1,41913,0.0495082297301307,0.00850680617525714,0.0328348896266267,0.0661815698336347,6.02610240764139e-09
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CDH5,Cadherin-5,42310,-0.0188203164010159,0.0032363574415462,-0.0251635769864465,-0.0124770558155854,6.18821618995374e-09
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SERPINA12,Serpin A12,41751,0.0672524223814214,0.0115646715675799,0.0445856661089649,0.0899191786538779,6.19193390048646e-09
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,UROS,Uroporphyrinogen-III synthase,39649,0.0411429325123359,0.00707561564423991,0.0272747258496257,0.0550111391750462,6.2406841745772e-09
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TACC3,Transforming acidic coiled-coil-containing protein 3,42070,0.0724240489361117,0.0124580731243373,0.0480062256124107,0.0968418722598128,6.25947136253474e-09
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,GFRAL,GDNF family receptor alpha-like,39574,-0.0393751590707186,0.0067740858150351,-0.0526523672681874,-0.0260979508732498,6.3217042513182e-09
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SERPINB8,Serpin B8,42296,0.0361917338145025,0.0062281462020999,0.0239845672583867,0.0483989003706183,6.34833148064861e-09
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TIMP3,Metalloproteinase inhibitor 3,42185,0.0789776293978752,0.0136070949708202,0.0523077232550676,0.105647535540683,6.61370030553429e-09
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CETN3,Centrin-3,39930,0.0488442827568002,0.0084247443057553,0.0323317839175198,0.0653567815960806,6.90183450896673e-09
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,LRRC38,Leucine-rich repeat-containing protein 38,39649,0.0291778008037812,0.00504043810004118,0.0192985421277005,0.0390570594798619,7.28450832769879e-09
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CSF2,Granulocyte-macrophage colony-stimulating factor,39575,0.0224014450132759,0.00387376587056173,0.0148088639069749,0.0299940261195769,7.54455837145382e-09
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ALDH5A1,"Succinate-semialdehyde dehydrogenase, mitochondrial",39934,0.0295356740779939,0.00510983493491684,0.0195203976055568,0.0395509505504309,7.65965804665911e-09
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,KEL,Kell blood group glycoprotein,41839,0.0223159702816056,0.00386357781365036,0.0147433577668509,0.0298885827963603,7.82232627756328e-09
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,DENR,Density-regulated protein,39657,0.0354862948359677,0.00615551168908493,0.0234214919253613,0.0475510977465742,8.38614465390996e-09
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,LAIR2,Leukocyte-associated immunoglobulin-like receptor 2,42016,0.0644859396064484,0.0111894953507589,0.0425545287189611,0.0864173504939358,8.4408892397788e-09
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,LEFTY2,Left-right determination factor 2,42247,0.031657234867645,0.00549342521772295,0.0208901214409081,0.042424348294382,8.45420322688267e-09
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,BOLA1,BolA-like protein 1,39586,0.0336617507230106,0.00584075593016641,0.0222138690998844,0.0451096323461367,8.47278703639791e-09
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CXCL5,C-X-C motif chemokine 5,42101,0.0691524390125332,0.0120049472353633,0.0456227424312212,0.0926821355938451,8.57806051196411e-09
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,NAGK,N-acetyl-D-glucosamine kinase,39627,0.0350916205647009,0.0060936100326264,0.0231481449007532,0.0470350962286487,8.69994841004385e-09
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TSPAN1,Tetraspanin-1,41900,0.0445756952114114,0.00776030054380587,0.0293655061455519,0.0597858842772709,9.44517246170244e-09
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PLA2G2A,"Phospholipase A2, membrane associated",42135,-0.0324083982271751,0.00564742661093606,-0.0434773543846098,-0.0213394420697404,9.74999778658308e-09
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,DPP4,Dipeptidyl peptidase 4,41948,-0.0170752371251376,0.00297574093889181,-0.0229076893653656,-0.0112427848849097,9.7797500450246e-09
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,RHOC,Rho-related GTP-binding protein RhoC,41963,0.0717871647904818,0.0125113392270309,0.0472649399055014,0.0963093896754623,9.80131527038836e-09
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TIA1,Nucleolysin TIA-1 isoform p40,41728,0.0754934127813542,0.0131909022304613,0.0496392444096501,0.101347581153058,1.06857730706481e-08
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,APRT,Adenine phosphoribosyltransferase,42002,0.0286517612867931,0.00500942766256076,0.018833283068174,0.0384702395054122,1.0907642157303e-08
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,EPHB4,Ephrin type-B receptor 4,42310,0.0154411476347167,0.00270238084184306,0.0101444811847043,0.0207378140847291,1.1270855563844e-08
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PHACTR2,Phosphatase and actin regulator 2,39934,0.069960513269562,0.012249729959928,0.045951042548103,0.0939699839910209,1.15011968841866e-08
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,GOT1,"Aspartate aminotransferase, cytoplasmic",39966,0.026349013034457,0.00463545358377511,0.0172635240102578,0.0354345020586562,1.3463348960094e-08
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,GGCT,Gamma-glutamylcyclotransferase,39952,0.0288850865453525,0.00508536389612406,0.0189177733089494,0.0388523997817557,1.37970481628195e-08
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PPBP,Platelet basic protein,39908,0.0519291460149974,0.0091578616541317,0.0339797371728993,0.0698785548570956,1.45918649214798e-08
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SFTPD,Pulmonary surfactant-associated protein D,42145,0.0408819821270812,0.00721128244792731,0.0267478685291437,0.0550160957250187,1.4642016587552e-08
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TBC1D23,TBC1 domain family member 23,42070,0.0543985317617804,0.00960433919921928,0.0355740269313107,0.0732230365922502,1.50949667509997e-08
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SPART,Spartin,39736,0.0471858429821532,0.00833426337251832,0.0308506867720173,0.0635209991922891,1.53616693058973e-08
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,HYOU1,Hypoxia up-regulated protein 1,42310,0.0138101280115508,0.00244013729083261,0.00902745892151885,0.0185927971015827,1.54792195458424e-08
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PDCD6,Programmed cell death protein 6,42145,-0.042612647396062,0.007529917246316,-0.0573712851988413,-0.0278540095932826,1.55242066401809e-08
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,LPO,Lactoperoxidase,41647,0.0370779177310626,0.0065575661082411,0.02422508815891,0.0499307473032152,1.59840381504091e-08
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ADAM9,Disintegrin and metalloproteinase domain-containing protein 9,39930,0.0183627178199269,0.00325196307278401,0.0119888701972702,0.0247365654425835,1.67535062844111e-08
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,NEXN,Nexilin,39990,0.0421721818154139,0.00747668929084975,0.0275178708053484,0.0568264928254794,1.7360935593921e-08
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,MRI1,Methylthioribose-1-phosphate isomerase,39649,0.0404714677798855,0.00717748189024927,0.0264036032749969,0.054539332284774,1.7557244958511e-08
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,COX5B,"Cytochrome c oxidase subunit 5B, mitochondrial",42070,0.0415987211197239,0.00738248902473912,0.0271290426312352,0.0560683996082125,1.78792120652578e-08
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PRKD2,Serine/threonine-protein kinase D2,39575,0.0263615387058959,0.00468217721430409,0.0171844713658599,0.0355386060459319,1.84435306650066e-08
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,MIF,Macrophage migration inhibitory factor,42105,0.0401312225166112,0.00713163931779219,0.0261532094537385,0.0541092355794839,1.86790883941302e-08
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ADA,Adenosine deaminase,42296,0.021290674499587,0.00378365788942469,0.0138747050363146,0.0287066439628594,1.86956082291456e-08
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,DEFB103A_DEFB103B,Beta-defensin 103,39596,0.0250498366890905,0.00445254740761679,0.0163228437701615,0.0337768296080194,1.88993060617073e-08
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PCDH7,Protocadherin-7,39930,0.0210187131185799,0.00373679125364048,0.0136946022614446,0.0283428239757153,1.90121673008465e-08
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,FCRL6,Fc receptor-like protein 6,42119,0.0411196988192942,0.0073130135892629,0.026786192184339,0.0554532054542495,1.91594476169107e-08
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TBC1D17,TBC1 domain family member 17,41839,0.025831126213928,0.00459739129166725,0.0168202392822601,0.0348420131455958,1.96337952920203e-08
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TPD52L2,Tumor protein D54,39736,0.0655006619148843,0.0116639969101999,0.0426392279708925,0.0883620958588761,2.00543170935823e-08
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SMS,Spermine synthase,39586,0.0386602400709044,0.00688483979363688,0.0251659540753761,0.0521545260664327,2.01020973962055e-08
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,OPTC,Opticin,42070,-0.0271475471585424,0.00484055313954898,-0.0366350313120584,-0.0176600630050264,2.08275984923245e-08
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PPP1CC,Serine/threonine-protein phosphatase PP1-gamma catalytic subunit,39919,0.0503630384306823,0.00898244187273607,0.0327574523601196,0.0679686245012451,2.10891388011726e-08
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SPRY2,Protein sprouty homolog 2,41913,0.0553859428835578,0.00987994208657389,0.036021256393873,0.0747506293732427,2.11296302088374e-08
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CST5,Cystatin-D,41846,0.0334985628051922,0.00598635374280585,0.0217653094692928,0.0452318161410917,2.23936136326173e-08
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,FKBP5,Peptidyl-prolyl cis-trans isomerase FKBP5,42016,0.0557271959095022,0.00996195646525341,0.0362017612376055,0.0752526305813988,2.26235366388909e-08
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ACADSB,"Short/branched chain specific acyl-CoA dehydrogenase, mitochondrial",39958,0.0530450432710359,0.00948840964947723,0.0344477603580606,0.0716423261840113,2.31629778907035e-08
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,LRRN1,Leucine-rich repeat neuronal protein 1,41913,-0.024058954644935,0.00430510352391518,-0.0324969575518087,-0.0156209517380612,2.33572830125327e-08
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,APP,Amyloid-beta precursor protein,42112,0.0393389082630616,0.00704717644801408,0.025526442424954,0.0531513741011692,2.42037254658287e-08
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CD300E,CMRF35-like molecule 2,42232,0.0247988653051461,0.00445630338075954,0.0160645106788574,0.0335332199314348,2.67254930510957e-08
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,VAMP8,Vesicle-associated membrane protein 8,39657,0.0524502388044383,0.00942392177502615,0.033979352125387,0.0709211254834895,2.67265100405773e-08
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,MAN2B2,Epididymis-specific alpha-mannosidase,39958,0.0354102867496063,0.00636755709024796,0.0229298748527203,0.0478906986464923,2.74222469715483e-08
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PPME1,Protein phosphatase methylesterase 1,42070,0.0344400004420395,0.00620098712618007,0.0222860656747266,0.0465939352093525,2.84567381182259e-08
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SPARC,SPARC,42181,0.0413687495414975,0.00745030602721123,0.0267661497281635,0.0559713493548315,2.86693403828968e-08
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CCN5,CCN family member 5,42137,0.0224586482548718,0.00404534876718459,0.01452976467119,0.0303875318385535,2.88192712871437e-08
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,DSC2,Desmocollin-2,41984,0.0207718510534236,0.00374274487920725,0.0134360710901774,0.0281076310166698,2.91269781196983e-08
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PRKAR1A,cAMP-dependent protein kinase type I-alpha regulatory subunit,42145,0.0488236264012928,0.00880045444861826,0.031574735682001,0.0660725171205846,2.94622229539803e-08
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PAM,Peptidyl-glycine alpha-amidating monooxygenase,42246,0.0167050597412775,0.0030137272407724,0.0107981543493636,0.0226119651331914,3.02865410587491e-08
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,KAZALD1,Kazal-type serine protease inhibitor domain-containing protein 1,42070,0.02652699628125,0.00479622771750187,0.0171263899549464,0.0359276026075537,3.24705192250959e-08
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TBCB,Tubulin-folding cofactor B,42016,0.0588441197094315,0.0106475367872586,0.0379749476064047,0.0797132918124583,3.32684845903354e-08
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,P4HB,Protein disulfide-isomerase,42073,0.0227137618566569,0.00411388590547223,0.0146505454819313,0.0307769782313825,3.42838695751432e-08
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SLAMF6,SLAM family member 6,41843,0.0227529945671758,0.00412429359268742,0.0146693791255085,0.0308366100088431,3.5166230172602e-08
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CD28,T-cell-specific surface glycoprotein CD28,41843,0.0218968458432376,0.00397058396983001,0.0141145012623707,0.0296791904241044,3.55786753807352e-08
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TBCA,Tubulin-specific chaperone A,39736,0.0496337859552437,0.00900340094771465,0.0319871200977229,0.0672804518127644,3.61077512480748e-08
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,OSCAR,Osteoclast-associated immunoglobulin-like receptor,42144,0.0204023127417062,0.00370239204826615,0.0131456243271045,0.0276590011563078,3.64194196406829e-08
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,NUDC,Nuclear migration protein nudC,42296,0.0372721498786084,0.00676548180854075,0.0240118055338685,0.0505324942233483,3.67046862246186e-08
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,DNAJB14,DnaJ homolog subfamily B member 14,39930,0.0379949602036067,0.00689820221515402,0.0244744838619048,0.0515154365453085,3.7095801281994e-08
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TMPRSS5,Transmembrane protease serine 5,41946,-0.0225791254001962,0.00410071845780974,-0.0306165335775033,-0.0145417172228891,3.73567520247743e-08
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,DNAJC21,DnaJ homolog subfamily C member 21,39929,0.0232168539892555,0.00421636348917806,0.0149527815504665,0.0314809264280445,3.7429686364233e-08
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PGA4,Pepsin A-4,39990,0.0441689767530008,0.00803370930943227,0.0284229065065135,0.0599150469994881,3.92502134379968e-08
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,FGF19,Fibroblast growth factor 19,42185,0.045498170591178,0.00827708064923088,0.0292750925186855,0.0617212486636705,3.93526929787884e-08
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ARSB,Arylsulfatase B,42070,0.0325345177151313,0.00592162722365561,0.0209281283567662,0.0441409070734963,3.99643716257005e-08
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SGSH,N-sulphoglucosamine sulphohydrolase,39807,0.0329561413399414,0.00600264681495413,0.0211909535826313,0.0447213290972515,4.10069307180914e-08
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PGLYRP1,Peptidoglycan recognition protein 1,42248,0.0245234203409737,0.00446984492175707,0.0157625242943298,0.0332843163876175,4.17482514601014e-08
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SYAP1,Synapse-associated protein 1,39736,0.0343435965785069,0.00627621118814589,0.022042222649741,0.0466449705072729,4.54548828837847e-08
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SPP1,Osteopontin,42286,-0.0256291234085901,0.0046870733828611,-0.0348157872389979,-0.0164424595781824,4.630080078666e-08
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ADGRF5,Adhesion G protein-coupled receptor F5,39958,0.0156844883256038,0.00286990972678405,0.010059465261107,0.0213095113901005,4.72281381427948e-08
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,VNN1,Pantetheinase,39990,0.0427898563092071,0.00784491192034477,0.0274138289453314,0.0581658836730829,5.0144845180531e-08
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CASP7,Caspase-7,39929,0.0493047304538254,0.00904629060025486,0.0315740008773259,0.067035460030325,5.13467607587121e-08
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PTGES2,Prostaglandin E synthase 2,39579,0.032536392303278,0.00596974956419286,0.02083568315746,0.044237101449096,5.13978989895909e-08
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PHYKPL,5-phosphohydroxy-L-lysine phospho-lyase,39736,0.0250414277732689,0.00459591066932448,0.0160334428613929,0.0340494126851449,5.18391485045804e-08
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SNX9,Sorting nexin-9,42145,0.0394768909306809,0.00725098886905692,0.0252649527473293,0.0536888291140325,5.29019353957763e-08
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,VPS28,Vacuolar protein sorting-associated protein 28 homolog,39757,0.0389248229143864,0.00715557640340662,0.0248998931637095,0.0529497526650634,5.4470076553825e-08
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CRYZL1,Quinone oxidoreductase-like protein 1,39638,0.0528915096014061,0.00972475494362564,0.0338309899118998,0.0719520292909123,5.47684875546832e-08
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,GYS1,"Glycogen [starch] synthase, muscle",41900,0.0536715398925061,0.00988977815501994,0.034287574708667,0.0730555050763452,5.8322858197622e-08
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,LONP1,"Lon protease homolog, mitochondrial",39638,0.0510067001315397,0.00940034502452479,0.0325820238834712,0.0694313763796083,5.88338324410126e-08
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SOD3,Extracellular superoxide dismutase,39990,-0.0353168219961821,0.0065090343900118,-0.0480745294006053,-0.022559114591759,5.88713546874044e-08
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,AKR1B10,Aldo-keto reductase family 1 member B10,39649,0.0376115477922654,0.00693264625927418,0.024023561124088,0.0511995344604428,5.90846208159635e-08
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,HRG,Histidine-rich glycoprotein,39925,0.0180208458378408,0.00332534800930257,0.0115031637396078,0.0245385279360738,6.10807373355086e-08
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ADAM12,Disintegrin and metalloproteinase domain-containing protein 12,39657,0.0196090984858951,0.00362203438496275,0.0125099110913681,0.0267082858804221,6.29787785427918e-08
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,NID1,Nidogen-1,42189,0.0207581428786939,0.0038398841014526,0.0132319700398468,0.028284315717541,6.55621175693092e-08
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,AIF1,Allograft inflammatory factor 1,41843,0.0301099395772886,0.00557549696051169,0.0191819655346857,0.0410379136198915,6.76387669692996e-08
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SLC27A4,Long-chain fatty acid transport protein 4,41839,0.0393422600101968,0.00728677352980976,0.0250601838917696,0.0536243361286239,6.81191564511905e-08
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SLAMF1,Signaling lymphocytic activation molecule,41913,0.0342578926979397,0.00634919285251025,0.0218134747070196,0.0467023106888598,6.94523781004838e-08
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CIAPIN1,Anamorsin,42181,0.0352122072813272,0.00653401500584952,0.0224055378698621,0.0480188766927922,7.2009137330521e-08
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PRDX2,Peroxiredoxin-2,39819,0.0348196556422406,0.00646294587103926,0.0221522817350036,0.0474870295494775,7.28554082485924e-08
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,MAX,Protein max,41839,0.0609962302975682,0.0113279065450113,0.038793533469346,0.0831989271257903,7.38461922507081e-08
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,UBE2L6,Ubiquitin/ISG15-conjugating enzyme E2 L6,39958,0.0354402889324108,0.006586636762682,0.022530480877554,0.0483500969872675,7.56981966092532e-08
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,GUCA2A,Guanylin,42083,0.0201743508507393,0.00375018351422551,0.0128239911628573,0.0275247105386213,7.59137004770687e-08
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,EIF2S2,Eukaryotic translation initiation factor 2 subunit 2,39638,0.0248442286077415,0.00462504482034112,0.0157791407598729,0.0339093164556101,7.95943090892705e-08
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,FABP3,"Fatty acid-binding protein, heart",39958,0.0312269352479151,0.00581806120338842,0.0198235352892738,0.0426303352065564,8.15233683777953e-08
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,MAP3K5,Mitogen-activated protein kinase kinase kinase 5,41843,0.0559166619690602,0.0104294164675543,0.0354750056926538,0.0763583182454666,8.39481706293932e-08
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,NAMPT,Nicotinamide phosphoribosyltransferase,41843,0.0296570347367722,0.0055369195167009,0.0188046724840384,0.0405093969895059,8.63954643405297e-08
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,LIFR,Leukemia inhibitory factor receptor,42119,0.0136884983863795,0.00255864176081061,0.00867356053519069,0.0187034362375683,8.94334472458215e-08
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,C1QTNF9,Complement C1q and tumor necrosis factor-related protein 9A,39713,-0.0280885240806474,0.00526159641842983,-0.0384012530607699,-0.0177757951005249,9.56153330317243e-08
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,LGALS1,Galectin-1,42145,0.0199228620216396,0.00373504984495804,0.0126021643255218,0.0272435597177574,9.76023684519592e-08
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,GGH,Gamma-glutamyl hydrolase,41933,0.0193242874143951,0.00362348000049154,0.0122222666134317,0.0264263082153586,9.81406649545595e-08
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SMPDL3A,Acid sphingomyelinase-like phosphodiesterase 3a,42162,-0.0373987452751594,0.00701288892856597,-0.0511440075751487,-0.0236534829751701,9.8230164250858e-08
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SPTLC1,Serine palmitoyltransferase 1,39929,0.022056095210964,0.00413696438544188,0.0139476450154979,0.0301645454064301,9.9293954578119e-08
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,FCER2,Low affinity immunoglobulin epsilon Fc receptor,42137,0.0300676227702083,0.00567110294090245,0.0189522610060395,0.0411829845343772,1.16404711052258e-07
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TRAF3,"TNF receptor-associated factor 3, Isoform 2",39657,0.0212298567196624,0.00400415918674845,0.0133817047136355,0.0290780087256894,1.1677946176692e-07
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CTF1,Cardiotrophin-1,41900,0.0477362665293007,0.00900683483042407,0.0300828702616695,0.0653896627969319,1.17649923876733e-07
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SPINK6,Serine protease inhibitor Kazal-type 6,42262,0.0302600138624795,0.00571820580794486,0.0190523304789076,0.0414676972460514,1.22942138787071e-07
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CD22,B-cell receptor CD22,42296,0.0240467060160819,0.00454494736630181,0.0151386091781303,0.0329548028540335,1.23614586106144e-07
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SPON1,Spondin-1,42144,0.0183667289422797,0.00347666744172844,0.0115524607564919,0.0251809971280674,1.29156498990039e-07
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SUSD1,Sushi domain-containing protein 1,41900,0.0273882030692688,0.00518550554553423,0.0172246122000217,0.0375517939385159,1.30019387561922e-07
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PRDX6,Peroxiredoxin-6,42262,-0.0338180333605717,0.00640396002502147,-0.0463697950096137,-0.0212662717115296,1.30593046458948e-07
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,NEK7,Serine/threonine-protein kinase Nek7,39757,0.0419896866264815,0.0079575072167097,0.0263929724817305,0.0575864007712325,1.33968289323065e-07
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,RAB10,Ras-related protein Rab-10,39958,0.0301866717627358,0.00572088838516688,0.0189737305278087,0.0413996129976629,1.34046879220508e-07
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ACE,Angiotensin-converting enzyme,39990,0.0152534114178864,0.00289593123118728,0.00957738620475929,0.0209294366310134,1.41055478629139e-07
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,EIF4E,Eukaryotic translation initiation factor 4E,39657,0.0508318043130576,0.00968178158979411,0.0318555123970611,0.069808096229054,1.54707726599944e-07
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,RBP2,Retinol-binding protein 2,42070,-0.0435705218623162,0.00831193155770232,-0.0598619077154128,-0.0272791360092197,1.6131136983307e-07
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PTK7,Inactive tyrosine-protein kinase 7,41839,0.0213554499632725,0.00408683635280046,0.0133452507117836,0.0293656492147614,1.76396399620835e-07
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TMED8,Protein TMED8,39930,0.0578358752166966,0.0110700110480254,0.036138653562567,0.0795330968708263,1.77674687604701e-07
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,BCL2L1,Bcl-2-like protein 1,39929,0.0556950510458026,0.0106669895954049,0.0347877514388089,0.0766023506527962,1.80864593078324e-07
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TIMM10,Mitochondrial import inner membrane translocase subunit Tim10,39958,0.0224432859937928,0.00430070218645358,0.0140139097083437,0.0308726622792418,1.83541906980402e-07
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ANKMY2,Ankyrin repeat and MYND domain-containing protein 2,39657,0.045160608086376,0.0086552356232609,0.0281963462647846,0.0621248699079673,1.84417112248656e-07
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,LTA,Lymphotoxin-alpha,42119,0.0222076538894723,0.00426663799974375,0.0138450434099746,0.0305702643689701,1.96887089718552e-07
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CD93,Complement component C1q receptor,41654,-0.0174707127792124,0.0033587946907959,-0.0240539503731724,-0.0108874751852524,2.00696673165163e-07
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,MMP10,Stromelysin-2,42124,-0.0319299498157686,0.0061416917248786,-0.0439676655965307,-0.0198922340350066,2.03409609830603e-07
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PEPD,Xaa-Pro dipeptidase,39990,-0.0146956800653995,0.00282677837779992,-0.0202361656858874,-0.00915519444491166,2.04122119637517e-07
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PRDX3,"Thioredoxin-dependent peroxide reductase, mitochondrial",41913,0.0398689684233745,0.00767822408953405,0.0248196492078877,0.0549182876388612,2.10577636440678e-07
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,NECAP2,Adaptin ear-binding coat-associated protein 2,39575,0.0364648276705754,0.00702851518970322,0.0226889378987571,0.0502407174423937,2.16209833541003e-07
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,USP28,Ubiquitin carboxyl-terminal hydrolase 28,39929,0.0202169118641751,0.00390229520430735,0.0125684132637327,0.0278654104646176,2.24763596403811e-07
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TLR3,Toll-like receptor 3,42296,0.0337406069021333,0.00651545901724297,0.0209703072283371,0.0465109065759295,2.26791017457675e-07
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,MCEMP1,Mast cell-expressed membrane protein 1,39657,0.0491105491581211,0.0094908169766974,0.0305085478837942,0.067712550432448,2.3248606611849e-07
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,39757,0.0585299933485476,0.0113126811525093,0.0363571382896293,0.0807028484074659,2.3331353655969e-07
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,L3HYPDH,Trans-3-hydroxy-L-proline dehydratase,39958,0.0495450409857098,0.00958748924386721,0.0307535620677301,0.0683365199036896,2.41045160083177e-07
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,NACC1,Nucleus accumbens-associated protein 1,39919,0.0305498031039596,0.0059383179173345,0.0189106999859839,0.0421889062219352,2.72692468246206e-07
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,RRM2B,Ribonucleoside-diphosphate reductase subunit M2 B,41843,0.0368465273000851,0.00716766174971843,0.022797910270637,0.0508951443295332,2.77672906226016e-07
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CRACR2A,EF-hand calcium-binding domain-containing protein 4B,41843,0.0461958736524881,0.0089911618948745,0.0285731963385341,0.0638185509664421,2.81745637775641e-07
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CACYBP,Calcyclin-binding protein,39713,0.0571007590765954,0.0111226106176718,0.0353004422659587,0.0789010758872321,2.88820335544308e-07
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TEK,Angiopoietin-1 receptor,42181,0.0121113325133401,0.00236025259240871,0.00748523743221906,0.0167374275944612,2.91606749602385e-07
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,VSTM1,V-set and transmembrane domain-containing protein 1,41839,0.0275533157001912,0.00537038366530952,0.0170273637161845,0.0380792676841979,2.92898134046635e-07
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,OTUD6B,Deubiquitinase OTUD6B,39930,0.0318419079785303,0.00621137814946591,0.0196676068055772,0.0440162091514835,3.00231216008028e-07
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,VCAN,Versican core protein,42249,-0.0163923785982567,0.00320798582974885,-0.0226800308245645,-0.010104726371949,3.26740312093252e-07
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CLMP,CXADR-like membrane protein,42262,0.0120398116604618,0.00236074185889059,0.00741275761703619,0.0166668657038873,3.44179714302013e-07
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,KIF22,Kinesin-like protein KIF22,39575,0.0678790748208011,0.0133108692645629,0.0417897710622578,0.0939683785793443,3.46192845104386e-07
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,GFAP,Glial fibrillary acidic protein,41820,-0.0247295938527079,0.00485872157130622,-0.0342526881324681,-0.0152064995729477,3.63492573790117e-07
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,BAG6,Large proline-rich protein BAG6,41900,0.0200179493752219,0.00393429909412628,0.0123067231507344,0.0277291755997094,3.66676333481184e-07
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SERPINB1,Leukocyte elastase inhibitor,42093,0.0485223774741184,0.00953899124806904,0.0298259546279031,0.0672188003203337,3.69158069505638e-07
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,BMP6,Bone morphogenetic protein 6,41886,0.0217055905867239,0.00426775869000318,0.0133407835543176,0.0300703976191301,3.7078162432251e-07
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,LXN,Latexin,41960,-0.037086438375434,0.00729821523950384,-0.0513909402448615,-0.0227819365060065,3.79369784286527e-07
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ARAF,Serine/threonine-protein kinase A-Raf,39757,0.0372913352616298,0.00734066331255724,0.0229036351690176,0.051679035354242,3.83326888383761e-07
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PCDH9,Protocadherin-9,39930,0.0184136206188558,0.003626813612443,0.0113050659384675,0.0255221752992441,3.89368480101076e-07
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ELAC1,Zinc phosphodiesterase ELAC protein 1,39934,0.046281320043658,0.00913608511374667,0.0283745932207145,0.0641880468666014,4.1315193933325e-07
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ARHGAP45,Rho GTPase-activating protein 45,39736,0.0451061675236295,0.00890836836836132,0.0276457655216413,0.0625665695256177,4.18545455820922e-07
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PTPRC,Receptor-type tyrosine-protein phosphatase C,39966,0.0125598587213046,0.00248164011668631,0.00769584409259939,0.0174238733500097,4.23337128183815e-07
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,FCRLB,Fc receptor-like B,41843,0.0332589249190057,0.0065784205913589,0.0203652205599422,0.0461526292780691,4.34402528639127e-07
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,EFNA1,Ephrin-A1,42113,0.0158325623621907,0.00313727532424314,0.00968350272667419,0.0219816219977073,4.55595032478181e-07
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CILP,Cartilage intermediate layer protein 1,39966,0.0297807665526229,0.00590895131696533,0.0181992219713709,0.041362311133875,4.72840630824587e-07
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,L1CAM,Neural cell adhesion molecule L1,42181,-0.0159348796175777,0.00316538268461778,-0.0221390296794285,-0.00973072955572684,4.86226300025484e-07
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,KLRK1,NKG2-D type II integral membrane protein,39929,0.0253702908498692,0.00504082697056146,0.0154902699875687,0.0352503117121697,4.90374575852504e-07
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,IL17C,Interleukin-17C,41913,0.0379418948141434,0.00754453611967077,0.0231546040195887,0.0527291856086982,4.99315670409783e-07
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PDCD1,Programmed cell death protein 1,42232,0.0224960941520999,0.00447606843684087,0.0137230000158918,0.031269188288308,5.0753489489632e-07
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,F2R,Proteinase-activated receptor 1,42166,0.0306434342689797,0.00610788927394819,0.0186719712920413,0.0426148972459182,5.31417100548581e-07
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,RANBP1,Ran-specific GTPase-activating protein,39638,0.0276940690765686,0.00552236287978525,0.0168702378321895,0.0385179003209477,5.38872694085809e-07
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SLC9A3R1,Na(+)/H(+) exchange regulatory cofactor NHE-RF1,39736,0.0467101597963959,0.0093206926428115,0.0284416022164854,0.0649787173763065,5.48522354079663e-07
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CCL18,C-C motif chemokine 18,42020,0.03748375746407,0.00748519645802745,0.0228127724063362,0.0521547425218038,5.57784811293391e-07
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CD200,OX-2 membrane glycoprotein,42119,-0.0144812891721079,0.00289829570724314,-0.0201619487583044,-0.00880062958591135,5.91145522371617e-07
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SIGLEC1,Sialoadhesin,42185,0.0220986571120577,0.00443169103541492,0.0134125426826445,0.030784771541471,6.22394507280559e-07
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ALDH2,"Aldehyde dehydrogenase, mitochondrial",39919,0.0279297343986231,0.00561088755467469,0.0169323947914607,0.0389270740057855,6.52665309806959e-07
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CALB1,Calbindin,42070,0.0240243300322323,0.00482755653436692,0.0145623192248731,0.0334863408395915,6.5544188511957e-07
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PSPN,Persephin,42119,0.0458436238752704,0.00921307671061847,0.0277859935224582,0.0639012542280826,6.57337851811344e-07
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,GSTP1,Glutathione S-transferase P,41759,-0.0371171093535765,0.00746656982205902,-0.0517515862048122,-0.0224826325023408,6.74101978199053e-07
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,HDGF,Hepatoma-derived growth factor,42243,0.0484097593055046,0.0097435565608313,0.0293123884462753,0.067507130164734,6.83300672178864e-07
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CDNF,Cerebral dopamine neurotrophic factor,42070,0.0173688852583095,0.00349685417324109,0.010515051078757,0.024222719437862,6.88290440054164e-07
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,IFNG,Interferon gamma,41913,0.0603469028710865,0.0121539923948127,0.0365250777772536,0.0841687279649194,6.94833231804002e-07
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,IL19,Interleukin-19,41756,0.0388724177638623,0.00784275886905855,0.0235006103805075,0.054244225147217,7.26782556335171e-07
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,STAU1,Double-stranded RNA-binding protein Staufen homolog 1,39560,0.0355912444913105,0.00719997333645271,0.0214792967518632,0.0497031922307579,7.79696367034062e-07
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PDAP1,28 kDa heat- and acid-stable phosphoprotein,39958,0.0520422832388667,0.0105457637349268,0.0313725863184102,0.0727119801593233,8.13299853457284e-07
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PSG1,Pregnancy-specific beta-1-glycoprotein 1,42016,-0.0591935003549562,0.0120014860472314,-0.0827164130075298,-0.0356705877023827,8.22904846189064e-07
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,EDF1,Endothelial differentiation-related factor 1,39934,0.035110368704796,0.00712005694464036,0.0211550570933009,0.0490656803162911,8.28881112664735e-07
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,GNAS,Neuroendocrine secretory protein 55,39934,0.0456875638404663,0.00927480098216405,0.0275089539154248,0.0638661737655079,8.51201149000797e-07
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",39929,0.0521057731839298,0.0105916131938255,0.0313462113240319,0.0728653350438277,8.79709968853467e-07
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,OSMR,Oncostatin-M-specific receptor subunit beta,42230,-0.0100844736273161,0.00205076554978675,-0.0141039741048981,-0.00606497314973402,8.87144974669506e-07
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,VAV3,Guanine nucleotide exchange factor VAV3,39586,0.0521325170945894,0.0106098590778286,0.0313371933020453,0.0729278408871334,9.07130906176909e-07
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,RAB37,Ras-related protein Rab-37,41913,0.0424416480250621,0.00864348380669558,0.0255004197639387,0.0593828762861854,9.2040474251695e-07
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TOR1AIP1,Torsin-1A-interacting protein 1,39638,0.0275970646883268,0.0056218277478861,0.01657828230247,0.0386158470741835,9.28928133159435e-07
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CD59,CD59 glycoprotein,41638,0.0123664558887326,0.0025200537604384,0.00742715051827329,0.0173057612591918,9.34933167021551e-07
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ECI2,Enoyl-CoA delta isomerase 2,39575,0.0319703546178197,0.00651775422607762,0.0191955563347076,0.0447451529009319,9.47107314968614e-07
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CRYM,Ketimine reductase mu-crystallin,39586,0.0397691999408129,0.00810834313214372,0.0238768474018112,0.0556615524798146,9.4898460974129e-07
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,HSPB1,Heat shock protein beta-1,41949,0.0366708532253116,0.00748167461270585,0.0220067709844082,0.0513349354662151,9.62627635861583e-07
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PSAP,Prosaposin,39886,0.0149150350066229,0.00305293166572242,0.00893128894180695,0.0208987810714388,1.04594552152965e-06
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CD58,Lymphocyte function-associated antigen 3,42100,-0.00905728457490504,0.00185640141640884,-0.0126958313510664,-0.00541873779874371,1.07870783586375e-06
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,C4BPB,C4b-binding protein beta chain,42181,-0.0198556448819738,0.00407297441265861,-0.0278386747307847,-0.0118726150331629,1.10053346710151e-06
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,LRTM2,Leucine-rich repeat and transmembrane domain-containing protein 2,39934,-0.0134210513665093,0.00275320588423785,-0.0188173348996155,-0.0080247678334031,1.10451854086627e-06
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,FCAR,Immunoglobulin alpha Fc receptor,42119,0.0252569229111338,0.00519210704114917,0.0150803931104815,0.0354334527117862,1.16048530260071e-06
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,VAMP5,Vesicle-associated membrane protein 5,41900,0.0268404560442856,0.00552452435768394,0.016012388303225,0.0376685237853461,1.19675231943005e-06
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,KIF1C,Kinesin-like protein KIF1C,39575,0.0181504384607321,0.00373574874228052,0.0108283709258623,0.0254725059956019,1.19864727772484e-06
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,DDX58,Antiviral innate immune response receptor RIG-I,41843,0.0293002239410393,0.00604627036639723,0.0174495340229007,0.0411509138591778,1.27403583838406e-06
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CDHR1,Cadherin-related family member 1,41839,0.0213854742315805,0.00441707770329617,0.01272800193312,0.030042946530041,1.30289896559005e-06
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,EDN1,Endothelin-1,39638,0.0152277657789852,0.00314658610394759,0.00906045701524791,0.0213950745427225,1.3195762637377e-06
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PKN3,Serine/threonine-protein kinase N3,39757,0.0381773260229088,0.00789678320919176,0.022699630932893,0.0536550211129247,1.35233374970072e-06
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ELOB,Elongin-B,39575,0.0203139828045307,0.00420272221630949,0.0120766472605641,0.0285513183484973,1.35951174017366e-06
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,NUDT16,U8 snoRNA-decapping enzyme,39915,0.0453542525736361,0.00939606938165253,0.0269379565855971,0.0637705485616751,1.40460426895956e-06
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,BIN2,Bridging integrator 2,42137,0.0458671132734875,0.00951079532676108,0.0272259544330358,0.0645082721139392,1.4321431994139e-06
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CD70,CD70 antigen,42119,-0.0227192171455841,0.00471142559050142,-0.0319536113029669,-0.0134848229882013,1.43563485641826e-06
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,REXO2,"Oligoribonuclease, mitochondrial",39575,-0.0240517073061871,0.00498881153169832,-0.0338297779083158,-0.0142736367040584,1.44663083719409e-06
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,MYO9B,Unconventional myosin-IXb,41913,0.0338162579139731,0.00701731012945809,0.0200623300602352,0.0475701857677109,1.4588805282016e-06
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,DIPK2B,Divergent protein kinase domain 2B,39736,-0.0154200154433921,0.00320589066289051,-0.0217035611426575,-0.0091364697441267,1.52984360494399e-06
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,IGHMBP2,DNA-binding protein SMUBP-2,39575,0.0289086407190327,0.00601169741160759,0.0171257137922819,0.0406915676457836,1.53908860087184e-06
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,AGER,Advanced glycosylation end product-specific receptor,42093,0.0209976907565697,0.00437437244972633,0.0124239207551061,0.0295714607580333,1.60238225220077e-06
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,MSR1,Macrophage scavenger receptor types I and II,42249,0.024201914847881,0.00504261474175479,0.0143183899540416,0.0340854397417204,1.60765462004369e-06
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,STX3,Syntaxin-3,39929,0.0195734341391145,0.00408021058934669,0.0115762213839949,0.027570646894234,1.6298065506519e-06
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CASP2,Caspase-2,42119,0.0349297535885633,0.00728293475959113,0.0206552014597647,0.0492043057173619,1.63502362667027e-06
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,NT5C,"5'(3')-deoxyribonucleotidase, cytosolic type",39958,0.03728746596293,0.007775212173275,0.022048050103311,0.052526881822549,1.64179341978813e-06
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CCL17,C-C motif chemokine 17,42107,0.0466581433275011,0.00974887297152721,0.0275503523033078,0.0657659343516945,1.71936454206744e-06
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PI3,Elafin,41966,0.0286365890420785,0.00599302049567253,0.0168902688705603,0.0403829092135967,1.78643028943525e-06
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,JPT2,Jupiter microtubule associated homolog 2,39930,0.0449703578424747,0.00941922885709536,0.0265086692825678,0.0634320464023816,1.82577488648658e-06
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,MSRA,Mitochondrial peptide methionine sulfoxide reductase,42181,0.0365458096758207,0.00766181279708065,0.0215286565935426,0.0515629627580988,1.86266115545605e-06
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,DCTN6,Dynactin subunit 6,41839,0.0367682193335217,0.00770889394538276,0.0216587872005715,0.051877651466472,1.86574834155079e-06
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ST6GAL1,"Beta-galactoside alpha-2,6-sialyltransferase 1",42310,0.0150582299194987,0.00316158424388271,0.00886152480148857,0.0212549350375088,1.92808374711286e-06
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PARD3,Partitioning defective 3 homolog,39757,0.0378884284425838,0.00795879339388783,0.0222891933905637,0.053487663494604,1.95469202532448e-06
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,BCAT1,"Branched-chain-amino-acid aminotransferase, cytosolic",39958,0.0151359994926769,0.00318035617694728,0.00890250138586025,0.0213694975994936,1.96743932016108e-06
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,FGF2,Fibroblast growth factor 2,42119,0.0349839479797393,0.00736466427324186,0.0205492060041852,0.0494186899552933,2.05260161414206e-06
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PKLR,Pyruvate kinase PKLR,42143,0.0315201055282285,0.00664178492029753,0.0185022070844453,0.0445380039720116,2.09881358490444e-06
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,RPE,Ribulose-phosphate 3-epimerase,39757,0.0364350485848515,0.0076802968970548,0.0213816666666241,0.0514884305030789,2.12175557383319e-06
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,HSPB6,Heat shock protein beta-6,42262,0.0205809590375895,0.00433912340129676,0.0120762771710479,0.0290856409041312,2.12585260462472e-06
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ERP29,Endoplasmic reticulum resident protein 29,39736,0.0607969058177651,0.0128365327150868,0.035637301696195,0.0859565099393352,2.20407347116094e-06
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,RBM17,Splicing factor 45,39934,0.039030422502698,0.00824696170603255,0.0228663775588742,0.0551944674465218,2.24228920621694e-06
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,COL2A1,Collagen alpha-1(II) chain,39638,0.0399363708731763,0.00843995705942808,0.0233940550366973,0.0564786867096554,2.25275819340614e-06
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,LACTB2,Endoribonuclease LACTB2,42145,0.0332725924777008,0.00703323388293224,0.0194874540671536,0.047057730888248,2.25931278825853e-06
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,NCAM1,Neural cell adhesion molecule 1,42217,-0.0165045434795254,0.00348998070779219,-0.0233449056667981,-0.0096641812922527,2.2775487673376e-06
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PMVK,Phosphomevalonate kinase,41832,0.0548467055131433,0.0116006899358457,0.0321093532388857,0.0775840577874009,2.29212394583044e-06
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PPP2R5A,Serine/threonine-protein phosphatase 2A 56 kDa regulatory subunit alpha isoform,39930,0.0607848530535208,0.0128566176520168,0.0355858824555679,0.0859838236514736,2.29583471191268e-06
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TREML2,Trem-like transcript 2 protein,42137,0.0173320329768542,0.00367414628457392,0.0101307062590893,0.024533359694619,2.41388880695271e-06
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CKAP4,Cytoskeleton-associated protein 4,42247,0.0142596818573303,0.00302434074134319,0.00833197400429763,0.0201873897103629,2.44135535493768e-06
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,C3,Complement C3,39445,0.0232359743902001,0.00493530326094245,0.0135627799987529,0.0329091687816473,2.53116345715284e-06
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,LRPAP1,Alpha-2-macroglobulin receptor-associated protein,42249,0.0281683552212,0.00598363636386825,0.0164404279480182,0.0398962824943818,2.53158454354409e-06
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ERN1,Serine/threonine-protein kinase/endoribonuclease IRE1,39919,0.0187454541558046,0.0039832951945673,0.0109381955744527,0.0265527127371565,2.55596966696635e-06
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,DGCR6,Protein DGCR6,39586,0.0211111284274751,0.00448782566989967,0.0123149901144718,0.0299072667404785,2.5811162461524e-06
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,FN1,Fibronectin,39979,0.0136865675068563,0.00291354735422484,0.00797601469257567,0.019397120321137,2.66367956396975e-06
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,DMD,Dystrophin,39638,0.0258816743815207,0.00551126921950686,0.0150795867112872,0.0366837620517541,2.68323981657655e-06
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CD7,T-cell antigen CD7,39636,0.0224708599049102,0.00479191025629009,0.0130787158025816,0.0318630040072387,2.77384166870202e-06
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CRISP3,Cysteine-rich secretory protein 3,39889,-0.0136677898424507,0.00292224819611543,-0.0193953963068369,-0.00794018337806443,2.94266176760497e-06
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PTRHD1,Putative peptidyl-tRNA hydrolase PTRHD1,39736,0.0297927641345514,0.00638213889118013,0.0172837719078384,0.0423017563612645,3.07476609360587e-06
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ITGAL,Integrin alpha-L,39657,0.0218358631631286,0.0046821116544292,0.0126589243204473,0.0310128020058098,3.14245718193718e-06
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CD1C,T-cell surface glycoprotein CD1c,42181,-0.0122960627767988,0.00263796816527001,-0.0174664803807281,-0.00712564517286963,3.17381180431353e-06
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,MCFD2,Multiple coagulation factor deficiency protein 2,42062,0.0225775057766887,0.00484694895130468,0.0130774858321316,0.0320775257212459,3.2221732159264e-06
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,FCRL2,Fc receptor-like protein 2,42229,0.0248455435322633,0.00533666859614592,0.0143856730838173,0.0353054139807093,3.2604184903822e-06
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,NAP1L4,Nucleosome assembly protein 1-like 4,39911,0.020085997526715,0.00431436274088156,0.0116298465545871,0.0285421484988429,3.26694842598955e-06
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PADI4,Protein-arginine deiminase type-4,41814,0.0363259453502754,0.00780324086062379,0.0210315932634528,0.051620297437098,3.26754397986292e-06
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,MICALL2,MICAL-like protein 2,39649,0.0341390889240423,0.00733968773439772,0.0197533009646228,0.0485248768834618,3.33677150509091e-06
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,OBP2B,Odorant-binding protein 2b,41979,-0.028364942917062,0.00609955995115791,-0.0403200804213315,-0.0164098054127925,3.34581778771828e-06
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CALB2,Calretinin,41839,0.0146006607455364,0.00314083883130234,0.00844461663618381,0.020756704854889,3.37340975618096e-06
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CLTA,Clathrin light chain A,41900,0.0231755535517064,0.00498714273825246,0.0134007537847316,0.0329503533186812,3.39930858040564e-06
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TGM2,Protein-glutamine gamma-glutamyltransferase 2,42120,0.0362400670830205,0.00781014217130404,0.0209321884272645,0.0515479457387764,3.51460934977471e-06
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,AKAP12,A-kinase anchor protein 12,39736,-0.0105640854698456,0.00227790440764827,-0.0150287781088362,-0.00609939283085501,3.56433254654121e-06
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CXCL12,Stromal cell-derived factor 1,41913,-0.0194761308039911,0.00420330792766775,-0.0277146143422199,-0.0112376472657624,3.62901150923265e-06
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,AHSG,Alpha-2-HS-glycoprotein,39990,0.0132754852110746,0.00286618965398553,0.007657753489263,0.0188932169328863,3.66596502056673e-06
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CTSC,Dipeptidyl peptidase 1,42123,0.0218772465878167,0.00472741056141048,0.0126115218874522,0.0311429712881813,3.73104823417488e-06
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,RSPO3,R-spondin-3,42262,0.0138659647562044,0.00299767070707414,0.00799053017033904,0.0197413993420697,3.76981107048911e-06
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PSAPL1,Proactivator polypeptide-like 1,39930,-0.0248983696271959,0.00538548830238816,-0.0354539266998767,-0.0143428125545151,3.81980827304344e-06
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,UNC79,Protein unc-79 homolog,39560,0.0276204417451165,0.00597435032392861,0.0159107151102164,0.0393301683800166,3.8223775735566e-06
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CD300A,CMRF35-like molecule 8,39736,0.0151469697293935,0.00327707218475537,0.00872390824727303,0.0215700312115141,3.84135716970985e-06
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,FCRL1,Fc receptor-like protein 1,42145,0.0225816866189537,0.00489012833338616,0.0129970350855168,0.0321663381523906,3.91377450262733e-06
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,LIPF,Gastric triacylglycerol lipase,39638,0.0310241973915327,0.00673227457681094,0.0178289392209833,0.0442194555620822,4.10566936264708e-06
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CERT,Ceramide transfer protein,41839,0.0301585148699576,0.00655206972358553,0.01731645821173,0.0430005715281853,4.20523669409792e-06
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,HMOX1,Heme oxygenase 1,42007,-0.0241960648671576,0.00525830818320978,-0.0345023489062488,-0.0138897808280664,4.2332052526953e-06
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,DCTN2,Dynactin subunit 2,42070,0.0465005551259836,0.0101227238865615,0.0266600163083229,0.0663410939436442,4.3944507307561e-06
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,STC2,Stanniocalcin-2,42113,0.0117420365690959,0.00255949494789415,0.00672542647122338,0.0167586466669684,4.52319608628551e-06
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,DXO,Decapping and exoribonuclease protein,39929,0.0222584438708974,0.00485160564514345,0.0127492968064163,0.0317675909353786,4.52639014590328e-06
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SV2A,Synaptic vesicle glycoprotein 2A,39649,0.03065078076483,0.00668457406047141,0.017549015606306,0.043752545923354,4.58313151440349e-06
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,DNAJA4,DnaJ homolog subfamily A member 4,39929,0.0338779334310032,0.00739328631322021,0.0193870922570916,0.0483687746049149,4.64899719463061e-06
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,AMFR,E3 ubiquitin-protein ligase AMFR,41839,0.0309859233807484,0.00676332464138468,0.0177298070836345,0.0442420396778624,4.65949698380078e-06
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SAT2,Thialysine N-epsilon-acetyltransferase,39757,0.0348344189758612,0.00760527624267458,0.0199280775402191,0.0497407604115034,4.69346625304859e-06
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SWAP70,Switch-associated protein 70,39930,0.017988945906526,0.00392777924369446,0.0102904985888848,0.0256873932241671,4.70095318234633e-06
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,GCLM,Glutamate--cysteine ligase regulatory subunit,39575,0.0216619189909838,0.00473113025032214,0.0123889037003525,0.0309349342816152,4.73261691859663e-06
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,LAP3,Cytosol aminopeptidase,41913,0.0233722511069702,0.00510987290765836,0.0133569002079598,0.0333876020059806,4.82955955716455e-06
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,AMOTL2,Angiomotin-like protein 2,39882,0.0239113105057291,0.00523710251126334,0.013646589583653,0.0341760314278053,5.0297314289543e-06
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ALPP,"Alkaline phosphatase, placental type",42070,0.0506234776643587,0.0111196357887042,0.0288289915184985,0.0724179638102189,5.3445924449633e-06
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,RNF5,E3 ubiquitin-protein ligase RNF5,39638,0.0358568494531061,0.00787761399509769,0.0204167260227147,0.0512969728834976,5.37727481632727e-06
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,NFYA,Nuclear transcription factor Y subunit alpha,39575,0.0187184970954729,0.00413221254456098,0.0106193605081334,0.0268176336828124,5.96351909602468e-06
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ZBP1,Z-DNA-binding protein 1,39657,0.0200510369889101,0.00442834035596572,0.0113714898912173,0.0287305840866029,6.01985782304448e-06
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CHM,Rab proteins geranylgeranyltransferase component A 1,39649,0.0296850718353346,0.00655613977815971,0.0168350378701416,0.0425351058005277,6.02166548335923e-06
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TRIAP1,TP53-regulated inhibitor of apoptosis 1,42262,0.0300329397634471,0.00663604664197953,0.0170262883451672,0.0430395911817269,6.06960700706716e-06
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PNMA1,Paraneoplastic antigen Ma1,39638,0.0277038113377762,0.00613784178066047,0.0156736414476817,0.0397339812278707,6.4393499874095e-06
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,FNDC1,Fibronectin type III domain-containing protein 1,39929,0.0228462016746806,0.00506839817232842,0.0129121412569169,0.0327802620924443,6.62293745954138e-06
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,RNASEH2A,Ribonuclease H2 subunit A,39934,0.0231282679640403,0.00513767113823337,0.0130584325331029,0.0331981033949777,6.80836502644679e-06
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ITGB1BP2,Integrin beta-1-binding protein 2,41900,0.0536873826712683,0.0119301429632496,0.0303043024632991,0.0770704628792376,6.84830121473775e-06
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,MINDY1,Ubiquitin carboxyl-terminal hydrolase MINDY-1,39919,0.0519989122227768,0.0115704612012819,0.0293208082682643,0.0746770161772893,7.0555158444918e-06
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CDC37,Hsp90 co-chaperone Cdc37,42181,0.0400551863062416,0.0089208164386719,0.0225703860864447,0.0575399865260386,7.17826206543373e-06
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ANXA11,Annexin A11,42087,0.0316753825397551,0.00705715332581396,0.0178433620211597,0.0455074030583504,7.23517969871323e-06
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,LGMN,Legumain,42185,0.017363060047341,0.00387086208107561,0.00977617036843278,0.0249499497262492,7.33124761685629e-06
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CASP3,Caspase-3,42310,0.0420589631957352,0.00938166985034856,0.023670890289052,0.0604470361024184,7.41631456528987e-06
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,XRCC4,DNA repair protein XRCC4,41839,0.0176641104357301,0.00394064866128337,0.00994043905961469,0.0253877818118455,7.4379538706712e-06
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CD101,Immunoglobulin superfamily member 2,39930,0.0207640567874235,0.0046319436611542,0.0116854472115612,0.0298426663632857,7.43948078943853e-06
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SLC39A14,Zinc transporter ZIP14,41839,0.0161415061872062,0.00360300544029132,0.00907961552423523,0.0232033968501772,7.52643087920526e-06
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,NID2,Nidogen-2,42137,0.0348153081555214,0.00777211061981179,0.0195819713406903,0.0500486449703525,7.54245149230904e-06
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SNX2,Sorting nexin-2,39919,0.0410062944017626,0.00915598403244969,0.0230605656981612,0.058952023105364,7.58581421614288e-06
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,APOL1,Apolipoprotein L1,39990,-0.0256180311146172,0.00572663073825729,-0.0368422273616015,-0.014393834867633,7.7698374522788e-06
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,NGF,Beta-nerve growth factor,42016,-0.00578274946902657,0.00129726230902553,-0.00832538359471661,-0.00324011534333653,8.35326266083647e-06
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,VPS4B,Vacuolar protein sorting-associated protein 4B,39919,0.0452295407055979,0.0101530407686405,0.0253295807990625,0.0651295006121333,8.47858391546752e-06
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,RCOR1,REST corepressor 1,41900,0.0211271085716609,0.00475807285716934,0.011801285771609,0.0304529313717128,9.05719051370297e-06
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PKD2,Polycystin-2,39575,0.0278421447492717,0.00627209836676645,0.0155488319504094,0.0401354575481339,9.12398512753983e-06
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SERPINB6,Serpin B6,42216,0.0277022351641127,0.00624432640681759,0.0154633554067502,0.0399411149214752,9.21999318612178e-06
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,NAPRT,Nicotinate phosphoribosyltransferase,39929,0.0158865284386584,0.00358461856755789,0.00886067604624489,0.0229123808310718,9.4301552291677e-06
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ROBO1,Roundabout homolog 1,42144,0.0112957469750695,0.00255399331850014,0.00628992007080923,0.0163015738793298,9.8199102642061e-06
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SCGB2A2,Mammaglobin-A,39575,-0.0147266281298414,0.0033365637850797,-0.0212662931485977,-0.00818696311108523,1.02584070213307e-05
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TBL1X,F-box-like/WD repeat-containing protein TBL1X,41843,0.0401212920142584,0.0090933798952119,0.0222982674196431,0.0579443166088737,1.03161004260465e-05
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,FHIT,Bis(5'-adenosyl)-triphosphatase,41839,0.0338820989026663,0.00769533598512677,0.0187992403718179,0.0489649574335148,1.07631069727614e-05
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CST7,Cystatin-F,42148,0.0442753738137825,0.0100656651449775,0.0245466701296266,0.0640040774979385,1.09755730425584e-05
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CRISP2,Cysteine-rich secretory protein 2,42262,-0.0248969818405678,0.00566526849080848,-0.0360009080825524,-0.0137930555985832,1.11778069234667e-05
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,MED18,Mediator of RNA polymerase II transcription subunit 18,41843,0.0355083693026423,0.00812378788882734,0.0195857450405407,0.0514309935647439,1.24670980242806e-05
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CDK1,Cyclin-dependent kinase 1,39560,0.0170757157859315,0.00390708099032132,0.00941783704490175,0.0247335945269613,1.25130609831806e-05
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SLC4A1,Band 3 anion transport protein,39966,0.0222577080480083,0.00509440477085081,0.0122726746971407,0.0322427413988759,1.25894986775211e-05
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SERPINA1,Alpha-1-antitrypsin,39795,-0.003801443698156,0.000871956493867913,-0.00551047842613711,-0.00209240897017489,1.3142121856359e-05
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,IGFBP7,Insulin-like growth factor-binding protein 7,42310,0.0144205639870725,0.00331364902047776,0.00792581190693612,0.0209153160672089,1.35959364367794e-05
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,GPIHBP1,Glycosylphosphatidylinositol-anchored high density lipoprotein-binding protein 1,39930,-0.033564783421104,0.00774493485044614,-0.0487448557279784,-0.0183847111142296,1.4784001239073e-05
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SCN4B,Sodium channel subunit beta-4,39638,0.0201898266791834,0.00466168069629022,0.0110529325144545,0.0293267208439122,1.49731883140441e-05
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CD300LF,CMRF35-like molecule 1,42262,0.0276270596680852,0.00640666967322645,0.0150699871085613,0.040184132227609,1.62746662012349e-05
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PROCR,Endothelial protein C receptor,39575,-0.0160021395802156,0.00371147068934405,-0.02327662213133,-0.00872765702910129,1.63539863645025e-05
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,LPA,Apolipoprotein(a),39775,-0.0839347356275644,0.0194969463400104,-0.122148750453985,-0.045720720801144,1.68394363837219e-05
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,DRG2,Developmentally-regulated GTP-binding protein 2,42070,0.0260803027428089,0.00605973402812698,0.01420322404768,0.0379573814379378,1.69025942991637e-05
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ARHGAP5,Rho GTPase-activating protein 5,39560,0.0350417690447429,0.00814763029735505,0.019072413661927,0.0510111244275588,1.71614565240268e-05
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,AGT,Angiotensinogen,39990,0.010034806862288,0.00233480877235209,0.00545858166847793,0.0146110320560981,1.7384605253218e-05
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,MAPKAPK2,MAP kinase-activated protein kinase 2,39757,0.0342106098974209,0.00796426566186931,0.0186006492001571,0.0498205705946848,1.7576516302823e-05
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,NMT1,Glycylpeptide N-tetradecanoyltransferase 1,39934,0.0303180856750599,0.00705826865032797,0.0164838791204171,0.0441522922297027,1.75831933108397e-05
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,STX16,Syntaxin-16,41843,0.0261050864801205,0.00609095632417071,0.0141668120847459,0.0380433608754951,1.83306729535877e-05
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,BCL2,Apoptosis regulator Bcl-2,39930,0.0244958460538501,0.00571835049667513,0.0132878790803668,0.0357038130273333,1.85305563427887e-05
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ARID4B,AT-rich interactive domain-containing protein 4B,41839,0.0189801738554242,0.00443696784512558,0.0102837168789781,0.0276766308318703,1.90129685804839e-05
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,COX6B1,Cytochrome c oxidase subunit 6B1,39958,0.0148258290895258,0.00346688999964545,0.00803072469022074,0.0216209334888309,1.9148760756135e-05
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SNU13,NHP2-like protein 1,39575,0.0288649980015481,0.00676034448510246,0.0156147228107473,0.0421152731923489,1.9733608502504e-05
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,OLR1,Oxidized low-density lipoprotein receptor 1,42017,0.0266927733620126,0.00625840611584375,0.0144262973749589,0.0389592493490663,2.0117454638702e-05
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,IL34,Interleukin-34,41814,0.0166093716544265,0.00390245112357613,0.00896056745221725,0.0242581758566357,2.09422835101294e-05
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CHRDL2,Chordin-like protein 2,42145,0.0207540026728206,0.00487939457599785,0.0111903893038648,0.0303176160417764,2.11965096293155e-05
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CNTN4,Contactin-4,42137,-0.0106569699022194,0.00250585437708886,-0.0155684444813135,-0.00574549532312519,2.12503941597027e-05
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,GRK5,G protein-coupled receptor kinase 5,41900,0.0233008789696329,0.00548360178954225,0.0125530194621301,0.0340487384771357,2.16003832023212e-05
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SNX18,Sorting nexin-18,39930,0.0199067919658347,0.00468640847829796,0.0107214313483707,0.0290921525832987,2.17632279673083e-05
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,RBP7,Retinoid-binding protein 7,39930,0.0283741610340439,0.00669106100102527,0.0152596814720344,0.0414886405960534,2.24685305705818e-05
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PHOSPHO1,Phosphoethanolamine/phosphocholine phosphatase,42016,0.0136051342260508,0.00321438372735405,0.00730494212043684,0.0199053263316647,2.32563058560751e-05
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SAFB2,Scaffold attachment factor B2,39934,0.0123630340326593,0.00292236391615569,0.00663520075699416,0.0180908673083245,2.35015182283283e-05
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ACVRL1,Serine/threonine-protein kinase receptor R3,41992,0.0115975375552446,0.00274172668546448,0.00622375325173423,0.016971321858755,2.35232093949549e-05
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,MCEE,"Methylmalonyl-CoA epimerase, mitochondrial",39934,-0.0190156668619241,0.00449696883653372,-0.0278297257815302,-0.010201607942318,2.37046058262495e-05
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,METAP1D,"Methionine aminopeptidase 1D, mitochondrial",42119,0.037223663444658,0.00881519975049096,0.0199458719336957,0.0545014549556202,2.43006564852754e-05
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SUSD5,Sushi domain-containing protein 5,39695,-0.0155775380257581,0.00368989926930091,-0.0228097405935879,-0.00834533545792834,2.44430992094908e-05
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,AK2,"Adenylate kinase 2, mitochondrial",39929,0.048386458582568,0.01146709393748,0.0259109544651072,0.0708619627000289,2.4665099612867e-05
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,DPT,Dermatopontin,42310,0.0114070444877908,0.00270662394742423,0.00610206155083931,0.0167120274247423,2.51944210110202e-05
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,GALNT2,Polypeptide N-acetylgalactosaminyltransferase 2,42262,-0.0119173071712681,0.00283105533722439,-0.0174661756322279,-0.00636843871030829,2.57581761699269e-05
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PHLDB1,Pleckstrin homology-like domain family B member 1,39930,0.0238971844058453,0.00567697208280704,0.0127703191235435,0.0350240496881471,2.57917471157281e-05
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,MFAP4,Microfibril-associated glycoprotein 4,39736,0.0148409650007709,0.00353780984295085,0.00790685770858728,0.0217750722929546,2.75036571008546e-05
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,LGALS7_LGALS7B,Galectin-7,42076,0.0196722361238888,0.0046903663560161,0.0104791180660972,0.0288653541816804,2.75613195929684e-05
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SPINK2,Serine protease inhibitor Kazal-type 2,39736,0.0160558855295935,0.00383185349108537,0.00854545268706619,0.0235663183721208,2.80970981865839e-05
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CSF1R,Macrophage colony-stimulating factor 1 receptor,39990,0.0183340589691767,0.00437607107235566,0.00975695966735963,0.0269111582709938,2.81533044780851e-05
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,IFNL1,Interferon lambda-1,41839,0.0203054877524378,0.00485596488981126,0.0107877965684077,0.0298231789364678,2.91384672996092e-05
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,AK1,Adenylate kinase isoenzyme 1,42145,0.0274075248475632,0.00656622556018762,0.0145377227495955,0.040277326945531,3.01147532797151e-05
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SNX5,Sorting nexin-5,39638,0.0133066050999609,0.00319150373823363,0.00705125777302299,0.0195619524268988,3.07756566381666e-05
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CSNK1D,Casein kinase I isoform delta,39657,0.0287065368345363,0.0068925985005866,0.0151970437733866,0.0422160298956861,3.1394333236985e-05
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SATB1,DNA-binding protein SATB1,39934,0.013074894473614,0.00313943519117984,0.00692160149890151,0.0192281874483265,3.14032277910574e-05
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TNFAIP2,Tumor necrosis factor alpha-induced protein 2,39930,0.0218525730002696,0.00525323487495391,0.0115562326453599,0.0321489133551793,3.20831174047163e-05
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CTSV,Cathepsin L2,42200,-0.0177554061357721,0.00427058036642862,-0.0261257436539722,-0.00938506861757205,3.23566078664001e-05
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SRC,Proto-oncogene tyrosine-protein kinase Src,42166,0.0529038263955252,0.0127310714878275,0.0279509262793832,0.0778567265116671,3.26583336630322e-05
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CPQ,Carboxypeptidase Q,39960,0.0166243296787706,0.00400483487232497,0.00877485332901365,0.0244738060285275,3.3334669195577e-05
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,NXPH3,Neurexophilin-3,39657,-0.0133292054353313,0.0032137681740412,-0.019628191056452,-0.00703021981421053,3.3859057388692e-05
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TGFBI,Transforming growth factor-beta-induced protein ig-h3,42114,0.0118554053228986,0.00286352464295927,0.0062428970226984,0.0174679136230987,3.49194288656623e-05
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,DPEP2,Dipeptidase 2,42070,-0.0132796776126323,0.00321026249961781,-0.0195717921118832,-0.00698756311338135,3.54578689237375e-05
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,RAB44,Ras-related protein Rab-44,39919,0.0198815529386016,0.00480995122033784,0.0104540485467394,0.0293090573304637,3.59978701844935e-05
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,NRGN,Neurogranin,39990,0.0409574032442327,0.00991013260436337,0.0215335433396805,0.0603812631487849,3.60807545819118e-05
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,LY75,Lymphocyte antigen 75,42119,0.0170262990751834,0.00412463341656662,0.00894201757871285,0.025110580571654,3.68200651198581e-05
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ADAMTSL5,ADAMTS-like protein 5,39958,-0.0176666001267645,0.0042950838268787,-0.0260849644274468,-0.00924823582608227,3.92938034469213e-05
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PDCD1LG2,Programmed cell death 1 ligand 2,42070,0.0139095887822514,0.00338338854160743,0.00727814724070087,0.020541030323802,3.96042390691329e-05
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CST1,Cystatin-SN,38503,0.0470758485146507,0.0114506943000154,0.0246324876866205,0.069519209342681,3.9682201934335e-05
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CAPG,Macrophage-capping protein,42015,0.0258125126898468,0.00628797953259559,0.0134880728059594,0.0381369525737341,4.06608748006585e-05
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SORBS1,Sorbin and SH3 domain-containing protein 1,39934,0.0172474359034515,0.00420164450131384,0.00901221268087639,0.0254826591260266,4.07280766681702e-05
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SERPINB9,Serpin B9,42016,0.014303972237803,0.00349646915697413,0.00745089269013367,0.0211570517854723,4.32071069858715e-05
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CXCL16,C-X-C motif chemokine 16,42295,0.0101579491891967,0.00248558822142014,0.00528619627521319,0.0150297021031801,4.39973813449931e-05
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CFP,Properdin,39979,0.0103480608915988,0.00253196086744183,0.00538541759141279,0.0153107041917848,4.40034756696825e-05
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PTPRN2,Receptor-type tyrosine-protein phosphatase N2,41973,0.0150266840914165,0.00367776453538396,0.00781826560206391,0.0222351025807691,4.41776374462172e-05
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PRTFDC1,Phosphoribosyltransferase domain-containing protein 1,41839,0.0486493975343047,0.0119076024833301,0.0253104966669777,0.0719882984016317,4.42269233667604e-05
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ATXN10,Ataxin-10,41839,0.0319901357936829,0.00783529385589723,0.0166329598361243,0.0473473117512415,4.47529303474211e-05
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CABP2,Calcium-binding protein 2,39649,0.0286159518995414,0.00700932549638182,0.0148776739266331,0.0423542298724498,4.48570977286757e-05
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,NTF3,Neurotrophin-3,42119,0.0149711450159867,0.00366989077269682,0.00777815910150097,0.0221641309304725,4.54008538164834e-05
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CNPY4,Protein canopy homolog 4,42070,0.0326929541043468,0.00801779146138577,0.0169780828400307,0.0484078253686629,4.57741081767133e-05
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,GMFG,Glia maturation factor gamma,39958,0.0314018738838654,0.00771062634855366,0.0162890462407002,0.0465147015270306,4.68177834399311e-05
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CPXM1,Probable carboxypeptidase X1,42181,0.0297994376870646,0.00733564322674665,0.0154215769626412,0.044177298411488,4.88687947891158e-05
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PCDHB15,Protocadherin beta-15,39919,0.0173167596272028,0.00427049750554619,0.00894658451633228,0.0256869347380734,5.04756108020109e-05
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,LY6D,Lymphocyte antigen 6D,42041,0.0171741520255402,0.00423604086330724,0.00887151193345798,0.0254767921176224,5.05694987107342e-05
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TMEM106A,Transmembrane protein 106A,39919,0.0311292276838356,0.00768691391022502,0.0160628764197945,0.0461955789478766,5.16385955572854e-05
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,IL10,Interleukin-10,41913,0.0331492275321764,0.00818786444407303,0.0171010132217933,0.0491974418425595,5.18208735241977e-05
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,IL3RA,Interleukin-3 receptor subunit alpha,41913,0.0135284762509302,0.00334591163275192,0.00697048945073645,0.020086463051124,5.30041881742994e-05
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,NFAT5,Nuclear factor of activated T-cells 5,39657,0.0369644531124506,0.00914216622876787,0.0190458073040656,0.0548830989208356,5.30633094052695e-05
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,GGACT,Gamma-glutamylaminecyclotransferase,39958,0.0307080255847915,0.00760552493841146,0.0158011967055051,0.045614854464078,5.4356784973823e-05
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CRADD,Death domain-containing protein CRADD,41997,0.0320706970569682,0.00794658891187161,0.0164953827896998,0.0476460113242365,5.47232435919083e-05
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,STXBP1,Syntaxin-binding protein 1,39934,0.0336235065193844,0.00836729746639425,0.0172236034852517,0.0500234095535171,5.89627185896496e-05
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,DLL1,Delta-like protein 1,42181,0.0131392267369021,0.00327396839187988,0.00672224868881749,0.0195562047849866,6.02118976672427e-05
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ENTPD2,Ectonucleoside triphosphate diphosphohydrolase 2,41843,0.0186071804929762,0.00464133593421576,0.0095101620619133,0.0277041989240391,6.13070365744492e-05
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TST,Thiosulfate sulfurtransferase,41809,0.0323214281291464,0.00806264030083964,0.0165186531395007,0.0481242031187921,6.13661064761549e-05
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,NARS1,"Asparagine--tRNA ligase, cytoplasmic",39934,0.0201582039069228,0.00502838174323384,0.0103025756901845,0.0300138321236611,6.13969347123262e-05
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,FKBP1B,Peptidyl-prolyl cis-trans isomerase FKBP1B,42202,0.048500053884186,0.0121195343274108,0.0247457666024608,0.0722543411659112,6.31933752085065e-05
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,BAX,Apoptosis regulator BAX,41814,0.0391509863965633,0.00980137972551051,0.0199402821345627,0.0583616906585639,6.51997253868639e-05
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PNLIPRP2,Pancreatic lipase-related protein 2,42123,0.127390019416103,0.0319276418950776,0.0648118413017512,0.189968197530455,6.64327646242298e-05
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,VIM,Vimentin,41900,0.0487074313662491,0.012243800996834,0.0247095814124545,0.0727052813200438,6.98275575931568e-05
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CD200R1,Cell surface glycoprotein CD200 receptor 1,42076,0.0149771474071053,0.00377391899001514,0.00758026618667559,0.022374028627535,7.26730829194886e-05
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CA9,Carbonic anhydrase 9,42262,0.01975798984036,0.00498215144525874,0.00999297300765282,0.0295230066730671,7.35371756914263e-05
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PPL,Periplakin,39657,0.0137168200081219,0.00345871277152759,0.00693774297592781,0.020495897040316,7.35883680036546e-05
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PSMD9,26S proteasome non-ATPase regulatory subunit 9,42070,0.0225982508764133,0.00569890403481386,0.0114283989681782,0.0337681027846485,7.36617005760929e-05
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ICAM2,Intercellular adhesion molecule 2,42310,0.013837149041346,0.00349024571163841,0.00699626744653473,0.0206780306361573,7.39170080960461e-05
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ANXA3,Annexin A3,42224,0.0293903933801575,0.00741371636564783,0.0148595093034877,0.0439212774568272,7.39792415930703e-05
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PODXL,Podocalyxin,42070,-0.00640211360712004,0.00161516831819156,-0.00956784351077549,-0.00323638370346458,7.41642529053039e-05
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,C9orf40,Uncharacterized protein C9orf40,39930,0.0329969460594302,0.00833158160786707,0.0166670461080108,0.0493268460108497,7.52613999030453e-05
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,FSTL1,Follistatin-related protein 1,39638,0.00985087632460054,0.00249046281379494,0.00496956920956246,0.0147321834396386,7.68715006298429e-05
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ADAMTSL4,ADAMTS-like protein 4,39638,0.0104732379064206,0.0026481122929262,0.00528293781228522,0.0156635380005559,7.7018536039804e-05
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TCL1A,T-cell leukemia/lymphoma protein 1A,42005,0.0429964883717889,0.0108766383491198,0.021678277207514,0.0643146995360638,7.7539794389511e-05
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,FUT8,"Alpha-(1,6)-fucosyltransferase",42016,0.0244099120642628,0.00617567921603499,0.0123055808008342,0.0365142433276913,7.77070807976616e-05
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,KIFBP,KIF-binding protein,42070,0.0347721086316604,0.00880862423364653,0.0175072051337132,0.0520370121296076,7.93704366364759e-05
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,RABEPK,Rab9 effector protein with kelch motifs,41843,0.0242636420107437,0.00616269598636049,0.0121847578774771,0.0363425261440102,8.28668251675135e-05
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,FGA,Fibrinogen alpha chain,39735,-0.0130598339645158,0.00332487468660461,-0.0195765883502608,-0.00654307957877077,8.620167296262e-05
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,MAN1A2,"Mannosyl-oligosaccharide 1,2-alpha-mannosidase IB",39638,0.0107663003742041,0.00274157725872057,0.00539280894711177,0.0161397918012964,8.65186334365205e-05
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TXNDC15,Thioredoxin domain-containing protein 15,42181,-0.0115689704349428,0.00294689116461112,-0.0173448771175806,-0.00579306375230502,8.68607045352577e-05
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PCDH12,Protocadherin-12,39934,0.0107274102355481,0.00273491071894181,0.00536698522642218,0.0160878352446741,8.81888177198792e-05
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,IFIT3,Interferon-induced protein with tetratricopeptide repeats 3,39757,0.0166308255416336,0.00424220380964286,0.00831610607473363,0.0249455450085336,8.8957704883671e-05
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,IGF2BP3,Insulin-like growth factor 2 mRNA-binding protein 3,39575,0.0193835435429078,0.0049479527165128,0.00968555621854267,0.0290815308672728,9.00190587406962e-05
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PRKG1,cGMP-dependent protein kinase 1,39736,0.05297097968007,0.0135406345571799,0.0264313359479974,0.0795106234121426,9.20783909850109e-05
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CEACAM19,Carcinoembryonic antigen-related cell adhesion molecule 19,39930,0.0168314440957704,0.00430612813833648,0.00839143294463086,0.0252714552469099,9.33271077841239e-05
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,DKK3,Dickkopf-related protein 3,42310,-0.0122654958865602,0.00314302449744038,-0.0184258239015434,-0.00610516787157708,9.56791577111345e-05
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CFB,Complement factor B,39794,0.0136500428290919,0.00350361744743945,0.00678295263211057,0.0205171330260732,9.83695074193319e-05
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CTRL,Chymotrypsin-like protease CTRL-1,39929,-0.0296433733963546,0.00761330753383026,-0.0445654561626619,-0.0147212906300473,9.93234813781798e-05
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,APCS,Serum amyloid P-component,39870,0.0135439793422277,0.00348338455152347,0.00671654562124172,0.0203714130632137,0.000101583835729558
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,LYAR,Cell growth-regulating nucleolar protein,41843,0.0221138748170959,0.00569334443164632,0.0109549197310691,0.0332728299031227,0.000103182515825471
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CDON,Cell adhesion molecule-related/down-regulated by oncogenes,42144,0.0106093099434814,0.00273854805996064,0.00524175574595857,0.0159768641410043,0.000107539247221226
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CXCL1,Growth-regulated alpha protein,42117,0.0384246128984818,0.009920757484988,0.0189799282279053,0.0578692975690583,0.000107942607713912
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,NDUFA5,NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 5,39641,0.0150119747065095,0.0038790800400443,0.00740897782802269,0.0226149715849963,0.000109469121566367
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SERPING1,Plasma protease C1 inhibitor,39959,-0.00765473483343537,0.00197915000459543,-0.0115338688424424,-0.00377560082442832,0.000110485185378958
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PON2,Serum paraoxonase/arylesterase 2,41900,0.0144959984163181,0.00374847415369921,0.00714898907506761,0.0218430077575685,0.00011062859023805
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TXNL1,Thioredoxin-like protein 1,39570,0.0421413813204317,0.0109042896903385,0.0207689735273682,0.0635137891134952,0.000111884571746164
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CD84,SLAM family member 5,42119,0.0130976961189493,0.00339736397506051,0.00643886272783075,0.0197565295100679,0.00011614553911339
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,S100A12,Protein S100-A12,41910,0.0302078939878507,0.0078387928690391,0.0148438599645341,0.0455719280111674,0.000116920639078917
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,DTD1,D-aminoacyl-tRNA deacylase 1,39736,0.0361221186698209,0.00937665296795886,0.0177438788526216,0.0545003584870203,0.00011764718043505
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SCT,Secretin,39649,0.0198610608070471,0.00515819119099555,0.0097510060726958,0.0299711155413984,0.000118593857021615
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,UNC5D,Netrin receptor UNC5D,39657,-0.0107679309426935,0.00279684135517091,-0.0162497399988285,-0.00528612188655853,0.000118767455569554
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,MYOC,Myocilin,42137,-0.0183480066834576,0.00476896674023716,-0.0276951814943224,-0.00900083187259276,0.000119937658268167
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PRG2,Bone marrow proteoglycan,39966,-0.0210971842069925,0.00548622949113538,-0.0318501940096179,-0.0103441744043672,0.000120973337617613
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,39958,0.0118280985053252,0.00307799169591947,0.00579523478132302,0.0178609622293273,0.000122302333116199
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,EPHX2,Bifunctional epoxide hydrolase 2,41900,0.0249564560929098,0.00649833994699415,0.0122197097968012,0.0376932023890183,0.000123385906403138
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,FCGR2B,Low affinity immunoglobulin gamma Fc region receptor II-b,41843,0.0237609522881716,0.00619214852771263,0.0116243411738548,0.0358975634024883,0.000124986926159498
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,DHRS4L2,Dehydrogenase/reductase SDR family member 4-like 2,39929,0.0196185688770336,0.00511688558337053,0.00958947313362741,0.0296476646204399,0.000126715365220198
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,FRMD4B,FERM domain-containing protein 4B,39575,0.028884711552506,0.00754050772107001,0.0141053164192088,0.0436641066858033,0.000128540131880076
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,MIA,Melanoma-derived growth regulatory protein,42181,0.0150824509203679,0.00394346709166434,0.0073532554207058,0.02281164642003,0.000131534314311688
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TBC1D5,TBC1 domain family member 5,42119,0.0317869720950043,0.00831423237902154,0.0154910766321221,0.0480828675578865,0.000132321952362465
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SLURP1,Secreted Ly-6/uPAR-related protein 1,39908,0.0148429867525958,0.00388962300566728,0.00721932566148789,0.0224666478437036,0.000136328804637412
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TK1,"Thymidine kinase, cytosolic",39757,0.0193086388677708,0.00506178997129518,0.00938753052403223,0.0292297472115093,0.000137146360537147
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,LUZP2,Leucine zipper protein 2,39919,0.0183481642127356,0.00481803713918912,0.00890481141992492,0.0277915170055463,0.000140707754764477
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ATRAID,All-trans retinoic acid-induced differentiation factor,39930,0.0121002155864869,0.00317826145037856,0.00587082314374496,0.0183296080292289,0.000141300936998686
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,FLT1,Vascular endothelial growth factor receptor 1,42042,-0.00882875978644012,0.00232039892160142,-0.0133767416727789,-0.00428077790010133,0.000142521392888838
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PDIA4,Protein disulfide-isomerase A4,39966,0.0249036636421407,0.00655877129008792,0.0120484719135684,0.037758855370713,0.000147218754769471
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PMS1,PMS1 protein homolog 1,39649,0.0200978586052412,0.00529525013176257,0.00971916834698661,0.0304765488634959,0.000148163106176643
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,BDNF,Brain-derived neurotrophic factor,39966,0.0339792780678031,0.00898583706755767,0.01636703741539,0.0515915187202161,0.000156731155567449
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CRNN,Cornulin,41749,-0.0271502276713435,0.00719185373028167,-0.0412462609826956,-0.0130541943599915,0.000160623594488589
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,VEGFB,Vascular endothelial growth factor B,39657,0.0119347702519982,0.00316366339931273,0.00573398998934524,0.0181355505146511,0.00016249413834047
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TXN,Thioredoxin,39854,0.0173723243560658,0.00461480077595383,0.00832731483519633,0.0264173338769353,0.000167744917576201
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PLG,Plasminogen,39742,0.00879696943130225,0.00233797539107778,0.0042145376647898,0.0133794011978147,0.000168988389988377
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,HSPA2,Heat shock-related 70 kDa protein 2,39919,0.0141827616526471,0.00376992867701223,0.00679370144570318,0.0215718218595911,0.000169358192960572
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CCER2,Coiled-coil domain-containing glutamate-rich protein 2,39638,0.0257340676672907,0.00684314733720203,0.0123214988863747,0.0391466364482067,0.000170408888796445
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SMTN,Smoothelin,39897,0.0372298932086184,0.00991668263347468,0.017793195247008,0.0566665911702288,0.000174719938334101
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CHRDL1,Chordin-like protein 1,42166,0.0130818895436389,0.00348826758042793,0.00624488508600012,0.0199188940012776,0.000177390037910633
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,AHNAK,Neuroblast differentiation-associated protein AHNAK,39638,0.012798765223262,0.00341928259655237,0.00609697133401933,0.0195005591125046,0.000182676028591119
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,COL9A1,Collagen alpha-1(IX) chain,42119,-0.0177940884522966,0.00475414541379499,-0.0271122134633347,-0.00847596344125836,0.000182692974645966
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,EPHA4,Ephrin type-A receptor 4,39736,0.011686297806303,0.0031318669381041,0.00554783860761901,0.0178247570049871,0.000191353270109534
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CLEC3B,Tetranectin,39726,-0.0083801124589374,0.0022463720718716,-0.0127830017198057,-0.00397722319806907,0.00019204292549601
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CASP1,Caspase-1,41839,0.0274206638281995,0.00736043806974322,0.0129942052115028,0.0418471224448962,0.00019580683014076
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,BRSK2,Serine/threonine-protein kinase BRSK2,39934,0.0149023449402779,0.00400172607847979,0.00705896182645749,0.0227457280540983,0.000197057778772986
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CNDP1,Beta-Ala-His dipeptidase,42217,0.0183102153871709,0.00492478080009283,0.00865764501898899,0.0279627857553529,0.000201630831714329
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TNR,Tenascin-R,42016,-0.0165448394520374,0.00446076732963568,-0.0252879434181233,-0.00780173548595145,0.000208945706164514
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,LCN15,Lipocalin-15,39934,0.0240790047674546,0.0065053982346442,0.011328424227552,0.0368295853073573,0.000215439073478048
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PTX3,Pentraxin-related protein PTX3,42119,-0.0196206248355851,0.00530176438020879,-0.0300120830207943,-0.00922916665037584,0.000215797069972295
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,C7orf50,Uncharacterized protein C7orf50,39929,0.00902895746825888,0.00244102888970917,0.0042445408444289,0.0138133740920889,0.000217617388728555
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,AKT2,RAC-beta serine/threonine-protein kinase,39934,0.050701249336054,0.0137120542649105,0.0238256229768293,0.0775768756952787,0.000218702572642292
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SUGT1,Protein SGT1 homolog,41843,0.0314924861705024,0.00852563083371607,0.0147822497364189,0.0482027226045859,0.000221764176589116
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,QSOX1,Sulfhydryl oxidase 1,39767,0.0157275413405385,0.0042615069795776,0.00737498766056643,0.0240800950205106,0.000224785028965456
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PSMG4,Proteasome assembly chaperone 4,39657,0.0221133509419181,0.00599302720805923,0.010367017614122,0.0338596842697142,0.000225466522480081
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,MYOM3,Myomesin-3,39736,-0.0383675200393192,0.0103987327740172,-0.0587490362763928,-0.0179860038022455,0.000225646933582235
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,EPHB6,Ephrin type-B receptor 6,41997,0.0128656713206156,0.0034897906300247,0.00602568168576724,0.019705660955464,0.000228113728331759
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PTPRK,Receptor-type tyrosine-protein phosphatase kappa,39930,0.0084928983169239,0.00230449424419698,0.00397608959829782,0.01300970703555,0.000229441703012392
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,HMOX2,Heme oxygenase 2,41839,0.0187982006653353,0.00510308037617299,0.00879616312803627,0.0288002382026344,0.000230791330663833
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,FKBP14,Peptidyl-prolyl cis-trans isomerase FKBP14,39934,0.0395339328404812,0.0107395286519633,0.0184844566826331,0.0605834089983292,0.00023325212179363
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,GZMH,Granzyme H,41900,0.0308562988040614,0.00839093005107294,0.0144100759039584,0.0473025217041643,0.000236607647059234
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,GADD45GIP1,Growth arrest and DNA damage-inducible proteins-interacting protein 1,39638,0.0209596735942785,0.00571504876000951,0.00975817802465988,0.0321611691638972,0.000246129820966433
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,DAPK2,Death-associated protein kinase 2,39657,0.0217553716571868,0.00593341984235518,0.0101258687661706,0.033384874548203,0.000246966228718897
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PROK1,Prokineticin-1,42119,0.0194276708674665,0.00530112601042763,0.00903746388702837,0.0298178778479047,0.000248459914763863
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,MESD,LRP chaperone MESD,42137,0.0475159758752118,0.0129916801519552,0.0220522827773796,0.072979668973044,0.000255737044693401
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,DAPP1,Dual adapter for phosphotyrosine and 3-phosphotyrosine and 3-phosphoinositide,42119,0.0473876544996465,0.0129643524352553,0.0219775237265462,0.0727977852727469,0.000257927741969535
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TREM2,Triggering receptor expressed on myeloid cells 2,42123,0.0210163683454736,0.0057592305443552,0.00972827647853741,0.0323044602124098,0.000264086883975743
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PLB1,"Phospholipase B1, membrane-associated",39929,-0.023158795497318,0.00635034638900389,-0.0356054744197656,-0.0107121165748704,0.000266659309814541
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SDC1,Syndecan-1,42145,0.0157576120958915,0.00432219101710584,0.00728611770236411,0.024229106489419,0.0002676152468295
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,UBQLN3,Ubiquilin-3,39575,0.0219650794583672,0.00602726002606073,0.0101516498072881,0.0337785091094462,0.000269369315159483
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,DUSP13,Dual specificity protein phosphatase 13 isoform A,39919,0.0168556925376368,0.00462992335341481,0.00778104276494373,0.0259303423103298,0.000273217613241184
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,DCTD,Deoxycytidylate deaminase,39736,0.0373688795640828,0.0102718052734902,0.0172361412280421,0.0575016179001236,0.000275999848064454
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,C2orf69,UPF0565 protein C2orf69,39649,0.0229842047942611,0.00631821109556488,0.0106005110469539,0.0353678985415682,0.000276260269034782
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SEMA4C,Semaphorin-4C,42070,-0.0108082111063687,0.00297213781122259,-0.0166336012163649,-0.0049828209963724,0.000277386873462958
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,HPGDS,Hematopoietic prostaglandin D synthase,41843,-0.0147455552486926,0.00405965320090704,-0.0227024755224704,-0.00678863497491479,0.000282054275222473
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CTRC,Chymotrypsin-C,42122,-0.0252772741441501,0.00696978995581338,-0.0389380624575443,-0.0116164858307559,0.000288132406125142
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,LILRA6,Leukocyte immunoglobulin-like receptor subfamily A member 6,39958,0.0290613736709694,0.00801410248644119,0.0133537327975446,0.0447690145443941,0.000288793174405971
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PER3,Period circadian protein homolog 3,39657,0.0476730677932664,0.0131677112261678,0.0218643537899775,0.0734817817965553,0.000295403316319169
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,GAS6,Growth arrest-specific protein 6,42236,-0.0097276164754138,0.00268903987972006,-0.0149981346396651,-0.00445709831116249,0.000298530654836842
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ACSL1,Long-chain-fatty-acid--CoA ligase 1,39575,-0.0143940769733047,0.00398371818288475,-0.0222021646117588,-0.00658598933485055,0.000303761834506524
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CCL8,C-C motif chemokine 8,42239,0.0232880643200108,0.00646741874593169,0.0106119235779847,0.0359642050620369,0.000318331068758031
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,VNN2,Vascular non-inflammatory molecule 2,42070,0.018162853238913,0.00504748902822759,0.00826977474358694,0.0280559317342391,0.000321336530178168
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TARS1,"Threonine--tRNA ligase 1, cytoplasmic",39919,0.0144333306868046,0.00401093585483879,0.00657189641132058,0.0222947649622886,0.00032143065668476
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SDK2,Protein sidekick-2,39736,0.015093646432756,0.00421857675118247,0.00682523600043839,0.0233620568650737,0.000347836374489216
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,STXBP3,Syntaxin-binding protein 3,41843,0.0165795177534513,0.0046400905983021,0.00748494018077921,0.0256740953261234,0.000354030037917011
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CRIM1,Cysteine-rich motor neuron 1 protein,42185,-0.00776117941735296,0.00217278219412823,-0.0120198325178443,-0.00350252631686164,0.000355489675163475
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SLAMF8,SLAM family member 8,41843,0.0205339399134881,0.00575104960300126,0.00926188269160568,0.0318059971353706,0.000357605841271708
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SCGB1A1,Uteroglobin,42165,0.0204010969570258,0.00571504579079675,0.00919960720706416,0.0316025867069874,0.000358601625252458
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,LRRC37A2,Leucine-rich repeat-containing protein 37A2,39930,0.0167383066812188,0.00469110720004121,0.00754373656913802,0.0259328767932996,0.00036107420320669
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,EDIL3,EGF-like repeat and discoidin I-like domain-containing protein 3,41900,0.0135644009090942,0.00380288482629733,0.00611074664955148,0.021018055168637,0.000362538063782788
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CYB5R2,NADH-cytochrome b5 reductase 2,39803,0.0213894953451926,0.00600486982945352,0.00961995047946373,0.0331590402109215,0.000369533144158839
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CIRBP,Cold-inducible RNA-binding protein,39930,0.036639319195918,0.0103384404639073,0.0163759758866597,0.0569026625051763,0.000395708862999305
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CRYBB1,Beta-crystallin B1,39958,0.025102150933871,0.00708383268626723,0.0112178388687872,0.0389864629989548,0.000396313652189744
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,STX6,Syntaxin-6,41843,0.0248138206905537,0.00700290734391132,0.0110881222964875,0.0385395190846199,0.000396423213535014
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ORM1,Alpha-1-acid glycoprotein 1,39922,0.00760418570947709,0.00214752414883406,0.00339503837776234,0.0118133330411918,0.000400354129152884
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,NPTXR,Neuronal pentraxin receptor,42145,-0.0128950816851688,0.00364557978964591,-0.0200404180728748,-0.00574974529746283,0.000405772096617335
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,KIAA0319,Dyslexia-associated protein KIAA0319,39929,-0.011583667420249,0.00327720001299933,-0.0180069794457277,-0.00516035539477029,0.000409985351689834
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CD99,CD99 antigen,42137,-0.00751126691836432,0.00212545212651813,-0.0116771530863398,-0.00334538075038879,0.000410745025546116
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ADAMTS8,A disintegrin and metalloproteinase with thrombospondin motifs 8,42181,-0.0172305850888013,0.00487798256518727,-0.0267914309165683,-0.00766973926103424,0.000413300520061696
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,NAGA,Alpha-N-acetylgalactosaminidase,39636,0.0217531657938259,0.00616065600420005,0.0096782800255938,0.033828051562058,0.00041570822775039
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,VASH1,Tubulinyl-Tyr carboxypeptidase 1,42119,0.0311418958177128,0.00882404497752594,0.0138467676617619,0.0484370239736636,0.000418189000164096
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,IGF1R,Insulin-like growth factor 1 receptor,42070,0.00802909298329774,0.00228785532685267,0.00354489654266651,0.012513289423929,0.000450515978449039
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SLC51B,Organic solute transporter subunit beta,39575,0.0272279455025031,0.00777689864602292,0.0119852241562982,0.042470666848708,0.000465127521348502
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PRUNE2,Protein prune homolog 2,39757,0.0108455549779258,0.00309842438056927,0.00477264319201001,0.0169184667638415,0.000466470239432489
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,MAGED1,Melanoma-associated antigen D1,41843,0.018014249211484,0.00515123957311012,0.00791781964818817,0.0281106787747799,0.000471938735924262
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PDZD2,PDZ domain-containing protein 2,39575,0.0219965163452815,0.00631655317330529,0.00961607212560316,0.0343769605649599,0.000498949025226826
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,KLK11,Kallikrein-11,42062,0.0119703533919837,0.00343892492478033,0.00523006053941426,0.0187106462445531,0.000501424501563588
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PLA2G4A,Cytosolic phospholipase A2,42185,0.0327232906747499,0.00940501890241779,0.014289453626011,0.0511571277234887,0.00050421966543843
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CLGN,Calmegin,39649,0.017017641378066,0.00489402576360177,0.00742535088140658,0.0266099318747255,0.000508576276548571
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PCSK7,Proprotein convertase subtilisin/kexin type 7,39919,0.0166757930199513,0.0048006559875015,0.00726650728444836,0.0260850787554542,0.000515352849701597
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,BLNK,B-cell linker protein,39657,0.0155432363028454,0.00448339109807784,0.00675578975061279,0.0243306828550779,0.000528600806769337
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CDKN2D,Cyclin-dependent kinase 4 inhibitor D,42070,0.0346473155732407,0.0100080280818685,0.0150315805327785,0.0542630506137029,0.000537936302330066
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CLSTN2,Calsyntenin-2,42296,-0.0147606747888401,0.0042696353431822,-0.0231291600614773,-0.00639218951620303,0.000547623496350449
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,HMGCL,"Hydroxymethylglutaryl-CoA lyase, mitochondrial",39638,0.0180999508199575,0.00524195864986865,0.00782571186621499,0.0283741897737001,0.00055667790630045
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,MEGF10,Multiple epidermal growth factor-like domains protein 10,42123,-0.014634440670244,0.00424190949033877,-0.022948583271308,-0.00632029806918002,0.000562369198582246
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ATP6V1G2,V-type proton ATPase subunit G 2,39575,0.0361170830878661,0.0104694585658288,0.0155969442988416,0.0566372218768906,0.000563201756742397
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ANK2,Ankyrin-2,39575,-0.0257758031964606,0.00749231337103744,-0.040460737403694,-0.0110908689892272,0.0005832327180864
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CEACAM21,Carcinoembryonic antigen-related cell adhesion molecule 21,42119,0.0312219047643221,0.0090775761740537,0.0134298554631768,0.0490139540654673,0.000584647937191007
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ACOT13,Acyl-coenzyme A thioesterase 13,39930,0.0421904194030712,0.0122889274508552,0.0181041215993949,0.0662767172067474,0.000598622288707395
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,DYNLT3,Dynein light chain Tctex-type 3,39919,0.0161368552282874,0.00470466683069449,0.00691570824012624,0.0253580022164487,0.000605806831308121
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,MGMT,Methylated-DNA--protein-cysteine methyltransferase,42119,0.0438458255171832,0.0128016621589034,0.0187545676857326,0.0689370833486338,0.00061660223755841
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,GBP4,Guanylate-binding protein 4,41839,0.017941158751186,0.00523938277137106,0.00767196851929875,0.0282103489830733,0.000618279607679563
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PINLYP,phospholipase A2 inhibitor and Ly6/PLAUR domain-containing protein,39736,0.0256239405705089,0.00751004417950552,0.0109042539786781,0.0403436271623397,0.000647278769689961
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ATP6V1F,V-type proton ATPase subunit F,41820,0.024254423604368,0.00712399003424564,0.0102914031372465,0.0382174440714894,0.000664549244053448
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SEMA4D,Semaphorin-4D,42249,0.0109104007583519,0.00320871098612951,0.00462132722553806,0.0171994742911657,0.000675185226024043
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,DBN1,Drebrin,39657,0.0185522517586165,0.0054684690079903,0.00783405250295549,0.0292704510142775,0.0006947895081494
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,LPCAT2,Lysophosphatidylcholine acyltransferase 2,42070,0.0148158886194782,0.00437199398532285,0.00624678040824545,0.023384996830711,0.000703959470506456
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CRTAP,Cartilage-associated protein,39649,0.017900404625031,0.00528523770529023,0.00754133872266215,0.0282594705273999,0.000709418054813103
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PI16,Peptidase inhibitor 16,39990,-0.00875209290139186,0.00258941869069886,-0.0138273535351616,-0.0036768322676221,0.000727436986174203
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SMARCA2,Probable global transcription activator SNF2L2,41839,0.0265323962677142,0.00786049386979736,0.0111258282829114,0.041938964252517,0.000739173456543792
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CLEC7A,C-type lectin domain family 7 member A,42296,0.0214101301631711,0.00634441464975902,0.00897507744964347,0.0338451828766988,0.000741167910981088
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,MAP2K6,Dual specificity mitogen-activated protein kinase kinase 6,42119,0.0357386623426812,0.0105907000410559,0.0149808902622117,0.0564964344231507,0.000741490117685033
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,IGFBP3,Insulin-like growth factor-binding protein 3,42217,0.0115868773582127,0.00343579862314313,0.00485271205685218,0.0183210426595733,0.000747243919112495
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,UBE2B,Ubiquitin-conjugating enzyme E2 B,39919,0.0104599110323908,0.00310371038372853,0.00437663868028291,0.0165431833844988,0.000753834852175412
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,C2CD2L,Phospholipid transfer protein C2CD2L,41820,0.0146660021243537,0.00435715022873499,0.00612598767603316,0.0232060165726743,0.000764944214367133
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,RGMB,RGM domain family member B,42249,0.0100446084493689,0.00299095213340316,0.00418234226789874,0.0159068746308391,0.000786289965431403
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,HPCAL1,Hippocalcin-like protein 1,42296,0.0263176027188018,0.00785026525744711,0.0109310828142055,0.0417041226233982,0.000803173061940944
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CCAR2,Cell cycle and apoptosis regulator protein 2,39929,0.0199707617881049,0.00595811265213475,0.00829286098992083,0.031648662586289,0.000805331311235256
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TIGAR,"Fructose-2,6-bisphosphatase TIGAR",41820,0.0167932328605404,0.00501666768865765,0.0069605641907714,0.0266259015303094,0.000817751554535082
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SIL1,Nucleotide exchange factor SIL1,39638,0.0117486803661033,0.00351493854673567,0.0048594008145014,0.0186379599177052,0.000833034562497365
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TPSAB1,Tryptase alpha/beta-1,42281,0.0185487614280532,0.00555413117621856,0.00766266432266484,0.0294348585334416,0.000841132750289682
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,BPIFA2,BPI fold-containing family A member 2,39281,-0.0395064910538944,0.0118527958295559,-0.0627379708798239,-0.0162750112279648,0.000861776370897184
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CGN,Cingulin,39649,0.0133473959535867,0.00401022235866046,0.00548736013061223,0.0212074317765612,0.000876497427775865
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ACOX1,Peroxisomal acyl-coenzyme A oxidase 1,42145,0.0174706854911098,0.00526842381873599,0.00714457480638724,0.0277967961758323,0.000915191340403676
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CLEC14A,C-type lectin domain family 14 member A,42137,0.0113523557141629,0.00342566574856454,0.00463805084697635,0.0180666605813493,0.00092241838829222
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ABO,Histo-blood group ABO system transferase,39990,-0.0514970038283316,0.0155489569455695,-0.0819729594416477,-0.0210210482150154,0.000929442873517797
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ELAVL4,ELAV-like protein 4,39586,0.029109247342544,0.00879046971682707,0.0118799266975629,0.046338567987525,0.000931114654647465
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PALM3,Paralemmin-3,39575,0.0269204284511863,0.00812959825234789,0.0109864158765844,0.0428544410257881,0.000931270035559975
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,REG3G,Regenerating islet-derived protein 3-gamma,39919,0.0140764898021743,0.00425488455327755,0.00573691607775034,0.0224160635265983,0.000941526740298959
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,NPTX2,Neuronal pentraxin-2,39966,-0.0120941796976724,0.00366297162604687,-0.0192736040847243,-0.00491475531062055,0.000963834543914867
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ASRGL1,Isoaspartyl peptidase/L-asparaginase,39638,0.0360401968629805,0.0109219118059913,0.0146332497232376,0.0574471440027234,0.000970580698987144
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,MTIF3,"Translation initiation factor IF-3, mitochondrial",39930,0.0312167607691527,0.00947419274813028,0.0126473429828174,0.0497861785554881,0.000987499838823726
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PRL,Prolactin,42249,0.0257314498866758,0.00785098617479454,0.0103435169840785,0.0411193827892731,0.00104999867571953
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TNFSF12,Tumor necrosis factor ligand superfamily member 12,42296,-0.00973942935660394,0.00297339093540218,-0.0155672755899922,-0.00391158312321567,0.00105726180462636
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SMAD5,Mothers against decapentaplegic homolog 5,42070,0.00696266232947095,0.00212704430107867,0.00279365549935675,0.0111316691595852,0.00106530582926526
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,STK4,Serine/threonine-protein kinase 4,42145,0.0305410492305628,0.00933173379695242,0.0122508509885361,0.0488312474725896,0.00106748404316477
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,LAMTOR5,Ragulator complex protein LAMTOR5,39919,-0.0143240683710513,0.00437680259481705,-0.0229026014568927,-0.00574553528520992,0.00106835568010881
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,MERTK,Tyrosine-protein kinase Mer,42296,0.00861070325447792,0.00263161309972748,0.00345274157901205,0.0137686649299438,0.00107044475633393
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,GP1BB,Platelet glycoprotein Ib beta chain,39575,0.0242682170035477,0.0074409120921333,0.00968402930296645,0.038852404704129,0.00111179430934312
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,FAM172A,Cotranscriptional regulator FAM172A,39638,0.0213502130385101,0.00655334483741244,0.00850565715718176,0.0341947689198385,0.0011257490694522
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SPTBN2,"Spectrin beta chain, non-erythrocytic 2",39586,0.0110728124419562,0.00340217832709845,0.00440454292084324,0.0177410819630692,0.00113885964538723
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ACRV1,Acrosomal protein SP-10,39657,0.037050359920809,0.0113869977730043,0.0147318442857206,0.0593688755558975,0.00114237457918336
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PPP1R12B,Protein phosphatase 1 regulatory subunit 12B,39757,0.0245776190005754,0.00756087218963207,0.00975830950889652,0.0393969284922542,0.00115489970623527
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,HAGH,"Hydroxyacylglutathione hydrolase, mitochondrial",42224,0.0237630585223532,0.00731202050683985,0.00943149832894712,0.0380946187157593,0.00115741091575698
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ACRBP,Acrosin-binding protein,39919,0.0139138141182527,0.00428152837449003,0.00552201850425221,0.0223056097322531,0.0011585166757342
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PMM2,Phosphomannomutase 2,39575,0.0209052675423405,0.00643340736388817,0.00829578910911969,0.0335147459755613,0.00115961848414505
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,S100A13,Protein S100-A13,39657,0.0123489272663422,0.00381530610735858,0.00487092729591943,0.019826927236765,0.00121284846708972
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,LTBP3,Latent-transforming growth factor beta-binding protein 3,41843,0.0184163859510101,0.00569035679575704,0.00726328663132629,0.0295694852706939,0.00121336560024567
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,MATN2,Matrilin-2,42144,0.0102182765345624,0.00316067921846024,0.00402334526638035,0.0164132078027445,0.00122817915801331
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CSF2RA,Granulocyte-macrophage colony-stimulating factor receptor subunit alpha,42016,0.0211248641377266,0.0065542012768798,0.00827862963504218,0.033971098640411,0.001271130879192
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PPIB,Peptidyl-prolyl cis-trans isomerase B,42155,0.0329362715726992,0.010224909792663,0.0128954483790796,0.0529770947663187,0.0012796536156782
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CRH,Corticoliberin,41830,0.0294697638101219,0.00915294389170007,0.0115299937823897,0.047409533837854,0.00128633078213413
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,LIF,Leukemia inhibitory factor,41839,0.0171901360083924,0.00534915818443166,0.00670578596690629,0.0276744860498784,0.00131389186411131
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,GPA33,Cell surface A33 antigen,42070,0.0457208353992517,0.0142754390679763,0.0177409748260182,0.0737006959724851,0.00136432851006154
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,KLKB1,Plasma kallikrein,39759,0.00837493794484729,0.0026188261546962,0.00324203868164274,0.0135078372080518,0.00138783101067877
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,IL6,Interleukin-6,42070,0.0254618403816431,0.00797161654044533,0.00983747196237026,0.0410862088009159,0.0014060872930824
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,POMC,Pro-opiomelanocortin,39638,0.0250818547366369,0.00787004791345096,0.00965656082627306,0.0405071486470008,0.001441566105337
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SPACA5_SPACA5B,Sperm acrosome-associated protein 5,39934,0.0102268227162857,0.00321982498437211,0.00391596574691636,0.016537679685655,0.00149615614008962
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,NAA10,N-alpha-acetyltransferase 10,39575,0.0172429118694963,0.00543575497847501,0.00658883211168531,0.0278969916273074,0.00151743033413424
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CLIC5,Chloride intracellular channel protein 5,39649,-0.0106839308456108,0.00337561303858365,-0.0173001324012348,-0.00406772928998687,0.00155485518637879
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ACTN2,Alpha-actinin-2,39575,-0.0218150899381041,0.00692556829350973,-0.0353892037933831,-0.008240976082825,0.00163745181585994
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TNFRSF13C,Tumor necrosis factor receptor superfamily member 13C,41913,0.0143951236966498,0.00458348329150367,0.00541149644530256,0.0233787509479969,0.00168941465880499
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TSPYL1,Testis-specific Y-encoded-like protein 1,39657,0.0136296419591378,0.00434212971586581,0.00511906771604077,0.0221402162022347,0.0017001188288095
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CA3,Carbonic anhydrase 3,42287,0.0196845885670656,0.00627203054513262,0.00739140869860564,0.0319777684355255,0.0017019214428057
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,AKT3,RAC-gamma serine/threonine-protein kinase,41791,0.0194256425790764,0.00619851309798815,0.00727655690701963,0.0315747282511332,0.00172866069769032
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,MANF,Mesencephalic astrocyte-derived neurotrophic factor,42185,0.0401979862803171,0.0128384934316666,0.0150345391542506,0.0653614334063836,0.00174550944115071
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,AKR1B1,Aldo-keto reductase family 1 member B1,41843,0.0246968293583849,0.00792445990854836,0.00916488793763014,0.0402287707791397,0.00183383499919975
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SIGLEC9,Sialic acid-binding Ig-like lectin 9,42239,0.0101463392189205,0.00326406346175149,0.00374877483388755,0.0165439036039534,0.00188426879246224
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,LEO1,RNA polymerase-associated protein LEO1,39934,0.00969039464874278,0.00312411732178041,0.00356712469805318,0.0158136645994324,0.00192818758434063
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,THAP12,52 kDa repressor of the inhibitor of the protein kinase,39539,0.0286160088990262,0.00925413956221867,0.0104778953570776,0.0467541224409748,0.00199152897535337
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CD40LG,CD40 ligand,42296,0.0260142301074076,0.00845084158572924,0.00945058059937825,0.0425778796154369,0.00208596335523424
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,FUCA1,Tissue alpha-L-fucosidase,42212,0.0274594848872493,0.00892577261181285,0.00996497056809613,0.0449539992064025,0.00209913535382948
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,RP2,Protein XRP2,42070,0.0139791188738777,0.00454576776601546,0.0050694140524874,0.022888823695268,0.00210786710395318
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,THBD,Thrombomodulin,42145,0.00969661961939079,0.00315633430233421,0.00351020438681574,0.0158830348519658,0.00212970022349108
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,LHPP,Phospholysine phosphohistidine inorganic pyrophosphate phosphatase,42129,0.0188904804268247,0.00616683405509462,0.00680348567883921,0.0309774751748101,0.00219386154404117
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ADAM23,Disintegrin and metalloproteinase domain-containing protein 23,42296,0.0114753623749102,0.00375556721039545,0.00411445064253512,0.0188362741072853,0.00225072473620013
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ARG1,Arginase-1,42015,0.0164272219250463,0.00539172234057104,0.00585944613752712,0.0269949977125656,0.00231780704457473
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,HCG22,Protein PBMUCL2,39575,-0.0189607712717786,0.00622647981730265,-0.0311646717136918,-0.00675687082986539,0.00233090033222119
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,DIABLO,"Diablo homolog, mitochondrial",42107,0.0355955206184324,0.0116942430389669,0.0126748042620573,0.0585162369748075,0.00234020856278439
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,VCAM1,Vascular cell adhesion protein 1,42199,0.00900064119833793,0.00295858663308892,0.00320181139748364,0.0147994709991922,0.00235295890614323
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,RNASE3,Eosinophil cationic protein,42081,0.0353774524093095,0.0116385574870718,0.0125658797346488,0.0581890250839702,0.00237286284148007
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CBLN4,Cerebellin-4,42262,0.0102332591446885,0.00338719749055577,0.00359435206319923,0.0168721662261778,0.00252275708130697
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TDGF1,Teratocarcinoma-derived growth factor 1,41839,0.0480101207488132,0.0158932026329344,0.0168594435882617,0.0791607979093646,0.00252592395092478
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ART5,Ecto-ADP-ribosyltransferase 5,39586,-0.0200274130414081,0.00664659457785947,-0.0330547384140127,-0.00700008766880355,0.00259111184894354
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ZNRF4,E3 ubiquitin-protein ligase ZNRF4,39919,0.0173346311394247,0.00578226083013611,0.00600139991235797,0.0286678623664915,0.00272438389784299
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,DDX1,ATP-dependent RNA helicase DDX1,39930,0.0154553184957728,0.00516256442769727,0.00533669221748611,0.0255739447740594,0.00276185388544696
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,NECTIN4,Nectin-4,42181,0.010714769088658,0.00358672443625558,0.00368478919359708,0.0177447489837189,0.00281918255875199
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ANXA1,Annexin A1,39699,0.0142147598625927,0.0047636701669896,0.0048779663352931,0.0235515533898923,0.00285132353619668
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ARFIP1,Arfaptin-1,39934,0.0221694493858408,0.00743091646694025,0.00760485311063793,0.0367340456610437,0.00285665733872852
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CCDC134,Coiled-coil domain-containing protein 134,39919,0.0154293941685739,0.00518933823858172,0.00525829122095377,0.0256004971161941,0.00295249110194571
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,EFCAB2,Dynein regulatory complex protein 8,39757,0.0112465634757716,0.00379167423017773,0.00381488198462326,0.01867824496692,0.00302221032176959
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SCP2,Non-specific lipid-transfer protein,41843,0.0234861959757169,0.00792590548424066,0.00795142122660517,0.0390209707248286,0.00304981018045445
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CLEC11A,C-type lectin domain family 11 member A,42118,-0.0152809404102585,0.00517233230695116,-0.0254187117318827,-0.00514316908863422,0.00313856500595011
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PRSS27,Serine protease 27,42107,0.0126587382717057,0.00429082149298205,0.00424872814546091,0.0210687483979505,0.00318123575010462
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,EIF5,Eukaryotic translation initiation factor 5,39575,0.0134521566995221,0.00456245317498086,0.00450974847655965,0.0223945649224846,0.00320046736683913
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,DDI2,Protein DDI1 homolog 2,39736,0.0236428795131716,0.00803213336627745,0.00789989811526776,0.0393858609110754,0.00325155172230789
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,XG,Glycoprotein Xg,42261,0.010853864108627,0.00369123736732264,0.00361903886867459,0.0180886893485794,0.00328295227282115
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SMPD1,Sphingomyelin phosphodiesterase,42176,-0.0160493859889472,0.00545899792503248,-0.0267490219220108,-0.00534975005588351,0.00328778724507812
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TPM3,Tropomyosin alpha-3 chain,39575,-0.0144983694661968,0.00496329397808506,-0.0242264256632435,-0.00477031326915007,0.00349487745989299
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,M6PR,Cation-dependent mannose-6-phosphate receptor,39638,0.0121104697213327,0.00415420882908454,0.00396822041632704,0.0202527190263384,0.00356142395708637
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TNFRSF8,Tumor necrosis factor receptor superfamily member 8,42249,0.0139115065822649,0.00479012258276136,0.00452286632005258,0.0233001468444771,0.00368775333169498
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,MPI,Mannose-6-phosphate isomerase,42070,0.026368743107344,0.00908629213785009,0.00855961051715787,0.0441778756975302,0.00371347259542651
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PBK,Lymphokine-activated killer T-cell-originated protein kinase,39560,-0.00968304140685673,0.00334157985860188,-0.0162325379297164,-0.00313354488399705,0.00376602483132426
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CASP9,Caspase-9,39657,0.0197839345776395,0.00684268549275409,0.0063722710118415,0.0331955981434375,0.0038445659537695
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ANP32C,Acidic leucine-rich nuclear phosphoprotein 32 family member C,39638,-0.0123327730448383,0.00427807284464079,-0.0207177958203343,-0.00394775026934239,0.00394934808816055
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PCDH1,Protocadherin-1,42264,0.00631311894031301,0.00219674580205428,0.00200749716828663,0.0106187407123394,0.00406126187897405
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,RGL2,Ral guanine nucleotide dissociation stimulator-like 2,39757,0.0194375775341632,0.00676653397890221,0.00617517093551485,0.0326999841328115,0.0040787078200913
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SERPINC1,Antithrombin-III,39959,0.00442818309758445,0.00154739670401039,0.00139528555772409,0.00746108063744482,0.00422147072940769
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TNN,Tenascin-N,39966,0.0132130708199445,0.00462660307771307,0.0041449287876269,0.0222812128522621,0.00429941150615527
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PRND,Prion-like protein doppel,39929,0.0149216591401914,0.00523354837074966,0.00466390433352204,0.0251794139468607,0.00436394156168555
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,FBLN2,Fibulin-2,39966,-0.00980407605481342,0.00343868754062617,-0.0165439036344407,-0.00306424847518613,0.00436453867526083
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,GAD2,Glutamate decarboxylase 2,39657,-0.0137926016608299,0.00485399493031839,-0.023306431724254,-0.0042787715974059,0.00449847088512002
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,F13B,Coagulation factor XIII B chain,39925,0.0077847436617431,0.00274040652910571,0.00241354686469591,0.0131559404587903,0.00450912925279476
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,GIPC3,PDZ domain-containing protein GIPC3,39930,0.030116300794709,0.0106057860735943,0.00932896009046419,0.0509036414989538,0.004524909281393
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,NEFL,Neurofilament light polypeptide,41797,0.0143478418583714,0.0050613377226625,0.00442761992195289,0.0242680637947899,0.004592514124416
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,FGFBP2,Fibroblast growth factor-binding protein 2,39966,-0.0155956300753815,0.00550353021578913,-0.0263825492983282,-0.00480871085243483,0.00460863298721851
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,MANSC1,MANSC domain-containing protein 1,42181,-0.008398404653469,0.0029650386517291,-0.014209880410858,-0.00258692889607997,0.00462568391920502
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,IL17RA,Interleukin-17 receptor A,42137,0.0133957315773064,0.00473256742473461,0.00411989942482658,0.0226715637297862,0.00465376460028988
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,IL22RA1,Interleukin-22 receptor subunit alpha-1,41913,0.012841356727534,0.00453842632486546,0.00394604113079765,0.0217366723242703,0.00466944185148527
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PPM1F,Protein phosphatase 1F,39958,0.0161363000211021,0.00571424026029972,0.00493638911091461,0.0273362109312895,0.00475294971073181
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,GP6,Platelet glycoprotein VI,42115,0.026471323954475,0.00939424819832284,0.00805859748576228,0.0448840504231878,0.00484207243589642
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TMCO5A,Transmembrane and coiled-coil domain-containing protein 5A,39649,0.0162504090964105,0.00578336771317634,0.00491500837858491,0.0275858098142362,0.00496513653878671
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CEP170,Centrosomal protein of 170 kDa,39638,0.0232606317792075,0.00828275602371594,0.00702642997272429,0.0394948335856908,0.00498881257310316
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CLNS1A,Methylosome subunit pICln,39649,0.0100951644471039,0.00359939340357466,0.00304035337609755,0.0171499755181102,0.00504537336636651
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TYMP,Thymidine phosphorylase,42070,0.0198982665416405,0.00709878142333558,0.00598465495190278,0.0338118781313783,0.00506935670262243
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,NMI,N-myc-interactor,39875,-0.0218878775215819,0.00781246326057693,-0.0372003055123126,-0.00657544953085108,0.00509268457947762
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,FCGR3B,Low affinity immunoglobulin gamma Fc region receptor III-B,42179,-0.0145547075132271,0.00519702405979369,-0.0247408746704227,-0.0043685403560315,0.00510821651224867
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,RPS10,40S ribosomal protein S10,39575,-0.0125300487348154,0.00447643922236134,-0.0213038696106437,-0.00375622785898721,0.00513330128747817
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CBX2,Chromobox protein homolog 2,39575,-0.0117856173852931,0.00423187278596577,-0.020080088045786,-0.00349114672480019,0.00536252534534981
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TPMT,Thiopurine S-methyltransferase,41843,0.0212624678209124,0.00763809792191076,0.00629179589396729,0.0362331397478574,0.00538125203124853
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,VGF,Neurosecretory protein VGF,39934,0.00901053205583876,0.0032386872130752,0.00266270511821136,0.0153583589934661,0.00540884130269464
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CD3G,T-cell surface glycoprotein CD3 gamma chain,39657,-0.0260202859419378,0.00936161513823737,-0.0443690516128831,-0.00767152027099258,0.00545404054003139
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,FXYD5,FXYD domain-containing ion transport regulator 5,41913,0.0192508304819847,0.00693286563312999,0.00566241384104988,0.0328392471229194,0.00549822371281901
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,YAP1,Transcriptional coactivator YAP1,39929,0.00820305208227365,0.00295465033080507,0.00241193743389572,0.0139941667306516,0.00550684811422225
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CUZD1,CUB and zona pellucida-like domain-containing protein 1,39649,0.0118631708946347,0.00428088698261205,0.00347263240871504,0.0202537093805543,0.00559444275960265
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,HEPACAM2,HEPACAM family member 2,39929,-0.0129455147689697,0.00467757582143497,-0.0221135633789822,-0.00377746615895713,0.00565677220792324
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CYTL1,Cytokine-like protein 1,39966,-0.00755902042367175,0.00273195326283682,-0.0129136488188319,-0.00220439202851159,0.00566849279635665
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,KLB,Beta-klotho,41839,-0.022083816500805,0.00798267402427935,-0.0377298575883925,-0.00643777541321749,0.00567456443042914
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,GPHA2,Glycoprotein hormone alpha-2,39930,-0.0129376339971304,0.00467809962556634,-0.0221067092632405,-0.0037685587310204,0.00569145707993944
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,EDA2R,Tumor necrosis factor receptor superfamily member 27,42262,0.012249046776695,0.00442983255964514,0.00356657495979053,0.0209315185935995,0.00569770871377928
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,GP1BA,Platelet glycoprotein Ib alpha chain,42117,0.00983083209984041,0.00355734720965862,0.00285843156890952,0.0168032326307713,0.00572573887970262
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ZCCHC8,Zinc finger CCHC domain-containing protein 8,39575,0.0174750848656722,0.00634532109735365,0.00503825551485908,0.0299119142164854,0.00589666750720806
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CELA2A,Chymotrypsin-like elastase family member 2A,39966,0.0189326711370097,0.00688293684733158,0.00544211491623976,0.0324232273577796,0.00595680855318528
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PRSS53,Serine protease 53,39929,-0.0112423199501719,0.00408945923873559,-0.0192576600580936,-0.00322697984225014,0.00598543929751118
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,FDX1,"Adrenodoxin, mitochondrial",39575,0.0185624435129449,0.0067529925372802,0.00532657813987568,0.031798308886014,0.0059916595889715
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,LILRA5,Leukocyte immunoglobulin-like receptor subfamily A member 5,42129,0.00960207062256219,0.00349604368476291,0.00274982500042688,0.0164543162446975,0.00603047197781264
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TRDMT1,tRNA (cytosine(38)-C(5))-methyltransferase,39757,0.0256707027814154,0.00934792958662488,0.00734876079163064,0.0439926447712002,0.00603980730571204
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,IL2RA,Interleukin-2 receptor subunit alpha,42041,0.0119241285276339,0.00434372360474682,0.00341043026233018,0.0204378267929377,0.00605654813252643
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,LMOD1,Leiomodin-1,39934,-0.0102045221280999,0.00372244030897845,-0.0175005051336976,-0.0029085391225021,0.00612826983590164
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,GSR,"Glutathione reductase, mitochondrial",39949,0.00672554719075805,0.00245927431706636,0.00190536952930799,0.0115457248522081,0.00625209602037557
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,NOS1,"Nitric oxide synthase, brain",41839,0.0171688245988759,0.00627941492256933,0.00486117135064006,0.0294764778471118,0.00626258350167841
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CFHR2,Complement factor H-related protein 2,39904,0.0166549912544823,0.00610194624863784,0.00469517660715209,0.0286148059018124,0.00635371691800002
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,LILRB1,Leukocyte immunoglobulin-like receptor subfamily B member 1,42310,0.00798068487897596,0.002930777276026,0.002236361417965,0.0137250083399869,0.00647619739718934
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,VTCN1,V-set domain-containing T-cell activation inhibitor 1,41843,-0.00924713277177443,0.00339602614512178,-0.0159033440162131,-0.00259092152733575,0.00647910058884739
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TDO2,"Tryptophan 2,3-dioxygenase",39649,0.0114604824880694,0.00420977372763586,0.00320932598190313,0.0197116389942357,0.00649208901554292
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CLEC12A,C-type lectin domain family 12 member A,39657,0.00593146696185514,0.00218647739974771,0.00164597125834963,0.0102169626653606,0.00668214432205215
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,MST1,Hepatocyte growth factor-like protein,39854,0.0195434741552397,0.00722046532085517,0.0053913621263636,0.0336955861841159,0.0068062659871337
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,LBP,Lipopolysaccharide-binding protein,42217,-0.0169197617552195,0.00625451723612779,-0.02917861553803,-0.00466090797240907,0.00683468296225888
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,FLT3,Receptor-type tyrosine-protein kinase FLT3,41843,-0.00871791881038451,0.00322864889397498,-0.0150460706425755,-0.00238976697819354,0.00693909615709045
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,FCRL5,Fc receptor-like protein 5,42137,0.0170019264593518,0.00630733435559839,0.004639551122379,0.0293643017963247,0.0070352949353612
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TSHB,Thyrotropin subunit beta,42145,0.0195950059954866,0.0072715528026728,0.00534276250224793,0.0338472494887253,0.00705286655821542
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SCRN1,Secernin-1,42119,0.0159064078078398,0.00590329751376228,0.00433594468086571,0.0274768709348138,0.00705823974953315
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,GNPDA1,Glucosamine-6-phosphate isomerase 1,39638,0.00971096143919673,0.00361423556446498,0.00262705973284537,0.0167948631455481,0.00722342300756261
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,REPS1,RalBP1-associated Eps domain-containing protein 1,39657,0.0109501471363444,0.00407824119771373,0.00295679438882552,0.0189434998838634,0.00726342895976357
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,COMMD9,COMM domain-containing protein 9,39919,0.0113653087746076,0.00427422499283336,0.00298782778865426,0.019742789760561,0.00784753779328982
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,IRAG2,"Inositol 1,4,5-triphosphate receptor associated 2",41900,0.025215617295746,0.00948558495358464,0.00662387078672011,0.0438073638047719,0.00786277762055606
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,NUP50,Nuclear pore complex protein Nup50,39575,-0.00901294331330614,0.00340071733234323,-0.0156783492846989,-0.0023475373419134,0.00805341286321101
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,C1QTNF6,Complement C1q tumor necrosis factor-related protein 6,39934,0.00892131938273241,0.0033703342968034,0.00231546416099774,0.0155271746044671,0.00813184757266603
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ICAM3,Intercellular adhesion molecule 3,42310,-0.00763941602367698,0.00288756126918334,-0.0132990361112763,-0.00197979593607762,0.00816322087450772
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,DTX3,Probable E3 ubiquitin-protein ligase DTX3,42070,0.00687792543998456,0.00260091189512763,0.0017801381255344,0.0119757127544347,0.00819238770647396
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PKD1,Polycystin-1,39958,0.00767534188964919,0.00291329266949773,0.00196528825743363,0.0133853955218647,0.00843524067921469
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,AIDA,"Axin interactor, dorsalization-associated protein",39649,0.0241615706807139,0.00918019920004358,0.0061683802486285,0.0421547611127994,0.00850212874634254
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,RYR1,Ryanodine receptor 1,39575,-0.00950119895565345,0.00361971993157513,-0.0165958500215407,-0.00240654788976619,0.00868088938106677
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CA4,Carbonic anhydrase 4,42310,-0.0067860443723078,0.00258712411322337,-0.0118568076342256,-0.00171528111039,0.00872539530748347
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,RNASE10,Inactive ribonuclease-like protein 10,39638,0.0133043432102807,0.00507458224085367,0.00335816201820748,0.0232505244023539,0.00875967126994822
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TNFRSF17,Tumor necrosis factor receptor superfamily member 17,39736,-0.0117505802846103,0.00448524677971658,-0.0205416639728548,-0.0029594965963658,0.00880931642397089
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,LAG3,Lymphocyte activation gene 3 protein,42070,-0.011358042912999,0.00433853371143591,-0.0198615689874133,-0.00285451683858458,0.00885599914543402
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,HSBP1,Heat shock factor-binding protein 1,39638,0.0269653703325364,0.0103153979081375,0.00674719043258694,0.0471835502324858,0.00895871583870539
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,HMCN2,Hemicentin-2,39721,0.016224834658233,0.00622035758480422,0.00403293379201672,0.0284167355244493,0.00911030367441234
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,DARS1,"Aspartate--tRNA ligase, cytoplasmic",41997,0.0200219900001942,0.00768219287038587,0.00496489197423789,0.0350790880261505,0.00916313721100942
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,EVI2B,Protein EVI2B,39560,-0.0111345225024734,0.00428138761532765,-0.0195260422285156,-0.00274300277643125,0.00931639087876246
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SOD2,"Superoxide dismutase [Mn], mitochondrial",42137,0.0105470193076667,0.00406204419770059,0.00258541268017353,0.0185086259351598,0.00942859969501785
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,NTRK2,BDNF/NT-3 growth factors receptor,42145,-0.00698412310026052,0.00269269777253243,-0.0122618107344241,-0.00170643546609696,0.00950439905580028
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ROR1,Inactive tyrosine-protein kinase transmembrane receptor ROR1,42145,-0.0089228658159395,0.00344266948448956,-0.015670498005539,-0.00217523362633996,0.00955652247637452
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SLC34A3,Sodium-dependent phosphate transport protein 2C,39560,-0.0134286814142003,0.00518384781271571,-0.0235890231271231,-0.00326833970127746,0.00959676239385691
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,RAD23B,UV excision repair protein RAD23 homolog B,41843,0.0127478085400002,0.00493880585654688,0.00306774906116832,0.0224278680188321,0.00985777450487512
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PAFAH1B3,Platelet-activating factor acetylhydrolase IB subunit alpha1,39934,0.0325960046894971,0.0126507470072303,0.00780054055532584,0.0573914688236684,0.00999006211654416
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ATXN2,Ataxin-2,39586,0.0292739703231238,0.0113692486866528,0.0069902428972843,0.0515576977489632,0.0100416779758783
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,DSG4,Desmoglein-4,42018,-0.0131496365054299,0.00511736567983506,-0.0231796732379066,-0.00311959977295317,0.0101919907079102
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,AXL,Tyrosine-protein kinase receptor UFO,42217,0.00746156234976659,0.00290710229509929,0.00176364185137198,0.0131594828481612,0.0102787177874689
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,BMP4,Bone morphogenetic protein 4,41992,-0.0129233518014964,0.00504241568286988,-0.0228064865399214,-0.00304021706307146,0.0103901639208902
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ANXA5,Annexin A5,41780,0.00830376665396238,0.00324837228439272,0.00193695697655265,0.0146705763313721,0.0105907416061237
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,EIF1AX,"Eukaryotic translation initiation factor 1A, X-chromosomal",39929,0.0153146579787232,0.00599285107216184,0.00356866987728597,0.0270606460801604,0.010616849167442
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,KLK3,Prostate-specific antigen,39966,-0.0313132574559656,0.012255521877883,-0.0553340803366162,-0.00729243457531492,0.0106306953126626
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ADAMTS1,A disintegrin and metalloproteinase with thrombospondin motifs 1,39657,0.00851932449490473,0.00333482856863814,0.00198306050037398,0.0150555884894355,0.0106426961833586
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,IFNW1,Interferon omega-1,39575,-0.00961192354605684,0.00378312069405694,-0.0170268401064084,-0.00219700698570523,0.0110754892306206
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,MAPRE3,Microtubule-associated protein RP/EB family member 3,39560,0.0399103513810634,0.0157213737157315,0.00909645889822974,0.0707242438638971,0.011143268356766
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,IL5RA,Interleukin-5 receptor subunit alpha,42119,-0.0154047587431591,0.00606978665532604,-0.0273015405875982,-0.00350797689872009,0.0111618161361653
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,KLK8,Kallikrein-8,41668,0.00989958975285738,0.00390972820879207,0.00223652246362493,0.0175626570420898,0.0113517055125995
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,MRC1,Macrophage mannose receptor 1,39990,0.00771818236867854,0.00304853513461026,0.00174305350484243,0.0136933112325146,0.0113622488052378
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,FCRL3,Fc receptor-like protein 3,41913,0.0144305861512681,0.00570326352945914,0.00325218963352818,0.025608982669008,0.0114101061710775
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CEACAM3,Carcinoembryonic antigen-related cell adhesion molecule 3,41843,0.0126958372397237,0.00502156026540533,0.00285357911952931,0.0225380953599182,0.0114742876953686
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TFRC,Transferrin receptor protein 1,42200,0.010116378266427,0.00400168745265529,0.00227307085922267,0.0179596856736314,0.0114817412230764
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,APPL2,DCC-interacting protein 13-beta,39736,0.0304646531350145,0.012112666424234,0.00672382694351588,0.0542054793265131,0.0119135882889081
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,MECR,"Enoyl-[acyl-carrier-protein] reductase, mitochondrial",39638,0.0248118351231893,0.00986718499862785,0.00547215252587872,0.0441515177204999,0.0119314945480208
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CD2,T-cell surface antigen CD2,39575,0.0104885889667198,0.00417237698498587,0.00231073007614751,0.0186664478572921,0.0119574610566054
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ITGB5,Integrin beta-5,42181,-0.0102660515357483,0.00410004581691153,-0.0183021413368949,-0.00222996173460169,0.0122953594944084
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,GNGT1,Guanine nucleotide-binding protein G(T) subunit gamma-T1,39649,0.0135258704281562,0.00540412487154801,0.00293378567992211,0.0241179551763903,0.01233308837157
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,IL17D,Interleukin-17D,41913,0.00906835442462202,0.00363062305309269,0.00195233324056034,0.0161843756086837,0.0125107355093882
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TPSD1,Tryptase delta,39934,0.00975921973035021,0.00392359514000366,0.00206897325594304,0.0174494662047574,0.0128853827302525
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TNNI3,"Troponin I, cardiac muscle",41900,0.0222091849882123,0.00895501269130374,0.00465736011325694,0.0397610098631676,0.0131474208498225
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,GLRX5,"Glutaredoxin-related protein 5, mitochondrial",39736,0.0236529015205662,0.00957075196919256,0.00489422766094881,0.0424115753801836,0.0134743681095494
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,MORF4L2,Mortality factor 4-like protein 2,39560,0.00997280369454436,0.00404675889772518,0.00204115625500301,0.0179044511340857,0.0137397892492659
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CCND2,G1/S-specific cyclin-D2,39757,-0.00981528744919471,0.00398477181635146,-0.0176254402092436,-0.00200513468914585,0.0137853172845748
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,EPCAM,Epithelial cell adhesion molecule,42125,0.024481066077568,0.0099776714157957,0.00492483010260842,0.0440373020525276,0.014156529308501
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,FKBP7,Peptidyl-prolyl cis-trans isomerase FKBP7,41820,0.0126488278465426,0.00516648531072069,0.00252251663753007,0.0227751390555552,0.0143682583263056
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SLIRP,"SRA stem-loop-interacting RNA-binding protein, mitochondrial",39560,0.0148782396827023,0.00608717835876481,0.00294737009952327,0.0268091092658813,0.0145333018845793
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,EDAR,Tumor necrosis factor receptor superfamily member EDAR,42119,0.0238254302013852,0.00976707345391372,0.00468196623171432,0.0429688941710561,0.0147259803949125
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,S100A11,Protein S100-A11,42027,0.0120313483908166,0.00494324167456982,0.00234259470865976,0.0217201020729735,0.0149501339045282
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,B3GAT3,Galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase 3,39575,-0.00543329586982061,0.00223229579268912,-0.00980859562349129,-0.00105799611614993,0.0149509094593059
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PTPRZ1,Receptor-type tyrosine-protein phosphatase zeta,39958,-0.00806697724497474,0.00331596946675956,-0.0145662773998235,-0.00156767709012601,0.0149993198806148
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,BGLAP,Osteocalcin,39966,0.0219106361783436,0.00901446254106999,0.00424228959784647,0.0395789827588408,0.0150888253545274
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,POLR2A,DNA-directed RNA polymerase II subunit RPB1,39657,-0.00777092481767943,0.00320084378771194,-0.0140445786415948,-0.00149727099376402,0.015207666712898
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,BCAM,Basal cell adhesion molecule,42137,-0.00633717966619953,0.00261853223840378,-0.0114695028534709,-0.00120485647892813,0.015528180716831
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ENTPD6,Ectonucleoside triphosphate diphosphohydrolase 6,41900,0.00710892240780275,0.00294099643108983,0.00134456940286668,0.0128732754127388,0.0156545748826909
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,AMIGO2,Amphoterin-induced protein 2,42070,0.00603440373950608,0.00250013254550925,0.00113414395030795,0.0109346635287042,0.0158075941015767
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,IL17A,Interleukin-17A,41877,0.0110125404373026,0.00457247937464771,0.00205048086299314,0.0199746000116122,0.0160344143370034
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,NPPB,Natriuretic peptides B,41900,0.0360217162928747,0.0149586601511016,0.00670274239671554,0.0653406901890339,0.01604999327056
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,DGKZ,Diacylglycerol kinase zeta,41913,0.00925334706473389,0.00384620152771895,0.00171479207040475,0.016791902059063,0.0161488577768342
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CTHRC1,Collagen triple helix repeat-containing protein 1,39966,0.00729850403593677,0.00304392327709103,0.00133241441283836,0.0132645936590352,0.0165130838353289
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,DRAXIN,Draxin,42016,0.0108515061479053,0.00453192719085195,0.00196892885383543,0.0197340834419751,0.0166586197960117
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,INSL4,Early placenta insulin-like peptide,39919,0.0123422386409211,0.00516158513094887,0.0022255317842613,0.0224589454975809,0.0168109085190477
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,DNLZ,DNL-type zinc finger protein,39586,-0.0216496369812365,0.00905971022497369,-0.0394066690221849,-0.00389260494028805,0.0168806833543988
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,STOML2,"Stomatin-like protein 2, mitochondrial",39560,0.0243586196684092,0.0101980778111652,0.00437038715852536,0.0443468521782931,0.016931822328168
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,NOP56,Nucleolar protein 56,39575,0.028683095505241,0.0120105940755961,0.00514233111707264,0.0522238598934094,0.0169502524458829
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,RAB2B,Ras-related protein Rab-2B,39919,0.0159164700028458,0.00668773061346405,0.0028085180004563,0.0290244220052354,0.0173314109928108
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SCGB3A1,Secretoglobin family 3A member 1,39736,-0.0066891734973095,0.00281268844386779,-0.0122020428472904,-0.00117630414732862,0.0174135215168078
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,RSPO1,R-spondin-1,42016,-0.00862041288968683,0.00363184344593154,-0.0157388260437126,-0.00150199973566101,0.0176313387013423
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,NDUFS6,"NADH dehydrogenase [ubiquinone] iron-sulfur protein 6, mitochondrial",41843,0.0198449327914589,0.00838789005424448,0.00340466828513974,0.0362851972977781,0.0180004813584998
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PDIA3,Protein disulfide-isomerase A3,39736,0.00622916324309395,0.00263621673233071,0.00106217844772577,0.0113961480384621,0.0181487828190053
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,FBN2,Fibrillin-2,39649,0.0151871858912168,0.00643848698492846,0.00256775140075702,0.0278066203816766,0.0183508079297751
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CLU,Clusterin,39979,-0.00754121778230295,0.00321993369937425,-0.0138522878330765,-0.00123014773152941,0.0191957414339145
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,FABP6,Gastrotropin,41881,0.0141874134470142,0.00606094298086023,0.00230796520452814,0.0260668616895002,0.0192575437086817
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ARNT,Aryl hydrocarbon receptor nuclear translocator,41913,0.00921766902750501,0.00394272888889082,0.00148992040527899,0.016945417649731,0.0194076520520243
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,NDRG1,Protein NDRG1,41839,0.0164729910051079,0.0070553564857645,0.00264449229300951,0.0303014897172063,0.019567666699035
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,KIRREL2,Kin of IRRE-like protein 2,41839,0.00992833323682166,0.00426033940458188,0.00157806800384116,0.0182785984698021,0.0197994900151103
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SLC12A2,Solute carrier family 12 member 2,39575,-0.00658685817345122,0.00283203453023887,-0.0121376458527194,-0.00103607049418303,0.0200452320786057
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,MICB_MICA,MHC class I polypeptide-related sequence A_MHC class I polypeptide-related sequence B,42119,0.0369923712329194,0.0160001794113713,0.00563201958663162,0.0683527228792072,0.0207927854349662
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ENO2,Gamma-enolase,42249,0.0160294081339523,0.00694655587291226,0.00241415862304423,0.0296446576448603,0.0210400006518015
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PLXDC2,Plexin domain-containing protein 2,39929,0.00676749996499082,0.00293460549317272,0.00101567319837228,0.0125193267316094,0.0211228903888943
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CDC26,Anaphase-promoting complex subunit CDC26,39911,0.0172922714936189,0.00752648685348028,0.00254035726079753,0.0320441857264402,0.0216071602487528
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SERPINF2,Alpha-2-antiplasmin,39786,0.00328962538823176,0.0014318865806987,0.000483127690062313,0.0060961230864012,0.0216139713651828
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CLC,Galectin-10,42119,-0.0163838695478907,0.00717568825711669,-0.0304482185318394,-0.00231952056394199,0.0224312618614847
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CASP4,Caspase-4,39757,-0.0406499621129808,0.0178132449600803,-0.0755639222347381,-0.00573600199122348,0.0225076278626957
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TMPRSS11D,Transmembrane protease serine 11D,39906,0.00935971380374749,0.00410171898757936,0.00132034458809194,0.017399083019403,0.0225137241313747
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CPTP,Ceramide-1-phosphate transfer protein,39575,0.00962959148040759,0.0042234217144069,0.00135168492017008,0.0179074980406451,0.0226241151802511
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,RNF31,E3 ubiquitin-protein ligase RNF31,39657,0.00884573824334461,0.00389236931292016,0.0012166943900211,0.0164747820966681,0.0230703383119276
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,RILPL2,RILP-like protein 2,39958,0.0240346457241507,0.0105874542682877,0.00328323535830681,0.0447860560899945,0.023219792300638
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,RTN4IP1,"Reticulon-4-interacting protein 1, mitochondrial",39934,0.0225678687765467,0.00994277321643689,0.00308003327233039,0.042055704280763,0.023239871971864
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PRELP,Prolargin,42123,0.00566522622233541,0.00249704826228399,0.000771011628258802,0.010559440816412,0.023298053252072
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,KLK10,Kallikrein-10,42138,0.00987403396169181,0.00436358649579729,0.00132140442992913,0.0184266634934545,0.0236622333147663
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ALCAM,CD166 antigen,42310,0.00474216467914078,0.00209912343384158,0.000627882748811291,0.00885644660947028,0.023891768063172
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CA12,Carbonic anhydrase 12,42070,0.00788350569649225,0.0034945838439308,0.00103412136238788,0.0147328900305966,0.0240915391447579
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CACNB1,Voltage-dependent L-type calcium channel subunit beta-1,39586,0.0142272069084106,0.00631007109486011,0.00185946756248481,0.0265949462543364,0.0241728731647158
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,XPNPEP2,Xaa-Pro aminopeptidase 2,42181,-0.0263962471576217,0.0117135753789492,-0.0493548549003621,-0.0034376394148813,0.0242451087501527
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,DAND5,DAN domain family member 5,39657,-0.0132021098141527,0.00586010062539307,-0.0246879070399231,-0.0017163125883823,0.0242861684977483
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,NXPH1,Neurexophilin-1,41839,0.00931132555426285,0.00414860998456966,0.00118004998450632,0.0174426011240194,0.0248202546389534
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,MYL6B,Myosin light chain 6B,39649,0.0219216974024017,0.00977980480610707,0.00275327998243181,0.0410901148223715,0.0250117235053106
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ITGB2,Integrin beta-2,42079,-0.00685973501017921,0.00306108147764612,-0.0128594547063656,-0.000860015313992817,0.0250454351905429
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,REST,RE1-silencing transcription factor,39560,-0.0082132658028342,0.00366807740386718,-0.0154026975144139,-0.00102383409125453,0.0251680851374005
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,VASP,Vasodilator-stimulated phosphoprotein,39990,0.0175886365382408,0.00786438287566397,0.00217444610193944,0.0330028269745422,0.0253387813594237
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,RBPMS,RNA-binding protein with multiple splicing,39657,0.0154542409017403,0.00691068732693726,0.00190929374094326,0.0289991880625373,0.0253532152042138
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SETMAR,Histone-lysine N-methyltransferase SETMAR,41976,0.00706841653030213,0.00316175495216343,0.000871376824061804,0.0132654562365425,0.0253944760597792
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,INSL3,Insulin-like 3,39929,-0.0215318934116026,0.00964510781789953,-0.0404363047346857,-0.00262748208851949,0.0256069449437382
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SH3GL3,Endophilin-A3,39690,0.0203439874705993,0.00914440321694846,0.00242095716538029,0.0382670177758183,0.0261182429072089
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,IL20,Interleukin-20,41913,-0.0110433672852216,0.00496929349349805,-0.0207831825324778,-0.0013035520379654,0.0262783311258623
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CSF3R,Granulocyte colony-stimulating factor receptor,39657,0.00719214487062333,0.00324283684746288,0.000836184649596098,0.0135481050916506,0.0265849044117372
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,RTKN2,Rhotekin-2,39575,-0.0120865608926327,0.00546017774265814,-0.0227885092682426,-0.00138461251702274,0.0268779098396488
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SF3B4,Splicing factor 3B subunit 4,42070,0.0170983876034733,0.00773113793933132,0.00194535724238393,0.0322514179645627,0.02700922415716
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,BRDT,Bromodomain testis-specific protein,39575,0.00866694223592344,0.00392278738218193,0.000978278966846866,0.016355605505,0.0271685412178963
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,MRPL46,"39S ribosomal protein L46, mitochondrial",41839,0.00655335784912813,0.00296861217850127,0.00073487797926564,0.0123718377189906,0.0272927898016756
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,LILRA2,Leukocyte immunoglobulin-like receptor subfamily A member 2,42137,0.00839812152661637,0.00381630041131923,0.000918172720430669,0.0158780703328021,0.0277817209209079
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,GUK1,Guanylate kinase,39575,-0.00948609918836824,0.00431574424482614,-0.0179449579082275,-0.00102724046850901,0.0279683718553705
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,FES,Tyrosine-protein kinase Fes/Fps,41843,0.0111196627525652,0.005066037759278,0.00119022874438033,0.0210490967607501,0.0281850019516534
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TLR1,Toll-like receptor 1,39657,0.00629091594191192,0.00286788548170822,0.000669860397763802,0.01191197148606,0.0282868702287503
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CHGB,Secretogranin-1,42210,0.00988804661492484,0.00451049640690203,0.00104747365739686,0.0187286195724528,0.0283797603937556
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,NPHS2,Podocin,39657,-0.0239186384013779,0.0109186392568954,-0.0453191713448929,-0.00251810545786296,0.0284997820188133
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,DNAJB8,DnaJ homolog subfamily B member 8,41900,0.0131214356303998,0.00599764338106071,0.00136605460352078,0.0248768166572787,0.0287040512624369
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PALLD,Palladin,39657,-0.00891835234516607,0.00408572798855895,-0.0169263792027416,-0.000910325487590527,0.0290710480100927
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,RNF43,E3 ubiquitin-protein ligase RNF43,39757,0.0134204689463863,0.00614937548527192,0.00136769299525336,0.0254732448975193,0.0290999447313489
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,MORC3,MORC family CW-type zinc finger protein 3,39929,0.0065548962354572,0.00300596159041295,0.000663211518247815,0.0124465809526666,0.0292311433946799
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SELENOP,Selenoprotein P,39979,-0.00527021664033655,0.00241911117059268,-0.0100116745346982,-0.000528758745974901,0.0293836606583892
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,DCUN1D1,DCN1-like protein 1,39586,0.0175950269267386,0.00808711923920648,0.00174427321789388,0.0334457806355833,0.0296000385847818
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CXCL14,C-X-C motif chemokine 14,41913,0.0132431712651973,0.00608876581430449,0.00130919026916047,0.0251771522612341,0.0296463572446831
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,COPB2,Coatomer subunit beta',39575,0.0100216229816904,0.00461409368816549,0.00097799935288607,0.0190652466104948,0.0298800845620493
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,LYVE1,Lymphatic vessel endothelial hyaluronic acid receptor 1,39979,-0.00449456031890706,0.00207170615839954,-0.00855510438937014,-0.000434016248443966,0.0300656014016214
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,IL7,Interleukin-7,42119,0.0149306220092409,0.00688756890657111,0.0014309869523615,0.0284302570661202,0.030194061327028
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ERVV_1,,39575,-0.0101147751844282,0.00467281248704544,-0.0192734876590373,-0.000956062709819124,0.0304397334889809
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,VWC2L,von Willebrand factor C domain-containing protein 2-like,39934,-0.0106591121922571,0.00493257012509586,-0.020326949637445,-0.000991274747069166,0.0307189101444211
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,NRTN,Neurturin,41913,0.0114019005442612,0.00527802364895996,0.00105697419229969,0.0217468268962227,0.0307703762025581
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,THPO,Thrombopoietin,41900,-0.00896404343107723,0.00415736765864678,-0.0171124840420249,-0.000815602820129532,0.0310872890409831
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,LY96,Lymphocyte antigen 96,42016,0.00833447801091177,0.00389499564582305,0.000700286545098588,0.0159686694767249,0.0323896182428231
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TNFRSF21,Tumor necrosis factor receptor superfamily member 21,42249,-0.00638104615280462,0.00298220052408471,-0.0122261591800106,-0.000535933125598595,0.0323958400130025
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PDP1,"[Pyruvate dehydrogenase [acetyl-transferring]]-phosphatase 1, mitochondrial",41843,0.0114376911676098,0.00534917643334309,0.000953305358257293,0.0219220769769622,0.0325175160145492
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TEX101,Testis-expressed protein 101,39649,0.0141127328005895,0.00660122304910518,0.00117433562434331,0.0270511299768356,0.0325470071735684
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CEACAM6,Carcinoembryonic antigen-related cell adhesion molecule 6,39966,-0.00933977308959047,0.00437121393947464,-0.0179073524109608,-0.000772193768220172,0.032647409589695
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,REG3A,Regenerating islet-derived protein 3-alpha,42310,0.0144140533293513,0.00674891678547524,0.00118617642981982,0.0276419302288828,0.0327168048662193
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SERPINA11,Serpin A11,42310,-0.00950961008408962,0.00445485216248514,-0.0182411203225605,-0.000778099845618749,0.0328061924977099
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CLEC2L,C-type lectin domain family 2 member L,39649,0.0116693553770361,0.00548809288413589,0.000912693324129755,0.0224260174299425,0.0335000368713017
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ADAM15,Disintegrin and metalloproteinase domain-containing protein 15,41900,0.00711782181506781,0.0033531520440354,0.000545643808758435,0.0136899998213772,0.033795270714874
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CXCL3,C-X-C motif chemokine 3,42129,0.0215247782084459,0.0101709600561714,0.00158969649835003,0.0414598599185417,0.0343377178499445
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,FZD8,Frizzled-8,39586,0.00976136135769245,0.004619333430351,0.000707467834204488,0.0188152548811804,0.0346101070000371
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SRPX,Sushi repeat-containing protein SRPX,39958,-0.00870398835407443,0.00412829547326894,-0.0167954474816816,-0.000612529226467297,0.035020546048826
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,MYH4,Myosin-4,39575,-0.0103550816238831,0.00491330385483603,-0.0199851571793617,-0.000725006068404466,0.0350917055988225
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SEZ6L,Seizure 6-like protein,42181,-0.00615080786065507,0.00293694603004512,-0.0119072220795435,-0.000394393641766637,0.0362529093592823
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ARMCX2,Armadillo repeat-containing X-linked protein 2,39586,-0.0128772397153902,0.00616300254021687,-0.0249567246942153,-0.00079775473656519,0.0366908512496199
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ARHGAP30,Rho GTPase-activating protein 30,39757,0.00899985325603193,0.00431712764392782,0.000538283073933403,0.0174614234381304,0.0371205447236956
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,HLA_A,,39934,0.00734049706939115,0.00352189127473169,0.000437590170917041,0.0142434039678653,0.0371598949877449
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PPM1A,Protein phosphatase 1A,41843,0.00697874059773124,0.00334858653226781,0.000415510994486344,0.0135419702009761,0.0371715119521423
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,AHSA1,Activator of 90 kDa heat shock protein ATPase homolog 1,39919,0.0145083448432582,0.00699434688462814,0.000799424949387041,0.0282172647371293,0.0380743912628501
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PREB,Prolactin regulatory element-binding protein,41913,0.00626167552379193,0.00302036118980128,0.000341767591781407,0.0121815834558024,0.0381770892421164
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SFRP1,Secreted frizzled-related protein 1,41968,0.00949719357773523,0.00458328430628025,0.000513956337425941,0.0184804308180445,0.038271781463332
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,UGDH,UDP-glucose 6-dehydrogenase,39575,0.022109006319866,0.0107003564863932,0.00113630760653524,0.0430817050331967,0.0388336272625833
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,NFIC,Nuclear factor 1 C-type,39934,0.0101319453663856,0.00490874593948761,0.00051080332498989,0.0197530874077813,0.0390347486774415
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TIGIT,T-cell immunoreceptor with Ig and ITIM domains,39757,0.00822094636432352,0.00398784349870792,0.000404773106855999,0.016037119621791,0.0392783091882381
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,MNAT1,CDK-activating kinase assembly factor MAT1,39757,0.00996837601422146,0.00484350625006695,0.00047510376409023,0.0194616482643527,0.0396045858743509
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PDIA5,Protein disulfide-isomerase A5,39560,0.0135366864571032,0.00660489634151591,0.000591089627732043,0.0264822832864744,0.0404377168112468
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CBLN1,Cerebellin-1,39586,-0.0203435899660896,0.00993857991766381,-0.0398232066047107,-0.000863973327468546,0.0406885746782895
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,MUC2,Mucin-2,39966,0.0203215128187994,0.00992968752727441,0.000859325265341528,0.0397837003722572,0.0407261251709632
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CLEC4G,C-type lectin domain family 4 member G,42119,0.00727527300369106,0.00356746388910828,0.000283043781038838,0.0142675022263433,0.041435477330485
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SLK,STE20-like serine/threonine-protein kinase,39757,-0.0172519156672635,0.00847783146387963,-0.0338684653364676,-0.000635365998059478,0.041880058797736
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ENSA,Alpha-endosulfine,39919,0.0115561350844535,0.0056847899981703,0.000413946688039695,0.0226983234808673,0.0420943529323714
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,IL20RB,Interleukin-20 receptor subunit beta,39657,-0.00913174089352049,0.00449227416548092,-0.0179365982578631,-0.00032688352917788,0.0421000421736469
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TP53INP1,Tumor protein p53-inducible nuclear protein 1,41900,-0.00636636608726566,0.00314101360689377,-0.0125227527567774,-0.000209979417753883,0.0426975782264385
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PPIF,"Peptidyl-prolyl cis-trans isomerase F, mitochondrial",39966,0.0136046586919688,0.00674544120192613,0.000383593936193565,0.026825723447744,0.043732848669097
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SLC44A4,Choline transporter-like protein 4,39649,-0.0148333704137291,0.00737478876216912,-0.0292879563875805,-0.000378784439877577,0.0443114640758575
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",39586,0.0118294199350937,0.00588994748243775,0.000285122869515729,0.0233737170006717,0.0446243403985934
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TNFSF8,Tumor necrosis factor ligand superfamily member 8,39966,0.00793009601053262,0.00395220431920637,0.000183775544888133,0.0156764164761771,0.0448266250541504
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ANPEP,Aminopeptidase N,42187,-0.00582444625471828,0.00291128916946642,-0.0115305730268725,-0.000118319482564093,0.0454508862958838
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,GNLY,Granulysin,42137,0.0115023461506135,0.00575540392287247,0.000221754461783463,0.0227829378394435,0.045679217589911
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CCS,Copper chaperone for superoxide dismutase,42016,0.00986599430824968,0.0049368865721747,0.000189696626787262,0.0195422919897121,0.045690819332282
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,AHNAK2,Protein AHNAK2,39638,0.00665519135058178,0.00333860587778635,0.000111523830120542,0.013198858871043,0.0462417624326373
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,FOSB,Protein fosB,41839,0.00819366998273203,0.00411091721232826,0.000136272246568647,0.0162510677188954,0.046265637253863
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,GSTT2B,Glutathione S-transferase theta-2B,39929,0.0514215638588758,0.0258370852899584,0.000780876690557292,0.102062251027194,0.0465903568091389
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,MKI67,Proliferation marker protein Ki-67,39657,0.00867293517033227,0.00436149945677138,0.000124396235060366,0.0172214741056042,0.0467786608470137
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,DCUN1D2,DCN1-like protein 2,39560,-0.0169847282376027,0.00855227114001849,-0.033747179672039,-0.000222276803166502,0.0470592627732323
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ACP1,Low molecular weight phosphotyrosine protein phosphatase,39657,0.00941890068661172,0.00474916299126951,0.000110541223723492,0.0187272601494999,0.0473613137589304
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CALY,Neuron-specific vesicular protein calcyon,39575,-0.00825441553310195,0.00416777950296853,-0.0164232633589203,-8.55677072836361e-05,0.0476688484618517
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,NUBP1,Cytosolic Fe-S cluster assembly factor NUBP1,39919,0.021277186704259,0.0107528724937348,0.00020155661653877,0.0423528167919792,0.04786898628338
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,IL22,Interleukin-22,39919,0.0149095159115743,0.00755027273367428,0.000110981353572683,0.0297080504695758,0.0483265832375506
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,COL4A4,Collagen alpha-4(IV) chain,39743,-0.0113438493612351,0.00574998774528749,-0.0226138253419986,-7.38733804716129e-05,0.0485376099582792
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,NLGN2,Neuroligin-2,39586,-0.00987692414370265,0.00501490113207163,-0.0197061303625631,-4.77179248422541e-05,0.0489190418388086
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,IL6R,Interleukin-6 receptor subunit alpha,42114,0.00715359954388307,0.00364221922891616,1.48498552073953e-05,0.0142923492325587,0.0495416117258054
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SIGLEC5,Sialic acid-binding Ig-like lectin 5,42137,0.0248801258965227,0.0126719839329487,4.3037387943156e-05,0.0497172144051022,0.0496205874302352
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TGFBR3,Transforming growth factor beta receptor type 3,42310,-0.00625701368522193,0.00320270754962708,-0.012534320482491,2.02931120471461e-05,0.0507613018018684
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,USP47,Ubiquitin carboxyl-terminal hydrolase 47,39575,0.018284771460709,0.00936081175227359,-6.24195737472313e-05,0.0366319624951652,0.0508056628854313
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,GP5,Platelet glycoprotein V,39736,0.0076636516374736,0.00392407675549222,-2.75388032911642e-05,0.0153548420782384,0.0508467292457507
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ART3,Ecto-ADP-ribosyltransferase 3,42217,-0.00746140110477669,0.00382701029765075,-0.0149623412881722,3.95390786187789e-05,0.0512361505775942
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,NLGN1,Neuroligin-1,39649,-0.0140110416454205,0.00719956711170006,-0.0281221931843527,0.000100109893511589,0.0516686454305434
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,MELTF,Melanotransferrin,39958,-0.00624692917378912,0.00322189250049922,-0.0125618384747676,6.79801271893481e-05,0.052538185701835
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,NUDT2,Bis(5'-nucleosyl)-tetraphosphatase [asymmetrical],42070,-0.0117020563709501,0.00604074171242078,-0.0235419101272948,0.00013779738539464,0.0527431661817627
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,MAP1LC3B2,Microtubule-associated proteins 1A/1B light chain 3 beta 2,39575,-0.0137007570911611,0.00707412543416794,-0.0275660429421303,0.000164528759808021,0.0528025021535435
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ARNTL,Aryl hydrocarbon receptor nuclear translocator-like protein 1,39575,-0.0105348526283842,0.00544542539890558,-0.0212078864102392,0.00013818115347069,0.0530620760503521
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,HIP1,Huntingtin-interacting protein 1,39575,0.00682587314472754,0.00353278166314002,-9.83789150269072e-05,0.013750125204482,0.0533663838961198
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,MRPL52,"39S ribosomal protein L52, mitochondrial",39541,-0.00550488991833268,0.00284968247063139,-0.0110902675607702,8.04877241048409e-05,0.0534154769016583
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,NINJ1,Ninjurin-1,41843,-0.0111875995553947,0.00580248895787457,-0.0225604779128288,0.000185278802039513,0.0538678891447546
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,C1QL2,Complement C1q-like protein 2,39657,-0.00885169583031672,0.00461478708190829,-0.017896678510857,0.000193286850223531,0.0551220608180666
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,LSM1,U6 snRNA-associated Sm-like protein LSm1,41843,-0.0110716424167472,0.0057822230519686,-0.0224047995986056,0.000261514765111279,0.0555430277861632
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ACTA2,"Actin, aortic smooth muscle",41900,0.00890178641292721,0.00465209117168269,-0.000216312283570864,0.0180198851094253,0.0557052439579941
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,UBE2Z,Ubiquitin-conjugating enzyme E2 Z,39657,0.0119879960556732,0.00627994475022914,-0.000320695654775922,0.0242966877661223,0.0562965496043989
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,UPK3BL1,Uroplakin-3b-like protein 1,39738,-0.0108210494037761,0.00567553907493008,-0.021945105990639,0.000303007183086875,0.0565965909111469
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SDHB,Succinate dehydrogenase,39930,0.0134148472882582,0.00703838302331791,-0.000380383437444884,0.0272100780139613,0.0566812143877122
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,WFDC12,WAP four-disulfide core domain protein 12,42223,0.0129479360072493,0.00679712566830567,-0.000374430302629847,0.0262703023171284,0.0568123617355207
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SLC28A1,Sodium/nucleoside cotransporter 1,39560,0.0121433737310164,0.0063761914322701,-0.000353961476233016,0.0246407089382658,0.0568729424412604
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CNTNAP2,Contactin-associated protein-like 2,42119,0.00871695691616983,0.00457834927510052,-0.000256607663027193,0.0176905214953669,0.0569376560070212
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,KIR2DL3,Killer cell immunoglobulin-like receptor 2DL3,41843,0.0159197724200097,0.00836591444791785,-0.000477419897909243,0.0323169647379287,0.0570709882276986
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,FADD,FAS-associated death domain protein,42145,0.0154897362646071,0.00814902209635338,-0.000482347044245489,0.0314618195734598,0.0573482136168954
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,IL31RA,Interleukin-31 receptor subunit alpha,39616,0.00764152537687456,0.00402102979976174,-0.000239693030658442,0.0155227437844076,0.0574080212565987
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,MMP13,Collagenase 3,41839,-0.00654850427632981,0.00344859900672119,-0.0133077583295033,0.000210749776843722,0.0576008846617632
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CD276,CD276 antigen,42123,0.00726867633325322,0.00383135824971002,-0.000240785836178415,0.0147781385026849,0.0578289097142318
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,LY9,T-lymphocyte surface antigen Ly-9,41960,0.00615674916713228,0.00324722546831408,-0.000207812750763313,0.0125213110850279,0.0579812071225832
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,IL18RAP,Interleukin-18 receptor accessory protein,41936,-0.0341055342495748,0.0179976207768792,-0.0693808709722581,0.0011698024731084,0.0581136933112762
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CTAG1A_CTAG1B,Cancer/testis antigen 1,39735,-0.0102543517531799,0.00541266526816029,-0.0208631756787741,0.000354472172414279,0.0581831532897479
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CACNA1H,Voltage-dependent T-type calcium channel subunit alpha-1H,39575,-0.011631207553591,0.00614753233022702,-0.0236803709208359,0.000417955813653987,0.0585156233276769
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CD99L2,CD99 antigen-like protein 2,42137,-0.00496139643203228,0.00262318853830295,-0.0101028459671061,0.000180053103041492,0.0585975024793357
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ATP1B2,Sodium/potassium-transporting ATPase subunit beta-2,39575,-0.00634255635575401,0.0033586116311761,-0.0129254351528592,0.000240322441351151,0.0589924628019943
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,HBQ1,Hemoglobin subunit theta-1,42262,-0.0123855959282809,0.00656291265438244,-0.0252489047308705,0.000477712874308676,0.0591532342055271
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,THSD1,Thrombospondin type-1 domain-containing protein 1,39585,-0.0069789483170443,0.00369926756045418,-0.0142295127355345,0.000271616101445889,0.059243766945298
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PNMA2,Paraneoplastic antigen Ma2,39586,0.00899918898104009,0.00477269607243432,-0.000355295320931183,0.0183536732830114,0.0593810811991041
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PNPT1,"Polyribonucleotide nucleotidyltransferase 1, mitochondrial",41913,0.0232281583368611,0.0123365490367437,-0.000951477775156452,0.0474077944488787,0.0597393302498084
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,EVPL,Envoplakin,39757,-0.00674671564827188,0.00358409958813133,-0.0137715508410093,0.000278119544465517,0.0598074777536627
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,VCPKMT,Protein-lysine methyltransferase METTL21D,39560,0.0168702005043383,0.00897360669345945,-0.000718068614842186,0.0344584696235189,0.0601373147384993
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,LRP2BP,LRP2-binding protein,39649,0.0155998512013069,0.00832807934461849,-0.000723184314145364,0.0319228867167591,0.0610722419637637
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,DNAJA1,DnaJ homolog subfamily A member 1,39560,-0.00939941693763422,0.00501817031775358,-0.0192350307604312,0.000436196885162795,0.0610844166546186
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ITGB1BP1,Integrin beta-1-binding protein 1,41843,0.0080260987846186,0.00428845759709829,-0.000379278105694054,0.0164314756749313,0.0612897528007761
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TCN2,Transcobalamin-2,42286,0.00603721790606567,0.00322650841659551,-0.000286738590461522,0.0123611744025929,0.0613483316168214
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CELA3A,Chymotrypsin-like elastase family member 3A,42293,0.011976213481664,0.00641865736533814,-0.000604354954398778,0.0245567819177267,0.0620845561329759
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,COL28A1,Collagen alpha-1(XXVIII) chain,39649,0.0164077738480648,0.00880167860152412,-0.000843516210922483,0.0336590639070521,0.0623251536852565
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,UPK3A,Uroplakin-3a,39586,-0.00966070920842762,0.00519644915428944,-0.0198457495508349,0.000524331133979676,0.063039940104911
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,C7,Complement component C7,39722,0.0066137902248351,0.00356424375230748,-0.000372127529687565,0.0135997079793578,0.0635378495432854
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PDGFRA,Platelet-derived growth factor receptor alpha,42145,-0.00564172505737426,0.00304405446765638,-0.0116080718139808,0.000324621699232243,0.063852682441844
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,IL31,Interleukin-31,39657,-0.0110128065192388,0.00595786076723369,-0.0226902136230168,0.000664600584539243,0.0645639828218958
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PLA2G1B,Phospholipase A2,42299,-0.00875545569222714,0.00475154945112994,-0.0180684926164418,0.000557581231987549,0.0654013203165587
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,IL10RA,Interleukin-10 receptor subunit alpha,41913,0.0109686343267256,0.00596944489126733,-0.000731477660158323,0.0226687463136096,0.0661638419088938
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,FMR1,Synaptic functional regulator FMR1,41843,0.00708038962343419,0.00385886195958331,-0.000482979817349088,0.0146437590642175,0.0665519962395913
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CLASP1,CLIP-associating protein 1,39560,0.0147749187202961,0.00805238166102672,-0.0010077493353163,0.0305575867759084,0.066554890256597
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PPP3R1,Calcineurin subunit B type 1,42016,0.00788771195093789,0.00430210076685717,-0.00054440555210215,0.0163198294539779,0.0667569461045627
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SEMA3G,Semaphorin-3G,39736,0.00893930841544727,0.00488258527810447,-0.000630558729637493,0.018509175560532,0.0671488111040717
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PPT1,Palmitoyl-protein thioesterase 1,39649,0.0151673535381101,0.00829948107587735,-0.00109962937060955,0.0314343364468297,0.0676506439421831
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,EPB41L5,Band 4.1-like protein 5,39649,0.0121782119108283,0.00666530634575856,-0.000885788526858493,0.0252422123485151,0.0677110045068312
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PAPPA,Pappalysin-1,41913,-0.00922344064818093,0.00505287490727223,-0.0191270754664345,0.000680194170072637,0.0679653865293492
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CYP24A1,"1,25-dihydroxyvitamin D(3) 24-hydroxylase, mitochondrial",39575,-0.0163982007995992,0.00898420125011003,-0.0340072352498149,0.00121083365061642,0.0679940453098922
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,FXN,"Frataxin, mitochondrial",42262,0.0141395717074747,0.00775827285948571,-0.00106664309711726,0.0293457865120667,0.0683986684114227
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ODAM,Odontogenic ameloblast-associated protein,41814,0.0104845417767446,0.00575331399879312,-0.000791953660889909,0.0217610372143791,0.0684247497859947
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,MSLNL,Mesothelin-like protein,39649,-0.00740397689799762,0.00406430275350735,-0.015370010294872,0.000562056498876788,0.068526176314265
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CPLX2,Complexin-2,39560,-0.00596460793509998,0.00328515224888651,-0.0124035063429176,0.000474290472717583,0.0694550721654534
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TEX33,Testis-expressed protein 33,39757,-0.00748780118853953,0.00413969664539943,-0.0156016066135224,0.000626004236443349,0.0705120708808092
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,MILR1,Allergin-1,41913,0.00977077336476983,0.00544816363431816,-0.00090762735849376,0.0204491740880334,0.0729305996615903
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,NGFR,Tumor necrosis factor receptor superfamily member 16,39958,0.00577638940868411,0.00322422385732256,-0.000543089351668105,0.0120958681690363,0.0732301419625392
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CREBZF,CREB/ATF bZIP transcription factor,39560,-0.00499045371307833,0.00279466082694283,-0.0104679889338863,0.000487081507729617,0.0741738695867679
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,IL6ST,Interleukin-6 receptor subunit beta,42145,0.00334643066734083,0.00187469620665745,-0.000327973897707774,0.00702083523238944,0.0742752138934969
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,IL13RA2,Interleukin-13 receptor subunit alpha-2,39586,-0.00561457488202031,0.00315537775423349,-0.011799115280318,0.000569965516277337,0.0752072607200091
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TG,Thyroglobulin,39919,-0.0199401931383026,0.0112339722986906,-0.0419587788437362,0.00207839256713096,0.0759263382149302
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ABHD14B,Protein ABHD14B,41976,0.0105128481899647,0.00595522380142748,-0.00115939046083316,0.0221850868407626,0.0775335885709199
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,42185,-0.00821323949202622,0.00466017639185719,-0.0173471852200663,0.000920706236013865,0.0780189833525435
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,RBP1,Retinol-binding protein 1,39649,0.0132536930006453,0.00752849662485306,-0.00150216038406675,0.0280095463853573,0.0783558003121418
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,RGS8,Regulator of G-protein signaling 8,41913,-0.0119733093347252,0.00680654116206527,-0.0253141300123731,0.0013675113429227,0.078585420731643
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SPON2,Spondin-2,42070,0.00655814563692466,0.00372849965915564,-0.000749713695020391,0.0138660049688697,0.0786132071857512
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,LRRC25,Leucine-rich repeat-containing protein 25,42070,-0.00735464790601696,0.00420045977735006,-0.0155875490696231,0.000878253257589156,0.0799833194404359
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,HEBP1,Heme-binding protein 1,41900,-0.0097027816676891,0.00554817287890654,-0.0205772005103459,0.00117163717496771,0.0803443969758011
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,DLGAP5,Disks large-associated protein 5,39934,-0.00925743881993083,0.00530308305141699,-0.0196514816007081,0.00113660396084646,0.0808952158024517
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,GJA8,Gap junction alpha-8 protein,39560,0.0116741784052578,0.00668756985728779,-0.00143345851502623,0.0247818153255419,0.0808992349198641
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SPESP1,Sperm equatorial segment protein 1,39958,0.00627084943246582,0.00359282924680585,-0.000771095891273639,0.0133127947562053,0.0809459252400228
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SSH3,Protein phosphatase Slingshot homolog 3,39560,0.00552983485834368,0.00317380563964487,-0.000690824195360258,0.0117504939120476,0.0814777701072035
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SOX2,Transcription factor SOX-2,39915,-0.00457957165305049,0.00263528188382841,-0.00974472414535417,0.0005855808392532,0.08227468555939
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,GC,Vitamin D-binding protein,39979,0.00479558218270799,0.0027631223817808,-0.000620137685582365,0.0102113020509984,0.0826676143480572
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,GFRA2,GDNF family receptor alpha-2,42070,0.00385877588125045,0.00222901731457729,-0.000510098055321049,0.00822764981782195,0.0834469082909073
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,FGL1,Fibrinogen-like protein 1,39990,-0.0120320608948304,0.00695532870305753,-0.0256645051528232,0.00160038336316236,0.0836742624753363
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PEAR1,Platelet endothelial aggregation receptor 1,42310,0.00417881509697398,0.00243711095732896,-0.000597922379390779,0.00895555257333874,0.0864302993944074
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PDRG1,p53 and DNA damage-regulated protein 1,39649,0.00927674969535807,0.0054131842874534,-0.00133309150805059,0.0198865908987667,0.0866059190787209
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SSBP1,"Single-stranded DNA-binding protein, mitochondrial",39657,-0.00629323302902176,0.0036804937350525,-0.0135070007497247,0.000920534691681132,0.0873145940384111
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SHPK,Sedoheptulokinase,39757,0.00733310432577245,0.00429024669134367,-0.00107577918926114,0.015741987840806,0.087432452723599
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SNAP25,Synaptosomal-associated protein 25,39586,0.00882132665757587,0.00516477910975305,-0.00130164039754012,0.0189442937126919,0.087668763415471
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,RANBP2,E3 SUMO-protein ligase RanBP2,39586,-0.00608724370811751,0.00356705928186664,-0.0130786799005761,0.000904192484341112,0.0879403129230631
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,MAPK13,Mitogen-activated protein kinase 13,39560,0.00797191855110929,0.00467587894677812,-0.00119280418457584,0.0171366412867944,0.0882409161363696
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,LILRB2,Leukocyte immunoglobulin-like receptor subfamily B member 2,42248,0.00628594845993881,0.0036908619502109,-0.000948140962474557,0.0135200378823522,0.0885700217022937
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CR1,Complement receptor type 1,39970,-0.00647388532725847,0.0038066132738211,-0.0139348473439478,0.000987076689430884,0.0890277601221065
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,MARCO,Macrophage receptor MARCO,42145,0.00466771244481542,0.0027599543674782,-0.00074179811544185,0.0100772230050727,0.090816246677819
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,IL15RA,Interleukin-15 receptor subunit alpha,41913,0.00624379306051092,0.00369662410995024,-0.00100159019499155,0.0134891763160134,0.0912327417194222
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TGOLN2,Trans-Golgi network integral membrane protein 2,39990,0.00476619733967782,0.00283213308994486,-0.000784783516614115,0.0103171781959697,0.0924218201233689
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PSTPIP2,Proline-serine-threonine phosphatase-interacting protein 2,39424,0.0195519489548639,0.0116313038979211,-0.00324540668506148,0.0423493045947893,0.0927963236272551
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,FGF7,Fibroblast growth factor 7,39560,-0.0139776221753903,0.00832903659779991,-0.0303025339070782,0.0023472895562975,0.0933404857612597
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SDC4,Syndecan-4,42145,-0.00847699336380205,0.00505681544299339,-0.0183883516320691,0.001434364904465,0.0936927032486315
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ID4,DNA-binding protein inhibitor ID-4,39757,-0.00754703932662932,0.00450572631531288,-0.0163782629046426,0.00128418425138393,0.0939645315141547
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,KLK6,Kallikrein-6,42158,0.00550516048478631,0.0032960637087488,-0.000955124384361344,0.011965445353934,0.0948983898882786
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,DEFB118,Beta-defensin 118,39586,0.0102050610536236,0.00611327053268004,-0.00177694919042928,0.0221870712976765,0.095080646723925
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PSMC3,26S proteasome regulatory subunit 6A,39560,-0.0054473916912044,0.00326347601955358,-0.0118438046895294,0.00094902130712061,0.0951064608400308
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,KLHL41,Kelch-like protein 41,39934,0.00938700393115588,0.00562900966180764,-0.0016458550059871,0.0204198628682989,0.095420405005382
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PAIP2B,Polyadenylate-binding protein-interacting protein 2B,39539,-0.00960694112533539,0.00576186689630627,-0.0209002002420957,0.00168631799142491,0.0954771675207878
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,MDM1,Nuclear protein MDM1,39649,0.00561145901030858,0.00337190454390949,-0.000997473895754015,0.0122203919163712,0.0961046477029506
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,MAMDC2,MAM domain-containing protein 2,39958,-0.00633279719465516,0.00381046075283771,-0.0138013002702171,0.00113570588090676,0.0965502935679298
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,RCC1,Regulator of chromosome condensation,39919,0.00929039456801932,0.00559102481634526,-0.00166801407201739,0.020248803208056,0.0966082176103087
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,IL2RB,Interleukin-2 receptor subunit beta,41913,-0.00642380983345452,0.0038762762381971,-0.0140213112603208,0.0011736915934118,0.0975002707425719
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,KRT14,"Keratin, type I cytoskeletal 14",41482,-0.00528583848031332,0.00319598793325089,-0.0115499748294851,0.000978297868858413,0.0981725762777293
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,VSIG10L,V-set and immunoglobulin domain-containing protein 10-like,39575,-0.00602110205316539,0.00364828124201919,-0.013171733287523,0.00112952918119222,0.0988909590595771
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,MDGA1,MAM domain-containing glycosylphosphatidylinositol anchor protein 1,42016,-0.0122334374226941,0.00742167384313085,-0.0267799181552306,0.00231304330984235,0.0993064589691976
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CRTAM,Cytotoxic and regulatory T-cell molecule,42016,-0.00898720635083053,0.00546623503923588,-0.0197010270277329,0.0017266143260718,0.100172581055781
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,DCC,Netrin receptor DCC,39649,0.00393933671788172,0.00239618066826555,-0.000757177391918751,0.00863585082768219,0.100203299275119
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ACADM,"Medium-chain specific acyl-CoA dehydrogenase, mitochondrial",39757,0.0121592858819419,0.00742642824936229,-0.00239651348680821,0.026715085250692,0.101596145822178
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,BCL7B,B-cell CLL/lymphoma 7 protein family member B,39919,0.00807885944953953,0.00494952022692291,-0.00162220019522937,0.0177799190943084,0.102654433085788
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SPRR1B,Cornifin-B,39757,0.0151127562808321,0.00927408482114504,-0.00306444996861219,0.0332899625302764,0.103220961427616
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CORO1A,Coronin-1A,41883,0.0153950069983673,0.00945649838596285,-0.00313972983811989,0.0339297438348545,0.103552467405782
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ADGRE1,Adhesion G protein-coupled receptor E1,39930,0.00948301905505418,0.0058379323457446,-0.00195932834260524,0.0209253664527136,0.104322603711695
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SPRING1,SREBP regulating gene protein,39560,0.0107603326818528,0.00665260574190196,-0.00227877457227502,0.0237994399359807,0.10580750898317
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ITGA6,Integrin alpha-6,42119,0.00877906492529679,0.00543180851410146,-0.00186727976234207,0.0194254096129357,0.106067408788622
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ACP6,Lysophosphatidic acid phosphatase type 6,42247,0.0116590635506889,0.00721904313424312,-0.00249026099242762,0.0258083880938054,0.106324546317431
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TNFRSF11B,Tumor necrosis factor receptor superfamily member 11B,42123,0.00507015655221619,0.00314018035987235,-0.00108459695313361,0.011224910057566,0.106419202767271
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,IGLC2,Immunoglobulin lambda constant 2,39963,0.00441530142848306,0.00273681652097417,-0.00094885895262632,0.00977946180959243,0.10670748522434
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CLEC4C,C-type lectin domain family 4 member C,42119,-0.00833145110379226,0.00517211918855378,-0.0184688047133577,0.00180590250577315,0.107238172179559
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ITGB6,Integrin beta-6,41913,-0.00525880456352089,0.0032727277482283,-0.0116733509500484,0.00115574182300658,0.108109518543174
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,MRPL58,"Peptidyl-tRNA hydrolase ICT1, mitochondrial",39934,0.0120401265988275,0.00751137060081041,-0.00268215977876091,0.0267624129764159,0.108980170102
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,BHMT2,S-methylmethionine--homocysteine S-methyltransferase BHMT2,39575,-0.00450647690306718,0.00281900831673426,-0.0100317332038663,0.00101877939773197,0.109937491123962
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CD82,CD82 antigen,39757,-0.00710262004140394,0.00444790719211432,-0.015820518137948,0.00161527805514012,0.110328498491884
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SERPINA7,Thyroxine-binding globulin,39979,0.0031356636326464,0.00196402903443011,-0.000713833274836615,0.00698516054012942,0.110394606701469
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SEZ6,Seizure protein 6 homolog,39649,-0.00531689510469921,0.00335632296270774,-0.0118952881116064,0.00126149790220797,0.113189828932712
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PECR,Peroxisomal trans-2-enoyl-CoA reductase,39638,0.00469969854584075,0.00296851908574199,-0.00111859886221355,0.010517995953895,0.113409207974076
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ZNF830,Zinc finger protein 830,39919,0.0131529331003015,0.00832384307347321,-0.00316179932370598,0.029467665524309,0.114100118027773
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,WAS,Wiskott-Aldrich syndrome protein,41913,0.0110392272514642,0.00698972711386846,-0.00266063789171795,0.0247390923946464,0.114279499926491
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,OTOA,Otoancorin,39586,-0.00889932832824887,0.005636824335241,-0.0199475040253212,0.00214884736882348,0.114414389777054
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SERPINB5,Serpin B5,41900,0.00819328248557871,0.005193751587614,-0.00198647062614473,0.0183730355973022,0.114698135883486
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ERC2,ERC protein 2,39649,0.0124649166744124,0.00790248732465222,-0.00302395848190591,0.0279537918307308,0.114745728198047
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,39930,0.00605695231923035,0.00384639019728918,-0.00148197246745644,0.0135958771059171,0.115351126363048
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,NENF,Neudesin,39919,0.0189614185244452,0.0120543771271886,-0.00466516064484439,0.0425879976937349,0.115749009220848
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,MPRIP,Myosin phosphatase Rho-interacting protein,39892,0.00766209367235262,0.00487106760256322,-0.00188519882867128,0.0172093861733765,0.115751382099097
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CENPJ,Centromere protein J,39757,0.0118515019908018,0.00754237686840587,-0.00293155667127373,0.0266345606528773,0.116136252194734
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,KLK13,Kallikrein-13,41839,0.00752861014997366,0.00479250338024768,-0.00186469647531179,0.0169219167752591,0.11622654823087
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,MRPL24,"39S ribosomal protein L24, mitochondrial",39575,0.00652630455525615,0.00415734636646521,-0.00162209432301567,0.014674703433528,0.116484753232172
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,DTX2,Probable E3 ubiquitin-protein ligase DTX2,39649,-0.0100038011626866,0.006388362090393,-0.0225249908598569,0.00251738853448365,0.117390956290169
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CA13,Carbonic anhydrase 13,41967,0.0175761226169525,0.0112631947077824,-0.00449973901030091,0.0396519842442059,0.118667387477515
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,KLK7,Kallikrein-7,39475,0.00662363111017156,0.00425604302505186,-0.00171821321893008,0.0149654754392732,0.119668587511944
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,RGS10,Regulator of G-protein signaling 10,39934,0.0099435713602715,0.00639019333671897,-0.00258120757969768,0.0224683503002407,0.11971999315262
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ATF2,Cyclic AMP-dependent transcription factor ATF-2,41839,0.0114026259212997,0.00733708466595931,-0.00297806002398051,0.02578331186658,0.120182432343497
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,BATF,Basic leucine zipper transcriptional factor ATF-like,39649,0.0134671857113886,0.00867743222027321,-0.00354058144034691,0.0304749528631241,0.120696078846541
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,KLK1,Kallikrein-1,42016,-0.0210001197497203,0.0136460611260403,-0.0477463995567593,0.00574616005731863,0.123848782767119
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ITPRIP,"Inositol 1,4,5-trisphosphate receptor-interacting protein",39586,0.00747569605840056,0.0048608673467931,-0.00205160394131392,0.017002996058115,0.124093406622454
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,STX5,Syntaxin-5,39657,0.00655587751385685,0.00426283706586443,-0.00179928313523744,0.0149110381629511,0.124098217323491
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,DOC2B,Double C2-like domain-containing protein beta,39649,0.00602093319706974,0.003933812763887,-0.00168933982014877,0.0137312062142882,0.125907007579369
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,GGA1,ADP-ribosylation factor-binding protein GGA1,41839,0.010888469192761,0.00714455885265492,-0.00311486615844259,0.0248918045439647,0.127526950236815
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,39575,-0.00592182971238496,0.003908032574322,-0.0135815735580561,0.00173791413328617,0.129726027323362
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CD3D,T-cell surface glycoprotein CD3 delta chain,39586,-0.00559674327463002,0.00370317346646739,-0.0128549632689061,0.00166147671964607,0.130731360181972
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ARL2BP,ADP-ribosylation factor-like protein 2-binding protein,39575,0.00650395813095561,0.00430888459378416,-0.00194145567286134,0.0149493719347726,0.131217809696254
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CREG1,Protein CREG1,41960,0.00649157054396027,0.00431050724874153,-0.00195702366357313,0.0149401647514937,0.132093994091409
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,MB,Myoglobin,42310,0.00898403378616314,0.00598336785648358,-0.00274336721254469,0.020711434784871,0.133249016149853
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,EPN1,Epsin-1,39757,0.00695793507759029,0.00464352343798767,-0.00214337086086555,0.0160592410160461,0.134053199200736
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,B4GAT1,"Beta-1,4-glucuronyltransferase 1",42137,-0.00380736205536763,0.00256910337494227,-0.00884280467025447,0.00122808055951921,0.138368661903886
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TGFB2,Transforming growth factor beta-2 proprotein,39919,0.00826274492463152,0.00557693180569072,-0.00266804141452229,0.0191935312637853,0.138476373386839
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,BTC,Probetacellulin,41843,0.0116072624268809,0.00783445716948752,-0.00374827362531469,0.0269627984790764,0.138479703795904
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ANGPTL1,Angiopoietin-related protein 1,41920,0.00452378079139213,0.00306679476416545,-0.00148713694637216,0.0105346985291564,0.140213517735713
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,STEAP4,Metalloreductase STEAP4,39586,0.0115095439889799,0.00780999473019908,-0.00379804568221029,0.0268171336601701,0.140592594830198
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CES2,Cocaine esterase,42070,0.00875637149845567,0.00594281487732264,-0.00289154566109671,0.020404288658008,0.140656236138368
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TIE1,Tyrosine-protein kinase receptor Tie-1,42310,-0.00636847480547226,0.00434872711857834,-0.0148919799578858,0.00215503034694128,0.143095133184538
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,EDNRB,Endothelin receptor type B,39657,0.0068758607080272,0.00469653091694007,-0.00232933988917533,0.0160810613052297,0.143214264336745
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,C1QTNF5,Complement C1q tumor necrosis factor-related protein 5,39736,-0.00577123877901498,0.00394389207094818,-0.0135012672380734,0.00195878968004347,0.143403717841401
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,HADH,"Hydroxyacyl-coenzyme A dehydrogenase, mitochondrial",39575,0.0105005323249794,0.00719691957007386,-0.00360543003236538,0.0246064946823242,0.144585057781131
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TNFAIP8L2,Tumor necrosis factor alpha-induced protein 8-like protein 2,39736,0.0099874700181761,0.0068546954379983,-0.00344773304030057,0.0234226730766528,0.145137377261031
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SPINK8,Serine protease inhibitor Kazal-type 8,39575,-0.00557006524946938,0.00383470490425817,-0.0130860868618154,0.00194595636287664,0.146379887021916
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,MRPL28,"39S ribosomal protein L28, mitochondrial",39934,-0.00564686928983865,0.00388855467543753,-0.0132684364536962,0.00197469787401891,0.146480103680368
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SUSD4,Sushi domain-containing protein 4,39919,-0.00599748006424824,0.00413261562624876,-0.0140974066916958,0.00210244656319934,0.146736514387233
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,RAB39B,Ras-related protein Rab-39B,39575,0.0142990240008552,0.00990122510407222,-0.00510737720312633,0.0337054252048368,0.148720509700158
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CACNA1C,Voltage-dependent L-type calcium channel subunit alpha-1C,39586,-0.00486807852214058,0.0033820207556325,-0.0114968392031803,0.00176068215889912,0.150065896140046
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ESPL1,Separin,39560,-0.00818442105635359,0.00571971023982184,-0.0193950531264044,0.00302621101369722,0.152482994062716
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,FGF16,Fibroblast growth factor 16,39657,0.00713051020628188,0.00498381253806966,-0.00263776236833466,0.0168987827808984,0.15253471533169
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PCARE,Photoreceptor cilium actin regulator,39586,-0.0127466190534096,0.00893027816576293,-0.030249964258305,0.00475672615148572,0.153507892210022
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,LTBR,Tumor necrosis factor receptor superfamily member 3,42063,0.00450149664567803,0.00316856966540318,-0.0017088998985122,0.0107118931898683,0.155435438103609
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,BEX3,Protein BEX3,39560,-0.00711309464489216,0.0050129307177158,-0.0169384388516151,0.00271224956183081,0.155942227895273
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PRTG,Protogenin,42262,0.00372015746353674,0.00262282297984389,-0.00142057557695727,0.00886089050403076,0.156102905392527
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PDGFRB,Platelet-derived growth factor receptor beta,42310,-0.00523344169791322,0.00370632930994503,-0.0124978471454055,0.00203096374957903,0.157964338715381
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ARHGAP1,Rho GTPase-activating protein 1,41843,0.00700665892144806,0.00497427577471862,-0.00274292159700044,0.0167562394398966,0.1589832565589
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,GFRA3,GDNF family receptor alpha-3,41989,0.00417176565821114,0.00296506886447075,-0.00163976931615154,0.00998330063257381,0.159459224549359
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TTN,Titin,39575,0.0104108405309516,0.00742642715920259,-0.00414495670108547,0.0249666377629887,0.160984157111541
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SPINK5,Serine protease inhibitor Kazal-type 5,42137,-0.00527375290771376,0.00378461826588946,-0.0126916047088571,0.00214409889342958,0.163500516929345
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,HLA_DRA,,42060,-0.00540610239072057,0.00388086667969617,-0.0130126010829251,0.00220039630148392,0.163638502315022
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SPRED2,"Sprouty-related, EVH1 domain-containing protein 2",39657,0.00666184382927697,0.00479021741824281,-0.00272698231047894,0.0160506699690329,0.164338802564339
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TRIM26,Tripartite motif-containing protein 26,39560,0.00853592688804502,0.00615350913889089,-0.00352495102418113,0.0205968048002712,0.165419940636449
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CD14,Monocyte differentiation antigen CD14,41932,0.00609956964678366,0.00440273681654524,-0.00252979451364501,0.0147289338072123,0.165952114394359
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,RAD51,DNA repair protein RAD51 homolog 1,39757,0.00778393796985673,0.00563657580447425,-0.0032637506069128,0.0188316265466263,0.167316069374164
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,C1QBP,"Complement component 1 Q subcomponent-binding protein, mitochondrial",39934,0.0099788051624425,0.00723186083968254,-0.00419564208333528,0.0241532524082203,0.167663375075225
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TIMP2,Metalloproteinase inhibitor 2,39958,0.00421604377748389,0.00305681153436932,-0.00177530682987998,0.0102073943848478,0.167851248943116
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,BLMH,Bleomycin hydrolase,42310,0.00454073409654362,0.0032960502556576,-0.00191952440454528,0.0110009925976325,0.16834037951157
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,BRD1,Bromodomain-containing protein 1,39757,0.00448234521339803,0.00326596866528387,-0.00191895337055835,0.0108836437973544,0.169954172216742
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CPVL,Probable serine carboxypeptidase CPVL,42223,0.00599305296122801,0.00438062242052411,-0.00259296698299924,0.0145790729054553,0.171308811654885
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,GZMB,Granzyme B,42119,0.00987256395383014,0.00723589845184203,-0.00430979701178024,0.0240549249194405,0.172468587613566
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,DNM1,Dynamin-1,39930,0.0169010132010537,0.0124073787399783,-0.00741744912930375,0.0412194755314112,0.173169944619108
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,KIF20B,Kinesin-like protein KIF20B,39586,-0.0109119283040293,0.00801982069840229,-0.0266307768728978,0.00480692026483914,0.173661726165298
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,DHODH,Dihydroorotate dehydrogenase,39575,0.0067742082477264,0.00498211181571501,-0.00299073091107502,0.0165391474065278,0.17395085282139
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PRDX5,"Peroxiredoxin-5, mitochondrial",42296,0.00957132103017895,0.007044207926592,-0.00423532650594136,0.0233779685662993,0.174248040424329
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,VIT,Vitrin,39958,0.00559426450462044,0.00411810639624025,-0.00247722403201045,0.0136657530412513,0.174346156223609
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SMPDL3B,Acid sphingomyelinase-like phosphodiesterase 3b,39919,-0.0110019999757878,0.00810766517686538,-0.026893023722444,0.00488902377086832,0.174812254178807
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CD3E,T-cell surface glycoprotein CD3 epsilon chain,39757,-0.00505459367543641,0.0037325627326819,-0.0123704166314929,0.00226122928062011,0.175703660545218
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,KLRC1,NKG2-A/NKG2-B type II integral membrane protein,39586,-0.00891403205559733,0.00660080073718748,-0.0218516015004848,0.00402353738929012,0.176900436316709
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,FGF9,Fibroblast growth factor 9,39539,-0.00594454719337734,0.00441544135055302,-0.0145988122404613,0.00270971785370659,0.178230871091647
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,C1QA,Complement C1q subcomponent subunit A,42230,0.00320227627851179,0.00238722309636141,-0.00147668099035658,0.00788123354738016,0.179805461600144
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,MYOM1,Myomesin-1,39586,0.00703653954474608,0.00525347760125673,-0.00326027655371711,0.0173333556432093,0.180466237545922
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PSMD1,26S proteasome non-ATPase regulatory subunit 1,39934,0.00706764595584926,0.00528797315496107,-0.00329678142787444,0.017432073339573,0.181396062593747
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TJP3,Tight junction protein ZO-3,39586,-0.00595845281973061,0.00446224111144049,-0.014704445398154,0.00278753975869274,0.181804212438993
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CRYGD,Gamma-crystallin D,39929,0.0139894093780641,0.0104999619587516,-0.00659051606108904,0.0345693348172172,0.182778726183604
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TPT1,Translationally-controlled tumor protein,41913,-0.00908501906729436,0.00682470284278536,-0.0224614366391537,0.00429139850456495,0.183147228721414
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ST8SIA1,"Alpha-N-acetylneuraminide alpha-2,8-sialyltransferase",39657,0.00707720321742393,0.00532306798131261,-0.00335601002594879,0.0175104164607966,0.183699077216758
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PRTN3,Myeloblastin,41800,0.00678882862682391,0.00512733816125453,-0.00326075416923497,0.0168384114228828,0.185510886160787
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,INPP1,Inositol polyphosphate 1-phosphatase,42070,0.00751388678975219,0.00567875293700178,-0.00361646896677131,0.0186442425462757,0.185805333734822
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,NEO1,Neogenin,39934,0.00320760188802776,0.00242450881292508,-0.0015444353853054,0.00795963916136092,0.185865259966319
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CPOX,"Oxygen-dependent coproporphyrinogen-III oxidase, mitochondrial",39657,0.00396687080635763,0.00299948845445343,-0.00191212656437109,0.00984586817708635,0.18602381260894
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CRYBB2,Beta-crystallin B2,39929,0.0098880537798262,0.00748961974444787,-0.00479160091929162,0.024567708478944,0.186783435990219
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,LELP1,Late cornified envelope-like proline-rich protein 1,39586,-0.0100141682580372,0.00758915430648067,-0.0248889106987393,0.00486057418266488,0.187017219217311
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,LTB,Lymphotoxin-beta,39919,0.00485129732734091,0.00369013139575813,-0.00238136020834503,0.0120839548630268,0.18864817227431
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CHGA,Chromogranin-A,39966,0.0119604160383889,0.00910252606629811,-0.0058805350515554,0.0298013671283332,0.188883932717276
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,MYBPC1,"Myosin-binding protein C, slow-type",39958,0.0108435173402968,0.00825703080623095,-0.00534026303991589,0.0270272977205094,0.189126407143398
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,WASF3,Wiskott-Aldrich syndrome protein family member 3,41839,-0.0118777227235272,0.00908737792289697,-0.0296889834524052,0.0059335380053509,0.191215987681227
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,WFIKKN1,"WAP, Kazal, immunoglobulin, Kunitz and NTR domain-containing protein 1",41976,0.0056804632413711,0.00435204605981883,-0.00284954703587382,0.014210473518616,0.191833695201715
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,GAD1,Glutamate decarboxylase 1,39560,-0.00367998980405712,0.00282242625746311,-0.00921194526868481,0.00185196566057058,0.192315820877068
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,KCNH2,Potassium voltage-gated channel subfamily H member 2,39649,0.0107452059082852,0.00826795779695039,-0.00545999137373755,0.026950403190308,0.193758247675699
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SCG3,Secretogranin-3,42144,-0.00460977822640901,0.00355098839038302,-0.0115697154715597,0.00235015901874171,0.194251839683916
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CADPS,Calcium-dependent secretion activator 1,39649,-0.00567538412201238,0.00437267329482406,-0.0142458237798675,0.00289505553584278,0.19434160609441
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ATP6V1D,V-type proton ATPase subunit D,42070,-0.00359561849390794,0.00277121739830917,-0.00902720459459391,0.00183596760677803,0.194485901931813
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,KHDC3L,KH domain-containing protein 3,39560,-0.00929153643718421,0.00719168418408313,-0.0233872374379871,0.00480416456361872,0.196390142122755
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,DCLRE1C,Protein artemis,39560,-0.00420639573165091,0.00326271527853322,-0.010601317677576,0.00218852621427419,0.197344780166286
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,AHCY,Adenosylhomocysteinase,42145,0.00925779248562742,0.00718380884264925,-0.00482247284596512,0.02333805781722,0.19752353970392
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,EBI3_IL27,Interleukin-27,42247,0.00419536231025507,0.00326934973768467,-0.00221256317560687,0.010603287796117,0.199429587596947
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,MYOM2,Myomesin-2,39575,-0.00765355417687743,0.00597720057997704,-0.0193688673136324,0.00406175895987757,0.200411174597288
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,GUCY2C,Heat-stable enterotoxin receptor,39757,-0.0112352393196154,0.0087892791888036,-0.0284622265296705,0.00599174789043965,0.201174120092052
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,41843,-0.00481537307901628,0.00377158092125802,-0.012207671684682,0.00257692552664944,0.201712241397609
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ITIH1,Inter-alpha-trypsin inhibitor heavy chain H1,39979,0.00250337026295192,0.00196354170047187,-0.00134517146997294,0.00635191199587679,0.202361485141408
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PODXL2,Podocalyxin-like protein 2,42181,-0.00388683409975597,0.00304895799746447,-0.00986279177478633,0.00208912357527439,0.202399243849402
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,FDX2,"Ferredoxin-2, mitochondrial",39575,0.00753875019742353,0.0059202742836259,-0.00406498739848324,0.0191424877933303,0.202910719530438
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,C1RL,Complement C1r subcomponent-like protein,39958,0.00268571524892109,0.0021097741686189,-0.00144944212157195,0.00682087261941414,0.203048683059128
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CEBPA,CCAAT/enhancer-binding protein alpha,39657,0.00494047179003948,0.0038904031964858,-0.00268471847507269,0.0125656620551516,0.204142511283171
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,NRXN3,Neurexin-3,39649,0.0048892730403684,0.00385476364692893,-0.0026660637076123,0.0124446097883491,0.204691973597474
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CNTNAP4,Contactin-associated protein-like 4,39649,0.0143369934207259,0.0113127676001818,-0.00783603107563037,0.0365100179170822,0.205064543645024
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,IDI2,Isopentenyl-diphosphate delta-isomerase 2,41839,0.00663877161372777,0.00524142419042672,-0.0036344197995086,0.0169119630269641,0.205321745886143
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SAP18,Histone deacetylase complex subunit SAP18,39757,-0.00980938466893892,0.00775942475594697,-0.025017857190595,0.00539908785271715,0.206188365156795
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,MAP1LC3A,Microtubule-associated proteins 1A/1B light chain 3A,39586,-0.00439654685313924,0.00347837479832364,-0.0112141614578536,0.00242106775157509,0.206269113184036
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SIRPA,Tyrosine-protein phosphatase non-receptor type substrate 1,42179,0.00778819440173848,0.0061701405721463,-0.00430528111966827,0.0198816699231452,0.206884340944986
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,HMMR,Hyaluronan mediated motility receptor,39541,0.00653653472466034,0.00518228741252266,-0.00362074860388408,0.0166938180532048,0.207219639042573
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CA7,Carbonic anhydrase 7,39757,-0.00453925662399713,0.00360195800896511,-0.0115990943215687,0.00252058107357448,0.207616657052803
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CST6,Cystatin-M,41864,0.00667684848391778,0.00530326769273966,-0.00371755619385196,0.0170712531616875,0.208050141503183
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,RAP1A,Ras-related protein Rap-1A,39657,-0.00931356457587735,0.00741179147448332,-0.0238406758658647,0.00521354671410996,0.208929586712302
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,OFD1,Oral-facial-digital syndrome 1 protein,39757,-0.00890912063056844,0.00710023975319438,-0.0228255905468294,0.00500734928569254,0.209590963657023
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,BRD2,Bromodomain-containing protein 2,39586,0.00471143220829426,0.00375818770052406,-0.00265461568473289,0.0120774801013214,0.209997842123249
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PGD,"6-phosphogluconate dehydrogenase, decarboxylating",39958,0.00704795854106801,0.00562774484160645,-0.00398242134848063,0.0180783384306166,0.210464759051308
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ADGRB3,Adhesion G protein-coupled receptor B3,41992,0.00449708178606777,0.00359428514729428,-0.00254771710262902,0.0115418806747646,0.21089228360415
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,FGF3,Fibroblast growth factor 3,39657,-0.00396589578648439,0.00317450559215855,-0.0101879267471151,0.00225613517414636,0.211583431650225
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,HDDC2,5'-deoxynucleotidase HDDC2,39930,-0.00586298442641496,0.00469368093164391,-0.015062599052437,0.0033366301996071,0.211645925058495
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,VIPR1,Vasoactive intestinal polypeptide receptor 1,39638,-0.00315938164693697,0.002530967100975,-0.00812007716484798,0.00180131387097404,0.211951247212326
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,S100A3,Protein S100-A3,39919,0.00569985299193009,0.00457837469967106,-0.00327376141942518,0.0146734674032854,0.213175469577433
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,RBM19,Probable RNA-binding protein 19,39575,-0.00640659009233917,0.00515705763948316,-0.0165144230657262,0.00370124288104782,0.214154056480446
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,RANGAP1,Ran GTPase-activating protein 1,41843,-0.00638214544424046,0.00514353311590416,-0.0164634703514126,0.00369917946293169,0.214698061719074
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,KIAA1549L,UPF0606 protein KIAA1549L,39757,-0.00363969960304178,0.00293564265309464,-0.00939355920310728,0.00211415999702372,0.215064132113708
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,GSTM4,Glutathione S-transferase Mu 4,39575,-0.00991923125756372,0.00801350728926617,-0.0256257055445254,0.00578724302939797,0.215811527163143
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,LCP1,Plastin-2,39966,-0.00634029058947794,0.00512766650521569,-0.0163905169397007,0.0037099357607448,0.216303317538668
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SIRT5,"NAD-dependent protein deacylase sirtuin-5, mitochondrial",41839,0.00692218194121141,0.00560796074666742,-0.00406942112225672,0.0179137850046795,0.21709471386801
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CEACAM1,Carcinoembryonic antigen-related cell adhesion molecule 1,42159,-0.00301101786119044,0.00243962436451345,-0.00779268161563681,0.00177064589325593,0.217144667060322
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,GPR15L,Protein GPR15L,39930,0.00824851528873165,0.00668676560680981,-0.00485754530061557,0.0213545758780789,0.217393125107339
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,AMBN,Ameloblastin,41913,-0.00359203902946194,0.00291419730665035,-0.00930386575049663,0.00211978769157274,0.217746876382193
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,NELL2,Protein kinase C-binding protein NELL2,42185,0.00380383654234785,0.00308914443428806,-0.00225088654885676,0.00985855963355245,0.218211060505441
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PFDN4,Prefoldin subunit 4,39560,-0.00696431243919373,0.00565645324717297,-0.0180509608036527,0.00412233592526529,0.218268725868033
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PADI2,Protein-arginine deiminase type-2,41913,0.00747119987434253,0.00607398925056315,-0.00443381905676124,0.0193762188054463,0.218706935495128
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,BABAM1,BRISC and BRCA1-A complex member 1,39657,0.00389107534437967,0.00316672741136004,-0.002315710381886,0.0100978610706453,0.219196555251562
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,FOLR2,Folate receptor beta,42249,0.0037988231563142,0.00310049710126431,-0.00227815116216385,0.00987579747479224,0.220509583883464
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,GBP6,Guanylate-binding protein 6,39575,-0.00586754556770809,0.00479515015866877,-0.0152660398786989,0.0035309487432827,0.221113700988158
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,GKN1,Gastrokine-1,41538,0.00370296043496384,0.00302881028639714,-0.00223350772637455,0.00963942859630222,0.221510946426976
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CYTH3,Cytohesin-3,39560,0.00953469480300476,0.00783390856908596,-0.00581976599240373,0.0248891555984132,0.223590207022536
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SCN2A,Sodium channel protein type 2 subunit alpha,39586,0.00632607523092488,0.00520335379110018,-0.00387249819963147,0.0165246486614812,0.224099128227113
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SNED1,"Sushi, nidogen and EGF-like domain-containing protein 1",39638,0.00409822777890999,0.00337331259779917,-0.00251346491277638,0.0107099204705964,0.224431317514721
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,GDF2,Growth/differentiation factor 2,42145,-0.00457870353784255,0.00377459670231533,-0.0119769130743806,0.0028195059986955,0.225139049213664
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SLC13A1,Solute carrier family 13 member 1,39919,0.00780114416165928,0.00644086270145266,-0.00482294673318793,0.0204252350565065,0.225845759225556
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PTPN9,Tyrosine-protein phosphatase non-receptor type 9,39635,-0.00506735738278668,0.00418669787934532,-0.0132732852263035,0.00313857046073015,0.226171679033401
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CYB5A,Cytochrome b5,39560,0.00919132337392547,0.00762948098589053,-0.00576245935841996,0.0241451061062709,0.228340713522574
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,LYPLA2,Acyl-protein thioesterase 2,39586,0.0140231159317288,0.0116560438928146,-0.00882273009818788,0.0368689619616455,0.228972529745797
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,LRFN2,Leucine-rich repeat and fibronectin type-III domain-containing protein 2,39649,0.00585481014915884,0.00486973443866663,-0.00368986935062775,0.0153994896489454,0.229278774157729
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,LHB,Lutropin subunit beta,41843,-0.0113081130324795,0.00945069036769696,-0.0298314661531656,0.00721524008820651,0.231507980454057
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TGFBR1,TGF-beta receptor type-1,39657,0.00281697520704309,0.00235604106094083,-0.00180086527240094,0.00743481568648712,0.231863002069205
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,VSIG10,V-set and immunoglobulin domain-containing protein 10,39919,0.0044395668757385,0.0037146105351072,-0.00284106977307162,0.0117202035245486,0.23204820176947
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,IL4,Interleukin-4,41913,-0.0120120947681449,0.0100543155620754,-0.0317185532698127,0.0076943637335228,0.23221761749687
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,GABARAP,Gamma-aminobutyric acid receptor-associated protein,39919,0.00618630740967364,0.00518451307078857,-0.00397533820907196,0.0163479530284192,0.232805007077108
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ITIH5,Inter-alpha-trypsin inhibitor heavy chain H5,39919,-0.00563413940828022,0.00472676175371266,-0.014898592445557,0.00363031362899659,0.233299557974367
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,DPP7,Dipeptidyl peptidase 2,42054,0.00800649575079315,0.00671796806032412,-0.00516072164744213,0.0211737131490284,0.233359447579209
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CAMLG,Guided entry of tail-anchored proteins factor CAMLG,39649,0.00693033012697541,0.00585644372363474,-0.00454829957134868,0.0184089598252995,0.236688656421085
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CHRM1,Muscarinic acetylcholine receptor M1,39649,-0.00458430526532817,0.0038802632738887,-0.01218962128215,0.00302101075149369,0.237452685173275
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ENAH,Protein enabled homolog,41913,0.00606254888824492,0.00513271133996011,-0.00399756533807689,0.0161226631145667,0.237560611692425
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,IL12RB2,Interleukin-12 receptor subunit beta-2,39657,-0.00523606543486363,0.00443346016598001,-0.0139256473601845,0.00345351649045719,0.237614777443707
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,EDDM3B,Epididymal secretory protein E3-beta,39919,-0.0077685982991815,0.00658909815747445,-0.0206832306878314,0.00514603408946842,0.238419841432911
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TINAGL1,Tubulointerstitial nephritis antigen-like,42126,0.00279439165782505,0.00237180384351332,-0.00185434387546105,0.00744312719111116,0.238748975039695
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CHIT1,Chitotriosidase-1,42207,0.0196334064909296,0.0166961665356526,-0.0130910799189495,0.0523578929008087,0.239646214365265
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,COL4A1,Collagen alpha-1(IV) chain,42145,-0.00490309828877693,0.00419509797096366,-0.0131254903118657,0.00331929373431186,0.242517490937243
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ICAM5,Intercellular adhesion molecule 5,42145,0.00574710977324409,0.0049175035009046,-0.00389119708852893,0.0153854166350171,0.24254316955826
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TOP1,DNA topoisomerase 1,39930,0.0151048402783263,0.0129333771601082,-0.0102445789554858,0.0404542595121384,0.242873267593115
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,GPC5,Glypican-5,42016,0.00699248793312251,0.00600297875522368,-0.0047733504271159,0.0187583262933609,0.244105948525212
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TPRKB,EKC/KEOPS complex subunit TPRKB,39560,-0.00842459750505392,0.00731441168262358,-0.0227608444029961,0.00591164939288828,0.249436363829591
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,MUCL3,Mucin-like protein 3,39560,-0.00524746740565255,0.00456703321382755,-0.0141988525047546,0.00370391769344946,0.250585908243471
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,IL36A,Interleukin-36 alpha,39657,-0.00707312621786515,0.00615659681166216,-0.019140055968723,0.00499380353299268,0.250634653327835
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,KIRREL1,Kin of IRRE-like protein 1,39586,-0.00687174963758748,0.00598799637298133,-0.0186082225286309,0.00486472325345593,0.251163892446961
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TP73,Tumor protein p73,39649,-0.00418651960886194,0.003673315626019,-0.0113862182358592,0.00301317901813531,0.254431272214995
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,IGDCC3,Immunoglobulin superfamily DCC subclass member 3,39586,-0.00596600370566032,0.00524111469502305,-0.0162385885079055,0.00430658109658485,0.255016643935862
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ITGB7,Integrin beta-7,42262,-0.00559879688645255,0.00492504261190218,-0.0152518804057808,0.00405428663287573,0.255641124912994
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SIGLEC15,Sialic acid-binding Ig-like lectin 15,41839,0.00919286710429498,0.00808679442255729,-0.00665724996391731,0.0250429841725073,0.255652861029332
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,RBM25,RNA-binding protein 25,39560,-0.00569209084068016,0.00501811087166556,-0.0155275881491447,0.00414340646778433,0.256689553366348
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,RICTOR,Rapamycin-insensitive companion of mTOR,39657,-0.00557630087307223,0.00491648506673789,-0.0152126116038785,0.00406000985773404,0.256733247412713
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SIRT1,NAD-dependent protein deacetylase sirtuin-1,39657,0.0104743070991299,0.00926101574819656,-0.00767728376733536,0.0286258979655952,0.258075155002677
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,KRT6C,"Keratin, type II cytoskeletal 6C",39575,0.00463336072630889,0.00409808449043655,-0.00339888487494675,0.0126656063275645,0.258241371262683
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,BTNL10,Butyrophilin-like protein 10,39560,-0.00483159039298349,0.00427419197747348,-0.0132090066688315,0.00354582588286453,0.258328136444803
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,IGSF21,Immunoglobulin superfamily member 21,39638,0.00487092822626134,0.00431130690442379,-0.00357923330640928,0.013321089758932,0.258583720955129
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,DPP6,Dipeptidyl aminopeptidase-like protein 6,42070,0.00411464151072722,0.00365556069635887,-0.00305025745413616,0.0112795404755906,0.260361596101361
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,COPE,Coatomer subunit epsilon,41839,-0.00557211156289301,0.00495846629681988,-0.01529070550466,0.00414648237887396,0.261136473829953
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,HRAS,GTPase Hras,39750,0.011937051677521,0.0106379861588084,-0.00891340119374353,0.0327875045487855,0.2618373969624
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,NMRK2,Nicotinamide riboside kinase 2,39560,-0.0046523191499162,0.00418600930732204,-0.0128568973922674,0.00355225909243499,0.266421783495523
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,BCL7A,B-cell CLL/lymphoma 7 protein family member A,39560,0.00762703822690935,0.0068801394504747,-0.00585803509602106,0.0211121115498398,0.267644941907799
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SLC1A4,Neutral amino acid transporter A,39649,0.00600671978872544,0.00544583076267676,-0.004667108506121,0.0166805480835719,0.270053703387972
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,HIF1A,Hypoxia-inducible factor 1-alpha,39657,0.00739845710943794,0.00671015382502733,-0.00575344438761563,0.0205503586064915,0.270235170105195
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TARM1,"T-cell-interacting, activating receptor on myeloid cells protein 1",39649,-0.00909974401771942,0.00827552304684794,-0.0253197691895414,0.00712028115410255,0.271531512245458
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,MYO6,Unconventional myosin-VI,39934,0.00439592860436871,0.00401617451719433,-0.00347577344933217,0.0122676306580696,0.273734385704846
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,IL1B,Interleukin-1 beta,41825,0.00653945210580992,0.0060083160851244,-0.00523684742103391,0.0183157516326538,0.276438330306928
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,HSP90B1,Endoplasmin,41774,-0.00737423262328885,0.00678684381552119,-0.0206764465017104,0.00592798125513269,0.277256428285543
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,RELB,Transcription factor RelB,39657,0.00546236672453822,0.00502727886188882,-0.00439109984476387,0.0153158332938403,0.27726145214233
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,RALB,Ras-related protein Ral-B,39657,0.00344604502166697,0.00317820902809252,-0.00278324467339436,0.0096753347167283,0.278267583797516
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TSLP,Thymic stromal lymphopoietin,41900,0.00695087495937695,0.00642420580746785,-0.00564056842326003,0.0195423183420139,0.279280149056243
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,VWF,von Willebrand factor,42310,-0.00854447130703237,0.00789810255498563,-0.0240247523148042,0.00693580970073947,0.279343330156202
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,IL25,Interleukin-25,39510,-0.0039780966580271,0.00368164274905666,-0.0111941164461782,0.00323792313012395,0.279933598859935
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,DUSP29,Dual specificity phosphatase 29,39649,-0.00779994871345002,0.00721890362743289,-0.0219489998232185,0.00634910239631843,0.27994789635881
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TPPP3,Tubulin polymerization-promoting protein family member 3,41839,-0.00447777806668963,0.00414881108378826,-0.0126094477909146,0.00365389165753536,0.280477299173319
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,MANEAL,"Glycoprotein endo-alpha-1,2-mannosidase-like protein",39560,0.00598994393547639,0.00556149695336985,-0.00491059009312851,0.0168904779640813,0.281486964738153
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SEPTIN3,Neuronal-specific septin-3,39934,-0.00903595719403249,0.00840524239949142,-0.0255102322970357,0.0074383179089707,0.282380482128066
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TUBB3,Tubulin beta-3 chain,39586,-0.00328160231722527,0.00307078211023222,-0.00930033525328043,0.00273713061882989,0.285249272832603
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,WNT9A,Protein Wnt-9a,41913,0.00331068945888209,0.00310457385701055,-0.00277427530085858,0.00939565421862276,0.286266290116045
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,GHRHR,Growth hormone-releasing hormone receptor,41839,-0.00615604012904171,0.00577976851687481,-0.0174843864221163,0.00517230616403293,0.286849424159326
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,FCER1A,High affinity immunoglobulin epsilon receptor subunit alpha,39934,0.00274930911358067,0.00259220260247423,-0.00233140798726883,0.00783002621443016,0.288890984437001
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SCN3B,Sodium channel subunit beta-3,39586,-0.0052797968763462,0.00499795681360743,-0.0150757922310168,0.00451619847832437,0.290812819736957
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,RUVBL1,RuvB-like 1,41843,0.0110838505276744,0.0105714768080701,-0.0096362440161431,0.0318039450714918,0.294442373317773
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SCARF2,Scavenger receptor class F member 2,42249,-0.00318225883908956,0.00303544628502438,-0.00913173355773735,0.00276721587955824,0.294488551070845
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,LAMA4,Laminin subunit alpha-4,42185,0.00379330982454755,0.00364876483124696,-0.0033582692446965,0.0109448888937916,0.298537412470377
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,EPGN,Epigen,39919,-0.0051555166860758,0.00496684787573901,-0.0148905385225242,0.00457950515037265,0.299298921278831
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SYNGAP1,Ras/Rap GTPase-activating protein SynGAP,39586,-0.00635315025151868,0.0061306775180895,-0.0183692781869741,0.00566297768393674,0.300090405703841
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,GPC1,Glypican-1,42262,0.00326074534647445,0.00315503540465424,-0.00292312404664787,0.00944461473959677,0.301385854516962
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,STX1B,Syntaxin-1B,39649,0.00444795017695933,0.00430412501771752,-0.00398813485776702,0.0128840352116857,0.301432041393493
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ATP1B3,Sodium/potassium-transporting ATPase subunit beta-3,39575,-0.00437451440074042,0.00423495481966819,-0.0126750258472901,0.00392599704580922,0.301648089854074
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,NPR1,Atrial natriuretic peptide receptor 1,39575,-0.00472842805980904,0.00457788880393579,-0.0137010901155232,0.00424423399590511,0.301680950786019
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PAEP,Glycodelin,42016,-0.0115122499411996,0.0111615465851084,-0.0333888812480121,0.0103643813656128,0.30236218141438
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,EFNB2,Ephrin-B2,39649,0.0063933205000164,0.00620109540895828,-0.00576082650154184,0.0185474675015746,0.302564057489587
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CORO6,Coronin-6,39586,0.00431252457428397,0.0041888061381524,-0.00389753545649473,0.0125225846050627,0.303250777549497
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,HTR1B,5-hydroxytryptamine receptor 1B,39586,0.00482075101934534,0.00468806794140898,-0.00436786214581626,0.0140093641845069,0.303830291303369
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ROBO2,Roundabout homolog 2,42249,0.00248214245310672,0.00241548016396332,-0.00225219866826139,0.00721648357447483,0.304157201205977
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PDE4D,"cAMP-specific 3',5'-cyclic phosphodiesterase 4D",39575,-0.00678108034501374,0.00660047860042226,-0.0197180184018414,0.00615585771181388,0.304272718779079
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CASP8,Caspase-8,42224,0.00666942459926549,0.00652524165189031,-0.00612004903843951,0.0194588982369705,0.306753526844176
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,KIR3DL1,Killer cell immunoglobulin-like receptor 3DL1,41843,0.0136929516168757,0.0134886406389224,-0.0127447840354122,0.0401306872691637,0.310054357862895
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,AFP,Alpha-fetoprotein,41976,-0.00704346081422796,0.0069458470015491,-0.0206573209372642,0.00657039930880829,0.310575542375733
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,HS3ST3B1,Heparan sulfate glucosamine 3-O-sulfotransferase 3B1,42070,0.00406455975679571,0.00401552117089126,-0.00380586173815116,0.0119349812517426,0.311454757180889
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SPINT1,Kunitz-type protease inhibitor 1,42081,0.00286926945261381,0.0028475220735918,-0.00271187381162611,0.00845041271685372,0.313646700906757
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CCL26,C-C motif chemokine 26,42119,0.00964085253698287,0.00957832307284903,-0.00913266068580123,0.028414365759767,0.314179555255305
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,IL13,Interleukin-13,41913,-0.00520686307894082,0.00517687124270473,-0.0153535307146421,0.00493980455676044,0.314533228999574
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TREML1,Trem-like transcript 1 protein,39990,-0.00569227017459618,0.00568763630676743,-0.0168400373358603,0.00545549698666799,0.316937649542987
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CNTF,Ciliary neurotrophic factor,39586,-0.00369181362271528,0.00370702062379131,-0.0109575740453463,0.00357394679991569,0.319321746699512
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TSC1,Hamartin,39657,-0.00787578289658966,0.00793075510713215,-0.0234200629065687,0.00766849711338936,0.320698315968824
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,APOH,Beta-2-glycoprotein 1,42137,-0.00387692476814239,0.00390415721421824,-0.0115290729080101,0.00377522337172537,0.32071563924815
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,BRK1,Protein BRICK1,41839,-0.00481797772319338,0.00485478421432442,-0.0143333547832692,0.00469739933688247,0.321011550218205
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ENG,Endoglin,42310,-0.00182732867296188,0.00184316204514319,-0.00543992628144254,0.00178526893551878,0.321503077484929
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,LYPD1,Ly6/PLAUR domain-containing protein 1,41839,-0.00638237736974968,0.00645397098836881,-0.0190321605069525,0.00626740576745318,0.322726696942575
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CLEC5A,C-type lectin domain family 5 member A,42107,0.0032096848441165,0.00325043660526525,-0.00316117090220338,0.00958054059043638,0.323433557444588
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,LAMA1,Laminin subunit alpha-1,39575,-0.00544628980159907,0.00554294625531898,-0.0163104644620243,0.00541788485882613,0.32584458553597
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,FSHB,Follitropin subunit beta,39638,-0.00431589471705394,0.00439724570283307,-0.0129344962946068,0.00430270686049888,0.326367963807843
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,MAPT,Microtubule-associated protein tau,41839,-0.00553027265424022,0.00564741927141989,-0.0165992144262232,0.00553866911774277,0.327471097278635
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,C5,Complement C5,39979,0.0015718230025917,0.00160779777362315,-0.00157946063370969,0.00472310663889308,0.328280702307621
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,MAG,Myelin-associated glycoprotein,39649,-0.00509587421673164,0.00521466053752786,-0.0153166088702862,0.00512486043682296,0.328481297488451
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,GLP1R,Glucagon-like peptide 1 receptor,39586,-0.0039150559890338,0.00401782137118344,-0.0117899858765533,0.00395987389848575,0.329868201973006
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PCNA,Proliferating cell nuclear antigen,39560,-0.00672639330735494,0.00691013568411219,-0.0202702592482148,0.00681747263350497,0.330371187757879
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TPPP2,Tubulin polymerization-promoting protein family member 2,39757,-0.00795531439645255,0.0081862079066269,-0.0240002818934413,0.00808965310053617,0.331173703290276
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,KLK4,Kallikrein-4,42262,-0.00647426136396793,0.00668287769876423,-0.0195727016535458,0.00662417892560995,0.332670391661821
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,MFAP3L,Microfibrillar-associated protein 3-like,39649,0.00667479031602879,0.0069055330364948,-0.00686005443550102,0.0202096350675586,0.333772281685956
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CCDC28A,Coiled-coil domain-containing protein 28A,39649,0.00310701270289451,0.00322908411502955,-0.0032219921625634,0.00943601756835242,0.335972077167821
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TCP11,T-complex protein 11 homolog,39757,-0.00595455726886926,0.00620875509658617,-0.0181237172581782,0.00621460272043964,0.337550226422032
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ATP1B1,Sodium/potassium-transporting ATPase subunit beta-1,39575,0.00496892527827594,0.005187560202823,-0.00519869271925715,0.015136543275809,0.338157485407661
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,KCNIP4,Kv channel-interacting protein 4,41839,-0.00520360411590593,0.00544354380560897,-0.0158729499748995,0.00546574174308765,0.339129020242043
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CAPS,Calcyphosin,39929,-0.00970010749586137,0.0101732982856043,-0.0296397721356458,0.010239557143923,0.340363731060074
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,OSBPL2,Oxysterol-binding protein-related protein 2,39929,0.00389559463900419,0.00411371705249269,-0.00416729078388149,0.0119584800618899,0.34367079517032
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,LILRB5,Leukocyte immunoglobulin-like receptor subfamily B member 5,42310,0.007072118682531,0.00747537991187955,-0.00757962594475291,0.0217238633098149,0.344137334195973
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,THRAP3,Thyroid hormone receptor-associated protein 3,39575,-0.010742712101119,0.011362636354546,-0.0330134793560291,0.0115280551537912,0.344454151275098
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,IKZF2,Zinc finger protein Helios,41843,-0.00890951907861522,0.00949506244216409,-0.0275198414652568,0.0097008033080264,0.348091032508811
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,HSD17B3,Testosterone 17-beta-dehydrogenase 3,39575,0.00480055344778509,0.00513579495269655,-0.00526560465950014,0.0148667115550703,0.34995085447209
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,GPR101,Probable G-protein coupled receptor 101,39586,-0.00581499323565017,0.00623395572960928,-0.0180335464656844,0.00640355999438401,0.350947109625418
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,NME1,Nucleoside diphosphate kinase A,39657,-0.0021911642005135,0.00235142466636915,-0.00679995654659704,0.00241762814557003,0.351436786792654
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,FH,"Fumarate hydratase, mitochondrial",39586,0.00819384924825494,0.00882829194814648,-0.00910960297011216,0.0254973014666221,0.353357790032083
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,DIPK1C,Divergent protein kinase domain 1C,39649,-0.00417114647325317,0.00450384016794004,-0.0129986732024157,0.00465638025590931,0.354398078485012
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,GADD45B,Growth arrest and DNA damage-inducible protein GADD45 beta,39757,0.00474228118910444,0.00515106548825518,-0.00535380716787571,0.0148383695460846,0.357257884744877
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CGB3_CGB5_CGB8,Choriogonadotropin subunit beta 3,39990,-0.0036155745946499,0.00395661964288662,-0.0113705490947077,0.00413939990540789,0.36083922177916
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,EXOSC10,Exosome component 10,39575,-0.00568996084577237,0.0062516642875438,-0.0179432228493582,0.00656330115781348,0.362762671700619
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ANXA4,Annexin A4,42088,0.007039138916279,0.00773591713060934,-0.00812325865971531,0.0222015364922733,0.362875970411119
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SSB,Lupus La protein,41839,0.00566453354014726,0.00629277624458475,-0.00666930789923884,0.0179983749795334,0.36804910882352
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,BSND,Barttin,39560,0.0032339920884357,0.0035962584864056,-0.00381467454491928,0.0102826587217907,0.368530881856125
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,DYNC1H1,Cytoplasmic dynein 1 heavy chain 1,39919,0.00452921350806799,0.0050552151378299,-0.00537900816207861,0.0144374351782146,0.370299207425942
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,MLLT1,Protein ENL,39560,-0.00636003190460206,0.00711101663792232,-0.0202976245149298,0.00757756070572568,0.371132168870439
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,VWA5A,von Willebrand factor A domain-containing protein 5A,39560,0.00735990013780479,0.00826959872944101,-0.0088485133718996,0.0235683136475092,0.373488195418946
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ISLR2,Immunoglobulin superfamily containing leucine-rich repeat protein 2,41619,0.00362817434443065,0.00407827622059541,-0.00436524704793635,0.0116215957367976,0.373678729161841
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,KRT17,"Keratin, type I cytoskeletal 17",39575,-0.00384334651692767,0.00432991647613048,-0.0123299828101434,0.00464328977628807,0.374761405197581
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SYT1,Synaptotagmin-1,39929,-0.00379930318179111,0.00429010080429676,-0.0122079007582128,0.00460929439463055,0.375853175881972
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TERF1,Telomeric repeat-binding factor 1,39657,-0.0027553570480379,0.00311642327975862,-0.0088635466763648,0.003352832580289,0.376639421773768
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SEPTIN9,Septin-9,42070,0.0027141516549934,0.00307059434949758,-0.00330421327002185,0.00873251658000865,0.376756600505844
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CCDC50,Coiled-coil domain-containing protein 50,39934,-0.00705539338903389,0.00798224305533897,-0.0227005897774983,0.00858980299943049,0.376776469705179
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,MCTS1,Malignant T-cell-amplified sequence 1,39930,0.00247843558291155,0.00280529086512797,-0.00301993451273928,0.00797680567856237,0.376992416368024
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,IL36G,Interleukin-36 gamma,39624,0.00635100318128212,0.00719810953260161,-0.00775729150261703,0.0204592978651813,0.377625487031022
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,BRME1,Break repair meiotic recombinase recruitment factor 1,39586,-0.00391329942238695,0.00443660137870494,-0.0126090381246486,0.00478243927987473,0.377769655232388
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,NFU1,"NFU1 iron-sulfur cluster scaffold homolog, mitochondrial",39930,0.00980297670898882,0.0111529587875753,-0.0120568225146587,0.0316627759326364,0.379442963326992
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PXDNL,Peroxidasin-like protein,39919,-0.00539006663013226,0.006137038629803,-0.0174186623445461,0.00663852908428162,0.379807923703118
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CLINT1,Clathrin interactor 1,39560,-0.00470398839313153,0.00535610508341194,-0.0152019543566189,0.00579397757035587,0.37982841949539
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,LYSMD3,LysM and putative peptidoglycan-binding domain-containing protein 3,39649,0.00974478887264809,0.0111193941633495,-0.012049223687517,0.0315388014328132,0.380843800070566
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,MZT1,Mitotic-spindle organizing protein 1,41843,0.0048887041737309,0.00561231587028859,-0.00611143493203474,0.0158888432794965,0.383733261484622
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,UXS1,UDP-glucuronic acid decarboxylase 1,41843,-0.00477172476083878,0.00547978797244318,-0.0155121091868274,0.00596865966514985,0.383886584777453
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,IL2RG,Cytokine receptor common subunit gamma,39919,0.00332261144267034,0.00381568232088934,-0.00415612590627276,0.0108013487916134,0.383893958167603
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,GBP2,Guanylate-binding protein 2,41913,0.00559998309782921,0.00646065650220012,-0.00706290364648302,0.0182628698421414,0.386076890008499
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,FAP,Prolyl endopeptidase FAP,42310,-0.00254051022734941,0.00293534834274578,-0.00829379297913115,0.00321277252443232,0.386785870616239
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,AIF1L,Allograft inflammatory factor 1-like,39638,-0.00525660476585144,0.00608221232723022,-0.0171777409272227,0.00666453139551978,0.387464586726288
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PRAME,Melanoma antigen preferentially expressed in tumors,39560,-0.00235342932647638,0.00272341058998885,-0.00769131408285453,0.00298445542990177,0.387525603441951
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,BTN1A1,Butyrophilin subfamily 1 member A1,39894,-0.00354610076677965,0.00410874197754197,-0.0115992350427619,0.00450703350920262,0.388121478819484
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,FOLH1,Glutamate carboxypeptidase 2,39657,0.00967106468894067,0.0112154210821188,-0.0123111606320121,0.0316532900098935,0.388540806101202
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,COL9A2,Collagen alpha-2(IX) chain,39757,0.00412428730825699,0.00478894687021531,-0.00526204855736501,0.013510623173879,0.389141087864316
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,FGFR4,Fibroblast growth factor receptor 4,39736,0.00484436580533083,0.00562568513050839,-0.00618197705046562,0.0158707086611273,0.389192861592594
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,MSMB,Beta-microseminoprotein,42103,0.0063797527948884,0.0074469670284717,-0.00821630258091612,0.0209758081706929,0.391630646607062
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PSMA1,Proteasome subunit alpha type-1,41843,0.0042268488866961,0.00494537459808971,-0.00546608532555973,0.0139197830989519,0.392728544646325
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,EXTL1,Exostosin-like 1,39575,0.00435830895292496,0.00510443679539258,-0.00564638716604451,0.0143630050718944,0.393219161737646
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,NECTIN1,Nectin-1,39657,0.00301726735133295,0.0035371172000402,-0.00391548236074585,0.00995001706341174,0.393661103819583
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,EIF2AK3,Eukaryotic translation initiation factor 2-alpha kinase 3,39575,0.005920706929761,0.00701647795676421,-0.00783158986549685,0.0196730037250188,0.398783410858354
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,MAEA,E3 ubiquitin-protein transferase MAEA,41843,0.00351669172002729,0.00417139773291772,-0.00465924783649145,0.011692631276546,0.399216395686006
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CD55,Complement decay-accelerating factor,41714,0.00237699318441726,0.00281954556971512,-0.00314931613222439,0.0079033025010589,0.39922075718859
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TMED4,Transmembrane emp24 domain-containing protein 4,39575,-0.00500801914376853,0.00594134697565261,-0.0166530592160476,0.00663702092851058,0.399297303417936
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,FOLR3,Folate receptor gamma,42132,0.0171545744104081,0.0204864484961465,-0.022998864642039,0.0573080134628552,0.402403881564201
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,RAB3GAP1,Rab3 GTPase-activating protein catalytic subunit,39586,0.00527610455754448,0.00630285674993748,-0.00707749467233298,0.0176297037874219,0.402556069835895
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ZNF75D,Zinc finger protein 75D,39757,-0.00547507514138341,0.006566010402171,-0.0183444555296386,0.00739430524687175,0.404382734924683
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ITGA2,Integrin alpha-2,39736,-0.00308583708475155,0.003713267329293,-0.0103638410501658,0.00419216688066274,0.405974417589019
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CLPS,Colipase,42115,-0.00652235381361966,0.00786775359236174,-0.0219431508546487,0.00889844322740935,0.407120048447074
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,VSTM2B,V-set and transmembrane domain-containing protein 2B,39757,0.0036469276419924,0.00440825438660242,-0.00499325095574833,0.0122871062397331,0.408087464023506
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TFPI2,Tissue factor pathway inhibitor 2,42142,-0.00336726168459933,0.00407327771845975,-0.0113508860127804,0.00461636264358178,0.408437971898472
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,IL9,Interleukin-9,39757,-0.00497539137516519,0.00602775605924687,-0.0167897932512891,0.00683901050095868,0.409154507194838
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TNFRSF10C,Tumor necrosis factor receptor superfamily member 10C,42178,0.0042952913503235,0.0052056331532324,-0.00590774963001199,0.014498332330659,0.409315854643645
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,LTO1,Protein LTO1 homolog,41913,-0.00362554356100032,0.00440005680126428,-0.0122496548914783,0.00499856776947766,0.409967651451364
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,AOC1,Amiloride-sensitive amine oxidase [copper-containing],41913,-0.00472565264901548,0.00573709901553219,-0.0159703667194586,0.00651906142142762,0.410124379837799
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,MTHFD2,"Bifunctional methylenetetrahydrofolate dehydrogenase/cyclohydrolase, mitochondrial",39929,0.00223119258120791,0.00271553457296998,-0.00309125518181326,0.00755364034422908,0.411298948927255
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CPB2,Carboxypeptidase B2,39959,0.00197332066606963,0.00240487804736248,-0.00274024030676082,0.00668688163890008,0.41192033437067
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,H2AP,Huntingtin-interacting protein M,39560,-0.00436753886068064,0.00539948694716701,-0.014950533277128,0.0062154555557667,0.418601534155574
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SAT1,Diamine acetyltransferase 1,39575,-0.0041946397286139,0.00518749688289466,-0.0143621336190874,0.00597285416185963,0.418759492494873
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,MANSC4,MANSC domain-containing protein 4,39575,-0.00588116480353245,0.0072887612034937,-0.0201671367623801,0.00840480715531521,0.419752383037071
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,MTR,Methionine synthase,39575,0.00565204251350887,0.00700605069037403,-0.00807981683962423,0.019383901866642,0.419835322951227
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ECSCR,Endothelial cell-specific chemotaxis regulator,39586,0.00431666806980752,0.00537148546492033,-0.00621144344143632,0.0148447795810514,0.421630100493711
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CCL24,C-C motif chemokine 24,42166,0.00706063141350922,0.00878602697770246,-0.0101599814627876,0.024281244289806,0.421630259179556
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,RAC3,Ras-related C3 botulinum toxin substrate 3,39649,0.00593838984974651,0.00740898235489718,-0.00858321556585196,0.020459995265345,0.422852412373677
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CA11,Carbonic anhydrase-related protein 11,41843,0.00261288066416905,0.00325996115428681,-0.0037766431982331,0.00900240452657119,0.422852755095179
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,MTPN,Myotrophin,41900,-0.00277620906011835,0.00346621264119606,-0.00956998583686262,0.00401756771662592,0.423183911596977
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,AOC3,Membrane primary amine oxidase,42217,0.00252635439234257,0.00316539503820071,-0.00367781988253081,0.00873052866721595,0.424816735124475
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TCN1,Transcobalamin-1,39806,-0.00303584856102342,0.00382474585721598,-0.0105323504411667,0.0044606533191199,0.427364409489597
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,DEFB104A_DEFB104B,Beta-defensin 104,39586,-0.00474154728399435,0.00599353801528335,-0.0164888817939497,0.00700578722596103,0.428896938655701
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TP53BP1,TP53-binding protein 1,39657,0.00726591243282322,0.00921632057071363,-0.0107980758857755,0.0253299007514219,0.430494563884703
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,METAP1,Methionine aminopeptidase 1,41839,0.00243432071672493,0.00310353689013407,-0.00364861158793784,0.0085172530213877,0.432837167249987
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,MUC16,Mucin-16,42070,0.0158106783119049,0.0203849773921397,-0.0241438773766888,0.0557652340004987,0.437996213605788
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SMC3,Structural maintenance of chromosomes protein 3,39560,0.00432462391482366,0.00558607608009557,-0.00662408520216365,0.015273333031811,0.43884152571334
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,INHBB,Inhibin beta B chain,39736,-0.00433428222713546,0.00560228841510865,-0.0153147675207484,0.00664620306647749,0.439146637846424
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ENOPH1,Enolase-phosphatase E1,39919,-0.00442089223662512,0.00571807814882302,-0.0156283254083182,0.006786540935068,0.439453885397745
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TFAP2A,Transcription factor AP-2-alpha,39586,0.00490609581341659,0.00638444294166236,-0.00760741235224162,0.0174196039790748,0.442239134448825
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,NPTX1,Neuronal pentraxin-1,42137,-0.00342346517647447,0.00445521308991377,-0.0121556828327055,0.00530875247975652,0.442252395262173
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ZNF174,Zinc finger protein 174,39657,-0.00302771241576992,0.00394132227620397,-0.0107527040771297,0.00469727924558985,0.442386490842248
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SEPTIN7,Septin-7,39757,-0.00437063634743178,0.00571175000197435,-0.0155656663513015,0.00682439365643795,0.444168098456255
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,AMY2A,Pancreatic alpha-amylase,41665,0.00399352052986087,0.00522030789931832,-0.00623828295280304,0.0142253240125248,0.444287074799427
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SOWAHA,Ankyrin repeat domain-containing protein SOWAHA,39649,0.00389389066607697,0.00509243709071124,-0.00608728603171706,0.013875067363871,0.444501154223828
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PLCB1,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-1",39657,-0.00349077335670629,0.00457552335270344,-0.012458799128005,0.00547725241459245,0.445525417970095
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PALM,Paralemmin-1,39859,-0.00250116422093033,0.00328171984609681,-0.00893333511928008,0.00393100667741942,0.445986187246656
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,AFAP1,Actin filament-associated protein 1,39736,0.00682705851579411,0.00896744927249076,-0.0107491420582878,0.024403259089876,0.446484739996734
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,FZD10,Frizzled-10,39649,0.00485831738601426,0.00639413758422555,-0.00767419227906783,0.0173908270510963,0.447385524799159
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CLSTN3,Calsyntenin-3,39929,0.00245172404888186,0.00324064547077349,-0.00389994107383417,0.0088033891715979,0.449332701495541
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TOP1MT,"DNA topoisomerase I, mitochondrial",39560,0.00390564518223376,0.00516676247795442,-0.00622120927455689,0.0140324996390244,0.449715022157577
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,MYL1,"Myosin light chain 1/3, skeletal muscle isoform",39575,0.00328281968307327,0.00434736563418394,-0.00523801695992726,0.0118036563260738,0.450188089463092
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SFTPA2,Pulmonary surfactant-associated protein A2,41843,-0.00416250246194544,0.00553841053415605,-0.0150177871088913,0.00669278218500042,0.4523231267434
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CLSPN,Claspin,41820,-0.00285239047018769,0.00379687348704009,-0.0102942625047863,0.00458948156441088,0.452517288211879
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PTEN,"Phosphatidylinositol 3,4,5-trisphosphate 3-phosphatase and dual-specificity protein phosphatase PTEN",41839,0.00241426504768804,0.00322788357305407,-0.00391238675549794,0.00874091685087401,0.454509296452998
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SFTPA1,Pulmonary surfactant-associated protein A1,41843,-0.00446421884036407,0.00607687201227933,-0.0163748879844316,0.00744645030370342,0.462581242600671
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,LEG1,Protein LEG1 homolog,39398,-0.00552760801583642,0.00755629475755073,-0.0203379457406358,0.00928272970896301,0.464475263514546
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,LILRA3,Leukocyte immunoglobulin-like receptor subfamily A member 3,39966,0.010854905455456,0.0148407058981379,-0.0182328781048942,0.0399426890158062,0.46453294458306
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,THBS4,Thrombospondin-4,42189,0.00353946477917292,0.00484890202239375,-0.00596438318471883,0.0130433127430647,0.465432227737341
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CSF2RB,Cytokine receptor common subunit beta,39657,-0.0033202105423251,0.00455891420103155,-0.0122556823763469,0.00561526129169674,0.466451650667291
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,RLN1,Prorelaxin H1,39934,0.0034612926462851,0.00475645210966733,-0.00586135348866286,0.0127839387812331,0.466809393003601
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,EFHD1,EF-hand domain-containing protein D1,39934,0.00280375581202475,0.00386366942806956,-0.00476903626699158,0.0103765478910411,0.468054998265537
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SCN3A,Sodium channel protein type 3 subunit alpha,39649,0.00284799596305185,0.00393486699049354,-0.0048643433383155,0.0105603352644192,0.469213334613245
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,KIR3DL2,Killer cell immunoglobulin-like receptor 3DL2,39560,-0.00630269630104763,0.00874644701703676,-0.0234457324544397,0.0108403398523444,0.471170559374473
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,YY1,Transcriptional repressor protein YY1,39657,-0.00213563165905926,0.00298957805271348,-0.00799520464237768,0.00372394132425917,0.475020365940695
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,HTR1A,5-hydroxytryptamine receptor 1A,39586,-0.00553478135462103,0.00776314109663034,-0.0207505379040165,0.00968097519477444,0.475887862042148
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,IL21R,Interleukin-21 receptor,39657,0.00413703015820733,0.00580278314431403,-0.00723642480464818,0.0155104851210628,0.475898576937552
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,AMY2B,Alpha-amylase 2B,41300,0.00378077641388072,0.00534259266375116,-0.00669070520707156,0.014252258034833,0.47916507361619
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,NFKB2,Nuclear factor NF-kappa-B p100 subunit,39757,0.0041883378805774,0.00595151627234482,-0.00747663401321844,0.0158533097743732,0.481607526534685
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CREB3,Cyclic AMP-responsive element-binding protein 3,39560,0.00420231640682404,0.00601866182610892,-0.00759426077234944,0.0159988935859975,0.485057930183257
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,MORF4L1,Mortality factor 4-like protein 1,39757,0.00294517492761824,0.00423014942081838,-0.00534591793718579,0.0112362677924223,0.486296642475768
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,MMUT,"Methylmalonyl-CoA mutase, mitochondrial",39575,-0.00377038033654029,0.00541771447414018,-0.014389100705855,0.00684834003277446,0.48648390221081
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,DDX25,ATP-dependent RNA helicase DDX25,39649,-0.00263526798978538,0.00384198882889958,-0.0101655660944286,0.00489503011485781,0.492782707362726
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,IL5,Interleukin-5,41913,0.0100753438985442,0.0147162540057065,-0.0187685139526405,0.0389192017497289,0.493582705110156
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,IL3,Interleukin-3,39560,-0.00447483879897076,0.00656385847918087,-0.0173400014181653,0.00839032382022374,0.495418360980275
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,IFNAR1,Interferon alpha/beta receptor 1,39930,0.00179166871610235,0.0026379638368523,-0.00337874040412816,0.00696207783633285,0.497033744344122
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ARTN,Artemin,41913,0.00325688048206239,0.00481548700188807,-0.00618147404163823,0.012695235005763,0.498839978307908
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,UHRF2,E3 ubiquitin-protein ligase UHRF2,39575,-0.00249228271964102,0.00368854153316092,-0.00972182412463643,0.00473725868535439,0.499256527597895
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CEACAM5,Carcinoembryonic antigen-related cell adhesion molecule 5,41662,-0.00450183298326748,0.00667103190379982,-0.0175770555147151,0.00857338954818017,0.499793767254418
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,MFAP3,Microfibril-associated glycoprotein 3,41900,0.00344260634842933,0.00510160125865953,-0.00655653211854335,0.013441744815402,0.499808863397681
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,FGF20,Fibroblast growth factor 20,39657,-0.00311584605628094,0.00462568062134618,-0.0121821800741194,0.00595048796155757,0.500581439037748
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CDC25A,M-phase inducer phosphatase 1,39560,-0.00288959074443847,0.00429312712257475,-0.011304119904685,0.00552493841580803,0.500914627664942
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,FRMD7,FERM domain-containing protein 7,39649,-0.00243764032008962,0.00364331088406726,-0.00957852965286145,0.00470324901268221,0.503463000571134
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SCN2B,Sodium channel subunit beta-2,39649,-0.00202233723042525,0.00302384103429752,-0.00794906565764839,0.00390439119679789,0.503638653919633
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,FCGR2A,Low affinity immunoglobulin gamma Fc region receptor II-a,42122,0.00418759285030157,0.00628639468029185,-0.00813374072307047,0.0165089264236736,0.505335637026646
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,FUT1,"Galactoside alpha-(1,2)-fucosyltransferase 1",39730,-0.00442571028583764,0.00665391401558567,-0.0174673817563856,0.00861596118471028,0.505981854714861
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TMEM25,Transmembrane protein 25,39934,0.00333823961828369,0.00502996943648705,-0.00652050047723093,0.0131969797137983,0.506915068361712
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,DDX53,Probable ATP-dependent RNA helicase DDX53,39649,-0.00257171098102469,0.00388215971570601,-0.0101807440238085,0.00503732206175909,0.507700930985061
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PGLYRP4,Peptidoglycan recognition protein 4,39575,-0.00417404327492192,0.00631058762283058,-0.0165427950156699,0.00819470846582602,0.508347297308953
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,GLT8D2,Glycosyltransferase 8 domain-containing protein 2,41839,0.00315762579740014,0.00479622561358567,-0.00624297640522778,0.0125582280000281,0.51032059705977
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,GHRL,Appetite-regulating hormone,42145,0.00584088780387635,0.00887308205987266,-0.0115503530334741,0.0232321286412268,0.510375544348224
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SKIV2L,Helicase SKI2W,39575,0.00278194137038874,0.00424418776221814,-0.00553666664355881,0.0111005493843363,0.512178385773861
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,RGMA,Repulsive guidance molecule A,42249,-0.00224741339936464,0.00343275666922487,-0.00897561647104539,0.00448078967231612,0.512674282008971
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TYRP1,"5,6-dihydroxyindole-2-carboxylic acid oxidase",39657,0.00432934110059042,0.00667685661495252,-0.00875729786471651,0.0174159800658974,0.516733220623926
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,DSG3,Desmoglein-3,42196,0.00242892137195509,0.00374834104732763,-0.00491782708080707,0.00977566982471726,0.516996518548578
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,DUSP3,Dual specificity protein phosphatase 3,41839,0.00593277485030553,0.00917949663164066,-0.0120590385477102,0.0239245882483212,0.518091623113494
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,BPIFB2,BPI fold-containing family B member 2,39927,-0.00423386126072593,0.00656457979862435,-0.0171004376660297,0.0086327151445778,0.518969143846797
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,GPNMB,Transmembrane glycoprotein NMB,41802,0.00200780202722777,0.00311414653559717,-0.00409592518254267,0.00811152923699822,0.519109558827224
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CEP290,Centrosomal protein of 290 kDa,39757,0.00367020320012187,0.00569316086676666,-0.00748839209874079,0.0148287984989845,0.519155091737077
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,EGFLAM,Pikachurin,39930,0.00213046953075722,0.00331446481971975,-0.00436588151589348,0.00862682057740792,0.520380293596083
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,IL17F,Interleukin-17F,41913,-0.00498707693780539,0.00781815728511398,-0.0203106652166288,0.010336511341018,0.523560206710414
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CNTN2,Contactin-2,42262,-0.00297597666728286,0.00469901082894708,-0.0121860378920191,0.00623408455745341,0.526535417496157
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,NUDT10,Diphosphoinositol polyphosphate phosphohydrolase 3-alpha,39638,0.00171664571058488,0.00274573166949772,-0.00366498836163064,0.00709827978280041,0.531849315729985
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CSF3,Granulocyte colony-stimulating factor,41913,-0.00319582074152185,0.00511310222518969,-0.0132175011028936,0.00682585961984994,0.531964846149911
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,IL33,Interleukin-33,41913,0.00260353258256446,0.00420216107097139,-0.00563270311653946,0.0108397682816684,0.535551581035766
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,MORN4,MORN repeat-containing protein 4,39560,0.00518371729538539,0.00838859298196591,-0.0112579249492678,0.0216253595400386,0.536622217687247
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CAPN3,Calpain-3,39919,-0.00258265458009053,0.00418439113191694,-0.0107840611986477,0.00561875203846667,0.537107606769411
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CA8,Carbonic anhydrase-related protein,39657,0.00175989050406394,0.00285522600751867,-0.00383635247067265,0.00735613347880053,0.537659606033265
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PDCL2,Phosducin-like protein 2,39560,0.00344884094895285,0.00559662329657609,-0.0075205407123363,0.014418222610242,0.537751546892674
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SHD,SH2 domain-containing adapter protein D,39554,0.00541527070657343,0.00884163696136023,-0.0119143377376926,0.0227448791508395,0.540237062060241
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TRAF3IP2,E3 ubiquitin ligase TRAF3IP2,39575,0.00311115829551174,0.00508111051163668,-0.00684781830729616,0.0130701348983196,0.540352713095348
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ZP4,Zona pellucida sperm-binding protein 4,39560,0.00204436289727567,0.00334390022326045,-0.00450968154031482,0.00859840733486616,0.540966820563584
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,COQ7,"5-demethoxyubiquinone hydroxylase, mitochondrial",39638,-0.0028641804457521,0.00473462200319416,-0.0121440395720127,0.00641567868050845,0.545228743951074
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,FRZB,Secreted frizzled-related protein 3,41973,0.00159101635075071,0.00263019883098212,-0.00356417335797424,0.00674620605947566,0.545253413300097
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PDIA2,Protein disulfide-isomerase A2,39560,-0.00258253699875652,0.00428347729073563,-0.0109781524885984,0.00581307849108532,0.546583258109043
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,AMY1A_AMY1B_AMY1C,Alpha-amylase 1A_Alpha-amylase 1B_Alpha-amylase 1C,39336,0.00332265801334307,0.00555608252969654,-0.00756726374486215,0.0142125797715483,0.549838057170836
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,GRIK2,"Glutamate receptor ionotropic, kainate 2",39934,0.00266541837597006,0.00446987375999642,-0.00609553419362293,0.011426370945563,0.550981860731756
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,NOTCH1,Neurogenic locus notch homolog protein 1,42310,0.00101553166096631,0.00172103045260948,-0.00235768802614826,0.00438875134808088,0.555152190512026
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,DLL4,Delta-like protein 4,39638,0.00555896250993064,0.0094529874334619,-0.0129688928596547,0.024086817879516,0.556501302281455
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,LILRA4,Leukocyte immunoglobulin-like receptor subfamily A member 4,39575,-0.00311138551236063,0.00530734237040988,-0.013513776558364,0.00729100553364273,0.557725146474299
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,LYPD3,Ly6/PLAUR domain-containing protein 3,42082,-0.00211448358591659,0.00360753225751184,-0.0091852468106398,0.00495627963880662,0.557797838628479
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CEP350,Centrosome-associated protein 350,39560,-0.00228726750647427,0.00391788715537044,-0.00996632633100034,0.0053917913180518,0.559366036173108
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,MN1,Transcriptional activator MN1,39649,-0.00368586386483139,0.00631394166582982,-0.0160611895298578,0.00868946180019506,0.559389737092369
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PRC1,Protein regulator of cytokinesis 1,39919,0.00274384734236249,0.00473043904922662,-0.00652781319412168,0.0120155078788467,0.561898693782173
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,GABARAPL1,Gamma-aminobutyric acid receptor-associated protein-like 1,39757,0.00406325400183537,0.00705350306555213,-0.00976161200664681,0.0178881200103175,0.564584998415693
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TBR1,T-box brain protein 1,39649,-0.00293909027056136,0.00514258941988001,-0.0130185655335262,0.00714038499240347,0.567659153206502
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,EIF5A,Eukaryotic translation initiation factor 5A-1,41913,-0.00187711609764282,0.00329250186135666,-0.00833041974590186,0.00457618755061623,0.568606974842246
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PRR5,Proline-rich protein 5,39657,-0.00287795291216164,0.00505719968494051,-0.012790064294645,0.00703415847032176,0.569313179336086
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,BRD3,Bromodomain-containing protein 3,39575,0.00289806042981429,0.00509375530633285,-0.0070856999705981,0.0128818208302267,0.569405931478472
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,HK2,Hexokinase-2,41900,-0.00163448123332444,0.00291192190527143,-0.00734184816765643,0.00407288570100756,0.574597941771641
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CEND1,Cell cycle exit and neuronal differentiation protein 1,39586,-0.00363314040976158,0.00649969721464245,-0.0163725469504608,0.00910626613093761,0.576193099005994
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,OGT,UDP-N-acetylglucosamine--peptide N-acetylglucosaminyltransferase 110 kDa subunit,39757,0.00379493517743035,0.00679775324395283,-0.00952866118071719,0.0171185315355779,0.57667590268653
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ATP2B4,Plasma membrane calcium-transporting ATPase 4,39575,0.00376323112637907,0.00674133670356774,-0.0094497888126137,0.0169762510653718,0.57669723239609
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CCL28,C-C motif chemokine 28,42075,0.00349420368283407,0.00628701376217398,-0.00882834329102694,0.0158167506566951,0.578369706644082
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CDKL5,Cyclin-dependent kinase-like 5,39586,0.00308813921140677,0.00560571681164052,-0.00789906573940866,0.0140753441622222,0.581719566470888
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PITHD1,PITH domain-containing protein 1,39539,-0.0045433193902235,0.00827604779892134,-0.0207643730761093,0.0116777342956623,0.583035797417909
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,MEPE,Matrix extracellular phosphoglycoprotein,42123,0.00137574863450286,0.00250888858366315,-0.00354167298947691,0.00629317025848263,0.583460768361156
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CD177,CD177 antigen,42123,-0.00751309347152192,0.013736866544614,-0.0344373518989653,0.0194111649559215,0.584436396450276
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CTSH,Pro-cathepsin H,41865,0.00433589890739406,0.00796193402636176,-0.011269491784275,0.0199412895990631,0.586052528657462
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CALCB,Calcitonin gene-related peptide 2,39929,-0.00236754487306569,0.00435057136865301,-0.0108946647556256,0.00615957500949421,0.586320265638147
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,DCN,Decorin,41900,-0.00133333876439612,0.00245398937723497,-0.00614315794377665,0.00347648041498442,0.586908151207296
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,GNPDA2,Glucosamine-6-phosphate isomerase 2,39736,0.00216440193025837,0.004004274533443,-0.0056839761552899,0.0100127800158066,0.588847309225949
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CSRP3,Cysteine and glycine-rich protein 3,39575,-0.00584741809406136,0.01085339001858,-0.0271200625304781,0.0154252263423554,0.590060489641839
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PHLDB2,Pleckstrin homology-like domain family B member 2,39560,0.00528516035810215,0.00980989343450242,-0.0139422307735226,0.0245125514897269,0.59006466363185
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PFDN6,Prefoldin subunit 6,39649,-0.0037246747159079,0.00695152985395505,-0.0173496732296598,0.009900323797844,0.592103090979194
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,OSTN,Osteocrin,39649,0.00232285918781115,0.00433723864868547,-0.00617812856361236,0.0108238469392347,0.592272238882733
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,IFNGR1,Interferon gamma receptor 1,42185,0.00122019137562071,0.002307635908911,-0.00330277500584485,0.00574315775708626,0.596978840011196
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,KIAA2013,Uncharacterized protein KIAA2013,39919,0.00302007862478271,0.0057613768699722,-0.0082722200403628,0.0143123772899282,0.600153945730307
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,NTF4,Neurotrophin-4,41843,0.00208465668514612,0.0040449468963609,-0.00584343923172125,0.0100127526020135,0.60630095240178
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ACTN4,Alpha-actinin-4,41913,-0.00172170039864365,0.00336064223129259,-0.00830855917197713,0.00486515837468983,0.608440530711582
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,IFNL2,Interferon lambda-2,39586,0.00320269118617269,0.0062800037624701,-0.0091061161882687,0.0155114985606141,0.610074059957021
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ISM2,Isthmin-2,39966,-0.00235553480605035,0.00464710617165796,-0.0114638629024999,0.00675279329039925,0.612247398623996
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ATF4,Cyclic AMP-dependent transcription factor ATF-4,39560,0.00181961947445935,0.003596068019394,-0.00522867384355288,0.00886791279247159,0.612865058695049
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,BAG3,BAG family molecular chaperone regulator 3,41992,0.00217831817918832,0.00432304575954776,-0.00629485150952529,0.0106514878679019,0.614350437344731
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TCL1B,T-cell leukemia/lymphoma protein 1B,41900,-0.00407774569561472,0.00810623201562596,-0.0199659604462416,0.0118104690550122,0.614945629361255
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,JUN,Transcription factor AP-1,41913,0.00256356263743676,0.00514315008906363,-0.00751701153712797,0.0126441368120015,0.618180689361949
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ARG2,"Arginase-2, mitochondrial",39919,-0.0022506165289503,0.00452318309651961,-0.0111160553981287,0.00661482234022814,0.618794275813091
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,LRIG1,Leucine-rich repeats and immunoglobulin-like domains protein 1,42224,0.00186866316222525,0.00376551435083237,-0.00551174496540619,0.0092490712898567,0.619721048518183
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TMED10,Transmembrane emp24 domain-containing protein 10,39575,0.00248091649232672,0.00499947105659144,-0.00731804677859251,0.0122798797632459,0.619737997208636
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,NDST1,Bifunctional heparan sulfate N-deacetylase/N-sulfotransferase 1,39919,-0.00313219454168372,0.00636045759334979,-0.0155986914246493,0.00933430234128185,0.622412233894177
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,MAGEA3,Melanoma-associated antigen 3,39757,0.00454661205945093,0.00925021956984152,-0.0135838182974384,0.0226770424163403,0.623072649324483
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,JMJD1C,Probable JmjC domain-containing histone demethylation protein 2C,39560,-0.0030848319053621,0.00630041578692678,-0.0154336468477386,0.00926398303701438,0.624410112409034
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,COL15A1,Collagen alpha-1(XV) chain,39966,0.00138080118081615,0.0028917826621931,-0.00428709283708233,0.00704869519871463,0.633021467099927
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SH3BGRL2,SH3 domain-binding glutamic acid-rich-like protein 2,39586,0.00315864097318413,0.00663569206437063,-0.0098473154729823,0.0161645974193506,0.634078308808985
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CEACAM18,Carcinoembryonic antigen-related cell adhesion molecule 18,39757,-0.00348703209218712,0.00732648250929068,-0.0178469378103969,0.0108728736260226,0.634120024531144
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,IL11,Interleukin-11,41913,-0.0030749960432338,0.0064899426108014,-0.0157952835604045,0.00964529147393694,0.635643575493855
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,LMOD2,Leiomodin-2,39586,0.00311066628841391,0.00659704637868696,-0.00981954461381253,0.0160408771906403,0.637275884750315
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ECE1,Endothelin-converting enzyme 1,41839,-0.00177764921210129,0.00377549508240516,-0.00917761957361541,0.00562232114941283,0.637763680354951
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,LMNB1,Lamin-B1,39908,0.00304711153707867,0.00654993608577187,-0.00979076319103419,0.0158849862651915,0.641788312473152
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CFD,Complement factor D,39979,0.00100459042354601,0.00216630259537631,-0.00324136266339156,0.00525054351048357,0.642846458642575
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,NPHS1,Nephrin,39657,-0.00165139146024763,0.00356932209944254,-0.00864726277515501,0.00534447985465975,0.64361541146852
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,GATA3,Trans-acting T-cell-specific transcription factor GATA-3,39560,0.00131612438432041,0.00285846305464016,-0.00428646320277429,0.00691871197141511,0.645216177708087
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,FOS,Proto-oncogene c-Fos,39539,-0.00177651118623327,0.0038687031390839,-0.00935916933883773,0.00580614696637118,0.646099172998576
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,DUOX2,Dual oxidase 2,41900,-0.0034271846985001,0.00749779131754035,-0.0181228556808792,0.011268486283879,0.64761197643575
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ECM1,Extracellular matrix protein 1,39720,-0.00177844895598157,0.00390304935466033,-0.00942842569111581,0.00587152777915267,0.648646061545629
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,C1S,Complement C1s subcomponent,39979,-0.0010270736933146,0.00225781882477388,-0.00545239858987141,0.0033982512032422,0.649192439048073
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ZPR1,Zinc finger protein ZPR1,39586,-0.00467653312175844,0.0103387099656798,-0.0249404046544908,0.0155873384109739,0.651038495124755
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PRRT3,Proline-rich transmembrane protein 3,39638,0.00187534766232478,0.00414959467250261,-0.00625785789578033,0.0100085532204299,0.651324586467624
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,JCHAIN,Immunoglobulin J chain,41913,-0.00293748251405391,0.00652906055838445,-0.0157344412084874,0.00985947618037961,0.652783448577064
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CEP164,Centrosomal protein of 164 kDa,41913,0.0029638184703932,0.00663034910545739,-0.0100316657763033,0.0159593027170897,0.654876623261243
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ENPP6,Glycerophosphocholine cholinephosphodiesterase ENPP6,39638,0.00173378666432131,0.00387928004747074,-0.00586960222872134,0.00933717555736396,0.654930642630569
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,FABP9,Fatty acid-binding protein 9,42119,-0.00267479406489726,0.006013158854655,-0.0144605854200211,0.00911099729022654,0.656454467958604
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,KIR2DS4,Killer cell immunoglobulin-like receptor 2DS4,39930,0.00819352849374167,0.0184536875006086,-0.0279756990074512,0.0443627559949345,0.657047488594461
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ENO1,Alpha-enolase,42119,-0.00372816679474137,0.00839750043867602,-0.0201872676545464,0.0127309340650636,0.657077533270445
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ENDOU,Poly(U)-specific endoribonuclease,39090,0.00268798214431689,0.00606090016692651,-0.00919138218285906,0.0145673464714928,0.657416496788132
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CDSN,Corneodesmosin,42246,0.00206932812267932,0.00467092418030331,-0.00708568327071517,0.0112243395160738,0.657755923228337
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TMOD4,Tropomodulin-4,39560,0.00186681196307672,0.00429196653127826,-0.00654544243822866,0.0102790663643821,0.663603712690658
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PSMD5,26S proteasome non-ATPase regulatory subunit 5,39649,-0.00251870497472311,0.00579879166709753,-0.0138843366422343,0.00884692669278805,0.664042805359941
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CASQ2,Calsequestrin-2,39575,-0.0021874480941954,0.00510326643655883,-0.0121898503098507,0.00781495412145991,0.668195929962906
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,DDA1,DET1- and DDB1-associated protein 1,39575,-0.00178774905679962,0.00420004132747543,-0.0100198300586515,0.00644433194505222,0.67037099278672
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,GART,Trifunctional purine biosynthetic protein adenosine-3,39934,0.00123325834850965,0.00291205552070948,-0.00447437047208094,0.00694088716910024,0.671937824356939
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,BNIP2,BCL2/adenovirus E1B 19 kDa protein-interacting protein 2,39958,-0.00154414570149459,0.00367257749061702,-0.00874239758310394,0.00565410618011476,0.674162615280589
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SHH,Sonic hedgehog protein,39657,0.00191448089776443,0.00457232908837175,-0.00704728411544421,0.0108762459109731,0.675436061707524
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TPBGL,Trophoblast glycoprotein-like,39649,-0.00182223184045165,0.00435676215462039,-0.0103614856635076,0.00671702198260431,0.675769774573504
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,RIPK4,Receptor-interacting serine/threonine-protein kinase 4,39575,-0.00305123488196381,0.00731777165191555,-0.0173940673197183,0.0112915975557907,0.676714140125554
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,RNF168,E3 ubiquitin-protein ligase RNF168,39657,0.0018184564242231,0.00437183120246481,-0.00675033273260793,0.0103872455810541,0.677455795767404
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,GABRA4,Gamma-aminobutyric acid receptor subunit alpha-4,39586,-0.00289355623950934,0.0069736951999085,-0.01656199883133,0.0107748863523113,0.678205355383728
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,IZUMO1,Izumo sperm-egg fusion protein 1,39560,-0.00217023449628503,0.00523953018158879,-0.0124397136521991,0.00809924465962901,0.678732799182532
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,KCNC4,Potassium voltage-gated channel subfamily C member 4,39586,-0.00244178793388262,0.00590486644506602,-0.014015326166212,0.00913175029844678,0.679232805894384
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,GFOD2,Glucose-fructose oxidoreductase domain-containing protein 2,41843,0.00546532679425165,0.0132213299731776,-0.0204484799531764,0.0313791335416797,0.679340824421895
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,NCLN,Nicalin,41913,-0.00224728060423624,0.00545546044793312,-0.0129399830821852,0.00844542187371267,0.680395645920648
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,MEGF11,Multiple epidermal growth factor-like domains protein 11,39575,0.00143842278034897,0.00351777628231507,-0.00545641873298857,0.00833326429368651,0.682620180919269
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ENPEP,Glutamyl aminopeptidase,39575,-0.00184521922595899,0.00455113623714572,-0.0107654462507646,0.00707500779884663,0.685160959012682
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PGM2,Phosphoglucomutase-2,39649,-0.00263783685370752,0.00650659525150595,-0.0153907635466592,0.0101150898392441,0.685184228770718
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,AMIGO1,Amphoterin-induced protein 1,39649,0.0021964764879454,0.00543757339763499,-0.00846116737141918,0.01285412034731,0.68626153628211
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PTPRR,Receptor-type tyrosine-protein phosphatase R,39929,-0.0016330269157064,0.00405014468224521,-0.00957131049290701,0.0063052566614942,0.686807150339407
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,GH2,Growth hormone variant,41843,-0.00696681513889811,0.0173153071064818,-0.0409048170676025,0.0269711867898062,0.687432899542216
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,MEP1B,Meprin A subunit beta,42145,0.00490356005115324,0.0122451993868913,-0.0190970307471537,0.0289041508494602,0.688833225827777
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TYRO3,Tyrosine-protein kinase receptor TYRO3,42145,-0.00120844567085798,0.00302553140856456,-0.00713848723164451,0.00472159588992856,0.689592999618977
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,DKKL1,Dickkopf-like protein 1,42070,0.00354610988881331,0.00894370308120375,-0.013983548150346,0.0210757679279727,0.691748128077511
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CHEK2,Serine/threonine-protein kinase Chk2,41900,0.00139149589151371,0.00353102426671096,-0.00552931167123977,0.00831230345426718,0.69353041687228
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PTPN6,Tyrosine-protein phosphatase non-receptor type 6,42166,0.00372744838576114,0.00958652183218018,-0.015062134405312,0.0225170311768343,0.697414097763899
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CD164L2,CD164 sialomucin-like 2 protein,39649,-0.00152344684946236,0.00391952577337841,-0.00920571736528404,0.00615882366635931,0.697519316625077
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,GSAP,Gamma-secretase-activating protein,41843,0.00348944128890826,0.0089991224194954,-0.0141488386533027,0.0211277212311192,0.698204685863604
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CLEC1A,C-type lectin domain family 1 member A,41900,-0.00140381961851651,0.00363553667163497,-0.00852947149492106,0.00572183225788804,0.699400490120856
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,NPTN,Neuroplastin,41843,0.0031829128243046,0.00836509026638395,-0.0132126640978079,0.0195784897464171,0.703580756154259
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,VTA1,Vacuolar protein sorting-associated protein VTA1 homolog,42249,0.00284751796433853,0.00748787893844607,-0.0118287247550158,0.0175237606836928,0.703740785359053
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,MED21,Mediator of RNA polymerase II transcription subunit 21,39575,0.00199020331231779,0.00523759442178574,-0.00827548175438226,0.0122558883790178,0.703964470128576
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,RRP15,RRP15-like protein,39586,-0.00370396703485771,0.00978390029135904,-0.0228804116059214,0.015472477536206,0.705008756927178
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,GAGE2A,G antigen 2A,39560,-0.00264426070105954,0.00700489991210357,-0.0163738645287825,0.0110853431266635,0.705818815668819
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,FGF12,Fibroblast growth factor 12,39657,0.0018184339265092,0.0048590712165992,-0.00770534565802523,0.0113422135110436,0.708236753067558
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,GM2A,Ganglioside GM2 activator,39733,0.00152621445969572,0.00412377106050119,-0.00655637681888661,0.00960880573827804,0.711313795574245
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,NOS2,"Nitric oxide synthase, inducible",39575,-0.0015863705587973,0.00432346416111711,-0.0100603603145868,0.00688761919699223,0.713684888517559
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,IL1RL1,Interleukin-1 receptor-like 1,42272,-0.00183487782128959,0.00508853185774493,-0.0118084002624697,0.00813864461989047,0.718410931491129
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TAGLN3,Transgelin-3,39560,-0.00226301420407929,0.00643228860130542,-0.0148702998626379,0.0103442714544793,0.724979272695674
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,RNF4,E3 ubiquitin-protein ligase RNF4,39757,0.00246249123587827,0.00701187661448237,-0.0112807869285072,0.0162057694002637,0.725453482112212
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CLSTN1,Calsyntenin-1,41839,-0.00189347210171289,0.00541683932292855,-0.0125104771746529,0.00872353297122707,0.726679794938938
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PYDC1,Pyrin domain-containing protein 1,39638,0.00154489595571829,0.00442139858271121,-0.00712104526639567,0.0102108371778323,0.726785632904443
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CEP112,Centrosomal protein of 112 kDa,39575,-0.00165604007587353,0.00476172642172995,-0.0109890238624642,0.00767694371071717,0.728010998277863
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,RAB6B,Ras-related protein Rab-6B,41839,0.00175671552506392,0.00506244640179977,-0.00816567942246363,0.0116791104725915,0.728589915444014
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CSPG5,Chondroitin sulfate proteoglycan 5,39586,-0.0018411864321253,0.00536281103999108,-0.0123522960705078,0.00866992320625722,0.73136063853953
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,NUDT15,Nucleotide triphosphate diphosphatase NUDT15,39575,0.00186861222892836,0.00545169959183494,-0.00881671897106813,0.0125539434289249,0.73178728530009
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,MSLN,Mesothelin,42048,0.002125436088741,0.00620948709967031,-0.0100451586266128,0.0142960308040948,0.732139130593403
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SUMF1,Formylglycine-generating enzyme,39657,-0.00236199499765616,0.00708137507311404,-0.0162414901409597,0.0115175001456474,0.738725228836501
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,MYLPF,"Myosin regulatory light chain 2, skeletal muscle isoform",39649,0.0020042630486641,0.00602211117125635,-0.00979907484699834,0.0138076009443266,0.739278479197665
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,GTF2IRD1,General transcription factor II-I repeat domain-containing protein 1,39757,0.0024600737618011,0.00740321495424092,-0.0120502275485111,0.0169703750721133,0.739670468179503
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ICOSLG,ICOS ligand,42070,0.000677315429391156,0.00204179482342003,-0.0033246024245121,0.00467923328329441,0.740101697071167
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TPK1,Thiamin pyrophosphokinase 1,39958,-0.000992588967606605,0.00299763747663826,-0.0068679584218176,0.00488278048660439,0.740557119934127
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,RASA1,Ras GTPase-activating protein 1,41839,-0.00115195488336518,0.00348424230509444,-0.00798106980135029,0.00567716003461992,0.740937919956448
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,DOCK9,Dedicator of cytokinesis protein 9,39586,0.00413417700433158,0.0126071394432148,-0.0205758163043694,0.0288441703130326,0.742975771154314
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SPINT3,Kunitz-type protease inhibitor 3,39930,-0.00583382192254569,0.0178062166429507,-0.040734006542729,0.0290663626976376,0.74319871411602
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ZP3,Zona pellucida sperm-binding protein 3,39638,-0.00933745952395986,0.0285754922767347,-0.0653454243863598,0.0466705053384401,0.743852125900855
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,IL20RA,Interleukin-20 receptor subunit alpha,41913,0.0015386801610087,0.00472347776867181,-0.00771933626558805,0.0107966965876054,0.744617465021288
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,IGLON5,IgLON family member 5,39560,-0.00322470893095622,0.00993046712077119,-0.0226884244876678,0.0162390066257553,0.745392513513581
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,KIAA1549,UPF0606 protein KIAA1549,39757,0.00236985744663314,0.00734662234308327,-0.0120295223458101,0.0167692372390764,0.747021035236224
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TNPO1,Transportin-1,39757,0.0012139627355968,0.00380890523645607,-0.0062514915278571,0.0086794169990507,0.749947111229904
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CSH1,Chorionic somatomammotropin hormone 1,39990,-0.000970902150844711,0.00305940712069218,-0.00696734010740138,0.00502553580571195,0.750984032235369
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TPSG1,Tryptase gamma,39657,-0.000880305122400877,0.00280825624153937,-0.00638448735581804,0.00462387711101628,0.753929241554642
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SHC1,SHC-transforming protein 1,39560,-0.00384821489295615,0.0125390077027443,-0.028424669990335,0.0207282402044227,0.758925718380921
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CTLA4,Cytotoxic T-lymphocyte protein 4,39966,0.000990143701759573,0.00323950645481822,-0.00535928894968414,0.00733957635320329,0.759879434529495
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,GP2,Pancreatic secretory granule membrane major glycoprotein GP2,41701,-0.00269185207287638,0.00901812341459837,-0.0203673739654892,0.0149836698197364,0.765331198313161
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,FHIP2A,FHF complex subunit HOOK interacting protein 2A,39575,-0.00147711346223257,0.00497135422814903,-0.0112209677494047,0.00826674082493954,0.766376726699632
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,MYH7B,Myosin-7B,39560,0.0013636319053046,0.0045969356345851,-0.0076463619384822,0.0103736257490914,0.766747501847172
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ATP5PO,"ATP synthase subunit O, mitochondrial",41839,-0.00131429603310503,0.00445535055432633,-0.0100467831195846,0.00741819105337457,0.768004057292047
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,MRPS16,"28S ribosomal protein S16, mitochondrial",39657,0.000926754505779308,0.00315484196456153,-0.00525673574476128,0.0071102447563199,0.768949691259555
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CHP1,Calcineurin B homologous protein 1,39586,0.00229611101893498,0.0079185350502921,-0.0132242176796375,0.0178164397175075,0.771847230001334
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,GAMT,Guanidinoacetate N-methyltransferase,39575,-0.00108898971813527,0.00379424434990144,-0.0085257086439421,0.00634772920767155,0.774109345550162
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PRR4,Proline-rich protein 4,39652,-0.00216819256235926,0.00762155755615678,-0.0171064453724266,0.012770060247708,0.77604669542174
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CRX,Cone-rod homeobox protein,41900,-0.00326200939520827,0.0114718053733357,-0.0257467479269463,0.0192227291365298,0.776146496388697
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,DCDC2C,Doublecortin domain-containing protein 2C,39560,0.00192683170648298,0.00680596006802245,-0.011412850026841,0.015266513439807,0.777098273936957
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TET2,Methylcytosine dioxygenase TET2,39750,0.0030238329193068,0.0107847213913203,-0.0181142210076809,0.0241618868462945,0.779190275408133
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,IL24,Interleukin-24,41913,-0.001419001221852,0.00513703032185575,-0.0114875806526893,0.00864957820898527,0.782375803695734
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,HBZ,Hemoglobin subunit zeta,39958,0.00316269204874618,0.0115043212504519,-0.0193857776021395,0.0257111616996319,0.783387773692978
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,IGFL4,Insulin growth factor-like family member 4,39657,-0.00209926449830322,0.00766135256480265,-0.0171155155253164,0.01291698652871,0.784084333980131
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,NXPE4,NXPE family member 4,39575,-0.00093631363654522,0.00343140922743758,-0.00766187572232288,0.00578924844923243,0.78496164227343
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TNFSF11,Tumor necrosis factor ligand superfamily member 11,42119,0.00177190337396329,0.00654109780331598,-0.011048648320536,0.0145924550684626,0.786481489956744
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,FAM171A2,Protein FAM171A2,39934,-0.00452326748092014,0.0167631797919906,-0.0373790998732217,0.0283325649113814,0.78729326132079
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,GID8,Glucose-induced degradation protein 8 homolog,39934,-0.000983148211208424,0.00364659484141592,-0.00813047410038362,0.00616417767796677,0.787467371552887
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CTNNA1,Catenin alpha-1,39586,-0.000973979197241808,0.00362823911990107,-0.00808532787224791,0.0061373694777643,0.788362578057705
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ERCC1,DNA excision repair protein ERCC-1,39560,-0.00095208977826861,0.00358245970772066,-0.0079737108054011,0.00606953124886388,0.790425763370579
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,COL24A1,Collagen alpha-1(XXIV) chain,39930,0.00160171218061681,0.00604508983392607,-0.0102466638938783,0.0134500882551119,0.791044436305091
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,GLI2,Zinc finger protein GLI2,39657,-0.000936500411625513,0.00355743898500993,-0.00790908082224497,0.00603607999899395,0.792361803900214
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SEMA6C,Semaphorin-6C,39657,0.000727074120459695,0.00276595029818538,-0.00469418846398365,0.00614833670490304,0.792658808188453
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,KIR2DL2,Killer cell immunoglobulin-like receptor 2DL2,39919,0.0025115463184209,0.00956587259869879,-0.0162375639750287,0.0212606566118705,0.792900087812135
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,MYBPC2,"Myosin-binding protein C, fast-type",39638,0.00246294821217059,0.00943188005898133,-0.0160235367034328,0.020949433127774,0.79399701691893
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,DDX4,Probable ATP-dependent RNA helicase DDX4,39657,-0.00151018540129603,0.00580668330122662,-0.0128912846717002,0.00987091386910815,0.794809138060698
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,FASLG,Tumor necrosis factor ligand superfamily member 6,42296,-0.00101049428897807,0.00392786804689053,-0.00870911566088352,0.00668812708292737,0.796979780624544
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,IL13RA1,Interleukin-13 receptor subunit alpha-1,41936,0.000656984857843461,0.00256077168765899,-0.00436212764996816,0.00567609736565508,0.797524442427662
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PMCH,Pro-MCH,39575,-0.00223216313789939,0.00885020006765659,-0.0195785552705063,0.0151142289947075,0.800878740392285
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PM20D1,N-fatty-acyl-amino acid synthase/hydrolase PM20D1,42085,0.00517208725825448,0.0205144169816976,-0.0350361700258729,0.0453803445423818,0.800952438247558
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,IMPG1,Interphotoreceptor matrix proteoglycan 1,39586,-0.00081133277349115,0.00325160135557464,-0.00718447143041744,0.00556180588343514,0.80296485392917
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,HDAC9,Histone deacetylase 9,39586,0.00178178111117184,0.00715803788111157,-0.0122479731358068,0.0158115353581505,0.803427066634673
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CPA4,Carboxypeptidase A4,39518,-0.00117403280763932,0.00472501055974003,-0.0104350535047298,0.00808698788945114,0.803773907575527
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,C1GALT1C1,C1GALT1-specific chaperone 1,39575,0.000828419573011284,0.00350030396395274,-0.00603217619633609,0.00768901534235866,0.812916643476548
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PZP,Pregnancy zone protein,39979,-0.000829082284158576,0.00355117237056828,-0.00778938013047241,0.00613121556215525,0.815402833004761
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,KLK12,Kallikrein-12,41843,0.00330623302987794,0.0142505298475376,-0.0246248054712958,0.0312372715310517,0.816535597594355
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,EPHA10,Ephrin type-A receptor 10,41839,-0.00156701921265521,0.007028193094943,-0.0153422776787435,0.0122082392534331,0.823568607356548
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PDE1C,"Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1C",39560,0.00127358768804101,0.00577953160903809,-0.0100542942656736,0.0126014696417557,0.82559353824551
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CCNE1,G1/S-specific cyclin-E1,39657,0.00213843485875555,0.00981830614015385,-0.017105445175946,0.0213823148934571,0.827588346086051
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CEP152,Centrosomal protein of 152 kDa,39560,-0.0009789881180041,0.00450700796885815,-0.00981272373696608,0.00785474750095788,0.828045118435405
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,OXCT1,"Succinyl-CoA:3-ketoacid coenzyme A transferase 1, mitochondrial",39638,0.00165362698977911,0.00765190985407098,-0.0133441163242,0.0166513703037582,0.828908774063214
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CINP,Cyclin-dependent kinase 2-interacting protein,39757,0.000966411339311771,0.00452807984982957,-0.00790862516635418,0.00984144784497772,0.830998366421673
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TLR2,Toll-like receptor 2,39757,-0.00053022506043658,0.00248476345488104,-0.00540036143200342,0.00433991131113026,0.831026243445411
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,LRP2,Low-density lipoprotein receptor-related protein 2,39649,-0.000802326322047584,0.003932863233304,-0.00851073825932343,0.00690608561522827,0.838352840556847
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,AGBL2,Cytosolic carboxypeptidase 2,39586,-0.00196541475518896,0.00986206476883009,-0.0212950617020959,0.017364232191718,0.842039282571522
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,OMP,Olfactory marker protein,39586,-0.00102125146451115,0.00514428939401319,-0.011104058676777,0.0090615557477547,0.842640826927553
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ITGAX,Integrin alpha-X,39757,-0.00108249562424739,0.0055440879355873,-0.0119489079779985,0.00978391672950373,0.845199034712858
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TRPV3,Transient receptor potential cation channel subfamily V member 3,39575,0.0010398589130286,0.00533887001674155,-0.00942432631978484,0.011504044145842,0.845575558417344
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,MMP15,Matrix metalloproteinase-15,39958,0.00101451341170641,0.00521082423434509,-0.00919870208760997,0.0112277289110228,0.8456364124736
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ARHGEF5,Rho guanine nucleotide exchange factor 5,39586,-0.00158087775202823,0.00812499338804219,-0.0175058647925909,0.0143441092885345,0.845733401519666
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TMED1,Transmembrane emp24 domain-containing protein 1,39757,0.00111945979487536,0.00577278787128061,-0.0101952044328346,0.0124341240225853,0.846241948998014
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PRKAG3,5'-AMP-activated protein kinase subunit gamma-3,39649,-0.000652084000279699,0.00336336987243161,-0.00724428895024565,0.00594012094968625,0.846274840213857
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ADAMTS16,A disintegrin and metalloproteinase with thrombospondin motifs 16,41900,0.00064661743957548,0.00335936192855535,-0.005937731940393,0.00723096681954396,0.847367433205195
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,STAM,Signal transducing adapter molecule 1,39919,-0.000742009973977015,0.00387966022363647,-0.0083461440123045,0.00686212406435047,0.848328123109172
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,IL2,Interleukin-2,41913,-0.000634895102391798,0.00340683635721404,-0.00731229436253131,0.00604250415774771,0.852165970086467
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,WASL,Neural Wiskott-Aldrich syndrome protein,39657,0.00117318040917863,0.00630562181683045,-0.011185838351809,0.0135321991701663,0.85240654305283
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ADGRV1,Adhesion G-protein coupled receptor V1,39586,-0.00137147155480838,0.00743666992952005,-0.0159473446166677,0.0132044015070509,0.853687291623072
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,APOB,Apolipoprotein B-100,39990,-0.000445744329350504,0.00244705163409363,-0.00524196553217403,0.00435047687347302,0.855463802943325
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ANKRA2,Ankyrin repeat family A protein 2,39560,-0.00104494541244279,0.00589902194271556,-0.0126070284201653,0.0105171375952797,0.859402673126204
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,DEFB116,Beta-defensin 116,39586,-0.00141859364247177,0.00805519039077423,-0.0172067668083893,0.0143695795234457,0.860211349890953
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PPIE,Peptidyl-prolyl cis-trans isomerase E,39757,-0.00115811030149407,0.00659059973474441,-0.0140756857815931,0.011759465178605,0.860515905129359
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,FLRT2,Leucine-rich repeat transmembrane protein FLRT2,42016,-0.000538617063309459,0.00307637095164264,-0.00656830412852902,0.00549107000191011,0.861017873371865
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ARID3A,AT-rich interactive domain-containing protein 3A,39586,-0.000755872113252291,0.0043216704226416,-0.00922634614162983,0.00771460191512525,0.861159259467189
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ESR1,Estrogen receptor,39657,-0.00106820746493877,0.0061258105397977,-0.0130747961229423,0.0109383811930647,0.861571483221429
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PDXDC1,Pyridoxal-dependent decarboxylase domain-containing protein 1,39560,0.0010096515616827,0.00580616046368079,-0.0103704229471317,0.012389726070497,0.861952643740927
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PRKCQ,Protein kinase C theta type,41913,0.000769415457146707,0.00455634362695667,-0.00816101805168837,0.00969984896598178,0.865903929409474
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,IVD,"Isovaleryl-CoA dehydrogenase, mitochondrial",41839,-0.000918922859678295,0.00544357677131874,-0.011588333331463,0.00975048761210644,0.865949731147384
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PGR,Progesterone receptor,39657,-0.00181246772915878,0.0107412497124502,-0.0228653171655612,0.0192403817072436,0.866005027967752
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PSCA,Prostate stem cell antigen,39930,-0.00458849235414767,0.0278595815278756,-0.0591932721487839,0.0500162874404886,0.869182510499913
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CDH6,Cadherin-6,42145,0.000672707986453927,0.00415824830194734,-0.00747745868536285,0.0088228746582707,0.871484058478074
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,C1R,Complement C1r subcomponent,39979,-0.000323200309271874,0.00201208713839983,-0.00426689110053555,0.0036204904819918,0.872388164971913
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,HGFAC,Hepatocyte growth factor activator,39897,0.000463548582809501,0.00290354915816965,-0.00522740776720302,0.00615450493282202,0.873160468797819
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,DBH,Dopamine beta-hydroxylase,39978,-0.00189836277556744,0.012234731673599,-0.0258784368558215,0.0220817113046866,0.876696528759004
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SLITRK6,SLIT and NTRK-like protein 6,41900,-0.000567773254437339,0.00369008779704085,-0.0078003453366374,0.00666479882776272,0.877718965495161
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PPM1B,Protein phosphatase 1B,39657,0.000991880652983019,0.00661175893548045,-0.0119671668605587,0.0139509281665247,0.880753412690203
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,INSR,Insulin receptor,39657,-0.000262375938682875,0.00183688577958529,-0.00386267206667004,0.00333792018930429,0.886421223238532
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,IL1A,Interleukin-1 alpha,41913,-0.00088009298526837,0.00616477147071278,-0.0129630450678654,0.0112028590973287,0.886480581210158
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,GIPR,Gastric inhibitory polypeptide receptor,39657,0.000686617616831957,0.00484053097248497,-0.00880082308923858,0.0101740583229025,0.887202982866118
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CRHR1,Corticotropin-releasing factor receptor 1,41900,0.000852977676038906,0.00622235309110966,-0.011342834382536,0.0130487897346138,0.890967411046847
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,HNF1A,Hepatocyte nuclear factor 1-alpha,39649,0.00101799268060254,0.00748957441092215,-0.0136615731648049,0.01569755852601,0.891885973963731
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,HMGCS1,"Hydroxymethylglutaryl-CoA synthase, cytoplasmic",39575,-0.00062084755971952,0.00456988609630956,-0.00957782430848626,0.00833612918904722,0.891937418687952
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,DDX39A,ATP-dependent RNA helicase DDX39A,39657,0.000346782052936219,0.00263173227280538,-0.00481141320176232,0.00550497730763476,0.895169006956559
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,GATD3,"Glutamine amidotransferase-like class 1 domain-containing protein 3B, mitochondrial",39638,-0.00107775027487434,0.00820658254082437,-0.0171626520548901,0.0150071515051414,0.895518602244536
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,NEDD9,Enhancer of filamentation 1,39657,0.000458442704153914,0.00362907175735633,-0.0066545379402645,0.00757142334857233,0.899476917752302
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,NT5C3A,Cytosolic 5'-nucleotidase 3A,42087,0.00116350752703908,0.00921411068053654,-0.0168961494068125,0.0192231644608907,0.899516496545776
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,HDAC8,Histone deacetylase 8,39657,-0.000810498184219653,0.00645309539057924,-0.013458565149755,0.0118375687813157,0.900052146356279
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ATP1B4,Protein ATP1B4,39560,-0.000546600052989864,0.00448879958687773,-0.00934464724327022,0.0082514471372905,0.903083595324141
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,DCTPP1,dCTP pyrophosphatase 1,42145,-0.00040662312516503,0.00338361593713147,-0.00703851036194272,0.00622526411161266,0.904346987340959
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ADRA2A,Alpha-2A adrenergic receptor,39575,-0.000884392163302347,0.00745241990759247,-0.0154911351821836,0.0137223508555789,0.905537542497903
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,GPR158,Probable G-protein coupled receptor 158,39934,-0.000425349474024491,0.00372156932076011,-0.00771962534271431,0.00686892639466533,0.90900752350013
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,S100A16,Protein S100-A16,41814,0.000737251195943037,0.00650668282753471,-0.012015847146025,0.0134903495379111,0.909789073670854
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SCARB1,Scavenger receptor class B member 1,41839,-0.000669357564428341,0.00593848040644823,-0.0123087791610669,0.0109700640322102,0.910257984674594
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ATP5F1D,"ATP synthase subunit delta, mitochondrial",39575,-0.00059993891593154,0.00532830102141387,-0.0110434089179027,0.00984353108603964,0.91035387777418
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TSPAN15,Tetraspanin-15,39575,-0.000585841275158943,0.00539353955811898,-0.0111571788090721,0.00998549625875426,0.913506616670827
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,LSM8,U6 snRNA-associated Sm-like protein LSm8,39757,0.000925503559497537,0.00859499878844754,-0.0159206940658596,0.0177717011848547,0.914252016600591
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,BTLA,B- and T-lymphocyte attenuator,39560,-0.000971229510114018,0.00918380866282416,-0.0189714944892494,0.0170290354690213,0.915779037366016
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,BST1,ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 2,42249,0.000526910676360908,0.00498357633271801,-0.0092408989357664,0.0102947202884882,0.915798584549425
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,IMPA1,Inositol monophosphatase 1,42016,0.00068777637889299,0.00651559062290905,-0.0120827812420088,0.0134583339997947,0.915934181584664
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SLAMF7,SLAM family member 7,42119,0.000662493590929685,0.00636753332571331,-0.0118178717274684,0.0131428589093278,0.917137226507815
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,FGF6,Fibroblast growth factor 6,39657,-0.000434029222365914,0.0041878095003755,-0.0086421358431019,0.00777407739837007,0.91745604242226
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PTTG1,Securin,39757,0.000459143868466009,0.00446756294681111,-0.00829727950728376,0.00921556724421578,0.918145155477325
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TSPAN7,Tetraspanin-7,39586,0.00104551551278221,0.0104667955626663,-0.0194694037900437,0.0215604348156081,0.920434441110411
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,BHLHE40,Class E basic helix-loop-helix protein 40,39586,0.000755276098663571,0.00760681521707208,-0.0141540817267977,0.0156646339241249,0.920910308089373
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,MYL3,Myosin light chain 3,39638,-0.000825532886358439,0.00842356101553424,-0.0173357124768056,0.0156846467040887,0.921931819211161
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PVALB,Parvalbumin alpha,42208,0.00109454653795778,0.0119348928474909,-0.0222978434431243,0.0244869365190398,0.926929967387434
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,F11,Coagulation factor XI,39822,0.000307475755702208,0.00336428361255821,-0.00628652012491189,0.0069014716363163,0.927181061351641
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TNFAIP8,Tumor necrosis factor alpha-induced protein 8,41913,0.000355549914365828,0.00392703567996596,-0.00734144001836745,0.0080525398470991,0.927860259496468
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PFDN2,Prefoldin subunit 2,41839,0.000531966555591797,0.00589799675713416,-0.0110281070883912,0.0120920401995748,0.928134061473796
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,NTproBNP,N-terminal prohormone of brain natriuretic peptide,42145,0.00105119465769145,0.0118155584306499,-0.0221072998663824,0.0242096891817653,0.929109460285526
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,KLK15,Kallikrein-15,39900,0.000499721985127708,0.00563941850962359,-0.0105535382937345,0.0115529822639899,0.929391583079919
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ITM2A,Integral membrane protein 2A,42119,-0.000573823849809703,0.00662068321000038,-0.0135503629414104,0.012402715241791,0.930933997887439
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SOX9,Transcription factor SOX-9,39649,0.00025199823275471,0.00296235516477493,-0.00555421789020416,0.00605821435571358,0.932209783099224
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TMEM132A,Transmembrane protein 132A,39638,0.000570929409939946,0.0067276198874901,-0.0126152055695407,0.0137570643894205,0.932371444238631
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SAG,S-arrestin,39586,-0.000470290378110051,0.00560966464012877,-0.0114652330727624,0.0105246523165423,0.933188560272608
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PLXDC1,Plexin domain-containing protein 1,41843,0.000286688628514632,0.00344071509868455,-0.00645711296490709,0.00703049022193636,0.933596451548708
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,GBA,Lysosomal acid glucosylceramidase,39649,0.000487145297612969,0.0059440197919315,-0.0111631334945728,0.0121374240897987,0.93468356015435
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CDC123,Cell division cycle protein 123 homolog,39560,0.000517041658758049,0.00672785987249901,-0.01266956369134,0.0137036470088561,0.938743611416009
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SULT1A1,Sulfotransferase 1A1,42249,-0.00104908266722184,0.0137174673356054,-0.0279353186450084,0.0258371533105647,0.939040041454147
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,EP300,Histone acetyltransferase p300,39657,0.000245504190343228,0.00330011518890211,-0.0062227215799049,0.00671372996059135,0.940699332658996
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,NRN1,Neuritin,39934,-0.000276697347195034,0.00373252896601797,-0.00759245412059026,0.00703905942620019,0.940907192045778
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,UNG,Uracil-DNA glycosylase,39919,0.000263150126248576,0.00377782250478846,-0.00714138198313681,0.00766768223563396,0.944468247019401
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,RPGR,X-linked retinitis pigmentosa GTPase regulator,39649,0.000301890382194774,0.00433664526456949,-0.00819793433636142,0.00880171510075097,0.944502307771532
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SCIN,Adseverin,39586,0.000528485574363232,0.00791660507226318,-0.0149880603672726,0.0160450315159991,0.946776695660987
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CD5L,CD5 antigen-like,39925,0.000316533859419525,0.00513645515115963,-0.00975091823685335,0.0103839859556924,0.950862584464879
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,PPP1R14D,Protein phosphatase 1 regulatory subunit 14D,39934,-0.000236938975503333,0.00407833924878231,-0.00823048390311666,0.00775660595210999,0.953672446750906
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,MOG,Myelin-oligodendrocyte glycoprotein,42262,-0.000195263696587655,0.00354940725767231,-0.00715210192162538,0.00676157452845007,0.956128876577397
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,IFIT1,Interferon-induced protein with tetratricopeptide repeats 1,39757,0.000294836265712706,0.00553476853541615,-0.0105533100637029,0.0111429825951284,0.957517859470181
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CDAN1,Codanin-1,39929,-0.000115153731170412,0.00234127824419379,-0.00470405908979025,0.00447375162744942,0.960773426214619
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TEF,Thyrotroph embryonic factor,39575,0.000221880636604895,0.00459319989808826,-0.00878079116364809,0.00922455243685787,0.961472987676844
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CDH23,Cadherin-23,39929,0.000137115876429151,0.00286605642736174,-0.00548035472119987,0.00575458647405817,0.961843561804719
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TMPRSS11B,Transmembrane protease serine 11B,39586,0.000387863538522746,0.00814418026753652,-0.0155747297858488,0.0163504568628943,0.962016271344535
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,DENND2B,DENN domain-containing protein 2B,39575,-0.000243724489992907,0.00525498193549216,-0.0105434890835575,0.0100560401035717,0.963008459345898
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,F2,Prothrombin,39979,7.36662124948695e-05,0.00159123113645499,-0.00304514681495692,0.00319247923994665,0.963075853196965
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TLR4,Toll-like receptor 4,39657,0.000140145130744812,0.00304263208786781,-0.00582341376147609,0.00610370402296572,0.963262867248821
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TAP1,Antigen peptide transporter 1,39757,-0.000286558889613188,0.00626305454568974,-0.0125621457991651,0.0119890280199387,0.963507257488268
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,BLOC1S2,Biogenesis of lysosome-related organelles complex 1 subunit 2,39586,-0.000365081966253292,0.00801743024166738,-0.0160792452399214,0.0153490813074148,0.963680882310762
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,RPA2,Replication protein A 32 kDa subunit,39657,0.00014652565028359,0.00331854225787074,-0.00635781717514306,0.00665086847571024,0.964782750003883
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,RASGRF1,Ras-specific guanine nucleotide-releasing factor 1,39560,0.000160125255050248,0.00471551438252936,-0.0090822829347073,0.0094025334448078,0.972911968142995
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CGA,Glycoprotein hormones alpha chain,42137,-0.000214209893963643,0.00660034251675115,-0.0131508812267959,0.0127224614388686,0.9741101905352
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,DPP10,Inactive dipeptidyl peptidase 10,42119,0.000124854509260312,0.00391345867173336,-0.00754552448733708,0.0077952335058577,0.974549176738933
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,SMPD3,Sphingomyelin phosphodiesterase 3,39657,0.000181936978047567,0.00611996680065771,-0.0118131979512415,0.0121770719073367,0.976284178080932
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ROBO4,Roundabout homolog 4,39638,5.62714785100408e-05,0.00195560207841203,-0.00377670859517755,0.00388925155219763,0.977044956058087
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ASGR2,Asialoglycoprotein receptor 2,39990,-7.60804205230809e-05,0.00283653400344689,-0.00563568706727899,0.00548352622623283,0.978602483717128
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CD109,CD109 antigen,42137,9.73991152212371e-05,0.003640344173374,-0.00703767546459181,0.00723247369503429,0.978655165566705
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CDH4,Cadherin-4,39586,0.000131596482512169,0.00499106671431247,-0.00965089427754028,0.00991408724256462,0.978965569263751
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,NEB,Nebulin,39575,-0.000106221964331234,0.00426876628910317,-0.00847300389097344,0.00826055996231097,0.98014831852747
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,ALMS1,Alstrom syndrome protein 1,39757,-0.000113888352118346,0.00476697766250591,-0.00945716457062993,0.00922938786639323,0.980939898662725
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,KDM3A,Lysine-specific demethylase 3A,39657,-0.00019494854954559,0.00950306001231039,-0.018820946173674,0.0184310490745828,0.983633481134492
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CNPY2,Protein canopy homolog 2,41900,-0.000114056373635664,0.00649597817926266,-0.0128461736049905,0.0126180608577192,0.98599172740146
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CNGB3,Cyclic nucleotide-gated cation channel beta-3,39586,9.80423825887924e-05,0.00577509854436138,-0.0112211507643595,0.0114172355295371,0.98645547518408
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CDH22,Cadherin-22,39757,-4.61757657812252e-05,0.00295921582132932,-0.0058462387755867,0.00575388724402425,0.987550549839814
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,FAM171B,Protein FAM171B,39919,-3.87215570384456e-05,0.00284795544166111,-0.00562071422269422,0.00554327110861733,0.98915232387579
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,BCAT2,"Branched-chain-amino-acid aminotransferase, mitochondrial",39586,-7.48093414343068e-05,0.00575604341802867,-0.0113566544407705,0.0112070357579019,0.989630693262993
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,AMDHD2,N-acetylglucosamine-6-phosphate deacetylase,39966,3.21867557445558e-05,0.00278797581239385,-0.00543224583654739,0.0054966193480365,0.990788951617635
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,FGF5,Fibroblast growth factor 5,41913,3.96488206972089e-05,0.00363189278784168,-0.00707886104347248,0.0071581586848669,0.991289952296301
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,LRTM1,Leucine-rich repeat and transmembrane domain-containing protein 1,39649,4.78136961989199e-05,0.0044801643572897,-0.00873330844408888,0.00882893583648672,0.991485084133567
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,CD33,Myeloid cell surface antigen CD33,42181,5.287867804802e-05,0.00847999998177366,-0.0165679212862284,0.0166736786423244,0.995024760517368
NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,TXK,Tyrosine-protein kinase TXK,39757,-1.3707656000936e-05,0.007860872449372,-0.0154210176567701,0.0153936023447682,0.998608694321826
